Publications Archive
A comprehensive online repository of publications from the CVC’s faculty, staff, and trainees. The publication archive can be filtered by both year and author.
Filter by Author:
Projecting the benefit of vericiguat in PARADIGM-HF and DAPA-HF populations: Insights from the VICTORIA trial.
Kittipibul V, Mentz RJ, Young R, Butler J, Ezekowitz JA, Lam CSP, Ponikowski P, Voors A, Corda S, McMullan C, O'Connor CM, Anstrom KJ, Armstrong PW; VICTORIA Study Group.
The Efficacy and Safety of Bisphosphonate Therapy for Osteopenia/Osteoporosis in Patients With Chronic Kidney Disease: A Systematic Review and Individual Patient-Level Meta-Analysis of Placebo-Controlled Randomized Trials.
Whitlock R, MacDonald K, Tangri N, Walsh M, Collister D.
Characterization of the literature informing health care of transgender and gender-diverse persons: A bibliometric analysis.
Pattar BSB, Gulamhusein N, Rytz CL, Turino Miranda K, Beach LB, Marshall Z, Collister D, Greene DN, Whitley CT, Saad N, Dumanski SM, Harrison TG, Peace L, Newbert AM, Ahmed SB.
Timeliness of reperfusion in ST-segment elevation myocardial infarction and outcomes in Kerala, India: results of the TRUST outcomes registry.
Mathew A, Moolla M, Jeemon P, Punnoose E, Ashraf SM, Pisharody S, Viswanathan S, Jayakumar TG, Jabir A, Mathew JP, John T, Thomas V, Bainey K.
Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia : A Target Trial Emulation Using MINT Trial Data.
Portela GT, Carson JL, Swanson SA, Alexander JH, Hébert PC, Goodman SG, Steg PG, Bertolet M, Strom JB, Fergusson DA, Simon T, White HD, Cooper HA, Abbott JD, Rao SV, Chaitman BR, Fordyce CB, Lopes RD, Daneault B, Brooks MM; MINT Investigators; MINT Investigators*.
Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up.
Sinnaeve PR, Welsh RC, Arias Mendoza A, Ristić AD, Averkov OV, Lambert Y, Kerr Saraiva JF, Sepulveda P, Rosell-Ortiz F, French JK, Musić LB, Vandenberghe K, Bogaerts K, Danays T, Bainey KR, Armstrong PW, Van de Werf F; STREAM-2 Investigators.
Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and Hyperkalemia.
Pitt B, Anker SD, Lund LH, Coats AJS, Filippatos G, Rossignol P, Weir MR, Friede T, Kosiborod MN, Metra M, Böhm M, Ezekowitz JA, Bayes-Genis A, Mentz RJ, Ponikowski P, Senni M, Piña IL, Pinto FJ, van der Meer P, Bahit C, Belohlavek J, Brugts JJ, Perrin A, Waechter S, Budden J, Butler J.
Pulmonary vascular structure and function are related to exercise capacity in health and COPD.
Collins SÉ, Kirby M, Smith BM, Tan W, Bourbeau J, Thompson S, van Diepen S, Jensen D, Stanojevic S, Stickland MK; CanCOLD Collaborative Research Group and the Canadian Respiratory Research Network.
A Multi-Specialty Delphi Consensus on Assessing and Managing Cardiopulmonary Risk in Patients with COPD.
Bhutani M, Bourbeau J, Goodman SG, Hawkins NM, Kaplan AG, Lin PJ, Penz ED, Verma S, Zieroth S.
Patiromer for Heart Failure Medication Optimization in Patients With Current or Past Hyperkalemia: DIAMOND Subanalysis.
Coats AJS, Anker SD, Lund LH, Filippatos G, Rossignol P, Pitt B, Weir MR, Kosiborod MN, Metra M, Böhm M, Ezekowitz JA, Bayes-Genis A, Mentz RJ, Ponikowski P, Senni M, Cleland JGF, Goudev A, Khintibidze I, Lindenfeld J, Merkely B, Waechter S, Budden J, Perrin A, Butler J.
International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial.
Ikemura N, Spertus JA, Nguyen D, Fu Z, Jones PG, Reynolds HR, Bangalore S, Bhargava B, Senior R, Elghamaz A, Goodman SG, Lopes RD, Pracoń R, López-Sendón J, Maggioni AP, Kohsaka S, Roth GA, White HD, Mavromatis K, Boden WE, Rodriguez F, Hochman JS, Maron DJ; ISCHEMIA Research Group.
Transcarotid transcatheter aortic valve replacement utilizing monitored anesthesia care: a case report.
El-Andari R, Kang JJ, Sidhu S, Cwinn M, Green J, Ma ML, Mathew A, Tyrrell BD, Welsh RC, Nagendran J.
Resilience and Renewal: Charting the Future of Cardiovascular Care in a Changing World.
Vranckx P, Morrow D, van Diepen S, Verbrugge FH.
Stress cardiomyopathy.
Motamed M, Nunes JT, Udell JA.
Should renin-angiotensin system inhibitors be stopped or not before non-cardiac surgery?
Halvorsen S, Vranckx P, van Diepen S.
Asundexian versus Apixaban in Patients with Atrial Fibrillation.
Piccini JP, Patel MR, Steffel J, Ferdinand K, Van Gelder IC, Russo AM, Ma CS, Goodman SG, Oldgren J, Hammett C, Lopes RD, Akao M, De Caterina R, Kirchhof P, Gorog DA, Hemels M, Rienstra M, Jones WS, Harrington J, Lip GYH, Ellis SJ, Rockhold FW, Neumann C, Alexander JH, Viethen T, Hung J, Coppolecchia R, Mundl H, Caso V; OCEANIC-AF Steering Committee and Investigators.
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome.
Zahger D, Schwartz GG, Du W, Szarek M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Jukema JW, Kiss RG, Harrington RA, Moriarty PM, Scemama M, Manvelian G, Pordy R, White HD, Zeiher AM, Fazio S, Geba GP, Steg PG; ODYSSEY OUTCOMES Investigators.
ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial.
Gibson CM, Chi G, Duffy D, Bahit MC, White H, Korjian S, Alexander JH, Lincoff AM, Anschuetz G, Girgis IG, Nicolau JC, Lopes RD, Cornel JH, Bainey KR, Libby P, Sacks FM, Ridker PM, Goodman SG, Mahaffey KW, Nicholls SJ, Pocock SJ, Mehran R, Harrington RA; AEGIS-II Committees and Investigators.
Hospital and Physician Variability in Revascularization Decisions and Outcomes for Patients With 3-Vessel and Left Main Coronary Artery Disease: A Population-Based Cohort Study.
Wilson T, James MT, Southern D, Har B, Graham MM, Brass N, Bainey K, Fedak PWM, Sajobi TT, Wilton SB.
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Henderson AD, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Abidin IZ, Alcocer-Gamba MA, Atherton JJ, Bauersachs J, Chang-Sheng M, Chiang CE, Chioncel O, Chopra V, Comin-Colet J, Filippatos G, Fonseca C, Gajos G, Goland S, Goncalvesova E, Kang S, Katova T, Kosiborod MN, Latkovskis G, Lee AP, Linssen GCM, Llamas-Esperón G, Mareev V, Martinez FA, Melenovský V, Merkely B, Nodari S, Petrie MC, Saldarriaga CI, Saraiva JFK, Sato N, Schou M, Sharma K, Troughton R, Udell JA, Ukkonen H, Vardeny O, Verma S, von Lewinski D, Voronkov L, Yilmaz MB, Zieroth S, Lay-Flurrie J, van Gameren I, Amarante F, Kolkhof P, Viswanathan P; FINEARTS-HF Committees and Investigators.
Embracing the Olympic Spirit: Pioneering Cardiac Care Insights from the 2024 European Society of Cardiology Scientific Meeting and More!
Vranckx P, Morrow D, van Diepen S, Verbrugge FH.
Proteomics Identify Clinical Phenotypes and Predict Functional Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF.
deFilippi CR, Shah P, Shah SJ, Alemayehu W, Lam CSP, Butler J, Roessig L, O'Connor CM, Westerhout CM, Armstrong PW; VITALITY-HFpEF Study Group.
Epidemiology of Cardiogenic Shock Using the Shock Academic Research Consortium (SHARC) Consensus Definitions.
Berg DD, Bohula EA, Patel SM, Alfonso CE, Alviar CL, Baird-Zars VM, Barnett CF, Barsness GW, Bennett CE, Chaudhry SP, Fordyce CB, Ghafghazi S, Gidwani UK, Goldfarb MJ, Katz JN, Menon V, Miller PE, Newby LK, Papolos AI, Park JG, Pierce MJ, Proudfoot AG, Sinha SS, Sridharan L, Thompson AD, van Diepen S, Morrow DA.
Clinical trial design, end-points, and emerging therapies in pulmonary arterial hypertension.
Weatherald J, Fleming TR, Wilkins MR, Cascino TM, Psotka MA, Zamanian R, Seeger W, Galiè N, Gomberg-Maitland M.
Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI: A 4-Way Comparison From AUGUSTUS.
Berwanger O, Wojdyla DM, Fanaroff AC, Budaj A, Granger CB, Mehran R, Aronson R, Windecker S, Goodman SG, Alexander JH, Lopes RD.
Empagliflozin and left atrial function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial.
Pourafkari M, Connelly KA, Verma S, Mazer CD, Teoh H, Quan A, Goodman SG, Rai A, Ng MY, Deva DP, Triverio P, Jiminez-Juan L, Yan AT, Ge Y.
Restrictive Versus Liberal Transfusion in Patients with Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the Myocardial Ischemia and Transfusion (MINT) Trial.
DeFilippis AP, Abbott JD, Herbert BM, Bertolet MH, Chaitman BR, White HD, Goldsweig AM, Polonsky TS, Gupta R, Alsweiler C, Silvain J, de Barros E Silva PGM, Hillis GS, Daneault B, Tessalee M, Menegus MA, Rao SV, Lopes RD, Hébert PC, Alexander JH, Brooks MM, Carson JL, Goodman SG; MINT Investigators.
Restrictive or Liberal Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: 6-Month Mortality in the MINT Trial.
Simon T, Herbert BM, Brooks MM, Goodman SG, Alexander JH, Steg PG, Lopes RD, Ghafghazi S, Bouleti C, Cooper HA, McCamant EL, Bainey KR, Aronow HD, Abbott JD, Alsweiler C, Bertolet M, Fergusson DA, Goldsweig AM, Hébert PC, Carson JL; MINT Trial Investigators.
Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial.
Gibson CM, Duffy D, Bahit MC, Chi G, White H, Korjian S, Alexander JH, Lincoff AM, Heise M, Kingwell BA, Nicolau JC, Lopes RD, Cornel JH, Lewis BS, Vinereanu D, Goodman SG, Bode C, Steg PG, Libby P, Sacks FM, Bainey KR, Ridker PM, Mahaffey KW, Aylward P, Nicholls SJ, Pocock SJ, Mehran R, Harrington RA; AEGIS-II Committees and Investigators.
In T2DM with CKD, semaglutide reduced major kidney disease events at 3 y.
Collister D, Pannu N.
Artificial Intelligence in Cardiovascular Medicine: From Clinical Care, Education, and Research Applications to Foundational Models-A Perspective.
Avram R, Dwivedi G, Kaul P, Manlhiot C, Tsang W.
Fostering diversity in clinical trials: need for evidence and implementation to improve representation.
Collister D, Song C, Ruzycki SM.
Current practices in the management of temporary mechanical circulatory support: A survey of CICU directors in North America.
Balgobind A, Pierce M, Alviar C, Barnett C, Barsness G, Chaudhry SP, Chonde M, Cooper H, Daniels L, Gidwani U, Fordyce C, Goldfarb M, Katz JN, Kontos M, Kwon Y, Liebner E, Liu S, Miller PE, Newby LK, O'Brien C, Papolos A, Pisani B, Potter B, Proudfoot A, Roswell RO, Sinha SS, Smith TD, Thompson AD, van Diepen S, Zakaria S, Morrow D, Villela MA.
Comparing Analytical Methods for Composite Endpoints in Clinical Trials: Insights from the Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) Trial.
Westerhout CM, Rathwell S, Anstrom KJ, Hernandez AF, Ponikowski P, Ezekowitz JA, Voors AA, Felker GM, Bakal JA, Blaustein RO, Nkulikiyinka R, O'Connor CM, Armstrong PW; VICTORIA Study Group.
Prevalence, Patient Awareness, Treatment, and Control of Hypertension in Canadian Adults With Common Comorbidities.
Leung AA, Williams JVA, Padwal RS, McAlister FA.
Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients With Heart Failure With or Without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized Trial.
Weir MR, Rossignol P, Pitt B, Lund LH, Coats AJS, Filippatos G, Perrin A, Waechter S, Budden J, Kosiborod M, Metra M, Boehm M, Ezekowitz JA, Bayes-Genis A, Mentz RJ, Ponikowski P, Senni M, Castro-Montes E, Nicolau JC, Parkhomenko A, Seferovic P, Cohen-Solal A, Anker SD, Butler J.
Glomerular filtration rate estimation in transgender adults using gender-affirming hormone therapy: an exploratory cross-sectional study.
Miranda KT, Dumanski SM, Saad N, Inker LA, White CA, Delanaye P, Collister D, Greene DN, Whitley CT, Harrison TG, Rytz CL, Peace L, Sola DY, Ahmed SB.
Cardiac Index in Comatose Survivors of Out-of-Hospital Cardiac Arrest.
Russo JJ, Boland P, Bernick J, Di Santo P, So DYF, Hibbert B, Fordyce CB, van Diepen S, Hassager C, Le May MR.
Care Gaps and System Issues With Delivering Cardiovascular Risk Reduction and Lipid-Lowering Therapy in Secondary Prevention.
Marquis-Gravel G, Bhatia S, Brown V, Goodman SG
Rationale and design of the multi organ inflammation with serial testing study: a comprehensive assessment of functional and structural abnormalities in patients with recovered COVID-19.
Paterson DI, White JA, Beaulieu C, Sherrington R, Prado CM, Tandon P, Halloran K, Smith S, McCombe JA, Ritchie B, Pituskin E, Haykowsky MJ, Coulden R, Emery D, Tsui AK, Wu KY, Oudit GY, Ezekowitz JA, Thompson RB.
Characteristics and Outcomes of Adults With Congenital Heart Disease in the Cardiac Intensive Care Unit.
Keane RR, Carnicelli AP, Loriaux DB, Kendsersky P, Krasuski RA, Brown KM, Arps K, Baird-Zars V, Dixson JA, Echols E, Granger CB, Harrison RW, Kontos M, Newby LK, Park JG, Shah KS, Ternus BW, Van Diepen S, Katz JN, Morrow DA.
What Guidelines Say About Risk Reduction: Major Data on the Link Between Lipid Lowering and Outcomes.
Thanassoulis G, Welsh RC, Hegele RA.
Biomarker profiles associated with reverse ventricular remodelling in patients with heart failure and a reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial
Tromp J, Lam CSP, Alemayehu W, de Filippi CR, Melenovský V, Sliwa K, Lopatin Y, Arango JL, Bahit MC, Roessig L, O'Connor CM, Shah P, Westerhout CM, Voors AA, Pieske B, Armstrong PW; VICTORIA Study Group.
eMPower: An online Mind-body wellness Program for adults living with chronic health conditions: A three-armed randomized controlled trial protocol.
Johnson E, Ismond K, Hyde A, Ezekowitz J, Wright G, Spiers J, Spence J, Thompson S, McNeely ML, Zheng Y, Round J, Tymchuk S, Lee-Baggley D, Isley S, Corrick S, Minckler H, Tandon P.
Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathy.
Gouda P, Liu Y, Butler J, Del Prato S, Ibrahim NE, Lam CSP, Marwick T, Rosenstock J, Tang W, Zannad F, Januzzi J, Ezekowitz J.
Sex Differences in Venous Thromboembolism after Covid-19 Infection: A Retrospective Population-based Matched Cohort Study.
Weatherald J, Wen C, Stickland MK, Damant R, Smith MP, Soril LJ, Zhang Z, D'Souza AG, Rennert-May E, Leal J, Lam GY.
Continuum of Preshock to Classic Cardiogenic Shock in the Critical Care Cardiology Trials Network Registry.
Patel SM, Berg DD, Bohula EA, Baird-Zars VM, Park JG, Barnett CF, Daniels LB, Fordyce CB, Ghafghazi S, Goldfarb MJ, Gorder K, Kwon Y, Leibner E, Menon V, Potter BJ, Prasad R, Solomon MA, Teuteberg JJ, Thompson AD, Zakaria S, Katz JN, van Diepen S, Morrow DA.
Stroke Risk Reduction in Atrial Fibrillation Through Pharmacist Prescribing: A Randomized Clinical Trial.
Sandhu RK, Fradette M, Lin M, Youngson E, Lau D, Bungard TJ, Tsuyuki RT, Dolovich L, Healey JS, McAlister FA.
Rethinking Composite Endpoints with the Win Ratio: A Breakthrough or Business as Usual?
Grubic N, Ezekowitz JA.
Is there a role for pre-hospital administration of potent antiplatelet therapy in STEMI?
Welsh RC.
Resource Utilization and Costs Associated With Cardiogenic Shock Complicating Myocardial Infarction: A Population-Based Cohort Study.
Parlow S, Fernando SM, Pugliese M, Qureshi D, Talarico R, Sterling LH, van Diepen S, Herridge MS, Price S, Brodie D, Fan E, McIsaac DI, Di Santo P, Jung RG, Slutsky AS, Scales DC, Combes A, Hibbert B, Thiele H, Tanuseputro P, Mathew R; LOTUS-ICU Research Group.
Global Collaborative Cardiovascular Research: The Collective Wisdom of Countries.
Armstrong PW.
Revolutionizing cardiac care: insights into shock prognosis, myocardial infarction management, and platelet inhibition
Vranckx P, Morrow D, van Diepen S, Verbrugge F.
Arterial hyperoxia and mortality in the cardiac intensive care unit.
Jentzer JC, van Diepen S, Alviar C, Miller PE, Metkus TS, Geller BJ, Kashani KB.
Effect of Qualifying Atherosclerotic Cardiovascular Disease Diagnosis Proximity on Cardiovascular Risk and Benefit of Empagliflozin in the EMPA-REG OUTCOME Trial.
Odutayo A, Zinman B, Wanner C, Zwiener I, Lund SS, Hantel S, Fitchett D, Udell JA; EMPA-REG OUTCOME Trial Investigators.
Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study.
Collister D, Pyne L, Bhasin AA, Smyth B, Herrington W, Jardine M, Mark PB, Badve S, Rossignol P, Dember LM, Wanner C, Ezekowitz J, Devereaux PJ, Parfrey P, Gansevoort R, Walsh M.
Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial.
Lopez J, Liu Y, Butler J, Del Prato S, Ezekowitz JA, Lam CSP, Marwick TH, Rosenstock J, Tang WHW, Perfetti R, Urbinati A, Zannad F, Januzzi JL Jr, Ibrahim NE.
Effect of Peripheral Interventions in Patients with Peripheral Artery Disease Receiving Rivaroxaban and Aspirin: Analyses from the XATOA Registry.
Debus ES, Aboyans V, Bosch J, Fox KAA, Patel MR, Welsh RC, Zeymer U, Gay A, Vogtländer K, Anand SS.
Diagnostic and Prognostic Models Based on Electrocardiograms for Rapid Clinical Applications.
Islam MS, Kalmady SV, Hindle A, Sandhu R, Sun W, Sepehrvand N, Greiner R, Kaul P.
Premature Acute Myocardial Infarction Treated with Invasive Revascularization: Comparing STEMI to NSTEMI in a Population-Based Study of Young Patients.
Roston TM, Aghanya V, Savu A, Fordyce CB, Lawler PR, Jentzer J, Wong GC, Brunham LR, Senaratne J, van Diepen S, Kaul P.
The Impact of an Accelerated Diagnostic Protocol Using Conventional Troponin I for Patients With Cardiac Chest Pain in the Emergency Department.
Hill J, Yang EH, Lefebvre D, Doran S, van Diepen S, Raizman JE, Tsui AKY, Rowe BH.
The impact of dialysate flow rate on haemodialysis adequacy: a systematic review and meta-analysis.
Iman Y, Bamforth R, Ewhrudjakpor R, Komenda P, Gorbe K, Whitlock R, Bohm C, Tangri N, Collister D.
Phenotypes in Pulmonary Hypertension.
Weatherald J, Hemnes AR, Maron BA, Mielniczuk LM, Gerges C, Price LC, Hoeper MM, Humbert M.
Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs.
Lincoff AM, Ray KK, Sasiela WJ, Haddad T, Nicholls SJ, Li N, Cho L, Mason D, Libby P, Goodman SG, Nissen SE.
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study.
Bittner VA, Schwartz GG, Bhatt DL, Chua T, De Silva HA, Diaz R, Goodman SG, Harrington RA, Jukema JW, McGinniss J, Pordy R, Garon G, Scemama M, White HD, Steg PG, Szarek M; ODYSSEY OUTCOMES Investigators.
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.
Chertow GM, Chang AM, Felker GM, Heise M, Velkoska E, Fellström B, Charytan DM, Clementi R, Gibson CM, Goodman SG, Jardine M, Levin A, Lokhnygina Y, Mears J, Mehran R, Stenvinkel P, Wang AY, Wheeler DC, Zoccali C, Ridker PM, Mahaffey KW, Tricoci P, Wolf M.
Rivaroxaban Versus Apixaban: A Comparison Without a Simple Solution.
Cohen M, Spyropoulos AC, Goodman SG, Spinler SA, Bonaca MP, Redling TM, Visveswaran G, Sohal S.
Editor’s Chronicles: Redefining Pathways in Acute Cardiac Care.
Vranckx P, Morrow D, van Diepen S, Verbrugge FH.
DIETARY SODIUM INTAKE AND OUTCOMES: A SECONDARY ANALYSIS FROM SODIUM-HF: Sodium Intake and Outcomes in Heart Failure.
Saldarriaga C, Colin-Ramirez E, Islam S, Alemayehu W, Macdonald P, Ross H, Escobedo J, Lanas F, Troughton RW, McAlister FA, Ezekowitz JA; SODIUM-HF investigators.
Moving the needle on proteasome inhibitor-induced pulmonary arterial hypertension: a definite maybe.
Budhram B, Zamanian RT, Weatherald J.
Strategies to Reduce CICU Critical Illness-Related Complications: Adding Information to an (Almost) Evidence-Free Zone.
van Diepen S, Lawler PR, Fordyce CB.
Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA Trial.
Khan MS, Butler J, Young R, Lewis BS, Escobedo J, Refsgaard J, Reyes E, Roessig L, Blaustein RO, Lam CSP, Voors AA, Ponikowski P, Anstrom KJ, Armstrong PW; VICTORIA Study Group.
Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART-FID.
Nouhravesh N, Garg J, Rockhold FW, De Pasquale CG, O'Meara E, Lewis GD, Butler J, Harrington J, Ezekowitz JA, Ponikowski P, Troughton RW, Wong YW, Blackman N, Numan S, Adamczyk R, Hernandez AF, Mentz RJ.
Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials.
Verma S, Butler J, Borlaug BA, Davies M, Kitzman DW, Shah SJ, Petrie MC, Barros E, Rönnbäck C, Vestergaard LS, Schou M, Ezekowitz JA, Sharma K, Patel S, Chinnakondepalli KM, Kosiborod MN; STEP-HFpEF Trial Committees and Investigators.
Sex Differences in Characteristics, Resource Utilization, and Outcomes of Cardiogenic Shock: Data From the Critical Care Cardiology Trials Network (CCCTN) Registry.
Daniels LB, Phreaner N, Berg DD, Bohula EA, Chaudhry SP, Fordyce CB, Goldfarb MJ, Katz JN, Kenigsberg BB, Lawler PR, Martillo Correa MA, Papolos AI, Roswell RO, Sinha SS, van Diepen S, Park JG, Morrow DA; Critical Care Cardiology Trials Network Investigators.
Risk Assessment in Immediate Versus Delayed Angiography after Out-of-Hospital Cardiac Arrest Without ST Segment Elevation Decisions.
van Diepen S, Le May MR, Alfaro P, Goldfarb MJ, Luk A, Mathew R, Peretz-Larochelle M, Rayner-Hartley E, Russo JJ, Senaratne JM, Ainsworth C, Belley-Côté E, Fordyce CB, Kromm J, Overgaard CB, Schnell G, Wong GC.
Temporal and spatial progression of microstructural cerebral degeneration in ALS: A multicentre longitudinal diffusion tensor imaging study.
Müller HP, Abrahao A, Beaulieu C, Benatar M, Dionne A, Genge A, Frayne R, Graham SJ, Gibson S, Korngut L, Luk C, Welsh RC, Zinman L, Kassubek J, Kalra S.
Influence of hypercapnia and hypercapnic hypoxia on the heart rate response to apnea.
O'Croinin BR, Young DA, Maier LE, van Diepen S, Day TA, Steinback CD.
Expert opinions for refractory cardiac arrest: Double Sequential External Defibrillation, Vector Change, and eCPR.
van Diepen S, Le May MR, Alfaro P, Goldfarb MJ, Luk A, Mathew R, Peretz-Larochelle M, Rayner-Hartley E, Russo JJ, Senaratne JM, Ainsworth C, Belley-Côté E, Fordyce CB, Kromm J, Overgaard CB, Schnell G, Wong GC.
Antithrombotic Strategies According to Age: Insights From the AUGUSTUS Trial.
Guimarães PO, Lopes RD, Wojdyla DM, Alexander JH, Goodman SG, Aronson R, Halvorsen S, Sinnaeve P, Vinereanu D, Storey RF, Berwanger O, Windecker S, Mehran R, Granger CB, Alexander KP; AUGUSTUS Investigators.
Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease: A Secondary Analysis of the INVESTED Randomized Clinical Trial.
Peikert A, Claggett BL, Udell JA, Joseph J, Hegde SM, Kim K, Mao L, Wang T, Havighurst TC, Farkouh ME, Bhatt DL, Tattersall MC, Cooper LS, Solomon SD, Vardeny O.
Role of Artificial Intelligence in Improving Syncope Management.
Thiruganasambandamoorthy V, Probst M, Poterucha TJ, Sandhu RK, Toarta C, Raj SR, Sheldon R, Rahgozar A, Grant L.
Association of Glomerular Filtration Rate Decline With Clinical Outcomes in a Population With Type 2 Diabetes.
Klarenbach SW, Collister D, Wiebe N, Bello A, Thompson S, Pannu N.
COVID-19 Pandemic on COPD Healthcare Utilization, Exacerbations and Mortality: A Population Study.
Lam GY, Wen C, Ronksley PE, Bakal JA, Bhutani M, Soril LJJ, Stickland MK, Gross DP, Weatherald J.
The clinical impact of heart failure with preserved ejection fraction in interstitial lung diseases.
Zanini U, Ferrara G, Moitra S, Varughese R, Kalluri M, Weatherald J.
Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program.
Petrie MC, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Shah SJ, Verma S, Jensen TJ, Einfeldt MN, Liisberg K, Perna E, Sharma K, Ezekowitz JA, Fu M, Melenovský V, Ito H, Lelonek M, Kosiborod MN; STEP-HFpEF Trial Committees and Investigators.
Schrodinger’s Shock: Confronting Uncertainty and Fatalism in Cardiogenic Shock Trials.
Higgins A, Gage A, van Diepen S, Katz JN.
Intravascular imaging in the diagnosis and management of patients with suspected intracoronary pathologies: A CJC White Paper.
• Sibbald M, Cioffi GM, Shenouda M, McGrath B, Elbarouni B, Har B, Akl E, Schampaert E, Bishop H, Minhas KK, Elkhateeb O, Pinilla-Echeverri N, Sheth T, Bainey K, Cantor WJ, Cohen E, Hubacek J, Kalra S, Lavoie AJ, Mansour S, Wijeysundera HC.
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis.
Harrington J, Hellkamp AS, Mahaffey KW, Breithardt G, Halperin JL, Hankey GJ, Becker RC, Nessel CC, Berkowitz SD, Fox KAA, Singer DE, Goodman SG, Patel MR, Piccini JP.
New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices.
Stewart DJ, Bradford JP, Sehdev S, Ramsay T, Navani V, Rawson NSB, Jiang DM, Gotfrit J, Wheatley-Price P, Liu G, Kaplan A, Spadafora S, Goodman SG, Auer RAC, Batist G.
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.
Chertow GM, Chang AM, Felker GM, Heise M, Velkoska E, Fellström B, Charytan DM, Clementi R, Gibson CM, Goodman SG, Jardine M, Levin A, Lokhnygina Y, Mears J, Mehran R, Stenvinkel P, Wang A, Wheeler DC, Zoccali C, Ridker PM, Mahaffey KW, Tricoci P, Wolf M.
Development and validation of machine learning algorithms based on electrocardiograms for cardiovascular diagnoses at the population level.
Kalmady SV, Salimi A, Sun W, Sepehrvand N, Nademi Y, Bainey K, Ezekowitz J, Hindle A, McAlister F, Greiner R, Sandhu R, Kaul P.
Diabetic retinopathy screening integrated in a multidisciplinary diabetes care clinic: a pilot project.
Lytvyn Y, Felfeli T, Dubrofsky L, Dharia A, Lee JF, Sutakovic O, Nash C, Oliver T, Ong SW, Udell JA, Farkouh ME, Lawler PR, Weisman A, Lovshin JA, Cherney DZI, Brent MH.
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis.
Usman MS, Bhatt DL, Hameed I, Anker SD, Cheng AYY, Hernandez AF, Jones WS, Khan MS, Petrie MC, Udell JA, Friede T, Butler J.
Unveiling new horizons: revolutionary insights into acute myocarditis and optimal mechanical circulatory support timing.
Vranckx P, Morrow D, van Diepen S, Verbrugge F.
Outrunning the grim reaper: longevity of the first 200 sub-4 min mile male runners.
Foulkes S, Hewitt D, Skow R, Dover D, Kaul P, La Gerche A, Haykowsky M.
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial.
Solomon SD, Ostrominski JW, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Abidin IZ, Alcocer-Gamba MA, Atherton JJ, Bauersachs J, Ma CS, Chiang CE, Chioncel O, Chopra V, Comin-Colet J, Filippatos G, Fonseca C, Gajos G, Goland S, Goncalvesová E, Kang SM, Katova T, Kosiborod MN, Latkovskis G, Lee AP, Linssen GCM, Llamas-Esperón G, Mareev V, Martinez FA, Melenovský V, Merkely B, Nodari S, Petrie MC, Saldarriaga CI, Saraiva JFK, Sato N, Schou M, Sharma K, Troughton R, Udell JA, Ukkonen H, Vardeny O, Verma S, von Lewinski D, Voronkov LG, Yilmaz MB, Zieroth S, Lay-Flurrie J, van Gameren I, Amarante F, Viswanathan P, McMurray JJV.
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI.
Povsic TJ, Korjian S, Bahit MC, Chi G, Duffy D, Alexander JH, Vinereanu D, Tricoci P, Mears SJ, Deckelbaum LI, Bonaca M, Ridker PM, Goodman SG, Cornel JH, Lewis BS, Parkhomenko A, Lopes RD, Aylward P, Lincoff AM, Heise M, Sacks F, Nicolau JC, Merkely B, Trebacz J, Libby P, Nicholls SJ, Pocock S, Bhatt DL, Kastelein J, Bode C, Mahaffey KW, Steg PG, Tendera M, Bainey KR, Harrington RA, Mehran R, Duerschmied D, Kingwell BA, Gibson CM; AEGIS-II Committees and Investigators.
Ambulatory Cardiology or General Internal Medicine Assessment Prior to Scheduled Major Vascular Surgery is Associated with Improved Outcomes.
de Mestral C, Abdel-Qadir HM, Austin PC, Chong AS, McAlister FA, Lindsay TF, Ross HJ, Oreopoulos G, Wijeysundera DN, Lee DS.
Mental health sequelae in survivors of cardiogenic shock complicating myocardial infarction. A population-based cohort study.
Fernando SM, Qureshi D, Talarico R, Vigod SN, McIsaac DI, Sterling LH, van Diepen S, Price S, Di Santo P, Kyeremanteng K, Fan E, Needham DM, Brodie D, Bienvenu OJ, Combes A, Slutsky AS, Scales DC, Herridge MS, Thiele H, Hibbert B, Tanuseputro P, Mathew R.
Acute cardiovascular and intensive care chronicles: Crossing New Frontiers in Advanced Cardiovascular Therapeutics.
Vranckx P, Morrow D, van Diepen S, Verbrugge F.
Pathways for Diagnosing and Treating CKD-Associated Pruritus: A Narrative Review.
Rigatto C, Collister D, Granger-Vallée A, Girard L, Hingwala J, Karaboyas A, Levin A, McFarlane P, Pisoni R, Prasad B, Proulx N, Schwartz D, Sood M, Suri R, Tennankore K.
Safety Of The Pcsk9 Inhibitor Alirocumab: insights From 47,296 Patient-Years Of Observation.
Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Manvelian G, Pordy R, Poulouin Y, Stipek W, Garon G, Schwartz GG.
Increased Virtual Visits to Physicians During the COVID-19 Pandemic and Estimated Impact on Physician Compensation: The Case of Lung and Colorectal Cancers, Chronic Obstructive Pulmonary Diseases, and Heart Failure in Alberta, Canada.
Thanh NX, Waye A, Stewart D, Weatherald J, Lam GY, Stickland MK, Hill MD, Choy J, Chuck AW, Wasylak T.
Potent P2Y12 Inhibitor Selection and De-escalation Strategies in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: Systematic Review and Meta-analysis.
Boivin-Proulx LA, Bainey KR, Marquis-Gravel G, Graham MM.
Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease With Recent or Remote Events: Systematic Review and Meta-analysis.
Hayek A, MacDonald BJ, Marquis-Gravel G, Bainey KR, Mansour S, Ackman ML, Cantor WJ, Turgeon RD.
Uptake of SGLT2i and Outcomes in Patients with Diabetes and Heart Failure: A Population-Based Cohort and a Specialized Clinic Cohort.
Gagnon LR, Hazra D, Perera K, Wang K, Kashyap N, Sadasivan C, Youngson E, Chu L, Dover DC, Kaul P, Simpson S, Bello A, McAlister FA, Oudit GY.
Time to SGLT2 Inhibitors Initiation in Patients With Heart Failure.
Moon J, Udell JA, Chong A, Fang J, Austin PC, Ko DT, Stukel TA, Atzema CL, Booth GL, Tu K, Naimark DMJ, Jackevicius CA.
Association Between Hemoglobin A1c and Development of Cardiovascular Disease in Canadian Men and Women Without Diabetes at Baseline: A Population-Based Study of 608 474 Adults.
Butalia S, Chu LM, Dover DC, Lau D, Yeung RO, Eurich DT, Senior P, Kaul P.
Increased frequency and mortality in persons with neurological disorders during COVID-19.
Marsters CM, Bakal JA, Lam GY, McAlister FA, Power C.
Outcomes of management strategies in patients with prior coronary artery bypass grafting presenting with an acute coronary syndrome.
Gouda P, Islam S, Dover DC, Kaul P, Bainey KR, Welsh RC.
Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Clinical Practice Update on Optimal Post Cardiac Arrest and Refractory Cardiac Arrest Patient Care.
van Diepen S, Le May MR, Alfaro P, Goldfarb MJ, Luk A, Mathew R, Peretz-Larochelle M, Rayner-Hartley E, Russo JJ, Senaratne JM, Ainsworth C, Belley-Côté E, Fordyce CB, Kromm J, Overgaard CB, Schnell G, Wong GC.
The REDUCE-AMI trial: An important step in cardiovascular drug de-prescription.
van Diepen S, Halvorsen S, Menon V.
Deep learning evaluation of echocardiograms to identify occult atrial fibrillation.
Yuan N, Stein NR, Duffy G, Sandhu RK, Chugh SS, Chen PS, Rosenberg C, Albert CM, Cheng S, Siegel RJ, Ouyang D.
Relationships Between Measures of the Physical Activity-Related Built Environment and Excess Weight in Preschoolers: A Retrospective, Population-Level Cohort Study.
Wijesundera J, Ball GDC, Wray AJ, Gilliland J, Savu A, Dover DC, Haqq AM, Kaul P.
Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy.
Januzzi JL Jr, Butler J, Del Prato S, Ezekowitz JA, Ibrahim NE, Lam CSP, Lewis GD, Marwick TH, Perfetti R, Rosenstock J, Solomon SD, Tang WHW, Zannad F.
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstrøm SZ, Davies MJ, Hovingh GK, Kitzman DW, Møller DV, Verma S, Einfeldt MN, Lindegaard ML, Rasmussen S, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Melenovský V, Merkely B, Núñez J, Perna E, Schou M, Senni M, Sharma K, van der Meer P, Von Lewinski D, Wolf D, Kosiborod MN; STEP-HFpEF Trial Committees and Investigators.
Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC.
Mullens W, Damman K, Dhont S, Banerjee D, Bayes-Genis A, Cannata A, Chioncel O, Cikes M, Ezekowitz J, Flammer AJ, Martens P, Mebazaa A, Mentz RJ, Miró Ò, Moura B, Nunez J, Ter Maaten JM, Testani J, van Kimmenade R, Verbrugge FH, Metra M, Rosano GMC, Filippatos G.
Impact of the method of calculating 30-day readmission rate after hospitalization for heart failure. Data from the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry.
Salimian S, Virani SA, Roston TM, Yao RJR, Turgeon RD, Ezekowitz J, Hawkins NM.
Global trends in chronic kidney disease-related mortality: a systematic review protocol.
Tungsanga S, Ghimire A, Hariramani VK, Abdulrahman A, Khan AS, Ye F, Kung JY, Klarenbach S, Thompson S, Collister D, Srisawat N, Okpechi IG, Bello AK.
Association between Serum Estradiol and Cardiovascular Health among Transgender Adults Using Gender-Affirming Estrogen Therapy.
Rytz CL, Turino Miranda K, Ronksley PE, Saad N, Raj SR, Somayaji R, Dumanski SM, Ganshorn H, Greene DN, Collister D, Newbert AM, Peace L, Ahmed SB
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
Gibson CM, Duffy D, Korjian S, Bahit MC, Chi G, Alexander JH, Lincoff AM, Heise M, Tricoci P, Deckelbaum LI, Mears SJ, Nicolau JC, Lopes RD, Merkely B, Lewis BS, Cornel JH, Trebacz J, Parkhomenko A, Libby P, Sacks FM, Povsic TJ, Bonaca M, Goodman SG, Bhatt DL, Tendera M, Steg PG, Ridker PM, Aylward P, Kastelein JJP, Bode C, Mahaffey KW, Nicholls SJ, Pocock SJ, Mehran R, Harrington RA; AEGIS-II Committees and Investigators.
Utilizing Quality of Life Adjusted Days Alive and Out of Hospital in Heart Failure Clinical Trials.
Gouda P, Rathwell S, Colin-Ramirez E, Felker GM, Ross H, Escobedo J, Macdonald P, Troughton RW, O'Connor CM, Ezekowitz JA.
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
Kosiborod MN, Petrie MC, Borlaug BA, Butler J, Davies MJ, Hovingh GK, Kitzman DW, Møller DV, Treppendahl MB, Verma S, Jensen TJ, Liisberg K, Lindegaard ML, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Melenovský V, Merkely B, Núñez J, Perna E, Schou M, Senni M, Sharma K, van der Meer P, Von Lewinski D, Wolf D, Shah SJ; STEP-HFpEF DM Trial Committees and Investigators.
Evaluating Readability, Understandability, and Actionability of Online Printable Patient Education Materials for Cholesterol Management: A Systematic Review.
Bhatt C, Lin E, Ferreira-Legere LE, Jackevicius CA, Ko DT, Lee DS, Schade K, Johnston S, Anderson TJ, Udell JA.
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
Hernandez AF, Udell JA, Jones WS, Anker SD, Petrie MC, Harrington J, Mattheus M, Seide S, Zwiener I, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, Figtree G, Ge J, Goodman S, Gotcheva N, Goto S, Gasior T, Jamal W, Januzzi JL, Jeong MH, Lopatin Y, Lopes RD, Merkely B, Parikh PB, Parkhomenko A, Ponikowski P, Rossello X, Schou M, Simic D, Steg PG, Szachniewicz J, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Butler J.
Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease: A Secondary Analysis of the INVESTED Randomized Clinical Trial
Peikert A, Claggett BL, Udell JA, Joseph J, Hegde SM, Kim K, Mao L, Wang T, Havighurst TC, Farkouh ME, Bhatt DL, Tattersall MC, Cooper LS, Solomon SD, Vardeny O.
Empagliflozin after Acute Myocardial Infarction.
Butler J, Jones WS, Udell JA, Anker SD, Petrie MC, Harrington J, Mattheus M, Zwiener I, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, Figtree G, Ge J, Goodman SG, Gotcheva N, Goto S, Gasior T, Jamal W, Januzzi JL, Jeong MH, Lopatin Y, Lopes RD, Merkely B, Parikh PB, Parkhomenko A, Ponikowski P, Rossello X, Schou M, Simic D, Steg PG, Szachniewicz J, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF.
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.
Udell JA, Petrie MC, Jones WS, Anker SD, Harrington J, Mattheus M, Seide S, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, Figtree G, Ge J, Goodman SG, Gotcheva N, Goto S, Gasior T, Jamal W, Januzzi JL, Jeong MH, Lopatin Y, Lopes RD, Merkely B, Martinez-Traba M, Parikh PB, Parkhomenko A, Ponikowski P, Rossello X, Schou M, Simic D, Steg PG, Szachniewicz J, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF, Butler J.
Iron Deficiency, Anemia, and Iron Supplementation in Patients With Heart Failure: A Population-Level Study.
Wahid M, Islam S, Sepehrvand N, Dover DC, McAlister FA, Kaul P, Ezekowitz JA.
The Evolving Role of Electroencephalography in Post Arrest Care.
Bencsik C, Josephson C, Soo A, Ainsworth C, Savard M, van Diepen S, Kramer A, Kromm J.
Early Serial Assessment of Aggregate Vasoactive Support and Mortality in Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry.
Patel SM, Berg DD, Bohula EA, Baird-Zars VM, Barsness GW, Chaudhry SP, Chonde MD, Cooper HA, Ginder C, Jentzer JC, Kontos MC, Miller PE, Newby LK, O'Brien CG, Park JG, Pierce MJ, Pisani BA, Potter BJ, Shah KS, Teuteberg JJ, Katz JN, van Diepen S, Morrow DA.
Applicability and impact of the COMPASS trial in a Canadian population of patients with atherosclerotic disease.
Welsh RC, Gouda P, Dover D, Bainey KR, McAlister FA, Kaul P.
Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death: Insights from the AEGIS-II Trial.
Povsic TJ, Korjian S, Bahit MC, Chi G, Duffy D, Alexander JH, Vinereanu D, Tricoci P, Mears SJ, Deckelbaum LI, Bonaca M, Ridker PM, Goodman SG, Cornel JH, Lewis BS, Parkhomenko A, Lopes RD, Aylward P, Lincoff AM, Heise M, Sacks F, Nicolau JC, Merkely B, Trebacz J, Libby P, Nicholls SJ, Pocock S, Bhatt DL, Kastelein J, Bode C, Mahaffey KW, Steg PG, Tendera M, Bainey KR, Harrington RA, Mehran R, Duerschmied D, Kingwell BA, Gibson CM; AEGIS-II Committees and Investigators(∗∗).
Real-World Use and Outcomes of Sodium Glucose Cotransporter 2 Inhibitors in Adults with Diabetes and Heart Failure: A Population Level Cohort Study in Alberta, Canada.
Butalia S, Wen C, Sigal R, Senior P, Quan H, Chu LM, Yeung RO, Kaul P.
Acute cardiac and intensive care chronicles: navigating the intersection of cardiovascular health, recreational drug use, and beyond!
Vranckx P, Morrow D, Van Diepen S, Verbrugge F.
Propofol vs etomidate for induction prior to invasive mechanical ventilation in patients with acute myocardial infarction.
Thomas A, Banna S, Shahu A, Ali T, Schenck C, Patel B, Notarianni A, Phommalinh M, Kochar A, Heck C, van Diepen S, Miller PE.
The Association Between Intradialytic Symptom Clusters and Recovery Time in Patients Undergoing Maintenance Hemodialysis: An Exploratory Analysis.
Bhasin AA, MacRae JM, Manns B, Leung KCW, Molnar AO, Busse JW, Collister D, Brimble KS, Rabbat CG, Tyrwhitt J, Mazzetti A, Walsh M.
Impact of a Medical Fitness Model on Incident Major Adverse Cardiovascular Events: A Prospective Cohort Study of 11 000 Members.
Brar R, Whitlock RH, Katz A, Di Nella M, Komenda P, Bohm C, Rigatto C, Tangri N, Solmundson C, Collister D.
Canadian Cost-Effectiveness of Coronary Artery Calcium Screening Based on the Multi-Ethnic Study of Atherosclerosis.
Qureshi H, Kaul P, Dover DC, Blaha MJ, Bellows BK, Mancini GBJ.
Feasibility and Findings of Including Self-Identified Adult Congenital Heart Disease Patients in the INVESTED Trial.
Dehghani P, Srivatsav V, Vardeny O, Grewal J, Opotowsky AR, Muhll IV, Keir M, Ducas R, Singh J, Kim KM, Joseph J, Aboulhosn J, Havighurst T, Hegde SM, Bhatt DL, Solomon S, Farkouh M, Goodman SG, Moe TG, Udell JA.
Pulmonary Artery Diastolic Pressure as a Surrogate for Pulmonary Capillary Wedge Pressure in Cardiogenic Shock.
Papolos AI, Kenigsberg BB, Singam NSV, Berg DD, Guo J, Bohula EA, Katz JN, van Diepen S, Morrow DA; Critical Care Cardiology Trials Network Investigators.
Frailty in the Cardiac Intensive Care Unit: Assessment and Impact.
Moumneh MB, Jamil Y, Kalra K, Ijaz N, Campbell G, Kochar A, Nanna MG, van Diepen S, Damluji AA.
Cardiovascular pathology, inheritance and prognosis in a familial cohort of Loeys-Dietz type III.
Kay RT, Gouda P, Welsh RC.
Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study.
Weatherald J, Nathan SD, El-Kersh K, Argula RG, DuBrock HM, Rischard FP, Cassady SJ, Tarver J, Levine DJ, Tapson VF, Deng C, Shen E, Das M, Waxman AB.
Health Canada advisory impacts on the prevalence of oral codeine use in the Pediatric Canadian population: comparative study across provinces.
Sheehy O, Eltonsy S, Hawken S, Walker M, Kaul P, Winquist B, Barrett O, Savu A, Dragan R, Pugliese M, Bernatsky S, Gorgui J, Bérard A.
Comparison of Change in Lipoprotein(a) Mass and Molar Concentrations by Alirocumab and Risk of Subsequent Cardiovascular Events in ODYSSEY OUTCOMES.
Szarek M, Reijnders E, Steg PG, Jukema JW, Schwertfeger M, Bhatt DL, Bittner VA, Diaz R, Fazio S, Garon G, Goodman SG, Harrington RA, White HD, Zeiher AM, Cobbaert C, Schwartz GG.
Constructing the Framework for Disease Modification in Pulmonary Arterial Hypertension.
Zamanian RT, Weatherald J, Sweatt AJ, Hemnes A, Rashid M, Psotka MA, Bogaard HJ, de Jesus Perez V.
Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis.
Budhram B, Weatherald J, Humbert M.
Targeted Coaching to Improve Osteoporosis Therapy Adherence: A Single Arm Variation of the C-STOP Study.
Ye C, McAlister FA, Bellerose D, Lin M.
Sex Differences in High-Cost Users of Healthcare for Atrial Fibrillation.
Sandhu RK, Qureshi H, Halperin H, Dover DC, Klassen N, Hawkins NM, Andrade JG, Kaul P.
A Holistic Framework for the Evaluation of Kidney Function in a Gender-Diverse Landscape.
Miranda KT, Greene DN, Collister D, Krasowski MD, Ahmed SB, Cirrincione LR, Rosas SE, Saad N, Pierre CC.
“HFpEF and Sex: Understanding the Role of Sex Differences”.
Smereka Y, Ezekowitz JA.
Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial.
Ezekowitz J, Alemayehu W, Edelmann F, Ponikowski P, Lam CSP, O'Connor CM, Butler J, Corda S, McMullan CJ, Westerhout CM, Voors AA, Mentz RJ, Armstrong PW; VICTORIA Study Group.
Treatments for pulmonary arterial hypertension: navigating through a network of choices.
Pitre T, Weatherald J, Humbert M.
POINT: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? Yes.
Weatherald J, Sitbon O.
Rebuttal From Drs Weatherald and Sitbon.
Weatherald J, Sitbon O.
“I Had to Know About It, I Had to Find It, I Had to Know How to Access it”: Experiences of Access to Rehabilitation Services Among People Living with Long COVID.
Hung P, Brehon K, Miciak M, Brown DA, Bostick G, Brown C, Churchill K, Hall M, Hoddinott L, Hudon A, Hunter S, Perreault K, Wieler M, Skolnik K, Lam GY, Weatherald J, Gross DP.
Randomized Trial Of Routine Versus On-demand Intraoperative Extracorporeal Membrane Oxygenation In Lung Transplantation: A Feasibility Study.
Nasir B, Weatherald J, Ramsay T, Cypel M, Donahoe L, Durkin C, Schisler T, Nagendran J, Liberman M, Landry C, Overbeek C, Moore A, Ferraro P.
Targeting the Natriuretic Peptide System to Improve Outcomes: PARADISE Lost or Found.
Udell JA, Armstrong DWJ.
Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics.
Goodman SG, Roy D, Pollack CV Jr, Leblanc K, Kwaku KF, Barnes GD, Bonaca MP, True Hills M, Campello E, Fanikos J, Connors JM, Weitz JI.
March 2024 issue of the European Heart Journal Acute Cardiovascular Care.
Vranckx P, Morrow D, Van Diepen S, Verbrugge FH.
Vascular health after assisted reproduction: A stroke of bad luck?
Dayan N, Udell JA.
Response by Van de Werf et al to Letter Regarding Article, “STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial”.
Van de Werf F, Sinnaeve P, Welsh RC, Armstrong PW.
Variation in risk-adjusted Cardiac Intensive Care Unit (CICU) length of stay and the association with in-hospital mortality: an analysis from the Critical Care Cardiology Trials Network (CCCTN) registry.
Koerber DM, Katz JN, Bohula E, Park JG, Dodson MW, Gerber DA, Hillerson D, Liu S, Pierce MJ, Prasad R, Rose SW, Sanchez PA, Shaw J, Wang J, Jentzer JC, Kristin Newby L, Daniels LB, Morrow DA, van Diepen S.
Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction.
Mentz RJ, Stebbins A, Butler J, Chiang CE, Ezekowitz JA, Hernandez AF, Hilkert R, Lam CSP, McDonald K, O'Connor CM, Pieske B, Ponikowski P, Roessig L, Sweitzer NK, Voors AA, Anstrom KJ, Armstrong PW; VICTORIA Study Group.
Generative Data by β-Variational Autoencoders Help Build Stronger Classifiers: ECG Use Case
Nademi Y, Kalmady SV, Sun W, Salimi A, Hindle A, Kaul P, Greiner R.
Supervised Electrocardiogram(ECG) Features Outperform Knowledge-based And Unsupervised Features In Individualized Survival Prediction.
Nademi Y, Kalmady SV, Sun W, Qi S, Hindle A, Kaul P, Greiner R.
Editors’ perspective.
Vranckx P, Morrow D, Van Diepen S, Verbrugge F.
Care Fragmentation After Hospital Discharge: Often Ignored, But Important.
McAlister FA.
Emergency Visits or Hospitalizations for Cardiovascular Diagnoses in the Post-Acute Phase of COVID-19.
McAlister FA, Nabipoor M, Wang T, Bakal JA.
Liberation From Mechanical Ventilation in the Cardiac Intensive Care Unit.
Shahu A, Banna S, Applefeld W, Rampersad P, Alviar CL, Ali T, Luk A, Fajardo E, van Diepen S, Miller PE.
Presentation and Outcomes of Patients With Preoperative Critical Illness Undergoing Cardiac Surgery.
Metkus TS, Alviar CL, Baird-Zars VM, Barsness GW, Berg DD, Bohula EA, Burke JA, Fordyce CB, Guo J, Katz JN, Keeley EC, Menon V, Miller PE, O'Brien CG, Sinha SS, So D, Ternus BW, Vadhar S, van Diepen S, Morrow DA.
Admission Total Leukocyte Count as a Predictor of Mortality in Cardiac Intensive Care Unit Patients.
Smith RJ, Sarma D, Padkins MR, Gajic O, Lawler PR, Van Diepen S, Kashani KB, Jentzer JC.
SGLT2 Inhibitors Squeak Out a Win in Patients Post-MI.
Udell JA.
Myocardial ischaemia and transfusion trial: a glimmer in the fog.
Menon V, van Diepen S.
Proteome-Wide Changes in Blood Biomarkers During Hemodialysis.
Lanktree MB, Collister D, Pigyere M, Mazzetti A, Paré G, Walsh M.
Reperfusion in Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock and Prolonged Interhospital Transport Times.
van Diepen S, Zheng Y, Senaratne JM, Tyrrell BD, Das D, Thiele H, Henry TD, Bainey KR, Welsh RC.
Heart Rhythm Society Quality Improvement Committee update.
Deering TF, Catanzaro JN, Sandhu RK, Singleton M, Das S, Deyell MW, Mulpuru SK, Magnelli-Reyes CL, Koplan BA, Vergara GR, Austin C, Assis FR, Xiang K, Moore M, Smith AM.
Optimizing post-acute coronary syndrome (ACS) dyslipidemia management: Insights from the North American Acute Coronary Syndrome ACS Reflective III.
Alanezi M, Yan AT, Tan MK, Bourgeois R, Malek-Marzban P, Beharry R, Alkurtass S, Gyenes GT, Nadeau PL, Nwadiaro N, Jedrzkiewicz S, Gao D, Chandna H, Nelson WB, Goodman SG; North American ACS Reflective III Pilot Investigators.
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial.
Januzzi JL, Del Prato S, Rosenstock J, Butler J, Ezekowitz J, Ibrahim NE, Lam CSP, Marwick T, Wilson Tang WH, Liu Y, Mohebi R, Urbinati A, Zannad F, Perfetti R.
Acute cardiovascular and intensive care chronicles: ‘inception revealed-navigating the veno-arterial extracorporeal membrane oxygenation terrain and beyond’.
Vranckx P, Morrow DA, van Diepen S, Verbrugge FH.
Filling in the Mitral Valve Transcatheter Edge-to-Edge Repair Data Gaps.
Ezekowitz JA.
Impact of inherited bleeding disorders on maternal bleeding and other pregnancy outcomes: A population-based cohort study.
Alam AU, Wu C, Kaul P, Jain V, Sun HL.
Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study.
Mackinnon ES, Leiter LA, Wani RJ, Burke N, Shaw E, Witges K, Goodman SG.
Hierarchical End Points in Prior Heart Failure Trials and the HEART-FID Trial.
Harrington J, Mentz RJ, Rockhold FW, Garg J, Butler J, De Pasquale CG, Ezekowitz JA, Lewis GD, O'Meara E, Ponikowski P, Troughton RW, Wong YW, Adamczyk R, Storie T, Blackman N, Hernandez AF.
Health Data Governance for Research Use in Alberta.
Sandhu N, Whittle S, Southern DA, Li B, Youngson E, Bakal JA, Mcleod C, Hilderman L, Williamson TS, Cheligeer K, Walker RL, Kaul P, Quan H, Eastwood CA.
Identifying the Highest Risk Vascular Patients: insights from the XATOA Registry.
Anand SS, Aboyans V, Bosch J, Debus S, Gay A, Patel MR, Vogtländer K, Welsh RC, Zeymer U, Foxj KAA; XATOA Steering Committee.
Administrative Databases: Friend or Foe in Paediatric Cardiomyopathy.
Conway J, Barrett O, Pidborochynski T, Schroeder K, Cunningham C, Jeewa A, Kaul P.
The current state of evidence for sodium and fluid restriction in heart failure.
Colin-Ramirez E, Arcand J, Saldarriaga C, Ezekowitz JA.
Effect of a High-Sensitivity Troponin I and Associated Diagnostic Protocol on Emergency Department Length of Stay: A Retrospective Cohort Study.
Hill J, Yang EH, Lefebvre D, Doran S, Graham M, van Diepen S, Raizman JE, Tsui AKY, Rowe BH.
Aspirin for the Primary Prevention of Vascular Ischemic Events: An Updated Systematic Review and Meta-analysis to Support Shared Decision-Making.
Laferrière C, Moazzami C, Belley-Côté E, Bainey KR, Marquis-Gravel G, Fama A, Lordkipanidzé M, Potter BJ.
Do the Risks of ECMO Outweigh the Potential Benefits.
Geller BJ, van Diepen S.
As we reflect on the year 2023……
Vranckx P, Morrow D, van Diepen S, Verbrugge F.
The Effect of Inhaled Nitric Oxide on Maximal Oxygen Consumption During Exercise in Acute Hypoxia: A Randomized Double-blind Crossover Trial.
Rampuri ZH, Collins SÉ, Mickelsen BSA, Brotto AR, Beaudry RI, Van Diepen S, Stickland MK.
Interhospital Variation in Admissions Managed With Critical Care Therapies or Invasive Hemodynamic Monitoring in Tertiary Cardiac Intensive Care Units: An Analysis From the Critical Care Cardiology Trials Network Registry.
Donnelly S, Barnett CF, Bohula EA, Chaudhry SP, Chonde MD, Cooper HA, Daniels LB, Dodson MW, Gerber D, Goldfarb MJ, Guo J, Kontos MC, Liu S, Luk AC, Menon V, O'Brien CG, Papolos AI, Pisani BA, Potter BJ, Prasad R, Schnell G, Shah KS, Sridharan L, So DYF, Teuteberg JJ, Tymchak WJ, Zakaria S, Katz JN, Morrow DA, van Diepen S.
Prognostic Performance of the IABP-SHOCK II Risk Score Among Cardiogenic Shock Subtypes in the Critical Care Cardiology Trials Network Registry.
Alviar CL, Li BK, Keller NM, Bohula-May E, Barnett C, Berg DD, Burke JA, Chaudhry SP, Daniels LB, DeFilippis AP, Gerber D, Horowitz J, Jentzer JC, Katrapati P, Keeley E, Lawler PR, Park JG, Sinha SS, Snell J, Solomon MA, Teuteberg J, Katz JN, van Diepen S, Morrow DA; CCCTN Investigators.
Antiplatelet Pretreatment Before Angiography With Anticipated or Planned Percutaneous Coronary Intervention in Stable Ischemic Heart Disease.
Welsh RC
Prognostic performance of serial determination of the Society for Cardiovascular Angiography and Interventions Shock Classification in adults with critical illness.
Jentzer JC, Sanghavi D, Patel PC, Bhattacharyya A, van Diepen S, Herasevich V, Gajic O, Kashani KB.
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative’s Real-world Evidence Working Group.
Morland K, Gerges C, Elwing J, Visovatti SH, Weatherald J, Gillmeyer KR, Sahay S, Mathai SC, Boucly A, Williams PG, Harikrishnan S, Minty EP, Hobohm L, Jose A, Badagliacca R, Lau EMT, Jing ZC, Vanderpool RR, Fauvel C, Leonidas Alves J Jr, Strange G, Pulido T, Qian J, Li M, Mercurio V, Zelt JGE, Moles VM, Cirulis MM, Nikkho SM, Benza RL, Elliott CG.
Coronary Artery Fistula: A Diagnostic Dilemma.
Kumar R, Kumar J, O'Connor C, Ullah I, Tyrell B, Pearson I, Matiullah S, Bainey K.
Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection Fraction.
Fuery MA, Leifer ES, Samsky MD, Sen S, O'Connor CM, Fiuzat M, Ezekowitz J, Piña I, Whellan D, Mark D, Felker GM, Desai NR, Januzzi JL, Ahmad T.
“None of us are lying”: an interpretive description of the search for legitimacy and the journey to access quality health services by individuals living with Long COVID.
Brehon K, Miciak M, Hung P, Chen SP, Perreault K, Hudon A, Wieler M, Hunter S, Hoddinott L, Hall M, Churchill K, Brown DA, Brown CA, Bostick G, Skolnik K, Lam G, Weatherald J, Gross DP.
Comparing the long-term outcomes in chronic coronary syndrome patients with prior ST-segment and non-ST-segment elevation myocardial infarction: findings from the TIGRIS registry.
Krishnamurthy SN, Pocock S, Kaul P, Owen R, Goodman SG, Granger CB, Nicolau JC, Simon T, Westermann D, Yasuda S, Andersson K, Brandrup-Wognsen G, Hunt PR, Brieger DB, Cohen MG.
Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy.
Primary Panel:; Bainey KR, Marquis-Gravel G, Belley-Côté E, Turgeon RD, Ackman ML, Babadagli HE, Bewick D, Boivin-Proulx LA, Cantor WJ, Fremes SE, Graham MM, Lordkipanidzé M, Madan M, Mansour S, Mehta SR, Potter BJ, Shavadia J, So DF, Tanguay JF, Welsh RC, Yan AT; Secondary Panel:; Bagai A, Bagur R, Bucci C, Elbarouni B, Geller C, Lavoie A, Lawler P, Liu S, Mancini J, Wong GC.
Prognostic significance of haemodynamic parameters in patients with cardiogenic shock.
Berg DD, Kaur G, Bohula EA, Baird-Zars VM, Alviar CL, Barnett CF, Barsness GW, Burke JA, Chaudhry SP, Chonde M, Cooper HA, Daniels LB, Dodson MW, Gerber DA, Ghafghazi S, Gidwani UK, Goldfarb MJ, Guo J, Hillerson D, Kenigsberg BB, Kochar A, Kontos MC, Kwon Y, Lopes MS, Loriaux DB, Miller PE, O'Brien CG, Papolos AI, Patel SM, Pisani BA, Potter BJ, Prasad R, Rowsell RO, Shah KS, Sinha SS, Smith TD, Solomon MA, Teuteberg JJ, Thompson AD, Zakaria S, Katz JN, van Diepen S, Morrow DA.
Ambitions for Pulmonary Arterial Hypertension Composite End Points: A Chain Is Only as Strong as Its Weakest Link.
Zelt JGE, Weatherald J, Mathai SC.
Electrocardiographic deep learning for predicting post-procedural mortality: a model development and validation study.
Ouyang D, Theurer J, Stein NR, Hughes JW, Elias P, He B, Yuan N, Duffy G, Sandhu RK, Ebinger J, Botting P, Jujjavarapu M, Claggett B, Tooley JE, Poterucha T, Chen JH, Nurok M, Perez M, Perotte A, Zou JY, Cook NR, Chugh SS, Cheng S, Albert CM.
Risk Factors for the Development of New-Onset Persistent Atrial Fibrillation: Subanalysis of the VITAL Study.
Middeldorp ME, Sandhu RK, Mao J, Gencer B, Danik JS, Moorthy V, Cook NR, Albert CM.
Sodium-glucose co-transporter-2 inhibitors are associated with kidney benefits at all degrees of albuminuria: A retrospective cohort study of adults with diabetes.
Fujita KK, Ye F, Collister D, Klarenbach S, Campbell DJT, Chew DS, Quinn AE, Ronksley P, Lau D.
Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction.
Butler J, Abildstrøm SZ, Borlaug BA, Davies MJ, Kitzman DW, Petrie MC, Shah SJ, Verma S, Abhayaratna WP, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Núñez J, Perna E, Schou M, Senni M, van der Meer P, von Lewinski D, Wolf D, Altschul RL, Rasmussen S, Kosiborod MN.
Editors’ perspective.
Vranckx P, Morrow D, Van Diepen S, Verbrugge F.
Association of Admission Serum Sodium and Outcomes Following Out-of-Hospital Cardiac Arrest.
Ye SC, Cheung CC, Lauder E, Grunau B, Moghaddam N, van Diepen S, Holmes DT, Sekhon MS, Christenson J, Tallon JM, Fordyce CB.
Prevalence of Peripheral Arterial Disease in Patients with Coronary Artery Disease following Cardiac Catheterization: A Prospective Observational Study.
Sunner SS, Welsh RC, Bainey KR.
Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic Review.
Nelson AJ, Lopes RD, Hong H, Hua K, Slovin S, Tan S, Nilsson J, Bhatt DL, Goodman SG, Evans CP, Clarke NW, Shore ND, Margel D, Klotz LH, Tombal B, Leong DP, Alexander JH, Higano CS.
Accelerometer vs. other activity measures in heart failure with preserved ejection fraction: the VITALITY-HFpEF trial.
Butler J, Khan MS, Gasior T, Erickson TR, Vlajnic V, Kramer F, Blaustein RO, Goldsbury D, Roessig L, Lam CSP, Anstrom KJ, Armstrong PW; VITALITY Study Group.
Myocardial ischemia and transfusion (MINT) trial: a glimmer in the fog.
Menon V, van Diepen S.
Time trends in preeclampsia and gestational diabetes in Denmark and Alberta, Canada, 2005-2018-A population-based cohort study.
Lihme F, Savu A, Basit S, Sia W, Yeung R, Barrett O, Luoma L, Ngwezi DP, Davidge S, Norris CM, Ospina MB, Cooke CL, Greiner R, Wohlfahrt J, Melbye M, Lykke J, Kaul P, Boyd HA.
Digital Tool-Assisted Hospitalization Detection in the Tailored Antiplatelet Initiation to Lessen Outcomes due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention Study Compared to Traditional Site-Coordinator Ascertainment: Intervention Study.
Avram R, Byrne J, So D, Iturriaga E, Lennon R, Murthy V, Geller N, Goodman SG, Rihal C, Rosenberg Y, Bailey K, Farkouh M, Bell M, Cagin C, Chavez I, El-Hajjar M, Ginete W, Lerman A, Levisay J, Marzo K, Nazif T, Tanguay JF, Pletcher M, Marcus GM, Pereira NL, Olgin J.
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.
Carson JL, Brooks MM, Hébert PC, Goodman SG, Bertolet M, Glynn SA, Chaitman BR, Simon T, Lopes RD, Goldsweig AM, DeFilippis AP, Abbott JD, Potter BJ, Carrier FM, Rao SV, Cooper HA, Ghafghazi S, Fergusson DA, Kostis WJ, Noveck H, Kim S, Tessalee M, Ducrocq G, Gabriel Melo de Barros E Silva P, Triulzi DJ, Alsweiler C, Menegus MA, Neary JD, Uhl L, Strom JB, Fordyce CB, Ferrari E, Silvain J, Wood FO, Daneault B, Polonsky TS, Senaratne M, Puymirat E, Bouleti C, Lattuca B, White HD, Kelsey SF, Steg PG, Alexander JH; MINT Investigators.
Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis.
Lawler PR, Manvelian G, Coppi A, Damask A, Cantor MN, Ferreira MAR, Paulding C, Banerjee N, Li D, Jorgensen S, Attre R, Carey DJ, Krebs K, Milani L, Hveem K, Damås JK, Solligård E, Stender S, Tybjærg-Hansen A, Nordestgaard BG, Hernandez-Beeftink T, Rogne T, Flores C, Villar J, Walley KR, Liu VX, Fohner AE, Lotta LA, Kyratsous CA, Sleeman MW, Scemama M, DelGizzi R, Pordy R, Horowitz JE, Baras A, Martin GS, Steg PG, Schwartz GG, Szarek M, Goodman SG.
Precision Medicine in Diabetic Kidney Disease: A Narrative Review Framed by Lived Experience.
Downie ML, Desjarlais A, Verdin N, Woodlock T, Collister D.
Systemic corticosteroids for outpatient respiratory viral infections in lung transplant recipients
Ghandi V, Li D, Weinkauf J, Lien D, Hirji A, Varughese R, Weatherald J, Sligl W, Kabbani D, Schwartz I, Doucette K, Cervera C, Halloran K.
The association of tibial vs. humeral intraosseous vascular access with patient outcomes in adult out-of-hospital cardiac arrests.
Brebner C, Asamoah-Boaheng M, Zaidel B, Yap J, Scheuermeyer F, Mok V, Christian M, Kawano T, Singh L, van Diepen S, Christenson J, Grunau B.
Serial assessment of shock severity in cardiac intensive care unit patients.
Jentzer JC, Van Diepen S, Patel PC, Henry TD, Morrow DA, Baran DA, Kashani KB.
The Canadian Cardiovascular Society Classification of Acute Atherothrombotic Myocardial Infarction Based on Stages of Tissue Injury Severity: An Expert Consensus Statement.
Kumar A, Connelly K, Vora K, Bainey KR, Howarth A, Leipsic J, Betteridge-LeBlanc S, Prato FS, Leong-Poi H, Main A, Atoui R, Saw J, Larose E, Graham MM, Ruel M, Dharmakumar R.
Clopidogrel Monotherapy in Older Stable Ischemic Heart Disease Patients Receiving Percutaneous Coronary Intervention: A Paradigm Shift?
Alkasab M, Bainey KR
The Need for Fiber Addition in Symptomatic Heart Failure (FEAST-HF): A Randomized Controlled Pilot Trial.
Colin-Ramirez E, Alemayehu W, McAlister FA, Howlett JG, Willing BP, Forgie A, Madsen K, Dyck JRB, Ezekowitz JA.
Psychosocial Factors of Women Presenting With Myocardial Infarction With or Without Obstructive Coronary Arteries.
Hausvater A, Spruill TM, Xia Y, Smilowitz NR, Arabadjian M, Shah B, Park K, Giesler C, Marzo K, Thomas D, Wei J, Trost J, Mehta PK, Har B, Bainey KR, Zhong H, Hochman JS, Reynolds HR.
The SCAI Shock Classification Has a New Home: The Cardiac Surgery Intensive Care Unit.
Jentzer JC, van Diepen S.
Impact of a Modified Screening Approach During the COVID-19 Pandemic on Diagnosis and Outcomes of Gestational Diabetes Mellitus: A Population-Level Analysis of 90,518 Pregnant Women.
Liyanage V, Barrett O, Ngwezi D, Savu A, Senior P, Yeung RO, Butalia S, Kaul P.
Lower Socioeconomic Status is Associated with an Increased Incidence and Spectrum of Major Congenital Heart Disease and Associated Extracardiac Pathology.
Smith C, Olugbuyi O, Kaul P, Dover DC, Mackie AS, Islam S, Eckersley L, Hornberger LK.
Does Gender-Affirming Hormone Therapy Affect the Kidney?
Collister D, Ahmed SB.
Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease (COMPLETE-AGE).
Bainey KR, Wood DA, Bossard M, Campo G, Cantor WJ, Lavi S, Madan M, Mehran R, Pinilla-Echeverri N, Rao S, Sarma J, Sheth T, Stankovic G, Steg PG, Storey RF, Tanguay JF, Velianou JL, Welsh RC, Mani T, Cairns JA, Mehta SR; COMPLETE trial investigators.
Shock Severity Classification and Mortality in Adults With Cardiac, Medical, Surgical, and Neurological Critical Illness.
Jentzer JC, Senghavi D, Patel PC, Bhattacharyya A, van Diepen S, Herasevich V, Gajic O, Kashani KB.
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC).
Waksman R, Pahuja M, van Diepen S, Proudfoot AG, Morrow D, Spitzer E, Nichol G, Weisfeldt ML, Moscucci M, Lawler PR, Mebazaa A, Fan E, Dickert NW, Samsky M, Kormos R, Piña IL, Zuckerman B, Farb A, Sapirstein JS, Simonton C, West NEJ, Damluji AA, Gilchrist IC, Zeymer U, Thiele H, Cutlip DE, Krucoff M, Abraham WT.
Integration of longitudinal and circumferential strain predicts volumetric change across the cardiac cycle and differentiates patients along the heart failure continuum.
Samuel TJ, Oneglia AP, Cipher DJ, Ezekowitz JA, Dyck JRB, Anderson T, Howlett JG, Paterson DI, Thompson RB, Nelson MD.
Comparing methods to classify admitted patients with SARS-CoV-2 as admitted for COVID-19 versus with incidental SARS-CoV-2: A cohort study.
Hohl CM, Cragg A, Purssel E, McAlister FA, Ting DK, Scheuermeyer F, Stachura M, Grant L, Taylor J, Kanu J, Hau JP, Cheng I, Atzema CL, Bola R, Morrison LJ, Landes M, Perry JJ, Rosychuk RJ; Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) investigators for the Network of Canadian Emergency Researchers; Canadian Critical Care Trials Group.
The COVID-19 pandemic did not negatively impact frequency or continuity of outpatient care in Alberta, Canada.
McAlister FA, Hsu Z, Dong Y, Youngson E.
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
Kosiborod MN, Abildstrøm SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, Hovingh GK, Kitzman DW, Lindegaard ML, Møller DV, Shah SJ, Treppendahl MB, Verma S, Abhayaratna W, Ahmed FZ, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Melenovsky V, Merkely B, Núñez J, Perna E, Schou M, Senni M, Sharma K, Van der Meer P, von Lewinski D, Wolf D, Petrie MC; STEP-HFpEF Trial Committees and Investigators.
Win Statistics in Pulmonary Arterial Hypertension Clinical Trials.
Weatherald J, Moutchia J, Al-Naamani N, McClelland RL, Ventetuolo CE, Palevsky HI, Harhay MO, Kawut SM.
Long-Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo-Controlled Observation in the ODYSSEY OUTCOMES Trial.
Goodman SG, Steg PG, Poulouin Y, Bhatt DL, Bittner VA, Diaz R, Garon G, Harrington RA, Jukema JW, Manvelian G, Stipek W, Szarek M, White HD, Schwartz GG, ODYSSEY OUTCOMES Investigators.
Esophageal motility in systemic sclerosis before and after autologous hematopoietic cell transplantation.
Woo MMK, Levin D, Li DY, David J, Buresi M, Gupta M, Nasser Y, Andrews CN, Durand C, Osman MS, Jamani K, Weatherald J, Johannson KA, Howlett JG, Hemmati I, Kim H, Curley M, Storek J.
Do Heart Failure Biomarkers Influence Heart Failure Treatment Response?
Yuen T, Gouda P, Margaryan R, Ezekowitz JA.
Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction.
Cochran J, Yura Y, Thel MC, Doviak H, Polizio AH, Arai Y, Arai Y, Horitani K, Park E, Chavkin NW, Kour A, Sano S, Mahajan N, Evans M, Huba M, Naya NM, Sun H, Ban Y, Hirschi KK, Toldo S, Abbate A, Druley TE, Ruberg FL, Maurer MS, Ezekowitz JA, Dyck JRB, Walsh K.
The stroke enigma: decoding the sex risk factor in atrial fibrillation.
Middeldorp ME, Sandhu RK.
Extracorporeal Membrane Oxygenation (VA-ECMO) in Management of Cardiogenic Shock.
Koziol KJ, Isath A, Rao S, Gregory V, Ohira S, Van Diepen S, Lorusso R, Krittanawong C.
Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical Trial.
Chew DS, Li Y, Bigelow R, Cowper PA, Anstrom KJ, Daniels MR, Davidson-Ray L, Hernandez AF, O'Connor CM, Armstrong PW, Mark DB, VICTORIA Study Group.
Reducing the pressure in PAH: Sotatercept, hemodynamics, and the right ventricle.
Price LC, McCabe C, Weatherald J.
Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry.
Tromp J, Ezekowitz JA, Ouwerkerk W, Chandramouli C, Yiu KH, Angermann CE, Dahlstrom U, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Dickstein K, Collins SP, Filippatos G, Cleland JGF, Lam CSP.
Rationale and Design of the Randomized Bayesian Multicenter COME-TAVI Trial in Patients With a New Onset Left Bundle Branch Block.
Rivard L, Nault I, Krahn AD, Daneault B, Roux JF, Natarajan M, Healey JS, Quadros K, Sandhu RK, Kouz R, Greiss I, Leong-Sit P, Gourraud JB, Ali WB, Asgar A, Aguilar M, Bonan R, Cadrin-Tourigny J, Cartier R, Dorval JF, Dürrleman N, Dyrda K, Guerra P, Ibrahim M, Ibrahim R, Macle L, Mondesert B, Moss E, Raymond-Paquin A, Denis Roy D, Tadros R, Thibault B, Talajic M, Nozza A, Guertin MC, Khairy P.
The Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock (ECLS-Shock) trial in Perspective.
van Diepen S, Menon V.
Long-Term Outcomes of Cardiogenic Shock Complicating Myocardial Infarction.
Sterling LH, Fernando SM, Talarico R, Qureshi D, van Diepen S, Herridge MS, Price S, Brodie D, Fan E, Di Santo P, Jung RG, Parlow S, Basir MB, Scales DC, Combes A, Mathew R, Thiele H, Tanuseputro P, Hibbert B.
Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis.
Bainey KR, Marquis-Gravel G, MacDonald BJ, Bewick D, Yan A, Turgeon RD.
Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure Registry.
Nguyen NV, Lindberg F, Benson L, Ferrannini G, Imbalzano E, Mol PGM, Dahlström U, Rosano GMC, Ezekowitz JA, Butler J, Lund LH, Savarese G.
Relationship Between Baseline Electrocardiographic Measurements and Outcomes in Patients with High-Risk Heart Failure: Insights from the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial.
Yogasundaram H, Zheng Y, Ly E, Ezekowitz JA, Ponikowski P, Lam CSP, O'Connor C, Blaustein RO, Roessig L, Temple T, Westerhout CM, Armstrong PW, Sandhu RK, VICTORIA Study Group.
Sexual and gender minority relevant policies in Canadian and U.S. organ and tissue donation and transplantation systems: An opportunity to improve equity and safety.
Leeies M, Collister D, Christie E, Doucette K, Hrymak C, Lee TH, Sutha K, Ho J.
Ferric Carboxymaltose in Heart Failure with Iron Deficiency.
Mentz RJ, Garg J, Rockhold FW, Butler J, De Pasquale CG, Ezekowitz JA, Lewis GD, O'Meara E, Ponikowski P, Troughton RW, Wong YW, She L, Harrington J, Adamczyk R, Blackman N, Hernandez AF, HEART-FID Investigators.
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial.
Borlaug BA, Kitzman DW, Davies MJ, Rasmussen S, Barros E, Butler J, Einfeldt MN, Hovingh GK, Møller DV, Petrie MC, Shah SJ, Verma S, Abhayaratna W, Ahmed FZ, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Melenovsky V, Núñez J, Perna E, Schou M, Senni M, van der Meer P, Lewinski DV, Wolf D, Kosiborod MN.
Frailty: A new Vital Sign in Heart Failure Comes of age.
McAlister FA.
Awake prone position in patients with acute hypoxic respiratory failure: A narrative review.
Duhailib ZA, Parhar KKS, Solverson K, Alhazzani W, Weatherald J.
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of Three Tests.
Szarek M, Reijnders E, Jukema JW, Bhatt DL, Bittner VA, Diaz R, Fazio S, Garon G, Goodman SG, Harrington RA, Ruhaak LR, Schwertfeger M, Tsimikas S, White HD, Steg PG, Cobbaert C, Schwartz GG, ODYSSEY OUTCOMES Investigators.
Prognostic Significance of Hemodynamic Parameters in Patients with Cardiogenic Shock.
Berg DD, Kaur G, Bohula EA, Baird-Zars VM, Alviar CL, Barnett CF, Barsness GW, Burke JA, Chaudhry SP, Chonde M, Cooper HA, Daniels LB, Dodson MW, Gerber DA, Ghafghazi S, Gidwani UK, Goldfarb MJ, Guo J, Hillerson D, Kenigsberg BB, Kochar A, Kontos MC, Kwon Y, Lopes MS, Loriaux DB, Miller PE, O'Brien CG, Papolos AI, Patel SM, Pisani BA, Potter BJ, Prasad R, Rowsell RO, Shah KS, Sinha SS, Smith TD, Solomon MA, Teuteberg JJ, Thompson AD, Zakaria S, Katz JN, van Diepen S, Morrow DA.
Gestational Diabetes: one size does not fit all- an observational study of maternal and neonatal outcomes by maternal glucose profile.
Yeung RO, Retnakaran R, Savu A, Butalia S, Kaul P.
Treatment of pulmonary arterial hypertension: recent progress and a look to the future.
Humbert M, Sitbon O, Guignabert C, Savale L, Boucly A, Gallant-Dewavrin M, McLaughlin V, Hoeper MM, Weatherald J.
Baseline Characteristics of Patients in the Randomized Study to Investigate the Efficacy and Safety of Ferric Carboxymaltose as Treatment for Heart Failure with Iron Deficiency: HEART-FID Trial.
Harrington J, Mentz RJ, Rockhold FW, Garg J, Butler J, De Pasquale CG, Ezekowitz JA, Lewis GD, O'Meara E, Ponikowski P, Troughton RW, Wong YW, Adamczyk R, Blackman N, Hernandez AF.
Long-term outcomes among stable post-acute myocardial infarction patients living in rural versus urban areas: insights from the prospective, observational TIGRIS registry.
Nicolau JC, Owen R, Furtado RHM, Goodman SG, Granger CB, Cohen MG, Westermann D, Yasuda S, Simon T, Hedman K, Hunt PR, Brieger DB, Pocock SJ.
Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome.
Steg PG, Szarek M, Valgimigli M, Islam S, Zeiher AM, Bhatt DL, Bittner VA, Chiang CE, Diaz R, Goodman SG, Gotcheva N, Harrington RA, Jukema JW, Kim HS, Kim SH, Morais J, Pordy R, Scemama M, White HD, Schwartz GG, ODYSSEY OUTCOMES Investigators.
Right Ventricular Systolic Pressure Trajectory as a Predictor of Hospitalization and Mortality in Patients With Chronic Heart Failure.
Kotrri G, Youngson E, Fine NM, Howlett JG, Lyons K, Paterson DI, Ezekowitz JA, McAlister FA, Miller RJH.
Reducing Dietary Acid With Fruit and Vegetables Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD): A Clinical Research Protocol.
Mollard R, Cachero K, Luhovyy B, Martin H, Moisiuk S, Mahboobi S, Balshaw R, Collister D, Cahill L, Tennankore KK, Tangri N, MacKay D.
Canadian Cardiovascular Society-Canadian Heart Failure Society Focused Clinical Practice Update of Patients With Differing Heart Failure Phenotypes.
Ducharme A, Zieroth S, Ahooja V, Anderson K, Andrade J, Boivin-Proulx LA, Ezekowitz JA, Howlett J, Lepage S, Leong D, McDonald MA, O'Meara E, Poon S, Swiggum E, Virani S.
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF.
Pitt B, Bhatt DL, Szarek M, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Voors AA, Metra M, Lund LH, Komajda M, Testani JM, Wilcox CS, Ponikowski P, Lopes RD, Ezekowitz JA, Sun F, Davies MJ, Verma S, Kosiborod MN, Steg PG, SOLOIST-WHF Investigators.
Kidney function monitoring and trajectories in patients with atrial fibrillation.
Hawkins NM, Wiebe N, Andrade JG, Sandhu RK, Ezekowitz JA, Kaul P, Tonelli M, McAlister FA.
Age, Sex, and Outcomes in Heart Failure With Reduced EF: Insights From the VICTORIA Trial.
Lam CSP, Piña IL, Zheng Y, Bonderman D, Pouleur AC, Saldarriaga C, Pieske B, Blaustein RO, Nkulikiyinka R, Westerhout CM, Armstrong PW, VICTORIA Study Group.
Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3.
Greene SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, Filippatos G, Gustafsson F, Lam CSP, Lund LH, Mentz RJ, Pieske B, Ponikowski P, Senni M, Skopicki N, Voors AA, Zannad F, Zieroth S, Butler J.
Family Engagement in the Adult Cardiac Intensive Care Unit: A Survey of Family Engagement Practices in the Cardiac Critical Care Trials Network.
Goldfarb M, Alviar C, Berg D, Katz J, Lee R, Liu S, Maitz T, Padkins M, Prasad R, Roswell R, Shah K, Thompson A, van Diepen S, Zakaria S, Morrow D.
People, Systems and Results matter in Heart Failure: Time for a change.
Ezekowitz JA.
Increased Classical Monocytes in South Asians Compared to White Caucasians at Risk for Coronary Atherosclerosis.
Hosseini F, Franco C, Whalen BA, Taylor CM, Sellers SL, Khan N, Kaila K, Bainey K, Farkouh M, Gupta M, Verma S, Ramanathan K.
Association Between the Pulmonary Artery Pulsatility Index and Prognosis in Pulmonary Arterial Hypertension: A Multicentre Study.
Ostad S, Sugarman J, Alkhodair A, Liang J, Mielniczuk LM, Hambly N, Helmersen D, Hirani N, Thakrar M, Varughese R, Norena M, Kularatne M, Swiston JR, Kapasi A, Weatherald J, Brunner NW.
Evolution of NT-proBNP During Prerandomization Screening in VICTORIA: Implications for Clinical Outcomes and Efficacy of Vericiguat.
Armstrong PA, Zheng Y, Lund LH, Butler J, Troughton RW, Emdin M, Lam CSP, Ponikowski P, Blaustein RO, O'Connor CM, Roessig L, Voors AA, Ezekowitz JA, Westerhout CM, VICTORIA Study Group.
Intrapulmonary and Intracardiac Shunts in Adult COVID-19 Versus Non-COVID Acute Respiratory Distress Syndrome ICU Patients Using Echocardiography and Contrast Bubble Studies (COVID-Shunt Study): A Prospective, Observational Cohort Study.
Lau VI, Mah GD, Wang X, Byker L, Robinson A, Milovanovic L, Alherbish A, Odenbach J, Vadeanu C, Lu D, Smyth L, Rohatensky M, Whiteside B, Gregoire P, Luksun W, van Diepen S, Anderson D, Verma S, Slemko J, Brindley P, Kustogiannis DJ, Jacka M, Shaw A, Wheatley M, Windram J, Opgenorth D, Baig N, Rewa OG, Bagshaw SM, Buchanan BM.
Patients’ perceptions on clinical trials outcomes in pulmonary arterial hypertension therapy.
Mai V, Gosselin C, Tremblay E, Rompré G, Lajoie AC, Weatherald J, Lega JC, Bonnet S, Provencher S.
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, Dixon DL, Fearon WF, Hess B, Johnson HM, Kazi DS, Kolte D, Kumbhani DJ, LoFaso J, Mahtta D, Mark DB, Minissian M, Navar AM, Patel AR, Piano MR, Rodriguez F, Talbot AW, Taqueti VR, Thomas RJ, van Diepen S, Wiggins B, Williams MS.
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
Writing Committee Members, Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, Dixon DL, Fearon WF, Hess B, Johnson HM, Kazi DS, Kolte D, Kumbhani DJ, LoFaso J, Mahtta D, Mark DB, Minissian M, Navar AM, Patel AR, Piano MR, Rodriguez F, Talbot AW, Taqueti VR, Thomas RJ, van Diepen S, Wiggins B, Williams MS.
Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial.
Mavromatis K, Jones PG, Ali ZA, Stone GW, Rhodes GM, Bangalore S, O'Brien S, Genereux P, Horst J, Dressler O, Goodman S, Alexander K, Mathew A, Chen J, Bhargava B, Uxa A, Boden WE, Mark DB, Reynolds HR, Maron DJ, Hochman JS, Spertus JA, ISCHEMIA Research Group.
Temporal trends in type 1, type 2, and gestational diabetes in pregnancy: Impact of rural residence, ethnicity, and material deprivation.
Ngwezi DP, Savu A, Yeung RO, Butalia S, Kaul P.
Outcomes Among Patients Hospitalized With Non-COVID-19 Conditions Before and During the COVID-19 Pandemic in Alberta and Ontario, Canada.
McAlister FA, Chu A, Qiu F, Dong Y, van Diepen S, Youngson E, Yu AYX, de Mestral C, Ross HJ, Austin PC, Lee DS, Kadri SS, Wijeysundera HC, CORONA Collaboration.
Myocardial Injury After Noncardiac Surgery in Major General Surgical Patients A Prospective Observational Cohort Study.
Jacka MJ, Youngson E, Bigam D, Graham MM, Heels-Ansdell D, Jaeyoung Park L, Bendtz Kanstrup CT, Nenshi R, Bagshaw SM, McAlister F, Pannu N, Townsend D, McMurtry MS, Devereaux PJ.
STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial
Van de Werf F, Ristic AD, Averkov OV, AriasMendoza A, Lambert Y, Kerr Saraiva JF, Sepulveda P, Rosell-Ortiz F, French JK, Music LB, Vandenberghe K, Bogaerts K, Westerhout CM, Pages A, Danays T, Bainey KR, Sinnaeve P, Goldstein P, Welsh RC, Armstrong PW, STREAM-2 Investigators.
Association Between Maternal Glucose Levels in Gestational Diabetes Screening and Subsequent Hypertension.
Liang XC, Savu A, Ngwezi D, Butalia S, Kaul P, Yeung RO.
Validity of alternative claims-based algorithms for type 1, type 2, and gestational diabetes in pregnancy.
Ngwezi DP, Savu A, Yeung RO, Butalia S, Kaul P.
Reply to ‘Vericiguat in heart failure with reduced ejection fraction: the right choice above all else?’.
Pieske B, Armstrong PW, VICTORIA Study Group.
Effect of alirocumab on cataracts in patients with acute coronary syndromes.
Suc G, Schwartz GG, Goodman SG, Jukema JW, Manvelian G, Poulouin Y, Pordy R, Scemama M, Szarek M, Steg PG, ODYSSEY OUTCOMES Investigators.
Fully Automated Artificial Intelligence Assessment of Aortic Stenosis by Echocardiography.
Krishna H, Desai K, Slostad B, Bhayani S, Arnold JH, Ouwerkerk W, Hummel Y, Lam CSP, Ezekowitz JA, Frost M, Jiang Z, Equilbec C, Twing A, Pellikka PA, Frazin L, Kansal M.
Background Medical Therapy and Clinical Outcomes From the VICTORIA Trial.
Ezekowitz JA, McMullan CJ, Westerhout CM, Pina IL, Lopez-Sendon J, Anstrom KJ, Hernandez AF, Lam CSP, O’Connor CM, Pieske B, Ponikowski P, Roessig L, Voors AA, Koglin J, Armstrong PW, Butler J, VICTORIA Study Group.
Trends in major adverse cardiac events and healthcare utilization during the COVID-19 pandemic in Alberta, Canada.
Mackinnon ES, Anderson T, Raggi P, Gregoire J, Wani RJ, Packalen MS, Graves E, Ekwaru P, McMullen S, Goodman SG.
Associations between social determinants of health and weight status in preschool children: a population-based study.
Wijesundera J, Kaul P, Davu A, Islam S, Dover DC, Moore LE, Haqq AM, Ball GDC.
Long Term Clinical Outcomes Following Cardiac Stress Testing After Percutaneous Coronary Intervention.
Bagai A, Madan M, Overgaard C, Porter J, Han L, Cheema AN, Yan AT, Kaul P, Goodman SG, Ko D.
Management of Pulmonary Arterial Hypertension.
Weatherald J, Varughese RA, Liu J, Humbert M.
Give a Nudge a Shot: NUDGE-FLU bridging the Cardiovascular Quality Chasm.
Chatur S, Ezekowitz JA.
AACC/NKF Guidance Document on Improving Equity in Chronic Kidney Disease Care.
Pierre CC, Marzinke MA, Ahmed SB, Collister D, Colon-Franco JM, Hoenig MP, Lorey T, Palevsky PM, Palmer OP, Rosas SE, Vassalotti J, Whitley CT, Greene DN.
Sexual orientation and gender identity in organ and tissue donation and transplantation.
Leeies M, Christie E, Collister D.
Comparative Analysis of Patients With STEMI and COVID-19 Between Canada and the United States.
Shavadia JS, Stanberry L, Singh J, Thao KR, Ghasemzadeh N, Mercado N, Nayak KR, Alraies MC, Bagur R, Saw J, Bagai A, Bainey KR, Madan M, Amlani S, Garberich R, Grines CL, Garcia S, Henry TD, Dehghani P.
Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19.
Stone GW, Farkouh ME, Lala A, Tinuoye E, Dressler O, Moreno PR, Palacios IF, Goodman SG, Esper RB, Abizaid A, Varade D, Betancur JF, Ricalde A, Payro G, Castellano JM, Hung IFN, Nadkarni GN, Giustino G, Godoy LC, Feinman J, Camaj A, Bienstock SW, Furtado RHM, Granada C, Bustamante J, Peyra C, Contreras J, Owen R, Bhatt DL, Pocock SJ, Fuster V; FREEDOM COVID Anticoagulation Strategy Randomized Trial Investigators.
Tolerability of bedtime diuretics: a prospective cohort analysis.
Garrison SR, Kelmer M, Korownyk T, Kolber MR, Allan GM, Bakal J, Singer A, Katz A, McAlister F, Padwal RS, Lewanczuk R, Hill MD, McGrail K, O’Neill B, Greiver M, Manca DP, Mangin D, Wong ST, Kirkwood JEM, McCormack JP, Yeung JMS, Green L.
The Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Anthracycline-Treated Patients With Cancer.
Abdel-Qadir H, Carrasco R, Austin PC, Chen Y, Zhou L, Fang J, Su HMH, Lega IC, Kaul P, Neilan TG, Thavendiranathan P.
Genetic-Guided Oral P2Y12 Inhibitor Selection and Cumulative Ischemic Events After Percutaneous Coronary Intervention.
Ingraham BS, Farkouh ME, Lennon RJ, So D, Goodman SG, Geller N, Bae JH, Jeong MH, Baudhuin LM, Mathew V, Bell MR, Lerman A, Fu YP, Hasan A, Iturriaga E, Tanguay JF, Welsh RC, Rosenberg Y, Bailey K, Rihal C, Pereira NL.
Neuroprognostication in the Post Cardiac Arrest Patient: A Canadian Cardiovascular Society Position Statement.
Primary Panel; Fordyce CB, Kramer AH, Ainsworth C, Christenson J, Hunter G, Kromm J, Lopez Soto C, Scales DC, Sekhon M, van Diepen S, Dragoi L, Josephson C, Kutsogiannis J, Le May MR, Overgaard CB, Savard M, Schnell G, Wong GC, Belley-Côté E; Secondary Panel; Fantaneanu TA, Granger CB, Luk A, Mathew R, McCredie V, Murphy L, Teitelbaum J.
Quality improvement and the Rumsfeld Matrix.
Sandhu RK, Andrade JG.
The burden of incidental SARS-CoV-2 infections in hospitalized patients across pandemic waves in Canada.
McAlister FA, Hau JP, Atzema C, McRae AD, Morrison LJ, Grant L, Cheng I, Rosychuk RJ, Hohl CM.
Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA.
Butler J, Zheng Y, Khan MS, Bonderman D, Lund LH, deFilippi CR, Blaustein RO, Ezekowitz JA, Freitas C, Hernandez AF, O'Connor CM, Voors AA, Westerhout CM, Lam CSP, Armstrong PW; VICTORIA Study Group.
Assisted human reproduction and pregnancy outcomes in Alberta, 2009-2018: a population-based study.
Moore LE, Haijhosseini M, Motan T, Kaul P.
Association Between Vaccination Status and Outcomes in Patients Admitted to the ICU With COVID-19.
van Diepen S, McAlister FA, Chu LM, Youngson E, Kaul P, Kadri SS.
Predicting Heart Failure With Reduced or Preserved Ejection Fraction From Health Records: External Validation Study.
Sepehrvand N, Dover DC, Islam S, Kaul P, McAlister FA, Miller RJH, Fine NM, Howlett JG, Armstrong PW, Ezekowitz JA.
Changes in vasoactive drug requirements and mortality in cardiac intensive care unit patients.
Jentzer JC, Patel PC, van Diepen S, Morrow DA, Barsness GW, Kashani KB.
Deep learning-based electrocardiographic screening for chronic kidney disease.
Holmstrom L, Christensen M, Yuan N, Weston Hughes J, Theurer J, Jujjavarapu M, Fatehi P, Kwan A, Sandhu RK, Ebinger J, Cheng S, Zou J, Chugh SS, Ouyang D.
Sex-Based Differences in Severe Outcomes, Including Cardiovascular Hospitalization, in Adults With COVID-19 in Ontario, Canada.
Behrouzi B, Sivaswamy A, Chu A, Ferreira-Legere LE, Abdel-Qadir H, Atzema CL, Jackevicius C, Kapral MK, Wijeysundera HC, Farkouh ME, Ross HJ, Ha ACT, Tadrous M, Paterson M, Gershon AS, Džavík V, Fang J, Kaul P, van Diepen S, Goodman SG, Ezekowitz JA, Bainey KR, Ko DT, Austin PC, McAlister FA, Lee DS, Udell JA.
Somatosensory Evoked Potential for Post-Arrest Neuroprognostication.
Kromm J, Bencsik C, Soo A, Ainsworth C, Savard M, van Diepen S, Kramer A.
Pulmonary Artery Catheter Use and Mortality in the Cardiac Intensive Care Unit.
Kadosh BS, Berg DD, Bohula EA, Park JG, Baird-Zars VM, Alviar C, Alzate J, Barnett CF, Barsness GW, Burke J, Chaudhry SP, Daniels LB, DeFilippis A, Delicce A, Fordyce CB, Ghafghazi S, Gidwani U, Goldfarb M, Katz JN, Keeley EC, Kenigsberg B, Kontos MC, Lawler PR, Leibner E, Menon V, Metkus TS, Miller PE, O'Brien CG, Papolos AI, Prasad R, Shah KS, Sinha SS, Snell RJ, So D, Solomon MA, Ternus BW, Teuteberg JJ, Toole J, van Diepen S, Morrow DA, Roswell RO.
The North American Perspective on Short-term Mechanical Circulatory Support for Cardiogenic Shock: – Could Differences in Policy be Driving Differences in Temporary Mechanical Circulatory Support Use?
van Diepen S, Arias-Mendoza A, Sinha SS.
Classification of Heart Failure Events by Severity: Insights from the VICTORIA Trial.
Felker GM, North R, Mulder H, Jones WS, Anstrom KJ, Patel MJ, Butler J, Ezekowitz JA, Lam CSP, O'Connor CM, Roessig L, Hernandez AF, Armstrong PW; VICTORIA Study Group.
The Seventh Prevention of Syncope Trial (POST VII)-A randomized clinical trial of atomoxetine for the prevention of vasovagal syncope: Rationale and study design.
Sandhu RK, Raj SR, Hamzeh R, Sheldon RS; POST 7 Investigators.
Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension.
Weatherald J, Zanini U, Humbert M.
Reperfusion Delays and Outcomes Among Patients With ST-Segment-Elevation Myocardial Infarction With and Without Cardiogenic Shock.
Kochan A, Lee T, Moghaddam N, Milley G, Singer J, Cairns JA, Wong GC, Jentzer JC, van Diepen S, Alviar C, Fordyce CB.
Dietary Sodium Restriction in Patients with Heart Failure.
Chang LL, DesJardin JT, Albert MA, Ezekowitz J, Yusuf S.
Data-Informed Medicine in CanMEDS 2025.
Thoma B, Paprica PA, Kaul P, Cheung WJ, Hall AK, Affleck E.
Sedation Strategies in Patients Undergoing Extracorporeal Cardiopulmonary Resuscitation.
Alviar CL, van Diepen S.
Effect of Vericiguat on Left Ventricular Structure and Function in Patients with Heart Failure with Reduced Ejection Fraction: The VICTORIA Echocardiographic Substudy.
Pieske B, Pieske-Kraigher E, Lam CSP, Melenovský V, Sliwa K, Lopatin Y, Arango JL, Bahit MC, O'Connor CM, Patel MJ, Roessig L, Morris DA, Kropf M, Westerhout CM, Zheng Y, Armstrong PW; VICTORIA Study Group.
Antithrombotic Therapies in Canadian Atrial Fibrillation Patients with Concomitant Coronary Artery Disease: Insights from the CONNECT AF+PCI-II Program.
Chow JK, Bagai A, Tan MK, Har BJ, Yip AMC, Paniagua M, Elbarouni B, Bainey KR, Paradis JM, Maranda R, Cantor WJ, Eisenberg MJ, Dery JP, Madan M, Cieza T, Matteau A, Roth S, Lavi S, Glanz A, Gao D, Tahiliani R, Welsh RC, Kim HH, Robinson SD, Daneault B, Chong AY, Le May MR, Ahooja V, Gregoire JC, Nadeau PL, Laksman Z, Heilbron B, Yung D, Minhas K, Bourgeois R, Overgaard CB, Bonakdar H, Logsetty G, Lavoie AJ, De LaRochelliere R, Mansour S, Spindler C, Yan AT, Goodman SG; CONNECT AF+PCI Investigators.
Virtual care and emergency department use.
McAlister FA.
BIOVASC Trial in Perspective: Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndromes and Multivessel Coronary Disease.
Vranckx P, van Diepen S.
Setting the Diagnosis of Heart Failure: Missed Opportunities for Earlier Detection.
Sepehrvand N, Ezekowitz JA.
Patient-Reported Frailty and Functional Status in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF.
Kaul P, Rathwell S, Lam CSP, Westerhout CM, Spertus JA, Anstrom KJ, Blaustein RO, Ezekowitz JA, Pieske B, Roessig L, Butler J, Armstrong PW; VITALITY-HFpEF Study Group.
Development and validation of echocardiography-based machine-learning models to predict mortality.
Valsaraj A, Kalmady SV, Sharma V, Frost M, Sun W, Sepehrvand N, Ong M, Equibec C, Dyck JRB, Anderson T, Becher H, Weeks S, Tromp J, Hung CL, Ezekowitz JA, Kaul P.
Patients acceptance and comprehension to written and verbal consent (PAC-VC).
Kashur R, Ezekowitz J, Kimber S, Welsh RC.
Clinical Implications of Negatively Adjudicated Heart Failure Events: Data From the VICTORIA Study.
Felker GM, North R, Mulder H, Jones WS, Anstrom KJ, Patel MJ, Butler J, Ezekowitz JA, Lam C, O'Connor CM, Roessig L, Hernandez AF, Armstrong PW; VICTORIA Study Group.
Novel Frontiers in Critical Care Cardiology – Point-of-Care Diagnostics, Evolving Systems of Care, and Contemporary Critical Care Management.
Randhawa VK, van Diepen S, Hibbert B, Dénault A, Butt W, Arora R.
The Association of the Post-Resuscitation On-Scene Interval and Patient Outcomes after Out-of-Hospital Cardiac Arrest.
Khan L, Hutton J, Yap J, Dodek P, Scheuermeyer F, Asamoah-Boaheng M, Heidet M, Wall N, Fordyce CB, van Diepen S, Christenson J, Grunau B.
Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial.
Carson JL, Brooks MM, Chaitman BR, Alexander JH, Goodman SG, Bertolet M, Abbott JD, Cooper HA, Rao SV, Triulzi DJ, Fergusson DA, Kostis WJ, Noveck H, Simon T, Steg PG, DeFilippis AP, Goldsweig AM, Lopes RD, White H, Alsweiler C, Morton E, Hébert PC; MINT Investigators.
The COVID-19 pandemic did not adversely impact follow-up patterns for patients with heart failure discharged from emergency departments.
McAlister FA, Dong Y.
Extracorporeal Membrane Oxygenation for Cardiogenic Shock: When to Open the Parachute?
Henry TD, Yannopoulos D, van Diepen S.
The empirical estimate of the survival and variance using a weighted composite endpoint.
Nabipoor M, Westerhout CM, Rathwell S, Bakal JA.
Towards artificial intelligence-based learning health system for population-level mortality prediction using electrocardiograms.
Sun W, Kalmady SV, Sepehrvand N, Salimi A, Nademi Y, Bainey K, Ezekowitz JA, Greiner R, Hindle A, McAlister FA, Sandhu RK, Kaul P.
Time to triple therapy in patients with de novo heart failure with reduced ejection fraction: a population-based study.
Sepehrvand N, Nabipoor M, Youngson E, McAlister FA, Ezekowitz JA.
Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial.
Sidhu MS, Alexander KP, Huang Z, Mathew RO, Newman JD, O'Brien SM, Pellikka PA, Lyubarova R, Bockeria O, Briguori C, Kretov EL, Mazurek T, Orso F, Roik MF, Sajeev C, Shutov EV, Rockhold FW, Borrego D, Balter S, Stone GW, Chaitman BR, Goodman SG, Fleg JL, Reynolds HR, Maron DJ, Hochman JS, Bangalore S; ISCHEMIA-CKD Research Group.
Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week.
Greene SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, Lam CSP, Lund LH, Ponikowski P, Voors AA, Zannad F, Zieroth S, Butler J.
The empirical estimate of the survival and variance using a weighted composite endpoint.
Nabipoor M, Westerhout CM, Rathwell S, Bakal JA.
Frequency and Type of Outpatient Visits for Patients With Cardiovascular Ambulatory-Care Sensitive Conditions During the COVID-19 Pandemic and Subsequent Outcomes: A Retrospective Cohort Study.
McAlister FA, Hsu Z, Dong Y, Tsuyuki RT, van Walraven C, Bakal JA.
Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure with Reduced Ejection Fraction: The VICTORIA Biomarker Substudy.
deFilippi CR, Alemayehu WG, Voors AA, Kaye D, Blaustein RO, Butler J, Ezekowitz JA, Hernandez AF, Lam CSP, Roessig L, Seliger S, Shah P, Westerhout CM, Armstrong PW, O'Connor CM; VICTORIA Study Group.
First-Line Catheter Ablation for Paroxysmal Atrial Fibrillation – Have We Reached the Tipping Point?
Sandhu RK, Albert CM.
Targeted Temperature Management Following Out-of-Hospital Cardiac Arrest: Integrating Evidence into Real World Practice.
Barker M, Sekhon M, Krychtiuk KA, van Diepen S, Alviar CL, Granger CB, Fordyce CB.
The new 2022 pulmonary hypertension guidelines: some small steps and some giant leaps forward for evidence-based care.
Price LC, Weatherald J.
Targeted Temperature Management Following Out-of-Hospital Cardiac Arrest: Integrating Evidence into Real World Practice.
Barker M, Sekhon M, Krychtiuk KA, van Diepen S, Alviar CL, Granger CB, Fordyce CB.
Eligibility and Implementation of Rivaroxaban for Secondary Prevention of Atherothrombosis in Clinical Practice-Insights From the CANHEART Study.
Sheth MS, Yu B, Chu A, Porter J, Tam DY, Ferreira-Legere LE, Goodman SG, Farkouh ME, Ko DT, Abdel-Qadir H, Udell JA.
Survival After Invasive or Conservative Management of Stable Coronary Disease.
Hochman JS, Anthopolos R, Reynolds HR, Bangalore S, Xu Y, O'Brien SM, Mavromichalis S, Chang M, Contreras A, Rosenberg Y, Kirby R, Bhargava B, Senior R, Banfield A, Goodman SG, Lopes RD, Pracoń R, López-Sendón J, Maggioni AP, Newman JD, Berger JS, Sidhu MS, White HD, Troxel AB, Harrington RA, Boden WE, Stone GW, Mark DB, Spertus JA, Maron DJ; ISCHEMIA-EXTEND Research Group.
Priorities for pulmonary hypertension research: A James Lind Alliance priority setting partnership.
Weatherald J, Iqbal H, Mielniczuk L, Syed AR, Legkaia L, Howard J, Dempsey N, Rader T, Swiston J, Provencher S.
Characteristics, Therapies, and Outcomes of In-Hospital vs Out-of-Hospital Cardiac Arrest in Patients Presenting to Cardiac Intensive Care Units: From the Critical Care Cardiology Trials Network (CCCTN).
Carnicelli AP, Keane R, Brown KM, Loriaux DB, Kendsersky P, Alviar CL, Arps K, Berg DD, Bohula EA, Burke JA, Dixson JA, Gerber DA, Goldfarb M, Granger CB, Guo J, Harrison RW, Kontos M, Lawler PR, Elliott Miller P, Nativi-Nicolau J, Kristin Newby L, Racharla L, Roswell RO, Shah KS, Sinha SS, Solomon MA, Teuteberg J, Wong G, van Diepen S, Katz JN, Morrow DA.
A Second Chance for Survival: Clinical Trial Evidence, Eligibility, and Barriers to Implementation of ECPR for Out-of-Hospital Cardiac Arrest.
Grunau B, Singh G, Bělohlávek J, Yannopoulos D, Tonna JE, Hutin A, Nagpal D, Cournoyer A, van Diepen S.
Use of Guideline-Directed Medical Therapy in Patients Aged ≥ 65 Years After the Diagnosis of Heart Failure: A Canadian Population-Based Study.
Wahid M, Aghanya V, Sepehrvand N, Dover DC, Kaul P, Ezekowitz J.
Healthcare implications of the COVID-19 pandemic for the cardiovascular practitioner Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study.
Mathew RO, Sidhu MS, Rihal CS, Lennon R, El-Hajjar M, Yager N, Lyubarova R, Abdul-Nour K, Weitz S, O'Cochlain DF, Murthy V, Levisay J, Marzo K, Graham J, Dzavik V, So D, Goodman S, Rosenberg YD, Pereira N, Farkouh ME.
Healthcare implications of the COVID-19 pandemic for the cardiovascular practitioner.
McAlister FA, Parikh H, Lee DS, Wijeysundera HC.
Elevated C-Reactive Protein Amplifies Association of Lipoprotein(a) With Cardiovascular Risk and Clinical Benefit of Alirocumab.
Schwartz GG, Szarek M, Zeiher A, White HD, Jukema JW, Harrington RA, Goodman SG, Diaz R, Bittner V, Bhatt DL, Steg PG.
Clinician and Algorithmic Application of the 2019 and 2022 Society of Cardiovascular Angiography and Intervention Shock Stages in the Critical Care Cardiology Trials Network Registry.
Patel SM, Berg DD, Bohula EA, Baird-Zars VM, Barnett CF, Barsness GW, Chaudhry SP, Daniels LB, van Diepen S, Ghafghazi S, Goldfarb MJ, Jentzer JC, Katz JN, Kenigsberg BB, Lawler PR, Miller PE, Papolos AI, Park JG, Potter BJ, Prasad R, Singam NSV, Sinha SS, Solomon MA, Teuteberg JJ, Morrow DA; CCCTN Investigators.
Ventricular-arterial decoupling is associated with in-hospital adverse events in normotensive pulmonary embolism.
Kiamanesh O, Prosperi-Porta G, Harper L, Solverson K, Boiteau P, Helmersen D, Ferland A, Fine N, Weatherald J.
Multimorbidity, functional impairment, and mortality in older patients stable after prior acute myocardial infarction: Insights from the TIGRIS registry.
Bagai A, Ali FM, Gregson J, Alexander KP, Cohen MG, Andersson Sundell K, Simon T, Westermann D, Yasuda S, Brieger D, Goodman SG, Nicolau JC, Granger CB, Pocock S.
Effective hospital readmission prediction models using machine-learned features.
Davis S, Zhang J, Lee I, Rezaei M, Greiner R, McAlister FA, Padwal R.
Performance of the medical priority dispatch system in correctly classifying out-of-hospital cardiac arrests as appropriate for resuscitation.
Yap J, Helmer J, Gessaroli M, Hutton J, Khan L, Scheuermeyer F, Wall N, Bolster J, van Diepen S, Puyat J, Asamoah-Boaheng M, Straight R, Christenson J, Grunau B.
Atomoxetine for suppression of vasovagal syncope.
Sheldon RS, Seifer C, Parkash R, Sandhu RK, Hamzeh R, Raj SR.
Toward a Broader Characterization of Macro- and Microcirculatory Uncoupling in Cardiogenic Shock.
Lawler PR, van Diepen S.
Leveraging Existing STEMI Networks to Regionalize Cardiogenic Shock Systems of Care: Efforts to Expand the Scope Could Improve Shock Outcomes.
Roston TM, So DY, Liu S, Fordyce CB, Grunau B, Jentzer JC, Bagai A, Luk A, Goodman SG, van Diepen S.
Sodium Restriction in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Colin-Ramirez E, Sepehrvand N, Rathwell S, Ross H, Escobedo J, Macdonald P, Troughton R, Saldarriaga C, Lanas F, Doughty R, McAlister FA, Ezekowitz JA.
A formal validation of a deep learning-based automated workflow for the interpretation of the echocardiogram.
Tromp J, Bauer D, Claggett BL, Frost M, Iversen MB, Prasad N, Petrie MC, Larson MG, Ezekowitz JA, Solomon SD.
Rationale and Design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in Patients with High-Risk Diabetic Cardiomyopathy.
Januzzi JL Jr, Butler J, Prato SD, Ezekowitz JA, Ibrahim NE, Lam CS, Lewis GD, Marwick TH, Rosenstock J, Tang WW, Zannad F, Lawson F, Perfetti R, Urbinati A.
The Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock (ECMO-CS) Trial in Perspective.
Morrow DA, van Diepen S.
Opportunities and challenges in heart rhythm research: Rationale and development of an electrophysiology collaborator.
Nguyen DT, Bilchick KC, Narayan SM, Chung MK, Thomas KL, Laurita KR, Vaseghi M, Sandhu R, Chelu MG, Kannankeril PJ, Packer DL, McManus DD, Verma A, Singleton M, Tarakji K, Al-Khatib SM, Kaltman JR, Balijepalli RC, Van Hare GF, Hurwitz JL, Russo AM, Kusumoto FM, Albert CM.
Economics of Minimalist Transcatheter Aortic Valve Replacement: Results From the 3M-TAVR Economic Study.
Butala NM, Wood DA, Li H, Chinnakondepalli K, Lauck SB, Sathananthan J, Cairns JA, Magnuson EA, Barker M, Webb JG, Welsh R, Cheung A, Ye J, Velianou JL, Wijeysundera HC, Asgar A, Kodali S, Thourani VH, Cohen DJ, 3M-TAVR Investigators.
Soluble Guanylate Cyclase Stimulators in Patients with Heart Failure with Reduced Ejection Fraction Across the Risk Spectrum.
Butler J, Usman MS, Anstrom KJ, Blaustein RO, Bonaca MP, Ezekowitz JA, Freitas C, Lam CS, Lewis EF, Lindenfeld J, McMullan CJ, Mentz RJ, O'Connor C, Rosano GM, Saldarriaga CI, Senni M, Udelson J, Voors AA, Zannad F.
Canadian Spontaneous Coronary Artery Dissection Cohort Study: 3-Year Outcomes.
Saw J, Starovoytov A, Aymong E, Inohara T, Alfadhel M, McAlister C, Samuel R, Grewal T, Parolis JA, Sheth T, So D, Minhas K, Brass N, Lavoie A, Bishop H, Lavi S, Pearce C, Renner S, Madan M, Welsh RC, McGrath BM, Vijayaraghavan R, Har B, Ibrahim R, Chaudhary P, Ganesh SK, Graham J, Matteau A, Martucci G, Ko DT, Humphries K, Mancini GBJ.
Linking Data Through the Chain of Survival: The Potential for Better Population-Based Out-of-Hospital Cardiac Arrest Epidemiology, Process of Care, Risk Prediction, and Outcomes.
van Diepen S, Jentzer JC.
Oxygen Supplementation and Hyperoxia in Critically Ill Cardiac Patients: From Pathophysiology to Clinical Practice.
Thomas A, van Diepen S, Beekman R, Sinha SS, Brusca SB, Alviar CL, Jentzer J, Bohula EA, Katz JN, Shahu A, Barnett C, Morrow DA, Gilmore EJ, Solomon MA, Miller PE.
The Impact of COVID-19 on Maternal Mental Health during Pregnancy: A Comparison between Canada and China within the CONCEPTION Cohort.
Pagès N, Gorgui J, Wang C, Wang X, Zhao JP, Tchuente V, Lacasse A, Côté S, King S, Muanda F, Mufike Y, Boucoiran I, Nuyt AM, Quach C, Ferreira E, Kaul P, Winquist B, O'Donnell KJ, Eltonsy S, Chateau D, Hanley G, Oberlander T, Kassai B, Mainbourg S, Bernatsky S, Vinet É, Brodeur-Doucet A, Demers J, Richebé P, Zaphiratos V, Bérard A.
Proposal for an Ambulatory Heart Failure Management Curriculum for Cardiology Residency Training Programs.
Almufleh A, Turgeon RD, Ducharme A, Billia F, Ezekowitz J.
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes.
Moriarty PM, Steg PG, McGinniss J, Zeiher AM, White HD, Manvelian G, Pordy R, Loy M, Jukema JW, Harrington RA, Gray JV, Gorby LK, Goodman SG, Diaz R, Bittner VA, Bhatt DL, Szarek M, Schwartz GG, ODYSSEY OUTCOMES Investigators.
Inotropes, vasopressors, and mechanical circulatory support for treatment of cardiogenic shock complicating myocardial infarction: a systematic review and network meta-analysis.
Fernando SM, Mathew R, Sadeghirad B, Brodie D, Belley-Côté EP, Thiele H, van Diepen S, Fan E, Di Santo P, Simard T, Russo JJ, Tran A, Lévy B, Combes A, Hibbert B, Rochwerg B.
Prediction of odds for emergency cesarean section: A secondary analysis of the CHILD term birth cohort study.
Tun MH, Chari R, Kaul P, Mamede FV, Paulden M, Lefebvre DL, Turvey SE, Moraes TJ, Sears MR, Subbarao P, Mandhane PJ.
Disparities in adherence to diabetes screening guidelines among males and females in a universal care setting: A population-based study of 1,380,697 adults.
Kaul P, Chu LM, Dover DC, Yeung RO, Eurich DT, Butalia S.
. Harnessing Electronic Medical Records in Cardiovascular Clinical Practice and Research.
Pishoy Gouda, Justin Ezekowitz.
Cardiogenic shock severity and mortality in patients receiving venoarterial extracorporeal membrane oxygenator support.
Jentzer JC, Baran DA, Bohman JK, van Diepen S, Radosevich M, Yalamuri S, Rycus P, Drakos SG, Tonna JE.
Predictors and Associated Clinical Outcomes of Low Cardiac Output Syndrome Following Cardiac Surgery: Insights from the LEVO-CTS Trial.
Kochar A, Zheng Y, van Diepen S, Mehta RH, Westerhout CM, Mazer CD, Duncan AI, Whitlock R, Lopes RD, Argenziano M, de Varennes B, Alexander JH, Goodman SG, Fremes S.
Left main coronary disease: evolving management concepts.
Armstrong PW, Bates ER, Gaudino M.
The Canadian Mother-Child Cohort Active Surveillance Initiative (CAMCCO): Comparisons between Quebec, Manitoba, Saskatchewan, and Alberta.
Bérard A, Kaul P, Eltonsy S, Winquist B, Chateau D, Hawken S, Sprague A, Walker M, Bernatsky S, Abrahamowicz M, Soares de Moura C, Vinet É, Carleton B, Hanley G, Oberlander T, Sheehy O, Gomez YH, Gorgui J, Savu A.
Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial.
Mehta SR, Wang J, Wood DA, Spertus JA, Cohen DJ, Mehran R, Storey RF, Steg PG, Pinilla-Echeverri N, Sheth T, Bainey KR, Bangalore S, Cantor WJ, Faxon DP, Feldman LJ, Jolly SS, Kunadian V, Lavi S, Lopez- Sendon J, Madan M, Moreno R, Rao SV, Rodés-Cabau J, Stankovic G, Bangdiwala SI, Cairns JA; COMPLETE Trial Investigators.
Oxygenation targets in post-resuscitation care: a perspective of the BOX randomized clinical trial.
Tavazzi G, van Diepen S, Morrow D.
Blood pressure and oxygenation targets after out-of-hospital cardiac arrest-trial (BOX).
van Diepen S, Tavazzi G, Morrow DA.
A single breath of nitric oxide does not alter pulmonary perfusion pressure.
Brotto A, Beaudry R, Rowland S, van Diepen S, Stickland MK.
Sequential Evaluation of NT-proBNP in Heart Failure: Insights Into Clinical Outcomes and Efficacy of Vericiguat.
Armstrong PW, Zheng Y, Troughton RW, Lund LH, Zhang J, Lam CSP, Westerhout CM, Blaustein RO, Butler J, Hernandez AF, Roessig L, O'Connor CM, Voors AA, Ezekowitz JA; VICTORIA Study Group.
Efficacy and Safety of Vericiguat in Patients with Heart Failure with Reduced Ejection Fraction Treated with Sacubitril/Valsartan: Insights from the VICTORIA Trial
Senni M, Alemayehu WG, Sim D, Edelmann F, Butler J, Ezekowitz J, Hernandez AF, Lam CSP, O'Connor CM, Pieske B, Ponikowski P, Roessig L, Voors AA, Westerhout CM, McMullan C, Armstrong PW; VICTORIA Study Group.
. Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES.
Chiang C-E, Schwartz GG, Elbez Y, Szarek M, Bhatt DL, Bittner VA, Diaz R, Erglis A, Goodman SG, Hagström E, Jukema JW, Liberopoulos E, Loy M, Pordy R, White HD, Simon T, Steg PG, ODYSSEY OUTCOMES Investigators.
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG, ODYSSEY OUTCOMES Investigators.
Impact of Socioeconomic Status and Residence Distance on Infant Heart Disease Outcomes in Canada.
Olugbuyi O, Smith C, Kaul P, Dover DC, Mackie AS, Islam S, Eckersley L, Hornberger LK.
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators.
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients with COVID-19: COVID-PACT.
Bohula EA, Berg DD, Lopes MS, Connors JM, Babar I, Barnett CF, Chaudhry SP, Chopra A, Ginete W, Ieong MH, Katz JN, Kim EY, Kuder JF, Mazza E, McLean D, Mosier JM, Moskowitz A, Murphy SA, O'Donoghue ML, Park JG, Prasad R, Ruff CT, Shahrour MN, Sinha SS, Wiviott SD, van Diepen S, Zainea M, Baird-Zars V, Sabatine MS, Morrow DA.
Incidence and Predictors of Adverse Events Among Initially Stable ST-Elevation Myocardial Infarction Patients Following Primary Percutaneous Coronary Intervention.
Amon J, Wong GC, Lee T, Singer J, Cairns J, Shavadia JS, Granger C, Gin K, Wang TY, van Diepen S, Fordyce CB.
. Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trial.
Okuno T, Dangas GD, Hengstenberg C, Sartori S, Herrmann HC, de Winter R, Gilard M, Tchétché D, Möllmann H, Makkar RR, Baldus S, De Backer O, Bendz B, Kini A, von Lewinski D, Mack M, Moreno R, Schäfer U, Wöhrle J, Seeger J, Snyder C, Nicolas J, Tijssen JGP, Welsh RC, Vranckx P, Valgimigli M, Mehran R, Kapadia S, Sondergaard L, Windecker S.
Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial.
Lewis GD, Voors AA, Cohen-Solal A, Metra M, Whellan DJ, Ezekowitz JA, Böhm M, Teerlink JR, Docherty KF, Lopes RD, Divanji PH, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Felker GM.
Patients With Acute Coronary Syndromes Admitted to Contemporary Cardiac Intensive Care Units: Insights From the CCCTN Registry.
Fagundes A Jr, Berg DD, Park JG, Baird-Zars VM, Newby LK, Barsness GW, Miller PE, van Diepen S, Katz JN, Phreaner N, Roswell RO, Menon V, Daniels LB, Morrow DA, Bohula EA; CCCTN Investigators.
The State of Heart Failure Care in Canada: Minimal Improvement in Readmissions Over Time Despite an Increased Number of Evidence-Based Therapies.
Poon S, Leis B, Lambert L, MacFarlane K, Anderson K, Blais C, Demers C, Ezekowitz JA, Hawkins NM, Lee DS, Moe G, Sandhu RK, Virani SA, Wilton S, Zieroth S, McKelvie R.
Polygenic Risk Score Predicts Sudden Death in Patients With Coronary Disease and Preserved Systolic Function.
Sandhu RK, Dron JS, Liu Y, Moorthy MV, Chatterjee NA, Ellinor PT, Chasman DI, Cook NR, Khera AV, Albert CM.
Critical Care Cardiology Trials Network (CCCTN): a cohort profile.
Metkus TS, Baird-Zars VM, Alfonso CE, Alviar CL, Barnett CF, Barsness GW, Berg DD, Bertic M, Bohula EA, Burke J, Burstein B, Chaudhry SP, Cooper HA, Daniels LB, Fordyce CB, Ghafghazi S, Goldfarb M, Katz JN, Keeley EC, Keller NM, Kenigsberg B, Kontos MC, Kwon Y, Lawler PR, Leibner E, Liu S, Menon V, Miller PE, Newby LK, O'Brien CG, Papolos AI, Pierce MJ, Prasad R, Pisani B, Potter BJ, Roswell RO, Sinha SS, Shah KS, Smith TD, Snell RJ, So D, Solomon MA, Ternus BW, Teuteberg JJ, van Diepen S, Zakaria S, Morrow DA.
Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial.
Chaitman BR, Cyr DD, Alexander KP, Pracoń R, Bainey KR, Mathew A, Acharya A, Kunichoff DF, Fleg JL, Lopes RD, Sidhu MS, Anthopolos R, Rockhold FW, Stone GW, Maron DJ, Hochman JS, Bangalore S.
Towards a Broader Characterization of Macro- and Micro-Circulatory Uncoupling in Cardiogenic Shock.
Lawler PR, van Diepen S.
Telemonitoring and protocolized case management for hypertensive community dwelling older adults (TECHNOMED): a randomized controlled trial.
Lau D, Ringrose J, McAlister FA, Fradette M, Wood PW, Boulanger P, Klarenbach S, Holroyd-Leduc JM, Alagiakrishnan K, Rabi D, Padwal R.
). A Pan-Canadian Survey of Cardiogenic Shock Management: A Report from the Canadian Cardiovascular Research Collaboratory (C3) Cardiogenic Shock Working Group.
So DY, Bagai A, van Diepen S, Fordyce CB, Liu S, Avram R, Russo J, Shah AH, Tanguay JF, Goodman SG, Luk A; Canadian Cardiovascular Research Collaboratory (C3).
Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies).
Davison BA, Takagi K, Edwards C, Adams KF Jr, Butler J, Collins SP, Dorobantu MI, Ezekowitz JA, Filippatos G, Greenberg BH, Levy PD, Masip J, Metra M, Pang PS, Ponikowski P, Severin TM, Teerlink JR, Teichman SL, Voors AA, Werdan K, Cotter G.
Balancing the Risks of Recurrent Ischaemic and Bleeding Events in a Stable Post ACS Population. Heart
Brieger D, Chew D, Goodman S, Hammett C, Lefkovits J, Farouque O, Atherton J, Hyun K, D'Souza M.
Clinical Phenotypes of Heart Failure across the spectrum of Ejection Fraction: A Cluster Analysis.
Gouda P, Alemayehu W, Rathwell S, Ian Paterson D, Anderson T, Dyck JRB, Howlett JG, Oudit GY, McAlister FA, Thompson RB, Ezekowitz J; Alberta HEART Study Investigators.
Trends in Uptake and Adherence to Oral Anticoagulation for Patients With Incident Atrial Fibrillation at High Stroke Risk Across Health Care Settings.
Yogasundaram H, Dover DC, Hawkins NM, McAlister FA, Goodman SG, Ezekowitz J, Kaul P, Sandhu RK.
The Evolution of Anticoagulation for Percutaneous Coronary Intervention:A 40-Year Journey.
Bainey KR, Marquis-Gravel G, Mehta SR, Tanguay JF.
Escalating and De-escalating Temporary Mechanical Circulatory Support in Cardiogenic Shock: A Scientific Statement From the American Heart Association.
Geller BJ, Sinha SS, Kapur NK, Bakitas M, Balsam LB, Chikwe J, Klein DG, Kochar A, Masri SC, Sims DB, Wong GC, Katz JN, van Diepen S; American Heart Association Acute Cardiac Care and General Cardiology Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Peripheral Vascular Disease; and Council on Cardiovascular Surgery and Anesthesia.
Patient Onboarding and Engagement to Build a Digital Study After Enrollment in a Clinical Trial (TAILOR-PCI Digital Study): Intervention Study.
Avram R, So D, Iturriaga E, Byrne J, Lennon R, Murthy V, Geller N, Goodman S, Rihal C, Rosenberg Y, Bailey K, Farkouh M, Bell M, Cagin C, Chavez I, El-Hajjar M, Ginete W, Lerman A, Levisay J, Marzo K, Nazif T, Olgin J, Pereira N.
Multi-vessel spontaneous coronary artery dissection in a patient with aortic dissection: a case report.
Alyamani M, Aziz A, Nagendran J, Welsh RC.
The Intersection between Heart Failure and Critical Care Cardiology: An International Perspective on Structure, Staffing, and Design Considerations.
Sinha SS, Bohula EA, van Diepen S, Leonardi S, Mebazaa A, Proudfoot AG, Sionis A, Chia YW, Zampieri FG, Lopes RD, Katz JN.
. Percutaneous coronary intervention with peripheral artery disease in the contemporary era: Still life or limb?
Kumar R, Bainey KR.
Population Pharmacokinetics of Vericiguat in Patients with Heart Failure with Reduced Ejection Fraction: An Integrated Analysis.
Trujillo ME, Arrington L, Patel Y, Passarell J, Wenning L, Blaustein RO, Armstrong PW, Meyer M, Becker C, Gheyas F.
Sex-Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial.
Madan M, Abbott JD, Lennon R, So DYF, MacDougall AM, McLaughlin MA, Murthy V, Saw J, Rihal C, Farkouh ME, Pereira NL, Goodman SG, TAILOR‐PCI Investigators.
Nationwide Study of Sex Differences in Incident Heart Failure in Newly Diagnosed Nonvalvular Atrial Fibrillation.
Yogasundaram H, Islam S, Dover DC, Hawkins NM, Ezekowitz JA, Kaul P, Sandhu RK.
Comparison of Mortality and Hospital Readmissions Among Patients Receiving Virtual Ward Transitional Care vs Usual Postdischarge Care: A Systematic Review and Meta-analysis.
Chauhan U, McAlister FA.
Relationship of frailty with excess mortality during the COVID-19 pandemic: a population-level study in Ontario, Canada.
Wijeysundera HC, Abdel-Qadir H, Qiu F, Manoragavan R, Austin PC, Kapral MK, Kwong JC, Sun LY, Ross HJ, Udell JA, Roifman I, Yu AYX, Chu A, McAlister FA, Lee DS.
Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT study.
Pahuja M, Leifer ES, Clarke JD, Ahmad T, Daubert MA, Mark DB, Cooper L, Desvigne-Nickens P, Fiuzat M, Adams K, Ezekowitz J, Whellan DJ, Januzzi JL, O'Connor CM, Felker GM, Piña IL.
Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial.
Bahit MC, Vora AN, Li Z, Wojdyla DM, Thomas L, Goodman SG, Aronson R, Jordan JD, Kolls BJ, Dombrowski KE, Vinereanu D, Halvorsen S, Berwanger O, Windecker S, Mehran R, Granger CB, Alexander JH, Lopes RD.
Clinical features and complications of Loeys-Dietz syndrome: A systematic review.
Gouda P, Kay R, Habib M, Aziz A, Aziza E, Welsh R.
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial.
Cantor WJ, Tan M, Berwanger O, Lavi S, White HD, Nicolau JC, Dehghani P, Tajer CD, Lopes RD, Moia DDF, Nicholls SJ, Parkhomenko A, Averkov O, Brass N, Lutchmedial S, Malaga G, Damiani LP, Piegas LS, Granger CB, Goodman SG.
Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease.
Primary Panel:, Abramson BL, Al-Omran M, Anand SS, Albalawi Z, Coutinho T, de Mestral C, Dubois L, Gill HL, Greco E, Guzman R, Herman C, Hussain MA, Huckell VF, Jetty P, Kaplovitch E, Karlstedt E, Kayssi A, Lindsay T, Mancini GBJ, McClure G, McMurtry MS, Mir H, Nagpal S, Nault P, Nguyen T, Petrasek P, Rannelli L, Roberts DJ, Roussin A, Saw J, Srivaratharajah K, Stone J, Szalay D, Wan D; Secondary Panel:, Cox H, Verma S, Virani S.
Transcatheter Aortic Valve Implantation in a Failed Perceval Sutureless Valve, Complicated by Aortic Annular Rupture.
Kay RT, Linjawi H, Butler C, Mathew A, Muhll IV, Khandekar S, Tyrrell BD, Nagendran J, Taylor D, Welsh RC.
Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada.
Udell JA, Behrouzi B, Sivaswamy A, Chu A, Ferreira-Legere LE, Fang J, Goodman SG, Ezekowitz JA, Bainey KR, van Diepen S, Kaul P, McAlister FA, Bogoch II, Jackevicius CA, Abdel-Qadir H, Wijeysundera HC, Ko DT, Austin PC, Lee DS.
Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial.
Butler J, Stebbins A, Melenovský V, Sweitzer NK, Cowie MR, Stehlik J, Khan MS, Blaustein RO, Ezekowitz JA, Hernandez AF, Lam CSP, Nkulikiyinka R, O'Connor CM, Pieske BM, Ponikowski P, Spertus JA, Voors AA, Anstrom KJ, Armstrong PW; VICTORIA Study Group.
Targeted temperature management after out of hospital cardiac arrest: quo vadis?
Krychtiuk KA, Fordyce CB, Hansen CM, Hassager C, Jentzer JC, Menon V, Perman SM, van Diepen S, Granger CB.
A Comprehensive Appraisal of Risk Prediction Models for Cardiogenic Shock.
Bhat AG, van Diepen S, Katz JN, Islam A, Tehrani BN, Truesdell AG, Kapur NK, Holmes DR Jr, Menon V, Jaber WA, Nicholson WJ, Zhao DX, Vallabhajosyula S.
The risk of death or unplanned readmission after discharge from a COVID-19 hospitalization in Alberta and Ontario.
McAlister FA, Dong Y, Chu A, Wang X, Youngson E, Quinn KL, Verma A, Udell JA, Yu AYX, Razak F, Ho C, de Mestral C, Ross HJ, van Walraven C, Lee DS; CORONA Collaboration.
Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry.
Fox KAA, Aboyans V, Debus ES, Zeymer U, Cowie MR, Patel M, Welsh RC, Bosch J, Gay A, Vogtländer K, Anand SS.
Evaluation and management of chronic kidney disease patients with stable ischemic heart disease.
Welsh RC, Kay R, Bainey KR.
Epidemiology of worsening heart failure in a population-based cohort from Alberta, Canada: Evaluating eligibility for treatment with vericiguat.
Sepehrvand N, Islam S, Dover DC, Kaul P, McAlister FA, Armstrong PW, Ezekowitz JA.
Diversity in the Expressed Genomic Host Response to Myocardial Infarction.
Toma A, Dos Santos C, Burzyńska B, Góra M, Kiliszek M, Stickle N, Kirsten H, Kosyakovsky L, Wang B, van Diepen S, Epelman S, Szekely Y, Marshall JC, Billia F, Lawler PR.
A Call to Move from Point-in-Time towards Comprehensive Dynamic Risk Prediction in Critically Ill Patients with Heart Failure.
van Diepen S, Katz JN.
Sex Differences in the Management of Oral Anticoagulation and Outcomes for Emergency Department Presentation of Incident Atrial Fibrillation.
Islam S, Dover DC, Daniele P, Hawkins NM, Humphries KH, Kaul P, Sandhu RK.
The impact of shifting demographics, variants of concern and vaccination on outcomes during the first 3 COVID-19 waves in Alberta and Ontario: a retrospective cohort study.
McAlister FA, Nabipoor M, Chu A, Lee DS, Saxinger L, Bakal JA; CORONA Collaboration.
Identifying subgroups of adult high-cost health care users: a retrospective analysis.
Wick J, Campbell DJT, McAlister FA, Manns BJ, Tonelli M, Beall RF, Hemmelgarn BR, Stewart A, Ronksley PE.
Heart Rhythm Society Atrial Fibrillation Centers of Excellence Study: A survey analysis of stakeholder practices, needs, and barriers.
Sandhu RK, Seiler A, Johnson CJ, Bunch TJ, Deering TF, Deneke T, Kirchhof P, Natale A, Piccini JP Sr, Russo AM, Hills MT, Varosy PD, Araia A, Smith AM, Freeman J.
Epidemiology and Outcomes of Patients Readmitted to the Intensive Care Unit After Cardiac Intensive Care Unit Admission.
Padkins M, Fanaroff A, Bennett C, Wiley B, Barsness G, van Diepen S, Katz JN, Jentzer JC.
Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial.
Ezekowitz JA, Colin-Ramirez E, Ross H, Escobedo J, Macdonald P, Troughton R, Saldarriaga C, Alemayehu W, McAlister FA, Arcand J, Atherton J, Doughty R, Gupta M, Howlett J, Jaffer S, Lavoie A, Lund M, Marwick T, McKelvie R, Moe G, Pandey AS, Porepa L, Rajda M, Rheault H, Singh J, Toma M, Virani S, Zieroth S; SODIUM-HF Investigators.
Fluid restriction: Time to let it flow?
Ezekowitz JA.
Objective risk assessment vs standard care for acute coronary syndromes-The Australian GRACE Risk tool Implementation Study (AGRIS): a process evaluation.
Gullick J, Wu J, Chew D, Gale C, Yan AT, Goodman SG, Waters D, Hyun K, Brieger D.
Associated factors and clinical outcomes in mechanical circulatory support use in patients undergoing high risk on-pump cardiac surgery: Insights from the LEVO-CTS trial.
Verma S, Rathwell S, Fremes S, Zheng Y, Mehta R, Lopes RD, Alexander JH, Goodman SG, van Diepen S, LEVO-CTS investigators.
Point of care CYP2C19 genotyping after percutaneous coronary intervention.
Baudhuin LM, Train LJ, Goodman SG, Lane GE, Lennon RJ, Mathew V, Murthy V, Nazif TM, So DYF, Sweeney JP, Wu AHB, Rihal CS, Farkouh ME, Pereira NL.
Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial.
Lopes RD, Guimarães PO, Schwartz GG, Bhatt DL, Bittner VA, Budaj A, Dalby AJ, Diaz R, Goodman SG, Harrington RA, Jukema JW, Kiss RG, Loy M, Pordy R, Poulouin Y, Szarek M, White HD, Steg PG, ODYSSEY OUTCOMES Investigators.
Sonothrombolysis Augments Reperfusion in ST-Elevation Myocardial Infarction With Primary Percutaneous Coronary Intervention: Insights From the SONOSTEMI Study.
Bainey KR, Abulhamayel A, Aziz A, Becher H.
. Changes in ischemic stroke presentations, management and outcomes during the first year of the COVID-19 pandemic in Alberta: a population study.
Ganesh A, Stang JM, McAlister FA, Shlakhter O, Holodinsky JK, Mann B, Hill MD, Smith EE.
Defining Changes in Physical Limitation from the Patient Perspective: Insights from the VITALITY-HFpEF Randomized Trial.
Butler J, Spertus JA, Bamber L, Khan MS, Roessig L, Vlajnic V, Norquist JM, Anstrom KJ, Blaustein RO, Lam CSP, Armstrong PW; VITALITY-HFpEF Study Group.
Medical Therapy During Hospitalization for Heart Failure with Reduced Ejection Fraction: The VICTORIA Registry: Medical Therapy During Hospitalization for HFrEF.
Greene SJ, Ezekowitz JA, Anstrom KJ, Demyanenko V, Givertz MM, Piña IL, O'Connor CM, Joerg, Roessig L, Hernandez AF, Armstrong PW, Mentz RJ.
Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk.
Miller RJH, Nabipoor M, Youngson E, Kotrri G, Fine NM, Howlett JG, Paterson ID, Ezekowitz J, McAlister FA.
2022 CCS/CAIC Guidelines for Training and Retraining in Adult Interventional Cardiology.
Bainey KR, Bastiany A, Cohen E, Eckstein J, Elbarouni B, Graham MM, Kidwai B, Lavoie A, Liu S, Mansour S, Matteau A, O'Neill B, Sathananthan J, Sibbald M, Welsh RC, Madan M.
Derivation and validation of a clinical risk score to predict death among patients awaiting cardiac surgery in Ontario, Canada: a population-based study.
Sun LY, Wijeysundera HC, Lee DS, van Diepen S, Ruel M, Eddeen AB, Mesana TG.
Temporal trends of suicide-related non-traumatic out-of-hospital cardiac arrest characteristics and outcomes with the COVID-19 pandemic.
Yap J, Scheuermeyer FX, van Diepen S, Barbic D, Straight R, Wall N, Asamoah-Boaheng M, Christenson J, Grunau B.
ABCD-GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial.
Capodanno D, Angiolillo DJ, Lennon RJ, Goodman SG, Kim S-W, O'Cochlain F, So DY, Sweeney J, Rihal CS, Farkouh M, Pereira NL.
Efficacy and safety of proton pump inhibitors versus histamine-2 receptor blockers in the cardiac surgical population: insights from the PEPTIC trial.
van Diepen S, Coulson T, Wang X, Opgenorth D, Zuege DJ, Harris J, Agyemang M, Niven DJ, Bellomo R, Wright SE, Young PJ, Bagshaw SM; PEPTIC study investigators and the ANZICS Clinical Trials Group.
The COVID-19 Pandemic Impacted Maternal Mental Health Differently Depending on Pregnancy Status and Trimester of Gestation.
Bérard A, Gorgui J, Tchuente V, Lacasse A, Gomez Y-H, Côté S, King S, Muanda F, Mufike Y, Boucoiran I, Nuyt AM, Quach C, Ferreira E, Kaul P, Winquist B, O'Donnell KJ, Eltonsy S, Chateau D, Zhao J-P, Hanley G, Oberlander T, Kassai B, Mainbourg S, Bernatsky S, Vinet É, Brodeur-Doucet A, Demers J, Richebé P, Zaphiratos V.
Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction.
Scanavini-Filho MA, Berwanger O, Matthias W, Aguiar MO, Chiang HP, Azevedo L, Baracioli LM, Lima FG, Furtado RHM, Dalcoquio TF, Menezes FR, Ferrari AG, de Luca F, Giugliano RP, Goodman S, Nicolau JC.
Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial.
Garrison SR, Kolber MR, Allan GM, Bakal J, Green L, Singer A, Trueman DR, McAlister FA, Padwal RS, Hill MD, Manns B, McGrail K, O'Neill B, Greiver M, Froentjes LS, Manca DP, Mangin D, Wong ST, MacLean C, Kirkwood JE, McCracken R, McCormack JP, Norris C, Korownyk T.
Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HF.
Lewis GD, Docherty KF, Voors AA, Cohen-Solal A, Metra M, Whellan DJ, Ezekowitz JA, Ponikowski P, Böhm M, Teerlink JR, Heitner SB, Kupfer S, Malik FI, Meng L, Felker GM.
Vericiguat in Patients with Coronary Artery Disease and Heart Failure with Reduced Ejection Fraction.
Saldarriaga C, Atar D, Stebbins A, Lewis BS, Zainal Abidin I, Blaustein RO, Butler J, Ezekowitz JA, Hernandez AF, Lam CSP, O'Connor CM, Pieske B, Ponikowski P, Roessig L, Voors AA, Anstrom KJ, Armstrong PW; VICTORIA Study Group
The Evolution of Antiplatelet Therapy Following Percutaneous Coronary Interventions: a 40-Year Journey.
Marquis-Gravel G, Robert-Halabi M, Bainey KR, Tanguay JF, Mehta SR.
A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes.
Alkhalil M, Kuzemczak M, Bell A, Stern S, Welsford M, Cantor WJ, Goodman SG.
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial.
Welsh RC, Dehghani P, Lopes R, Wojdyla DM, Aronson R, Granger CB, Windecker S, Vora AN, Vinereanu D, Halvorsen S, Parkhomenko A, Mehran R, Alexander JH, Goodman S.
Arrhythmias in Female Patients: Incidence, Presentation and Management.
Zeitler EP, Poole JE, Albert CM, Al-Khatib SM, Ali-Ahmed F, Birgersdotter-Green U, Cha YM, Chung MK, Curtis AB, Hurwitz JL, Lampert R, Sandhu RK, Shaik F, Sullivan E, Tamirisa KP, Santos Volgman A, Wright JM, Russo AM
A Randomized Controlled Trial of Renin-Angiotensin-Aldosterone System Inhibitor Management in Patients Admitted in Hospital with COVID-19.
Sharma A, Elharram M, Afilalo J, Flannery A, Afilalo M, Tselios C, Ni J, Ezekowitz JA, Cheng MP, Ambrosy AP, Zannad F, Brophy J, Giannetti N, Bessissow A, Kronfli N, Marelli A, Aziz H, Alqahtani M, Aflaki M, Craig M, Lopes RD, Ferreira JP
Modeling optimal AED placement to improve cardiac arrest survival: The challenge is implementation.
van Diepen S, Hansen CM.
A pragmatic lab-based tool for risk assessment in cardiac critical care: data from the Critical Care Cardiology Trials Network (CCCTN) Registry.
Patel SM, Jentzer JC, Alviar CL, Baird-Zars VM, Barsness GW, Berg DD, Bohula EA, Daniels LB, DeFilippis AP, Keeley EC, Kontos MC, Lawler PR, Miller PE, Park JG, Roswell RO, Solomon MA, van Diepen S, Katz JN, Morrow DA.
Concomitant Sepsis Diagnoses in Acute Myocardial Infarction-Cardiogenic Shock: 15-Year National Temporal Trends, Management, and Outcomes.
Jentzer JC, Bhat AG, Patlolla SH, Sinha SS, Miller PE, Lawler PR, van Diepen S, Khanna AK, Zhao DX, Vallabhajosyula S.
Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration.
Rivard L, Friberg L, Conen D, Healey JS, Berge T, Boriani G, Brandes A, Calkins H, Camm AJ, Yee Chen L, Lluis Clua Espuny J, Collins R, Connolly S, Dagres N, Elkind MSV, Engdahl J, Field TS, Gersh BJ, Glotzer TV, Hankey GJ, Harbison JA, Georg Haeusler K, Hills MT, Johnson LSB, Joung B, Khairy P, Kirchhof P, Krieger D, Lip GYH, Løchen ML, Madhavan M, Mairesse GH, Montaner J, Ntaios G, Quinn TJ, Rienstra M, Rosenqvist M, Sandhu RK, Smyth B, Schnabel RB, Stavrakis S, Themistoclakis S, Van Gelder IC, Wang JG, Freedman B.
SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021.
Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, Grines CL, Diercks DB, Hall S, Kapur NK, Kent W, Rao SV, Samsky MD, Thiele H, Truesdell AG, Henry TD.
Factors associated with SARS-CoV-2 test positivity in long-term care homes: A population-based cohort analysis using machine learning.
Lee DS, Wang CX, McAlister FA, Ma S, Chu A, Rochon PA, Kaul P, Austin PC, Wang X, Kalmady SV, Udell JA, Schull MJ, Rubin BB, Wang B.
Inhaled nitric oxide does not improve maximal oxygen consumption in endurance trained and untrained healthy individuals.
Brotto AR, Phillips DB, Meah VL, Ross BA, Fuhr DP, Beaudry RI, van Diepen S, Stickland MK.
The Introduction of Direct Oral Anticoagulants Has Not Resolved Treatment Gaps for Frail Patients With Nonvalvular Atrial Fibrillation.
Orlandi M, Dover DC, Sandhu RK, Hawkins NM, Kaul P, McAlister FA.
The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial.
McDonald EG, Wu PE, Rashidi B, Wilson MG, Bortolussi-Courval É, Atique A, Battu K, Bonnici A, Elsayed S, Wilson AG, Papillon-Ferland L, Pilote L, Porter S, Murphy J, Ross SB, Shiu J, Tamblyn R, Whitty R, Xu J, Fabreau G, Haddad T, Palepu A, Khan N, McAlister FA, Downar J, Huang AR, MacMillan TE, Cavalcanti RB, Lee TC.
Representation of Females in Atrial Fibrillation Clinical Practice Guidelines.
Alipour P, Azizi Z, Norris CM, Raparelli V, McMurtry MS, Macle L, Andrade J, Pilote L.
Long-Term Outcomes for Patients With Acute Coronary Syndrome and Nonvalvular Atrial Fibrillation.
Gouda P, Dover DC, Savu A, Bainey K, Goodman SG, Welsh R, Kaul P, Sandhu RK.
Association between maternal glucose and large for gestational outcomes: Real-world evidence to support Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study findings.
Kaul P, Savu A, Yeung RO, Ryan EA.
End-of-life care in the cardiac intensive care unit: a contemporary view from the Critical Care Cardiology Trials Network (CCCTN) Registry.
Fagundes A, Berg DD, Bohula EA, Baird-Zars VM, Barnett CF, Carnicelli AP, Chaudhry SP, Guo J, Keeley EC, Kenigsberg BB, Menon V, Miller PE, Newby LK, van Diepen S, Morrow DA, Katz JN.
Predicting 30-Day Readmissions in Patients With Heart Failure Using Administrative Data: A Machine Learning Approach.
Sharma V, Kulkarni V, McAlister F, Eurich D, Keshwani S, Simpson SH, Voaklander D, Samanani S.
Prevalence of Cardiovascular Disease in a Population-Based Cohort of High-Cost Healthcare Services Users.
Kaul P, Klassen N, Dover DC, Sepehrvand N, Sandhu RK, van Diepen S, Bainey K, McMurtry MS, Welsh RC, Ezekowitz JA, Goodman SG, Armstrong PW, McAlister FA.
Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial.
Fudim M, Wojdyla DM, Alexander JH, Goodman SG, Mehran R, Windecker S, Aronson R, Vinereanu D, Halvorsen S, Bahit MC, Granger CB, Lopes RD.
Shock Severity Assessment in Cardiac Intensive Care Unit Patients With Sepsis and Mixed Septic-Cardiogenic Shock.
Jentzer JC, van Diepen S, Hollenberg SM, Lawler PR, Kashani KB.
A Population-Based Study of Unexplained/Lone Atrial Fibrillation: Temporal Trends, Management, and Outcomes.
Roston TM, Islam S, Hawkins NM, Krahn AD, Sandhu R, Kaul P.
Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction.
Carnicelli AP, Owen R, Pocock SJ, Brieger DB, Yasuda S, Nicolau JC, Goodman SG, Cohen MG, Simon T, Westermann D, Hedman K, Andersson Sundell K, Granger CB.
Provision of a DAPT Score to Cardiologists and Extension of Dual Antiplatelet Therapy Beyond 1 Year After ACS: Randomized Substudy of the Prospective Canadian ACS Reflective II Study.
Arbel Y, Patel AD, Goodman SG, Tan MK, Suskin N, McKelvie RS, Mathew AL, Ahmed F, Lutchmedial S, Dehghani P, Lavoie AJ, Huynh T, Lavi S, Khan R, Yan AT, Fordyce CB, Heffernan M, Jedrzkiewicz S, Madan M, Ahmed S, Barry C, Dery J-P, Bagai A.
Association of Cardiology Billing Amounts With Health Care Utilization and Clinical Outcomes in Patients With Atrial Fibrillation.
Bhatia RS, Chu C, Kaoutskaia A, Ko DT, Shojania KG, Dorian P, Yu B, Shurrab M, Fang J, Ross H, Austin PC, Bouck Z, Goodman SG, Crystal E.
Peripheral blood neutrophil-to-lymphocyte ratio is associated with mortality across the spectrum of cardiogenic shock severity.
Jentzer JC, Szekely Y, Burstein B, Ballal Y, Kim EY, van Diepen S, Tabi M, Wiley B, Kashani KB, Lawler PR.
Clarifying Transcatheter Aortic Valve Implantation Training Requirement Recommendations for Physicians Currently in Practice.
Asgar AW, Ouzounian M, Adams C, Afilalo J, Fremes S, Lauck S, Leipsic J, Piazza N, Rodes-Cabau J, Welsh R, Wijeysundera HC, Webb JG, 2019 CCS TAVI Position Statement Committee.
Contemporary Management of Cardiogenic Shock: A RAND Appropriateness Panel Approach.
Proudfoot AG, Kalakoutas A, Meade S, Griffiths MJD, Basir M, Burzotta F, Chih S, Fan E, Haft J, Ibrahim N, Kruit N, Lim HS, Morrow DA, Nakata J, Price S, Rosner C, Roswell R, Samaan MA, Samsky MD, Thiele H, Truesdell AG, van Diepen S, Voeltz MD, Irving PM.
Sex and Medium-term Outcomes of ST-Segment Elevation Myocardial Infarction in Kerala, India: A Propensity Score–Matched Analysis.
Mathew A, Hong Y, Yogasundaram H, Nagendran J, Punnoose E, Ashraf SM, Fischer L, Abdullakutty J, Pisharody S, Bainey K, Graham M.
Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: Findings From the CONNECT AF+PCI Study.
Valle FD, Goodman SG, Tan M, Ha A, Mansour S, Welsh RC, Yan AT, Bainey KR, Rinfret S, Potter BJ, Khan R, Simkus G, Natarajan MK, Schwalm JD, Daneault B, Eisenberg MJ, Abunassar J, Har B, Gregoire J, Tanguay J-F, Overgaard CB, Dery J-P, De Larochelliere R, Paradis J-M, Madan M, Elbarouni B, So DYF, Ata-Ur-Rehman Quraishi A-U-R, Bagai A, on behalf of the CONNECT AF+PCI Study Investigators.
Automated interpretation of systolic and diastolic function on the echocardiogram: a multicohort study.
Tromp J, Seekings PJ, Hung CL, Iversen MB, Frost MJ, Ouwerkerk W, Jiang Z, Eisenhaber F, Goh RSM, Zhao H, Huang W, Ling LH, Sim D, Cozzone P, Richards AM, Lee HK, Solomon SD, Lam CSP, Ezekowitz JA.
Chloride in Heart Failure: The Neglected Electrolyte.
Zandijk AJL, van Norel MR, Julius FEC, Sepehrvand N, Pannu N, McAlister FA, Voors AA, Ezekowitz JA.
Survival in Patients With Suspected Myocardial Infarction With Nonobstructive Coronary Arteries: A Comprehensive Systematic Review and Meta-Analysis From the MINOCA Global Collaboration.
Pasupathy S, Lindahl B, Litwin P, Tavella R, Williams MJA, Air T, Zeitz C, Smilowitz NR, Reynolds HR, Eggers KM, Nordenskjöld AM, Barr P, Jernberg T, Marfella R, Bainey K, Sodoon Alzuhairi K, Johnston N, Kerr A, Beltrame JF.
The influence of comorbidities on achieving an N-terminal pro-b-type natriuretic peptide target: a secondary analysis of the GUIDE-IT trial.
Ezekowitz JA, Alemayehu W, Rathwell S, Grant AD, Fiuzat M, Whellan DJ, Ahmad T, Adams K, Piña IL, Cooper LS, Januzzi JL, Leifer ES, Mark D, O'Connor CM, Felker GM.
Duration at high altitude influences the onset of arrhythmogenesis during apnea.
Berthelsen LF, van Diepen S, Steele AR, Vanden Berg ER, Bird J, Thrall S, Skalk A, Byman B, Pentz B, Wilson RJA, Jendzjowsky NG, Day TA, Steinback CD.
Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial.
Lam CSP, Mulder H, Lopatin Y, Vazquez-Tanus JB, Siu D, Ezekowitz J, Pieske B, O'Connor CM, Roessig L, Patel MJ, Anstrom KJ, Hernandez AF, Armstrong PW; VICTORIA Study Group.
Statins and SARS-CoV-2 Infection: Results of a Population-Based Prospective Cohort Study of 469 749 Adults From 2 Canadian Provinces.
McAlister FA, Wang T, Wang X, Chu A, Goodman SG, van Diepen S, Jackevicius CA, Kaul P, Udell J, Ko DT, Kwong JC, Austin PC, Lee DS; CORONA Collaboration *.
Novel multi-marker proteomics in phenotypically matched patients with ST-segment myocardial infarction: association with clinical outcomes.
Shavadia JS, Alemayehu W, deFilippi C, Westerhout CM, Tromp J, Granger CB, Armstrong PW, van Diepen S.
Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine.
Sharma A, Zheng Y, Ezekowitz JA, Westerhout CM, Udell JA, Goodman SG, Armstrong PW, Buse JB, Green JB, Josse RG, Kaufman KD, McGuire DK, Ambrosio G, Chuang LM, Lopes RD, Peterson ED, Holman RR.
Canadian Registry of Electronic Device Outcomes: remote monitoring outcomes in the Abbott battery performance alert-a multicentre cohort.
Kumar S, Davis J, Thibault B, Mangat I, Coutu B, Bennett M, Philippon F, Sandhu R, Sterns L, Essebag V, Nery P, Wells G, Yee R, Exner D, Krahn A, Parkash R.
Early invasive coronary angiography and acute ischaemic heart failure outcomes.
Kosyakovsky LB, Austin PC, Ross HJ, Wang X, Abdel-Qadir H, Goodman SG, Farkouh ME, Croxford R, Lawler PR, Spertus JA, Lee DS
Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes
Sarak B, Verma S, Mazer CD, Teoh H, Quan A, Gilbert RE, Goodman SG, Bami K, Coelho-Filho OR, Ahooja V, Deva DP, Garg V, Gandhi S, Connelly KA, Yan AT.
Biventricular function and shock severity predict mortality in cardiac intensive care unit patients.
Burstein B, van Diepen S, Wiley BM, Anavekar NS, Jentzer JC.
De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry.
Bhatt AS, Berg DD, Bohula EA, Alviar CL, Baird-Zars VM, Barnett CF, Burke JA, Carnicelli AP, Chaudhry SP, Daniels LB, Fang JC, Fordyce CB, Gerber DA, Guo J, Jentzer JC, Katz JN, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Nativi-Nicolau J, Phreaner N, Roswell RO, Sinha SS, Jeffrey Snell R, Solomon MA, van Diepen S, Morrow DA.
Cardiac remodelling predicts outcome in patients with chronic heart failure.
Xu L, Pagano J, Chow K, Oudit GY, Haykowsky MJ, Mikami Y, Howarth AG, White JA, Howlett JG, Dyck JRB, Anderson TJ, Ezekowitz JA, Thompson RB, Paterson DI.
Predictors of Outcome in the ISCHEMIA-CKD Trial: Anatomy versus Ischemia.
Bainey KR, Fleg JL, Hochman JS, Kunichoff DF, Anthopolos R, Chernyavskiy AM, Demkow M, Lopez-Quijano JM, Escobedo J, Poh KK, Ramos RB, Lima EG, Schuchlenz H, Ali ZA, Stone GW, Maron DJ, O'Brien SM, Spertus JA, Bangalore S.
Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams.
Papolos AI, Kenigsberg BB, Berg DD, Alviar CL, Bohula E, Burke JA, Carnicelli AP, Chaudhry SP, Drakos S, Gerber DA, Guo J, Horowitz JM, Katz JN, Keeley EC, Metkus TS, Nativi-Nicolau J, Snell JR, Sinha SS, Tymchak WJ, van Diepen S, Morrow DA, Barnett CF; Critical Care Cardiology Trials Network Investigators.
Participation in a Heart Failure Clinical Trial: Perspectives and Opportunities From the VICTORIA Trial and VICTORIA Simultaneous Registry.
Ezekowitz J, Mentz RJ, Westerhout CM, Sweitzer NK, Givertz MM, Piña IL, O'Connor CM, Greene SJ, McMullan C, Roessig L, Hernandez AF, Armstrong PW.
Residuals: Mitral Regurgitation, Bias, and Effects of Medical Therapy.
Ezekowitz JA.
Clinical factors associated with peripheral artery disease in patients with documented coronary artery disease: A post hoc analysis of the COMPASS trial. Atherosclerosis.
Gouda P, Ramasundarahettige C, Anand S, Muhlhoffer E, Berkowitz S, Fox KA, Eikelboom J, Welsh R.
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
REMAP-CAP Investigators; ACTIV-4a Investigators; ATTACC Investigators, Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF, Kornblith LZ, Kahn SR, Marshall JC, Kim KS, Houston BL, Derde LPG, Cushman M, Tritschler T, Angus DC, Godoy LC, McQuilten Z, Kirwan BA, Farkouh ME, Brooks MM, Lewis RJ, Berry LR, Lorenzi E, Gordon AC, Berry SM, McArthur CJ, Neal MD, Hochman JS, Webb SA, Zarychanski R, Ahuja T, Al-Beidh F, Annane D, Arabi YM, Aryal D, Baumann Kreuziger L, Beane A, Bhimani Z, Bihari S, Billett HH, Bond L, Bonten M, Brunkhorst F, Buxton M, Buzgau A, Castellucci LA, Chekuri S, Chen JT, Cheng AC, Chkhikvadze T, Coiffard B, Contreras A, Costantini TW, de Brouwer S, Detry MA, Duggal A, Džavík V, Effron MB, Eng HF, Escobedo J, Estcourt LJ, Everett BM, Fergusson DA, Fitzgerald M, Fowler RA, Froess JD, Fu Z, Galanaud JP, Galen BT, Gandotra S, Girard TD, Goodman AL, Goossens H, Green C, Greenstein YY, Gross PL, Haniffa R, Hegde SM, Hendrickson CM, Higgins AM, Hindenburg AA, Hope AA, Horowitz JM, Horvat CM, Huang DT, Hudock K, Hunt BJ, Husain M, Hyzy RC, Jacobson JR, Jayakumar D, Keller NM, Khan A, Kim Y, Kindzelski A, King AJ, Knudson MM, Kornblith AE, Kutcher ME, Laffan MA, Lamontagne F, Le Gal G, Leeper CM, Leifer ES, Lim G, Gallego Lima F, Linstrum K, Litton E, Lopez-Sendon J, Lother SA, Marten N, Saud Marinez A, Martinez M, Mateos Garcia E, Mavromichalis S, McAuley DF, McDonald EG, McGlothlin A, McGuinness SP, Middeldorp S, Montgomery SK, Mouncey PR, Murthy S, Nair GB, Nair R, Nichol AD, Nicolau JC, Nunez-Garcia B, Park JJ, Park PK, Parke RL, Parker JC, Parnia S, Paul JD, Pompilio M, Quigley JG, Rosenson RS, Rost NS, Rowan K, Santos FO, Santos M, Santos MO, Satterwhite L, Saunders CT, Schreiber J, Schutgens REG, Seymour CW, Siegal DM, Silva DG Jr, Singhal AB, Slutsky AS, Solvason D, Stanworth SJ, Turner AM, van Bentum-Puijk W, van de Veerdonk FL, van Diepen S, Vazquez-Grande G, Wahid L, Wareham V, Widmer RJ, Wilson JG, Yuriditsky E, Zhong Y.
Impact of Atrial Fibrillation Case Volume in the Emergency Department on Early and Late Outcomes of Patients With New Atrial Fibrillation.
Hawkins NM, Youngson E, Sandhu RK, Scheuermeyer FX, Ezekowitz JA, Kaul P, McAlister FA.
Complete Revascularization in Patients Undergoing a Pharmacoinvasive Strategy for ST-Segment-Elevation Myocardial Infarction: Insights From the COMPLETE Trial.
Dehghani P, Cantor WJ, Wang J, Wood DA, Storey RF, Mehran R, Bainey KR, Welsh RC, Rodés-Cabau J, Rao S, Lavi S, Velianou JL, Natarajan MK, Ziakas A, Guiducci V, Fernández-Avilés F, Cairns JA, Mehta SR.
The association between cardiac intensive care unit mechanical ventilation volumes and in-hospital mortality.
Nandiwada S, Islam S, Jentzer JC, Miller PE, Fordyce CB, Lawler P, Alviar CL, Sun LY, Dover DC, Lopes RD, Kaul P, van Diepen S.
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg P; ODYSSEY Outcomes Committees and Investigators.
Treatment Inertia in Patients With Familial Hypercholesterolemia.
Langer A, Mancini GBJ, Tan M, Goodman SG, Ahooja V, Grégoire J, Lin PJ, Stone JA, Leiter LA.
Sex-Differences in Cause of Death for Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction (from the ASCEND-HF Trial).
Chow C, Greene SJ, North R, Blumer V, Truby LK, Alhanti B, Butler J, Ezekowitz JA, Starling RC, Mentz RJ.
Effect of patient-centered transitional care services on patient-reported outcomes in heart failure: sex-specific analysis of the PACT-HF randomized controlled trial.
Blumer V, Gayowsky A, Xie F, Greene SJ, Graham MM, Ezekowitz JA, Perez R, Ko DT, Thabane L, Zannad F, Van Spall HG.
Medical Management of Peripheral Arterial Disease: Deciphering the Intricacies of Therapeutic Options.
Sunner SS, Welsh RC, KR Bainey.
Cost-Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation.
au D, Sandhu RK, Andrade JG, Ezekowitz J, So H, Klarenbach S.
An updated reference for age-sex-specific birth weight percentiles stratified for ethnicity based on data from all live birth infants between 2005 and 2014 in Alberta, Canada.
Hajihosseini M, Savu A, Moore L, Dinu I, Kaul P.
Use of Antithrombotic Therapy for Secondary Prevention in Patients with Stable Atherosclerotic Cardiovascular Disease: Insights from the COordinated National Network to Engage Cardiologists in the antithrombotic Treatment of patients with CardioVascular Disease (CONNECT-CVD) Study.
Verma S, Goodman SG, Tan MK, Daneault B, Lubelsky BJ, Mansour S, Lam AS, Laflamme D, Tymchak WJ, Welsh RC, Rose RC, Chetty RM, Constance CM, Cieza T, Potter BJ, Hartleib MC, Khan R, Choi RF, Keeble W, Dery JP, Shukla D, Chua GL, Bainey KR.
Feasibility of Incorporating Voice Technology and Virtual Assistants in Cardiovascular Care and Clinical Trials.
Gouda P, Ganni E, Chung P, Randhawa VK, Marquis-Gravel G, Avram R, Ezekowitz JA, Sharma A.
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial.
Mentz RJ, Mulder H, Mosterd A, Sweitzer NK, Senni M, Butler J, Ezekowitz JA, Lam CSP, Pieske B, Ponikowski P, Voors AA, Anstrom KJ, Armstrong PW, O'Connor CM, Hernandez AF; VICTORIA Study Group.
Long-term risk of death and recurrent cardiovascular events following acute coronary syndromes.
Gouda P, Savu A, Bainey KR, Kaul P, Welsh RC.
Vericiguat in Patients with Atrial Fibrillation and Heart Failure with Reduced Ejection Fraction: Insights from the VICTORIA trial.
Ponikowski P, Alemayehu W, Oto A, Bahit MC, Noori E, Patel MJ, Butler J, Ezekowitz JA, Hernandez AF, Lam CSP, O'Connor CM, Pieske B, Roessig L, Voors AA, Westerhout C, Armstrong PW; VICTORIA Study Group.
Intercountry Differences in Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure
Fuery MA, Chouairi F, Januzzi JL, Moe GE, Caraballo C, McCullough M, Miller PE, Reinhardt SW, Clark K, Oseran A, Milner A, Pacor J, Kahn PA, Singh A, Ravindra M, Guha A, Vadlamani L, Kulkarni NS, Fiuzat M, Felker GM, O'Connor CM, Ahmad T, Ezekowitz J, Desai NR.
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial.
Szarek M, Bhatt DL, Steg PG, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Voors AA, Metra M, Lund LH, Komajda M, Testani JM, Wilcox CS, Ponikowski P, Lopes RD, Banks P, Tesfaye E, Ezekowitz JA, Verma S, Pitt B; SOLOIST-WHF committees and investigators.
The Many Care Models to Treat Thoracic Aortic Disease in Canada: A Nationwide Survey of Cardiac Surgeons, Cardiologists, Interventional Radiologists, and Vascular Surgeons.
McClure RS, Berry RF, Dagenais F, Forbes TL, Grewal J, Keir M, Klass D, Kotha VK, McMurtry MS, Moore RD, Payne D, Rommens K.
2021 Update on Safety of Magnetic Resonance Imaging: Joint Statement From Canadian Cardiovascular Society/Canadian Society for Cardiovascular Magnetic Resonance/Canadian Heart Rhythm Society.
Primary Panel, Ian Paterson D, White JA, Butler CR, Connelly KA, Guerra PG, Hill MD, James MT, Kirpalani A, Lydell CP, Roifman I, Sarak B, Sterns LD, Verma A, Wan D; Secondary Panel, Crean AM, Grosse-Wortmann L, Hanneman K, Leipsic J, Manlucu J, Nguyen ET, Sandhu RK, Villemaire C, Wald RM, Windram J.
Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association.
Damluji AA, van Diepen S, Katz JN, Menon V, Tamis-Holland JE, Bakitas M, Cohen MG, Balsam LB, Chikwe J; American Heart Association Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Surgery and Anesthesia; and Council on Cardiovascular and Stroke Nursing. Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association.
Drug Adherence and Long-Term Outcomes in Non-Revascularized Patients Following Acute Myocardial Infarction.
Khan R, Kaul P, Islam S, Savu A, Bagai A, van Diepen S, Bainey KR, Welsh RC, Goodman SG.
Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week.
Van Spall HGC, Lala A, Deering TF, Casadei B, Zannad F, Kaul P, Mehran R, Pearson GD, Shah MR, Gulati M, Grines C, Volgman AS, Revkin JH, Piña I, Lam CSP, Hochman JS, Simon T, Walsh MN, Bozkurt B; Global CardioVascular Clinical Trialists (CVCT) Forum and Women As One Scientific Expert Panel.
Differences in NT-proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction.
Daubert MA, Yow E, Barnhart HX, Piña IL, Ahmad T, Leifer E, Cooper L, Desvigne‐Nickens P, Fiuzat M, Adams K, Ezekowitz J, Whellan DJ, Januzzi JL, O’Connor CM, Felker GM.
An Association Between Cardiologist Billing Patterns, Health Care Use, and Outcomes in Cardiac Patients.
Bhatia RS, Ko DT, Chu C, Croxford R, Bouck Z, Tharmaratnam T, Dorian P, Ross H, Austin PC, Shojania K, Goodman SG.
Clinical risk prediction models for the prognosis and management of acute coronary syndromes.
Haghbayan H, Gale CP, Chew DP, Brieger D, Fox KA, Goodman SG, Yan AT.
The predictive ability of EQ-5D-3L compared to the LACE index and its association with 30-day post-hospitalization outcomes.
Al Sayah F, McAlister FA, Ohinmaa A, Majumdar SR, Johnson JA.
Laboratory Markers of Acidosis and Mortality in Cardiogenic Shock: Developing a Definition of Hemometabolic Shock.
Jentzer JC, Kashani KB, Wiley BM, Patel PC, Baran DA, Barsness GW, Henry TD, van Diepen S.
Contemporary use of guideline-based higher potency P2Y12 receptor inhibitor therapy in patients with moderate-to-high risk non-ST-segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross-sectional study.
Patel A, Goodman SG, Tan M, Suskin N, McKelvie R, Mathew AL, Lutchmedial S, Dehghani P, Lavoie AJ, Huynh T, Lavi S, Philipp R, Khan R, Yan AT, Radhakrishnan S, Sedlak T, Brunner N, Kim HH, Cieza T, Kassam S, Fordyce CB, Heffernan M, Jedrzkiewicz S, Madan M, Ahmed S, Barry C, Dery J-P, Bagai A, Canadian ACS Reflective II Investigators.
Cardiac reverse remodelling and health status in patients with chronic heart failure.
Wang K, Youngson E, Bakal JA, Thomas J, McAlister FA, Oudit GY.
Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design.
Mentz RJ, Ambrosy AP, Ezekowitz JA, Lewis GD, Butler J, Wong YW, De Pasquale CG, Troughton RW, O'Meara E, Rockhold FW, Garg J, Samsky MD, Leloudis D, Dugan M, Mundy LM, Hernandez AF; HEART-FID Trial Investigators.
COVID-19 pandemic and coronary angiography for ST-elevation myocardial infarction, use of mechanical support and mechanical complications in Canada; a Canadian Association of Interventional Cardiology national survey.
Rinfret S, Jahan I, McKenzie K, Dendukuri N, Bainey KR, Mansour S, Natarajan M, Ybarra LF, Chong AY, Bérubé S, Breton R, Curtis MJ, Rodés-Cabau J, Amlani S, Bagherli A, Ball W, Barolet A, Beydoun HK, Brass N, Chan AW, Colizza F, Constance C, Fam NP, Gobeil F, Haghighat T, Hodge S, Joyal D, Kim HH, Lutchmedial S, MacDougall A, Malik P, Miner S, Minhas K, Orvold J, Palisaitis D, Parfrey B, Potvin JM, Puley G, Radhakrishnan S, Spaziano M, Tanguay JF, Vijayaraghaban R, Webb JG, Zimmermann RH, Wood DA, Brophy JM.
Renal Function and the Effects of Vericiguat in Patients with Worsening Heart Failure with Reduced Ejection Fraction: Insights from VICTORIA (VerICiguaT Global Study in Subjects with HFrEF) Trial.
Voors AA, Mulder H, Reyes E, Cowie MR, Lassus J, Hernandez AF, Ezekowitz JA, Butler J, O'Connor CM, Koglin J, Lam CSP, Pieske B, Roessig L, Ponikowski P, Anstrom KJ, Armstrong PW; VICTORIA Study Group.
2020 in review.
Hayanga JWA, Likosky DS, van Diepen S, Holst K, Whitson BA, Whitman G, Arkley J, Dunning J, Arora RC.
Pregnancy as Oracle: What It Augurs for Women’s Health.
Kaul P, Sia WW.
Influence of intra-aortic balloon pump on mortality as a function of cardiogenic shock severity.
Jentzer JC, van Diepen S, Henry TD, Baran DA, Barsness GW, Holmes DR Jr.
Variability in reporting of key outcome predictors in acute myocardial infarction cardiogenic shock trials.
Tyler JM, Brown C, Jentzer JC, Baran DA, van Diepen S, Kapur NK, Garberich RF, Garcia S, Sharkey SW, Henry TD.
Mechanisms of rumination change in adolescent depression (RuMeChange): study protocol for a randomised controlled trial of rumination-focused cognitive behavioural therapy to reduce ruminative habit and risk of depressive relapse in high-ruminating adolescents.
Roberts H, Jacobs RH, Bessette KL, Crowell SE, Westlund-Schreiner M, Thomas L, Easter RE, Pocius SL, Dillahunt A, Frandsen S, Schubert B, Farstead B, Kerig P, Welsh RC, Jago D, Langenecker SA, Watkins ER.
Surveillance for Outcomes Selected as Atrial Fibrillation Quality Indicators in Canada: 10-Year Trends in Stroke, Major Bleeding, and Heart Failure.
Wilton SB, Kaul P, Islam S, Atzema CL, Cruz J, MacFarlane K, McKelvie R, Poon S, Lambert L, Rush K, Deyell M, Wyse DG, Cox JL, Skanes A, Sandhu RK.
Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23,000 Patients from 40 Countries.
Johansson I, Joseph P, Balasubramanian K, McMurray JJV, Lund LH, Ezekowitz JA, Kamath D, Alhabib K, Bayes-Genis A, Budaj A, Dans ALL, Dzudie A, Probstfield JL, Fox KAA, Karaye KM, Makubi A, Fukakusa B, Teo K, Temizhan A, Wittlinger T, Maggioni AP, Lanas F, Lopez-Jaramillo P, Silva-Cardoso J, Sliwa K, Dokainish H, Grinvalds A, McCready T, Yusuf S.
Reply: Optimal Positioning of Novel Heart Failure Pharmacotherapies: The Case of Vericiguat.
Armstrong PW, Ezekowitz JA.
Computing the polytomous discrimination index
Dover DC, Islam S, Westerhout CM, Moore LE, Kaul P, Savu A.
Luminaries: The Women Presidents of HRS.
Tamirisa KP, Hsue P, Beck H, Chiamvimonvat N, Zeitler EP, Sandhu RK, Hurwitz JL.
Electrophysiological Studies for Predicting Atrioventricular Block in Patients with Syncope: A Systematic Review and Meta-Analysis
Sheldon RS, Lei LY, Solbiati M, Chew DS, Raj SR, Costantino G, Morillo C, Sandhu RK.
The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry.
Lawler PR, Berg DD, Park JG, Katz JN, Baird-Zars VM, Barsness GW, Bohula EA, Carnicelli AP, Chaudhry SP, Jentzer JC, Menon V, Metkus T, Nativi-Nicolau J, Phreaner N, Sinha SS, Teuteberg JJ, van Diepen S, Morrow DA; Critical Care Cardiology Trials Network Investigators.
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction.
McDonald M, Virani S, Chan M, Ducharme A, Ezekowitz JA, Giannetti N, Heckman GA, Howlett JG, Koshman SL, Lepage S, Mielniczuk L, Moe GW, O'Meara E, Swiggum E, Toma M, Zieroth S, Anderson K, Bray SA, Clarke B, Cohen-Solal A, D'Astous M, Davis M, De S, Grant ADM, Grzeslo A, Heshka J, Keen S, Kouz S, Lee D, Masoudi FA, McKelvie R, Parent MC, Poon S, Rajda M, Sharma A, Siatecki K, Storm K, Sussex B, Van Spall H, Yip AMC.
Primary Percutaneous Coronary Intervention and Application of the Pharmacoinvasive Approach Within ST-Elevation Myocardial Infarction Care Networks: CJC Supplement – 40 Years of Innovation in Interventional Cardiology in Canada.
Welsh RC, Cantor WJ, Traboulsi M, Schampaert E, May ML.
Incidence and outcomes of acute kidney injury stratified by cardiogenic shock severity.
Padkins M, Breen T, van Diepen S, Barsness G, Kashani K, Jentzer JC.
Prior adherence to statins is a predictor of subsequent adherence and persistence to oral, but not parenteral, osteoporosis medications.
Gupta A, Lin M, McAlister FA, Ye C.
Informing COVID-19 vaccination priorities based on the prevalence of risk factors among adults in Canada.
McAlister FA, Bushnik T, Leung AA, Saxinger L.
Lipid testing, lipid modifying therapy and PCSK9 inhibitor eligibility in 27,979 patients with incident acute coronary syndrome.
Sarak B, Savu A, Kaul P, McAlister FA, Welsh RC, Yan AT, Goodman SG.
Visit-to-visit blood pressure variability is common in primary care patients: Retrospective cohort study of 221,803 adults.
McAlister FA, Lethebe BC, Leung AA, Padwal RS, Williamson T.
Temporal Trends in in-Hospital Bleeding and Transfusion in a Contemporary Canadian ST-Elevation Myocardial Infarction Patient Population.
Das D, Savu A, Bainey KR, Welsh RC, Kaul P.
Sex Differences in Clinical Course and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure.
Blumer V, Greene SJ, Wu A, Butler J, Ezekowitz JA, Lindenfeld J, Alhanti B, Hernandez AF, O'Connor CM, Mentz RJ.
Diabetes after pregnancy: a study protocol for the derivation and validation of a risk prediction model for 5-year risk of diabetes following pregnancy.
Read SH, Rosella LC, Berger H, Feig DS, Fleming K, Kaul P, Ray JG, Shah BR, Lipscombe LL.
Machine-Learning, Predictive Analytics, and the Emperor’s New Clothes: Why Artificial Intelligence hasn’t yet Replaced Conventional Approaches.
Weaver CG, McAlister FA.
Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association.
Dezfulian C, Orkin AM, Maron BA, Elmer J, Girotra S, Gladwin MT, Merchant RM, Panchal AR, Perman SM, Starks MA, van Diepen S, Lavonas EJ; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Council on Clinical Cardiology.
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Schwartz GG, Szarek M, Bittner VA, Bhatt DL, Diaz R, Goodman SG, Jukema JW, Loy M, Manvelian G, Pordy R, White HD, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.
Association of Thrombus Aspiration With Time and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction: A Post Hoc Analysis of the Randomized TOTAL Trial.
Moxham R, Džavík V, Cairns J, Natarajan MK, Bainey KR, Akl E, Tsang MB, Lavi S, Cantor WJ, Madan M, Liu YY, Jolly SS.
Validity of different dose reduction criteria for apixaban.
Hawkins NM, Er L, Sandhu RK, Kaul P, McAlister FA, Levin A, Andrade JG.
Screening the Older Population for Atrial Fibrillation-Have We Moved the Needle Forward?
Sandhu RK, Albert C.
DAPT risk stratification using coronary artery angioscopy at 2 weeks: Personalized medicine at its finest?
Bainey KR.
Cardiac and Cardiometabolic Phenotyping of Trastuzumab-Mediated Cardiotoxicity: a Secondary Analysis of the MANTICORE trial.
Kirkham AA, Pituskin E, Thompson RB, Mackey JR, Koshman SL, Jassal D, Pitz M, Haykowsky MJ, Pagano JJ, Chow K, Tsui AK, Ezekowitz JA, Oudit GY, Paterson DI.
Risk stratifying patients with out-of-hospital cardiac arrest: The case for dynamic predictions models.
van Diepen S, Henry TD.
Elevated Blood Pressures Are Common in the Emergency Department but Are They Important? A Retrospective Cohort Study of 30,278 Adults.
McAlister FA, Youngson E, Rowe BH.
Association between Respiratory Failure and Clinical Outcomes in Patients with Acute Heart Failure: Analysis of 5 Pooled Clinical Trials.
Miller PE, van Diepen S, Metkus TS, Alviar CL, Rayner-Hartley E, Rathwell S, Katz JN, Ezekowitz J, Desai NR, Ahmad T.
Potential growth in cardiogenic shock research though an international registry collaboration: the merits and challenges of a Hub-of-Spokes model.
van Diepen S, Morrow DA.
The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease.
Tran DT, Palfrey D, Welsh R.
Transcatheter Mitral Valve Replacement After Surgical Repair or Replacement: Comprehensive Midterm Evaluation of Valve-in-Valve and Valve-in-Ring Implantation From the VIVID Registry.
Simonato M, Whisenant B, Ribeiro HB, Webb JG, Kornowski R, Guerrero M, Wijeysundera H, Søndergaard L, De Backer O, Villablanca P, Rihal C, Eleid M, Kempfert J, Unbehaun A, Erlebach M, Casselman F, Adam M, Montorfano M, Ancona M, Saia F, Ubben T, Meincke F, Napodano M, Codner P, Schofer J, Pelletier M, Cheung A, Shuvy M, Palma JH, Gaia DF, Duncan A, Hildick-Smith D, Veulemans V, Sinning J-M, Arbel Y, Testa L, de Weger A, Eltchaninoff H, Hemery T, Landes U, Tchetche D, Dumonteil N, Rodés-Cabau J, Kim W-K, Spargias K, Kourkoveli P, Ben-Yehuda O, Teles RC, Barbanti M, Fiorina C, Thukkani A, Mackensen GB, Jones N, Presbitero P, Petronio AS, Allali A, Champagnac D, Bleiziffer S, Rudolph T, Iadanza A, Salizzoni S, Agrifoglio M, Nombela-Franco L, Bonaros N, Kass M, Bruschi G, Amabile N, Chhatriwalla A, Messina A, Hirji SA, Andreas M, Welsh R, Schoels W, Hellig F, Windecker S, Stortecky S, Maisano F, Stone GW, Dvir D.
Trauma of Hospitalization Is Common in Medical Inpatients But Is Not Associated with Post-Discharge Outcomes.
Raghuveer A, Youngson E, Mathura P, Kassam N, McAlister FA.
Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M, Flannery A, Ferreira JP, Cheng MP, Kronfli N, Marelli A, Zannad F, Brophy J, Afillalo J, Huynh T, Giannetti N, Bessissow A, Ezekowitz JA, Lopes RD, Ambrosy AP, Craig M, Sharma A.
Normoxic low-altitude simulation (at 714 mmHg) improves limb blood perfusion in mice with hindlimb ischemia.
Shahid A, Stenson TH, McMurtry MS.
Interleukin-6 and Outcomes in Acute Heart Failure: An ASCEND-HF Sub-Study.
Perez AL, Grodin JL, Chaikijurajai T, Wu Y, Hernandez AF, Butler J, Metra M, Michael Felker G, Voors AA, McMurray JJ, Armstrong PW, O'Connor C, Starling RC, Wilson Tang WH.
Defining Shock and Preshock for Mortality Risk Stratification in Cardiac Intensive Care Unit Patients
Jentzer JC, Burstein B, van Diepen S, Murphy J, Holmes DR Jr, Bell MR, Barsness GW, Henry TD, Menon V, Rihal CS, Naidu SS, Baran DA.
Real world Data on the Concurrent Use of P-glycoprotein or Cytochrome 3A4 Drugs and Non-vitamin K Antagonist Oral Anticoagulants in Non-Valvular Atrial Fibrillation.
Sandhu RK, Islam S, Dover D, Andrade JG, Ezekowitz J, McAlister FA, Hawkins NM, Kaul P.
Effect of high-dose trivalent vs standard-dose quadrivalent influenza vaccine on mortality or cardiopulmonary hospitalization in patients with high-risk cardiovascular disease: A randomized clinical trial.
Vardeny O, Kim KM, Udell JA, Joseph J, Desai AS, Farkouh ME, Hegde SM, Hernandez AF, McGeer A, Talbot HK, Anand I, Bhatt DL, Cannon CP, DeMets D, Gaziano JM, Goodman SG, Nichol K, Tattersall MC, Temte JL, Wittes J, Yancy C, Claggett B, Chen Y, Mao L, Havighurst TC, Cooper LS, Solomon SD, INVESTED Committees and Investigators.
Objective Risk Assessment vs Standard Care for Acute Coronary Syndromes: A Randomized Clinical Trial.
Chew DP, Hyun K, Morton E, Horsfall M, Hillis GS, Chow CK, Quinn S, D'Souza M, Yan AT, Gale CP, Goodman SG, Fox K, Brieger D.
Meta-Analysis of Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin According to Time in Therapeutic Range in Atrial Fibrillation.
Lee JJ, Ha ACT, Dorian P, Verma M, Goodman SG, Friedrich JO.
Is Screening for Atrial Fibrillation and Its Risk Factors Useful and Cost-Effective?
Sandhu RK, Healey JS.
Review: Evidence-Based Management of Acute Heart Failure.
Can J Cardiol.
Short-term hypoxia does not promote arrhythmia during voluntary apnea.
Busch SA, van Diepen S, Roberts R, Steele AR, Berthelsen LF, Smorschok MP, Bourgoin C, Steinback CD.
Inhaled nitric oxide improves ventilatory efficiency and exercise capacity in patients with mild COPD: A randomized-control crossover trial.
Phillips DB, Brotto AR, Ross BA, Bryan TL, Wong EYL, Meah VL, Fuhr DP, van Diepen S, Stickland MK.
Learning whether to subtract beta-blockers: it’s about time.
van Diepen S, Armstrong PW.
Cardiogenic shock teams and centres: a contemporary review of multidisciplinary care for cardiogenic shock.
Moghaddam N, van Diepen S, So D, Lawler PR, Fordyce CB.
Derivation of Patient-Defined Adverse Cardiovascular and Noncardiovascular Events Through a Modified Delphi Process.
Sun LY, Rodger J, Duffett L, Tulloch H, Crean AM, Chong AY, Rubens FD, MacPhee E, Mesana TG, Lee DS, van Diepen S, Beanlands RS, Ruel M, Julien AM, Bilodeau J.
Association between the antepartum oral glucose tolerance test and the risk of future diabetes mellitus among women with gestational diabetes: A systematic review and meta-analysis.
Moore LE, Voaklander B, Savu A, Yeung RO, Ryan E, Chojecki D, Kaul P, Ospina MB.
Long-Term Clinical Outcomes Following Revascularization in High-Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease.
Bainey KR, Alemayehu W, Welsh RC, Kumar A, King SB 3rd, Kirtane AJ.
Post-operative pain following cardiac implantable electronic device implantation: insights from the BRUISE CONTROL trials.
Nair GM, Birnie DH, Sumner GL, Krahn AD, Healey JS, Nery PB, Kalfon E, Verma A, Ayala-Paredes F, Coutu B, Becker G, Philippon F, Eikelboom J, Sandhu RK, Sapp J, Leather R, Yung D, Thibault B, Simpson CS, Ahmad K, Sturmer M, Kavanagh K, Crystal E, Wells GA, Essebag V.
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial.
De Caterina R, Patti G, Westerbergh J, Horowitz J, Ezekowitz JA, Lewis BS, Lopes RD, McMurray JJV, Atar D, Bahit MC, Keltai M, López-Sendón JL, Ruzyllo W, Granger CB, Alexander JH, Wallentin L.
Canadian Registry of Electronic Device Outcomes (CREDO): The Abbott ICD Premature Battery Depletion Advisory, a Multicentre Cohort Study.
Davis J, Thibault B, Mangat I, Coutu B, Bennett M, Philippon F, Sandhu R, Sterns L, Essebag V, Nery P, Wells G, Yee R, Exner D, Krahn A, Parkash R.
Age, Sex, and Remote Monitoring Differences in Device Acceptance for Patients With Implanted Cardioverter Defibrillators in Canada.
Ng J, Sears SF, Exner DV, Reyes L, Cravetchi X, Cassidy P, Morton J, Lohrenz C, Low A, Sandhu RK, Sheldon RS, Raj SR.
National Interhospital Transfer for Patients With Acute Cardiovascular Conditions.
Burstein B, Bibas L, Rayner-Hartley E, Jentzer JC, van Diepen S, Goldfarb M.
Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care Patients.
Jentzer JC, Lawler PR, van Diepen S, Henry TD, Menon V, Baran DA, Džavík V, Barsness GW, Holmes DR Jr, Kashani KB.
Management of Acute Coronary Syndromes Beyond the First Year: A Canadian Clinical Practice Survey.
Bui KA, Matteau A, Elbarouni B, Bainey KR, Fordyce CB, Bagai A, Rose B, Lutchmedial S, Leis B, Lavoie A, Cox J, Mansour S, Potter BJ.
Which adults presenting for SARS-CoV-2 testing are most likely to have a positive swab? A population-based cohort of 15,132 adults from Alberta, Canada.
McAlister FA, Whitten TA, King JA, Bakal JA.
Preoperative levels of natriuretic peptides and the incidence of postoperative atrial fibrillation after noncardiac surgery: a prospective cohort study.
Szczeklik W, LeManach Y, Fronczek J, Polok K, Conen D, McAlister FA, Srinathan S, Alonso-Coello P, Biccard B, Duceppe E, Heels-Ansdell D, Górka J, Pettit S, Roshanov PS, Devereaux PJ.
Layer-specific strain in patients with heart failure using cardiovascular magnetic resonance: not all layers are the same.
Xu L, Pagano JJ, Haykowksy MJ, Ezekowitz JA, Oudit GY, Mikami Y, Howarth A, White JA, Dyck JRB, Anderson T, Paterson DI, Thompson RB, AB HEART Investigators.
Routine Unloading in Patients Treated With Extracorporeal Membrane Oxygenation for Cardiogenic Shock: Mixed Outcomes Set the Stage for Future Trials.
van Diepen S.
Diabetes association with self-reported health, resource utilization, and prognosis post-myocardial infarction.
Nicolau JC, Brieger D, Owen R, Furtado RHM, Goodman SG, Cohen MG, Simon T, Westermann D, Granger CB, Grieve R, Yasuda S, Chen J, Hedman K, Mellström C, Brandrup-Wognsen G, Pocock SJ.
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.
Tuñón J, Steg PG, Bhatt DL, Bittner VA, Díaz R, Goodman SG, Jukema JW, Kim Y-U, Li QH, Mueller C, Parkhomenko A, Pordy R, Sritara P, Szarek M, White HD, Zeiher AM, Schwartz GG, ODYSSEY OUTCOMES Investigators.
Is There a Sex Gap in Surviving an Acute Coronary Syndrome or Subsequent Development of Heart Failure?
Ezekowitz JA, Savu A, Welsh RC, McAlister FA, Goodman SG, Kaul P.
Landscape of Lipid Management Following an Acute Coronary Syndrome Event: Survey of Canadian Specialists.
Gouda P, Welsh RC, Padarath M, Grégoire JC, Hegele RA, Gupta M.
Symptoms associated with a positive result for a swab for SARS-CoV-2 infection among children in Alberta.
King JA, Whitten TA, Bakal JA, McAlister FA.
Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study.
Felker GM, McMurray JJV, Cleland JG, O'Connor CM, Teerlink JR, Voors AA, Belohlavek J, Böhm M, Borentain M, Bueno H, Cole RT, DeSouza MM, Ezekowitz JA, Filippatos G, Lang NN, Kessler PD, Martinez FA, Mebazaa A, Metra M, Mosterd A, Pang PS, Ponikowski P, Sato N, Seiffert D, Ye J.
Advanced Respiratory Support in the Contemporary Cardiac ICU.
Metkus TS, Miller PE, Alviar CL, Baird-Zars VM, Bohula EA, Cremer PC, Gerber DA, Jentzer JC, Keeley EC, Kontos MC, Menon V, Park JG, Roswell RO, Schulman SP, Solomon MA, van Diepen S, Katz JN, Morrow DA.
Implications of the Covid-19 pandemic for cardiovascular disease and risk factor management.
Lau D, McAlister FA.
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial.
Lam CSP, Giczewska A, Sliwa K, Edelmann F, Refsgaard J, Bocchi E, Ezekowitz JA, Hernandez AF, O'Connor CM, Roessig L, Patel MJ, Pieske B, Anstrom KJ, Armstrong PW; VICTORIA Study Group.
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation.
Andrade JG, Aguilar M, Atzema C, Bell A, Cairns JA, Cheung CC, Cox JL, Dorian P, Gladstone DJ, Healey JS, Khairy P, Leblanc K, McMurtry MS, Mitchell LB, Nair GM, Nattel S, Parkash R, Pilote L, Sandhu RK, Sarrazin JF, Sharma M, Skanes AC, Talajic M, Tsang TSM, Verma A, Verma S, Whitlock R, Wyse DG, Macle L; members of the Secondary Panel.
Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of MINOCA in Women.
Reynolds HR, Maehara A, Kwong RY, Sedlak T, Saw J, Smilowitz NR, Mahmud E, Wei J, Marzo K, Matsumura M, Seno A, Hausvater A, Giesler C, Jhalani N, Toma C, Har B, Thomas D, Mehta LS, Trost J, Mehta PK, Ahmed B, Bainey KR, Xia Y, Shah B, Attubato M, Bangalore S, Razzouk L, Ali ZA, Bairey-Merz CN, Park K, Hada E, Zhong H, Hochman JS.
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction.
Gibson CM, Kastelein JJP, Phillips AT, Aylward PE, Yee MK, Tendera M, Nicholls SJ, Pocock S, Goodman SG, Alexander JH, Lincoff M, Bode C, Duffy D, Heise M, Berman G, Mears SJ, Tricoci P, Deckelbaum LI, Steg PG, Ridker P, Mehran R.
Plasma Volume Status and Its Association With In-Hospital and Postdischarge Outcomes in Decompensated Heart Failure.
Fudim M, Lerman JB, Page C, Alhanti B, Califf RM, Ezekowitz JA, Girerd N, Grodin JL, Miller WL, Pandey A, Rossignol P, Starling RC, Tang WHW, Zannad F, Hernandez AF, O'Connor CM, Mentz RJ.
The Associations Between Direct and Delayed Critical Care Unit Admission with Mortality and Readmissions Among Patients with Heart Failure.
Raslan IR, Ross HJ, Fowler RA, Scales DC, Stelfox HT, Mak S, Tu JV, Farkouh ME, Stukel TA, Wang X, van Diepen S, Wunsch H, Austin PC, Lee DS.
Lack of benefit from hospitalization in patients with syncope: A propensity analysis.
Kaul P, Tran DT, Sandhu RK, Solbiati M, Costantino G, Sheldon RS.
Despite Having Worse Risk Profiles, Northern Albertans Wait Longer for Specialist Follow-up After Emergency Department Visits for Atrial Fibrillation.
Rowe BH, McAlister FA, Graham MM, Holroyd BR, Rosychuk RJ.
Prevention of Complications in the Cardiac Intensive Care Unit: A Scientific Statement From the American Heart Association.
Fordyce CB, Katz JN, Alviar CL, Arslanian-Engoren C, Bohula EA, Geller BJ, Hollenberg SM, Jentzer JC, Sims DB, Washam JB, van Diepen S; American Heart Association Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; and Stroke Council.
Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: Insights from the LEVO-CTS trial.
Jawitz OK, Stebbins AS, Raman V, Alhanti B, van Diepen S, Heringlake M, Fremes S, Whitlock R, Meyer SR, Mehta RH, Stafford-Smith M, Goodman SG, Alexander JH, Lopes RD.
Prevalence of Non-Cardiac Multimorbidity in Patients Admitted to Two Cardiac Intensive Care Units and Their Association with Mortality.
Miller PE, Thomas A, Breen TJ, Chouairi F, Kunitomo Y, Aslam F, Damluji AA, Anavekar NS, Murphy JG, van Diepen S, Barsness GW, Brennan J, Jentzer J.
A Systematic Review of the Risk of Motor Vehicle Collision in Patients With Syncope.
Chee JN, Simpson C, Sheldon RS, Dorian P, Dow J, Guzman J, Raj SR, Sandhu RK, Thiruganasambandamoorthy V, Green M, Krahn AD, Plonka S, Rapoport MJ.
All for one, but not one for all.
Ezekowitz JA.
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial.
Armstrong PW, Lam CSP, Anstrom KJ, Ezekowitz J, Hernandez AF, O'Connor CM, Pieske B, Ponikowski P, Shah SJ, Solomon SD, Voors AA, She L, Vlajnic V, Carvalho F, Bamber L, Blaustein RO, Roessig L, Butler J; VITALITY-HFpEF Study Group.
The Basics of ARDS Mechanical Ventilatory Care for Cardiovascular Specialists.
Rayner-Hartley E, Miller PE, Burstein B, Bibas L, Goldfarb M, Rampersad P, van Diepen S.
Association between intensive care unit utilization for patients with non-ST segment elevation myocardial infarction and patient experience.
Fanaroff AC, Chen AY, van Diepen S, Mylod D, Peterson ED, Wang TY.
Plasma Volume Status and its Association with In-Hospital and Post-Discharge Outcomes in Decompensated Heart Failure.
Fudim M, Lerman JB, Page C, Alhanti B, Califf RM, Ezekowitz JA, Girerd N, Grodin JL, Miller WL, Pandey A, Rossignol P, Starling RC, Tang WHW, Zannad F, Hernandez AF, O'Connor CM, Mentz RJ.
Temporal and spatial effect of air pollution on hospital admissions for myocardial infarction: a case-crossover study.
Liu X, Bertazzon S, Villeneuve PJ, Johnson M, Stieb D, Coward S, Tanyingoh D, Windsor JW, Underwood F, Hill MD, Rabi D, Ghali WA, Wilton SB, James MT, Graham M, McMurtry MS, Kaplan GG.
N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study.
Ezekowitz JA, O'Connor CM, Troughton RW, Alemayehu WG, Westerhout CM, Voors AA, Butler J, Lam CSP, Ponikowski P, Emdin M, Patel MJ, Pieske B, Roessig L, Hernandez AF, Armstrong PW.
In Memoriam: James T. Willerson, 1939 to 2020.
Armstrong PW, Fuster V.
A Review of the Evidence for Treatment of Myocardial Infarction With Nonobstructive Coronary Arteries.
Sluchinski SL, Pituskin E, Bainey KR, Norris CM.
Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease.
Sheth T, Pinilla-Echeverri N, Moreno R, Wang J, Wood DA, Storey RF, Mehran R, Bainey KR, Bossard M, Bangalore S, Schwalm JD, Velianou JL, Valettas N, Sibbald M, Rodés-Cabau J, Ducas J, Cohen EA, Bagai A, Rinfret S, Newby DE, Feldman L, Laster SB, Lang IM, Mills JD, Cairns JA, Mehta SR.
Cardiac Stress Testing After Coronary Revascularization.
Dhoot A, Liu S, Savu A, Cheema ZM, Welsh RC, Bainey KR, Ko DT, Bhavnani SP, Goodman SG, Kaul P, Bagai A.
Frequency of laboratory testing and associated abnormalities in patients with hypertension.
Quan S, Chen G, Padwal RS, McAlister FA, Tran KC, Campbell NRC, Liang Z, Feng Y, Rabi DM, Leung AA, for Hypertension Canada’s Research, Evaluation Committee.
Press 1 to Speak to a Representative.
Ezekowitz JA.
Age and shock severity predict mortality in cardiac intensive care unit patients with and without heart failure.
Padkins M, Breen T, Anavekar N, van Diepen S, Henry TD, Baran DA, Barsness GW, Kashani K, Holmes DR Jr, Jentzer JC.
Relation of High Lipoprotein (a) Concentrations to Platelet Reactivity in Individuals with and Without Coronary Artery Disease.
Salsoso R, Dalcoquio TF, Furtado RHM, Franci A, Barbosa CJDG, Genestreti PRR, Strunz CMC, Lima V, Baracioli LM, Giugliano RP, Goodman SG, Gurbel PA, Maranhão RC, Nicolau JC.
Optimizing screening and management of cardiovascular health in prostate cancer.
Kenk M, Grégoire JC, Coté M-A, Connelly KA, Davis MK, Dresser G, Ghosh N, Goodman S, Johnson C, Fleshner N.
Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease.
Sheth T, Pinilla-Echeverri N, Moreno R, Wang J, Wood DA, Storey RF, Mehran R, Bainey KR, Bossard M, Bangalore S, Schwalm J-D, Velianou JL, Valettas N, Sibbald M, Rodés-Cabau J, Ducas J, Cohen EA, Bagai A, Rinfret S, Newby DE, Feldman L, Laster SB, Lang IM, Mills JD, Cairns JA, Mehta SR.
Non‐vitamin K antagonist oral anticoagulant (NOAC) use and dosing in Canadian practice: Insights from the optimising pharmacotherapy in the management approach to lowering risk in atrial fibrillation (OPTIMAL AF) Programme.
Leblanc K, Bell AD, Ezekowitz JA, Tan MK, Laflamme D, Goldin L, Habert J, Lin PJ, Saunders K, Ngui D, Ng AP, Desroches J, Goodman SG, for the OPTIMAL AF Investigators.
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
Pereira NL, Farkouh ME, So D, Lennon R, Geller N, Mathew V, Bell M, Bae J-H, Jeong MH, Chavez I, Gordon P, Abbott JD, Cagin C, Baudhuin L, Fu Y-I, Goodman SG, Hasan A, Iturriaga E, Lerman A, Sidhu M, Tanguay J-F, Wang L, Weinshilboum R, Welsh R, Rosenberg Y, Bailey K, Rihal C.
Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.
Marquis-Gravel G, Neely ML, Valgimigli M, Costa F, Van Klaveren D, Altner R, Bhatt DL, Armstrong PW, Fox KAA, White HD, Ohman EM, Roe MT.
Understanding How Cardiac Arrest Complicates the Analysis of Clinical Trials of Cardiogenic Shock.
Jentzer JC, van Diepen S, Henry TD.
Patients’ Experiences of Nurse Case-Managed Osteoporosis Care: A Qualitative Study.
Wozniak LA, Rowe BH, Ingstrup M, Johnson JA, McAlister FA, Bellerose D, Beaupre LA, Majumdar SR.
RE: Patient-Reported Quality of Hospital Discharge Transitions.
McAlister FA.
Change of Health-Related Quality of Life Over Time and Its Association With Patient Outcomes in Patients With Heart Failure.
Sepehrvand N, Savu A, Spertus JA, Dyck JRB, Anderson T, Howlett J, Paterson I, Oudit GY, Kaul P, McAlister FA, Ezekowitz JA; Alberta HEART Investigators.
Ambulance Use, Health Outcomes and Costs for Emergency Department Visits for Primary Diagnosis of Syncope in Canada.
Gupta AK, Savu A, Sheldon RS, Raj SR, Kaul P, Sandhu RK.
Outcome and Cost of Optimal Control of Dyslipidemia in Adults With High Risk for Cardiovascular Disease.
Tran DT, Palfrey D, Lo TKT, Welsh R.
Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives.
Jentzer JC, Bihorac A, Brusca SD, Del Rio-Pertuz G, Kashani K, Kazory A, Kellum JA, Mao M, Moriyama B, Morrow DH, Patel HN, Rali AS, van Diepen S, Solomon MA, for the Critical Care Cardiology Working Group of the Heart Failure and Transplant Section Leadership Council.
Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves.
Bleiziffer S, Simonato M, Webb JG, Rodés-Cabau J, Pibarot P, Kornowski R, Windecker S, Erlebach M, Duncan A, Seiffert M, Unbehaun A, Frerker C, Conzelmann L, Wijeysundera H, Kim W-K, Montorfano M, Latib A, Tchetche D, Allali A, Abdel-Wahab M, Orvin K, Stortecky S, Nissen H, Holzamer A, Urena M, Testa L, Agrifoglio M, Whisenant B, Sathananthan J, Napodano M, Landi A, Fiorina C, Zittermann A, Veulemans V, Sinning J-M, Saia F, Brecker S, Presbitero P, De Backer O, Søndergaard L, Bruschi G, Nombela Franco L, Petronio AS, Barbanti M, Cerillo A, Spargias K, Schofer J, Cohen M, Muñoz-Garcia A, Finkelstein A, Adam M, Serra V, Campante Teles R, Champagnac D, Iadanza A, Chodor P, Eggebrecht H, Welsh R, Caixeta A, Salizzoni S, Dager A, Auffret V, Cheema A, Ubben T, Ancona M, Rudolph T, Gummert J, Tseng E, Noble S, Bunc M, Roberts D, Kass M, Gupta A, Leon MB, Dvir D.
Safety and Efficacy of Intracoronary Thrombolysis as Adjunctive Therapy to Primary PCI in STEMI: A Systematic Review and Meta-analysis.
Alyamani M, Campbell S, Navarese E, Welsh RC, Bainey KR.
Influence of Clinical Trials of Acute Coronary Syndrome Beyond the Primary Hypothesis: A Systematic Review.
Luoma LM, Westerhout CM, Granger CB, Armstrong PW.
Approach to Ventricular Arrhythmias in the Intensive Care Unit.
Senaratne J M, Sandhu R, Barnett C F, Grunau B, Wong GC, van Diepen S.
The Basics of ARDS Mechanical Ventilatory Care for Cardiovascular Specialists.
Rayner-Hartley E, Miller PE, Burstein B, Bibas L, Goldfarb M, Rampersad P, van Diepen S.
Optimizing Access to Heart Failure Care in Canada During the COVID-19 Pandemic.
Virani SA, Clarke B, Ducharme A, Ezekowitz JA, Heckman GA, McDonald M, Mielniczuk LM, Swiggum E, Van Spall HCG, Zieroth S, on behalf of the Canadian Heart Failure Society.
A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry.
Joseph P, Dokainish H, McCready T, Budaj A, Roy A, Ertl G, Gomez-Mesa JE, Leong D, Ezekowitz J, Hage C, Lanas F, Maggioni AP, Sliwa K, Zhu J, Rouleau J, Balasubramanian K, Yusuf S, CHF Investigators.
Nonculprit Lesion Plaque Morphology in Patients With ST-Segment-Elevation Myocardial Infarction: Results From the COMPLETE Trial Optical Coherence Tomography Substudys.
Pinilla-Echeverri N, Mehta SR, Wang J, Lavi S, Schampaert E, Cantor WJ, Bainey KR, Welsh RC, Kassam S, Mehran R, Storey RF, Nguyen H, Meeks B, Wood DA, Cairns JA, Sheth T.
Canadian Cardiovascular Society Clinical Practice Update on the Assessment and Management of Syncope.
Primary Writing Committee, Sandhu RK, Raj SR, Thiruganasambandamoorthy V, Kaul P, Morillo CA, Krahn AD, Guzman JC, Sheldon RS; Secondary Writing Committee, Banijamali HS, MacIntyre C, Manlucu J, Seifer C, Sivilotti M.
The Impact of Preoperative Risk on the Association between Hypotension and Mortality after Cardiac Surgery: An Observational Study.
Ristovic V, de Roock S, Mesana TG, van Diepen S, Sun LY.
Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI.
Marquis-Gravel G, Dalgaard F, Jones AD, Lokhnygina Y, James SK, Harrington RA, Wallentin L, Steg PG, Lopes RD, Storey RF, Goodman SG, Mahaffey KW, Tricoci P, White HD, Armstrong PW, Ohman EM, Alexander JH, Roe MT.
Persistence and adherence to parenteral osteoporosis therapies: a systematic review.
Koller G, Goetz V, Vandermeer B, Homik J, McAlister FA, Kendler D, Ye C.
Association Between HbA1c Levels and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Cardiovascular Disease: A Secondary Analysis of the TECOS Randomized Clinical Trial.
McAlister FA, Zheng Y, Westerhout CM, Buse JB, Standl E, McGuire DK, Van de Werf F, Green JB, Armstrong PW, Holman RR; TECOS Study Group.
Long-term Outcomes of Complete Revascularization with Percutaneous Coronary Intervention in Acute Coronary Syndromes.
Bainey KR, Alemayehu W, Armstrong PW, Westerhout CM, Kaul P, Welsh RC.
COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery: JACC Review Topic of the Week.
Katz JN, Sinha SS, Alviar CL, Dudzinski CM, Gage A, Brusca SB, Flanagan C, Welch T, Geller BJ, Miller E, Leonardi S, Bohula EA, Price S, Chaudhry S-P, Metkus TS, O’Brien CB, Sionis A, Barnett CF, Jentzer JC, Solomon S, Morrow DA, van Diepen S.
Very Early Changes in Quality of Life After Transcatheter Aortic Valve Replacement: Results From the 3M TAVR Trial.
Lauck SB, Arnold SV, Borregaard B, Sathananthan J, Humphries KH, Baron SJ, Wijeysundera HC, Asgar A, Welsh R, Velianou JL, Webb JG, Wood DA, Cohen DJ, 3M TAVR Investigators.
Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery.
van Diepen S, Mehta RH, Leimberger JD, Goodman SG, Fremes S, Jankowich R, Heringlake M, Anstrom KJ, Levy JH, Luber J, Nagpal AD, Duncan AE, Argenziano M, Toller W, Teoh K, Knight JD, Lopes RD, Cowper PA, Mark DB, Alexander JH.
Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction.
Howlett JG, Sharma N, Alemayehu WG, Dyck JRB, Anderson T, Fine N, Becker H, White JA, Paterson DI, Thompson RB, Oudit GY, Haykowsky MJ, Ezekowitz JA.
The Current and Future Hospitalization Cost Burden of Syncope in Canada.
Tran DT, Sheldon RS, Kaul P, Sandhu RK.
Inequity in Access to Transcatheter Aortic Valve Replacement: A Pan-Canadian Evaluation of Wait-Times.
Wijeysundera HC, Henning KA, Qiu F, Adams C, Al Qoofi F, Asgar A, Austin P, Bainey KR, Cohen EA, Daneault B, Fremes S, Kass M, Ko DT, Lambert L, Lauck SB, MacFarlane K, Najaf Nadeem S, Oakes G, Paddock V, Pelletier M, Peterson M, Piazza N, Potter BJ, Radhakrishnan S, Rodes-Cabau J, Toleva O, Webb JG, Welsh R, Wood D, Woodward G, Zimmermann R.
Novel Biomarkers, ST-Elevation Resolution, and Clinical Outcomes Following Primary Percutaneous Coronary Intervention.
Shavadia JS, Granger CB, Alemayehu W, Westerhout CM, Povsic TJ, van Diepen S, Defilippi C, Armstrong PW.
The Second Strategic Reperfusion Early After Myocardial Infarction (STREAM-2) Study Optimizing Pharmacoinvasive Reperfusion Strategy in Older ST-elevation Myocardial Infarction Patients.
Armstrong PW, Bogaerts K, Welsh R, Sinnaeve PR, Goldstein P, Pages A, Danays T, Van de Werf F, STREAM 2 Study Groups.
Conducting Clinical Trials in Heart Failure During (And After) the COVID-19 Pandemic: An Expert Consensus Position Paper From the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
Anker SD, Butler J, Shahzeb Khan M, Abraham WT, Bauersachs J, Bocchi E, Bozkurt B, Braunwald E, Chopra VK, Cleland JG, Ezekowitz J, Filippatos G, Friede T, Hernandez AF, Lam CSP, Lindenfeld J, McMurray JJV, Mehra M, Metra M, Packer M, Pieske B, Pocock SJ, Ponikowski P, Rosano GMC, Teerlink JR, Tsutsui H, Van Veldhuisen DJ, Verma S, Voors AA, Wittes J, Zannad F, Zhang J, Seferovic P, Coats AJS.
Guidelines for Clinical Practice – Mind the Gap!
Sheldon RS, Sandhu RK, Raj SR.
Applying evidence-based antiplatelet therapy in patients following a myocardial infarction without percutaneous coronary revascularization.
Welsh RC.
The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey.
Writing Group, Virani SA, Zieroth S, Bray S, Ducharme A, Harkness K, Koshman SL, McDonald M, O'Meara E, Swiggum E; Canadian Heart Failure Society and the Canadian Cardiovascular Society Heart Failure Guidelines Panel; CCS HF Guidelines Primary and Secondary Panel, Chan M, Ezekowitz JA, Giannetti N, Grzeslo A, Heckman GA, Howlett JG, Lepage S, Mielniczuk L, Moe GW, Toma M, Abrams H, Al-Hesaye A, Cohen-Solal A, D'Astous M, De S, Delgado D, Desplantie O, Estrella-Holder E, Green L, Haddad H, Hernandez AF, Kouz S, LeBlanc MH, Lee D, Masoudi FA, Matteau S, McKelvie R, Parent MC, Rajda M, Ross HJ, Sussex B.
Comparative Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Older Heart Failure Patients With Diabetes Mellitus.
Sharma A, Wu J, Xu H, Hernandez A, Felker GM, Al-Khatib S, Green J, Matsouaka R, Fonarow GC, Singh JP, Heidenreich PA, Ezekowitz JA, DeVore A.
Procedural Volume and Outcomes After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction in Kerala, India: Report of the Cardiological Society of India-Kerala Primary Percutaneous Coronary Intervention Registry.
Jabir A, Mathew A, Zheng Y, Westerhout C, Viswanathan S, Sebastian P, Kumar P, Bangalore S, Bainey KR, Welsh R.
A Systematic Review of the Risk of Motor Vehicle Collision in Patients With Syncope.
Chee JN, Simpson C, Sheldon RS, Dorian P, Dow J, Guzman J, Raj SR, Sandhu RK, Thiruganasambandamoorthy V, Green MS, Krahn AD, Plonka S, Rapoport MJ.
Worsening Hypertension Awareness, Treatment, and Control Rates in Canadian Women Between 2007 and 2017.
Leung AA, Williams JVA, McAlister FA, Campbell NRC, Padwal RS, Hypertension Canada’s Research and Evaluation Committee.
Association Between Delays in Mechanical Ventilation Initiation and Mortality in Patients With Refractory Cardiogenic Shock.
van Diepen S, Hochman JS, Stebbins A, Alviar CL, Alexander JH, Lopes RD.
Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.
Bainey KR, Engstrøm T, Smits PC, Gershlick AH, James SK, Storey RF, Wood DA, Mehran R, Cairns JA, Mehta SR.
Precautions and Procedures for Coronary and Structural Cardiac Interventions During the COVID-19 Pandemic: Guidance from Canadian Association of Interventional Cardiology.
Wood DA, Sathananthan J, Gin K, Mansour S, Ly HQ, Quraishi AU, Lavoie A, Lutchmedial S, Nosair M, Bagai A, Bainey KR, Boone RH, Liu S, Krahn A, Virani S, Mehta SR, Natarajan MK, Velianou JL, Dehghani P, Wijeysundera HC, Asgar AW, Virani A, Welsh RC, Webb JG, Cohen EA.
Impact of Cardiology Follow-Up Care on Treatment and Outcomes of Patients With New Atrial Fibrillation Discharged From the Emergency Department.
Hawkins NM, Scheuermeyer FX, Youngson E, Sandhu RK, Ezekowitz JA, Kaul P, McAlister FM.
Optimizing Access to Heart Failure Optimizing Access to Heart Failure Care in Canada during the COVID-19 Pandemic.
Virani SA, Clarke B, Ducharme A, Ezekowitz JA, Heckman GA, McDonald M, Mielniczuk LM, Swiggum E, Van Spall HGC, Zieroth S; Canadian Heart Failure Society.
SCAI Expert Consensus Statement on Out of Hospital Cardiac Arrest.
Lotfi A, Klein LW, Hira RS, Mallidi J, Mehran R, Messenger JC, Pinto DS, Mooney MR, Rab T, Yannopoulos D, van Diepen S.
Low Prevalence of Transcatheter Mitral Valve Repair Eligibility in a Community Heart Failure Population.
Fine NM, McAlister FA, Howlett JG, Youngson E, Ezekowitz JA.
Temporal Trends in Population Rates of Incident Atrial Fibrillation/Atrial Flutter Hospitalizations, Stroke Risk and Mortality Show Decline in Hospitalizations.
Sandhu RK, Wilton SB, Islam S, Aztema CL, Deyell M, Wyse DG, Cox JL, Skanes A, Kaul P.
Cardiovascular disease burden in adult patients with cancer: An 11-year nationwide population-based cohort study.
Youn JC, Chung WB, Ezekowitz JA, Hong JH, Nam H, Kyoung DS, Kim IC, Lyon AR, Kang SM, Jung HO, Chang K, Oh YS, Youn HJ, Baek SH, Kim HC.
Canada-wide mixed methods analysis evaluating the reasons for inappropriate emergency department presentation in patients with a history of atrial fibrillation: the multicentre AF-ED trial.
Hong KL, Babiolakis C, Zile B, Bullen M, Haseeb S, Halperin F, Hohl CM, Magee K, Sandhu RK, Tian SY, Kennedy A, Lobban T, Mariano Z, Dorian P, Angaran P, Evans M, Leong-Sit P, Glover BM.
Enhancing Cardiovascular Care: Global Collaboration Is How It Happens.
Armstrong PW.
Left atrial remodelling, mid-regional pro-atrial natriuretic peptide, and prognosis across a range of ejection fractions in heart failure.
Putko BN, Savu A, Kaul P, Ezekowitz J, Dyck JR, Anderson TJ, White JA, Paterson DI, Thompson RB, Oudit GY.
STEMI Care and COVID-19: The Value Proposition of Pharmacoinvasive Therapy.
Bainey KR, Bates ER, Armstrong PW.
Admission diagnosis and mortality risk prediction in a contemporary cardiac intensive care unit population.
Jentzer JC, van Diepen S, Murphree DH, Ismail AS, Keegan MT, Morrow DA, Barsness GW, Anavekar NS.
Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
Fiuzat M, Ezekowitz J, Alemayehu W, Westerhout CM, Sbolli M, Cani D, Whellan DJ, Ahmad T, Adams K, Piña IL, Patel CB, Anstrom KJ, Cooper LS, Mark D, Leifer ES, Felker GM, Januzzi JL, O'Connor CM.
Incidence, predictors and prognosis of respiratory support in non-ST segment elevation myocardial infarction.
Metkus T, Miller PE, Alviar CL, Jentzer JC, van Diepen S, Katz JN, Morrow DA, Schulman S, Eid S.
Cardiovascular risk factor control in British adults with diabetes mellitus: Retrospective cohort study.
Collins SÉ, Lethebe BC, Williamson T, McAlister FA.
Reduced myocardial blood flow reserve in kidney transplant candidates may hamper risk stratification.
Malak M, Christie E, Wen K, Wasse H, Hajihosseini M, Kaul P, Raggi P.
Canada-wide mixed methods analysis evaluating the reasons for inappropriate emergency department presentation in patients with a history of atrial fibrillation: the multicentre AF-ED trial.
Hong KL, Babiolakis C, Zile B, Bullen M, Haseeb S, Halperin F, Hohl CM, Magee K, Sandhu RK, Tian SY, Kennedy A, Lobban T, Mariano Z, Dorian P, Angaran P, Evans M, Leong-Sit P, Glover BM.
Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes.
Varshney AS, Berg DD, Katz JN, Baird-Zars VM, Bohula EA, Carnicelli AP, Chaudhry SP, Guo J, Lawler PR, Nativi-Nicolau J, Sinha SS, Teuteberg JJ, van Diepen S, Morrow DA; Critical Care Cardiology Trials Network Investigators.
Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic: An International Perspective.
Katz JN, Sinha SS, Alviar CL, Dudzinski DM, Gage A, Brusca SB, Flanagan MC, Welch T, Geller BJ, Miller PE, Leonardi S, Bohula EA, Price S, Chaudhry SP, Metkus TS, O'Brien CG, Sionis A, Barnett CF, Jentzer JC, Solomon MA, Morrow DA, van Diepen S.
Impact of the Generic Valsartan Recall in Alberta, Canada.
McAlister FA, Youngson E.
Worsening Hypertension Awareness, Treatment, and Control Rates in Canadian Women Between 2007 and 2017.
Leung AA, Williams JVA, McAlister FA, Campbell NRC, Padwal RS; Hypertension Canada’s Research and Evaluation Committee.
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Boden WE, Chaitman BR, Senior R, López-Sendón J, Alexander KP, Lopes RD, Shaw LJ, Berger JS, Newman JD, Sidhu MS, Goodman SG, Ruzyllo W, Gosselin G, Maggioni AP, White HD, Bhargava B, Min JK, Mancini GBJ, Berman DS, Picard MH, Kwong RY, Ali ZA, Mark DB, Spertus JA, Krishnan MN, Elghamaz A, Moorthy N, Hueb WA, Demkow M, Mavromatis K, Bockeria O, Peteiro J, Miller TD, Szwed H, Doerr R, Keltai M, Selvanayagam JB, Steg PG, Held C, Kohsaka S, Mavromichalis S, Kirby R, Jeffries NO, Harrell FE Jr, Rockhold FW, Broderick S, Ferguson TB Jr, Williams DO, Harrington RA, Stone GW, Rosenberg Y; ISCHEMIA Research Group.
Precautions and Procedures for Coronary and Structural Cardiac Interventions During the COVID-19 Pandemic: Guidance from Canadian Association of Interventional Cardiology.
Wood DA, Sathananthan J, Gin K, Mansour S, Ly HQ, Quraishi AU, Lavoie A, Lutchmedial S, Nosair M, Bagai A, Bainey KR, Boone RH, Liu S, Krahn A, Virani S, Mehta SR, Natarajan MK, Velianou JL, Dehghani P, Wijeysundera HC, Asgar AW, Virani A, Welsh RC, Webb JG, Cohen EA.
Commentary: More evidence for 24-7 intensivist cardiac surgical intensive care unit coverage.
van Diepen S.
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, Lam CSP, Ponikowski P, Voors AA, Jia G, McNulty SE, Patel MJ, Roessig L, Koglin J, O'Connor CM; VICTORIA Study Group.
The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial – insights from ASCEND-HF.
Bhatt AS, Ambrosy AP, Dunning A, DeVore AD, Butler J, Reed S, Voors A, Starling R, Armstrong PW, Ezekowitz JA, Metra M, Hernandez AF, O'Connor CM, Mentz RJ.
OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B).
Paterson DI, Wells G, Erthal F, Mielniczuk L, O'Meara E, White J, Connelly KA, Knuuti J, Radja M, Laine M, Chow BJW, Kandolin R, Chen L, Dick A, Dennie C, Garrard L, Ezekowitz J, Beanlands R, Chan KL; IMAGE-HF Investigators.
Comparing the Benefit Of Novel Therapies Across Clinical Trials: Insights from the VICTORIA Trial.
Butler J, Anstrom KJ, Armstrong PW; VICTORIA Study Group.
The Effect of Carotid Chemoreceptor Inhibition on Exercise Tolerance in Chronic Heart Failure.
Collins SÉ, Phillips DB, McMurtry MS, Bryan TL, Paterson DI, Wong E, Ezekowitz JA, Forhan MA, Stickland MK.
Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial.
Rubini Giménez M, Miller PE, Alviar CL, van Diepen S, Granger CB, Montalescot G, Windecker S, Maier L, Serpytis P, Serpytis R, Oldroyd KG, Noc M, Fuernau G, Huber K, Sandri M, de Waha-Thiele S, Schneider S, Ouarrak T, Zeymer U, Desch S, Thiele H.
Elevated Blood Pressure and Associations with Sodium Intake Among Multiethnic Youth in Edmonton, Canada: Findings from WHY ACT NOW.
Kolahdooz F, Nader F, Jang SL, Daemi M, Ezekowitz JA, Johnston N, Cruickshank K, Sharma S.
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Boden WE, Chaitman BR, Senior R, López-Sendón J, Alexander KP, Lopes RD, Shaw LJ, Berger JS, Newman JD, Sidhu MS, Goodman SG, Ruzyllo W, Gosselin G, Maggioni AP, White HD, Bhargava B, Min JK, Mancini GBJ, Berman DS, Picard MH, Kwong RY, Ali ZA, Mark DB, Spertus JA, Krishnan MN, Elghamaz A, Moorthy N, Hueb WA, Demkow M, Mavromatis K, Bockeria O, Peteiro J, Miller TD, Szwed H, Doerr R, Keltai M, Selvanayagam JB, Steg PG, Held C, Kohsaka S, Mavromichalis S, Kirby R, Jeffries NO, Harrell FE Jr, Rockhold FW, Broderick S, Ferguson TB Jr, Williams DO, Harrington RA, Stone GW, Rosenberg Y; ISCHEMIA Research Group.
Reduced myocardial blood flow reserve in kidney transplant candidates may hamper risk stratification.
Malak M, Christie E, Wen K, Wasse H, Hajihosseini M, Kaul P, Raggi P.
A Population-Based Study Evaluating Sex Differences in Patients Presenting to Emergency Departments With Syncope.
Bernier R, Tran DT, Sheldon RS, Kaul P, Sandhu RK.
Association Between Intensive Care Unit Usage and Long-Term Medication Adherence, Mortality, and Readmission Among Initially Stable Patients With Non-ST-Segment-Elevation Myocardial Infarction.
Fanaroff AC, Chen AY, van Diepen S, Peterson ED, Wang TY.
Influence of cardiac arrest and SCAI shock stage on cardiac intensive care unit mortality.
Jentzer JC, Henry TD, Barsness GW, Menon V, Baran DA, van Diepen S.
The ecology of medical care for adults in Alberta, 2002/03 to 2016/17: a retrospective cohort study.
McAlister FA, Tonelli M, Wiebe N, Lin M, Svenson LW, Dean S.
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients with Prior Percutaneous Coronary Intervention (COMPASS-PCI).
Bainey KR, Welsh RC, Connolly SJ, Marsden T, Bosch J, Fox KAA, Steg PG, Vinereanu D, Connolly DL, Berkowitz SD, Foody JM, Probstfield JL, Branch KR, Lewis BS, Diaz R, Muehlhofer E, Widimsky P, Yusuf S, Eikelboom JW, Bhatt DL; COMPASS Investigators.
The Supine Position Improves but does not Normalize the Blunted Pulmonary Capillary Blood Volume Response to Exercise in Mild COPD.
Ross BA, Brotto AR, Fuhr DP, Phillips DB, van Diepen S, Bryan TL, Stickland MK.
The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regions.
Motiejūnaitė J, Akiyama E, Cohen-Solal A, Maggioni AP, Mueller C, Choi DJ, Kavoliūnienė A, Čelutkienė J, Parenica J, Lassus J, Kajimoto K, Sato N, Miró Ò, Peacock WF, Matsue Y, Voors AA, Lam CSP, Ezekowitz JA, Ahmed A, Fonarow GC, Gayat E, Regitz-Zagrosek V, Mebazaa A.
Public Access Defibrillators: Gender-Based Inequities in Access and Application.
Grunau B, Humphries K, Stenstrom R, Pennington S, Scheuermeyer F, van Diepen S, Award E, Al Assil R, Kawano T, Brooks S, Gu B, Christenson J.
Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial.
HIP ATTACK Investigators. (McAlister F).
Pragmatic vs Explanatory Trials-Reply.
Sepehrvand N, Alemayehu W, Ezekowitz JA.
Screening and Initiating Supportive Care in Patients With Heart Failure.
Nguyen Q, Wang K, Nikhanj A, Chen-Song D, DeKock I, Ezekowitz J, Mirhosseini M, Cujec B, Oudit GY.
Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials.
Bozkurt B, Ezekowitz J.
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis.
O'Meara E, McDonald M, Chan M, Ducharme A, Ezekowitz JA, Giannetti N, Grzeslo A, Heckman GA, Howlett JG, Koshman SL, Lepage S, Mielniczuk LM, Moe GW, Swiggum E, Toma M, Virani SA, Zieroth S, De S, Matteau S, Parent MC, Asgar AW, Cohen G, Fine N, Davis M, Verma S, Cherney D, Abrams H, Al-Hesayen A, Cohen-Solal A, D'Astous M, Delgado DH, Desplantie O, Estrella-Holder E, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Lee D, Masoudi FA, McKelvie RS, Rajda M, Ross HJ, Sussex B.
Global REACH: Assessment of Brady-Arrhythmias in Andeans and Lowlanders During Apnea at 4330 m.
Busch SA, van Diepen S, Steele AR, Meah VL, Simpson LL, Figueroa-Mujíca RJ, Vizcardo-Galindo G, Villafuerte FC, Tymko MM, Ainslie PN, Moore JP, Stembridge M, Steinback CD.
Positive Pressure Ventilation in Cardiogenic Shock: Review of the Evidence and Practical Advice for Patients With Mechanical Circulatory Support.
Alviar CL, Rico-Mesa JS, Morrow DA, Thiele H, Miller PE, Maselli DJ, van Diepen S.
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial.
Bethel MA, Mentz RJ, Merrill P, Buse JB, Chan JC, Goodman SG, Iqbal N, Jakuboniene N, Katona B, Lokhnygina Y, Lopes RD, Maggioni AP, Ohman P, Tankova T, Bakris GL, Hernandez AF, Holman RR.
Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES.
Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators.
Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: An analysis from the Critical Care Cardiology Trials Network Registry.
van Diepen S, Tymchak W, Bohula EA, Park JG, Daniels LB, Phreaner N, Barnett CF, Kenigsberg BB, DeFilippis A, Singam NS, Barsness GW, Jentzer JC, Ternus B, Morrow DA, Katz JN; Critical Care Cardiology Trials Network Investigators.
Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial.
Tavenier AH, Hermanides RS, Fabris E, Lapostolle F, Silvain J, Ten Berg JM, Lassen JF, Bolognese L, Cantor WJ, Cequier Á, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Ecollan P, Collet JP, Willems FF, Diallo A, Vicaut E, Hamm CW, Montalescot G, van 't Hof AWJ; ATLANTIC investigators.
What Is the Role of Medical Therapy in Cardiogenic Shock in the Era of Mechanical Circulatory Support?
van Diepen S, Baran DA, Mebazaa A.
Design and Region-Specific Adaptation of the Dietary Intervention Used in the SODIUM-HF Trial: A Multicentre Study.
Colin-Ramirez E, Arcand J, Woo E, Brum M, Morgan K, Christopher W, Velázquez L, Sharifzad A, Feeney S, Ezekowitz JA.
A Novel In-hospital Congestion Score to Risk Stratify Patients Admitted for Worsening Heart Failure (from ASCEND-HF).
Masson R, Ambrosy AP, Kheder K, Fudim M, Clare RM, Coles A, Hernandez AF, Starling RC, Ezekowitz JA, O'Connor CM, Mentz RJ.
Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study.
McAlister FA, Mian R, Oldgren J, Wallentin L, Ezekowitz M, Yusuf S, Connolly SJ, Healey JS; RE-LY Atrial Fibrillation Registry Investigators.
What Is the Role of Medical Therapy in Cardiogenic Shock in the Era of Mechanical Circulatory Support?
van Diepen S, Baran DA, Mebazaa A.
The Search for the Genes of Vasovagal Syncope.
Sheldon RS, Sandhu RK.
Syncope in the Emergency Department.
Sandhu RK, Sheldon RS.
A comparison of four risk models for the prediction of cardiovascular complications in patients with a history of atrial fibrillation undergoing non-cardiac surgery.
McAlister FA, Youngson E, Jacka M, Graham M, Conen D, Chan M, Szczeklik W, Alonso-Coello P, Devereaux PJ; vascular events in non-cardiac surgery patIents cohort evaluation (VISION) investigators.
Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49).
Gibson CM, Kumar V, Gopalakrishnan L, Singh P, Guo J, Kazziha S, Devireddy C, Pinto D, Marshall JJ, Stouffer GA, Mavromatis K, Grip L, Bainey KR; TIMI & PERFUSE Study Group.
Applying evidence-based antiplatelet therapy in patients following a myocardial infarction without percutaneous coronary revascularization.
Welsh RC.
Atrial fibrillation and stroke: chicken or egg? Does it really matter?
Sandhu RK, Healey JS.
Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial.
Vora AN, Alexander JH, Wojdyla DM, Aronson R, Granger CB, Darius H, Windecker S, Mehran R, Averkov O, Budaj A, Kong DF, Kobalava Z, Mehta RH, Mirza Z, Guimaraes PO, Parkhomenko A, Quadros A, Thiele H, Goodman SG, Lopes RD.
Older Adults in the Cardiac Intensive Care Unit: Factoring Geriatric Syndromes in the Management, Prognosis, and Process of Care: A Scientific Statement From the American Heart Association.
Damluji AA, Forman DE, van Diepen S, Alexander KP, Page RL 2nd, Hummel SL, Menon V, Katz JN, Albert NM, Afilalo J, Cohen MG.
Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician.
Eckman PM, Katz JN, El Banayosy A, Bohula EA, Sun B, van Diepen S.
High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction.
Shavadia JS, Granger CB, Alemayehu W, Westerhout CM, Povsic TJ, Brener SJ, van Diepen S, Defilippi C, Armstrong PW.
Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial.
Pieske B, Patel MJ, Westerhout CM, Anstrom KJ, Butler J, Ezekowitz J, Hernandez AF, Koglin J, Lam CSP, Ponikowski P, Roessig L, Voors AA, O'Connor CM, Armstrong PW; VICTORIA Study Group.
Impact of cardiology follow-up care on treatment and outcomes of patients with new atrial fibrillation discharged from the emergency department.
Hawkins NM, Scheuermeyer FX, Youngson E, Sandhu RK, Ezekowitz JA, Kaul P, McAlister FA.
Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS.
De Ferrari GM, Stevens SR, Ambrosio G, Leonardi S, Armstrong PW, Green JB, Wamil M, Holman RR, Peterson ED; TECOS Study Group.
Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry.
Pocock SJ, Brieger D, Gregson J, Chen JY, Cohen MG, Goodman SG, Granger CB, Grieve R, Nicolau JC, Simon T, Westermann D, Yasuda S, Hedman K, Rennie KL, Sundell KA; TIGRIS Study Investigators.
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
Verma S, Mazer CD, Yan AT, Mason T, Garg V, Teoh H, Zuo F, Quan A, Farkouh ME, Fitchett DH, Goodman SG, Goldenberg RM, Al-Omran M, Gilbert RE, Bhatt DL, Leiter LA, Jüni P, Zinman B, Connelly KA.
Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: Results From the EXSCEL Trial.
Badjatiya A, Merrill P, Buse JB, Goodman SG, Katona B, Iqbal N, Pagidipati NJ, Sattar N, Holman RR, Hernandez AF, Mentz RJ, Patel MR, Jones WS.
The effect of dopamine on pulmonary diffusing capacity and capillary blood volume responses to exercise in young healthy humans.
Michaelchuk WW, Tedjasaputra V, Bryan TL, van Diepen S, Stickland MK.
Eligibility of sodium-glucose co-transporter-2 inhibitors among patients with diabetes mellitus admitted for heart failure.
Sharma A, Wu J, Ezekowitz JA, Felker GM, Udell JA, Heidenreich PA, Fonarow GC, Mahaffey KW, Hernandez AF, DeVore AD.
The Burden of Atherosclerotic Cardiovascular Disease in South Asians Residing in Canada: A Reflection From the South Asian Heart Alliance.
Bainey KR, Gupta M, Ali I, Bangalore S, Chiu M, Kaila K, Kaul P, Khan N, King-Shier KM, Palaniappan L, Pare G, Ramanathan K, Ross S, Shah BR.
Heart failure treatment and the art of medical decision making.
McAlister FA, Ezekowitz JA, Armstrong PW.
Eligibility of sodium-glucose co-transporter-2 inhibitors among patients with diabetes mellitus admitted for heart failure.
Sharma A, Wu J, Ezekowitz JA, Felker GM, Udell JA, Heidenreich PA, Fonarow GC, Mahaffey KW, Hernandez AF, DeVore AD.
Prevalence of undiagnosed atrial fibrillation in elderly individuals and potential cost-effectiveness of non-invasive ambulatory electrocardiographic screening: The ASSERT-III study.
McIntyre WF, Yong JHE, Sandhu RK, Gladstone DJ, Simek K, Liu YY, Quinn FR, Tytus R, Zizzo D, Henein S, Ivers N, Healey JS.
The effect of carotid chemoreceptor inhibition on exercise tolerance in chronic obstructive pulmonary disease: A randomized-controlled crossover trial.
Phillips DB, Collins SÉ, Bryan TL, Wong EYL, McMurtry MS, Bhutani M, Stickland MK.
Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial.
Szarek M, Steg PG, DiCenso D, Bhatt DL, Bittner VA, Budaj A, Diaz R, Goodman SG, Gotcheva N, Jukema JW, Pordy R, Roe MT, Sourdille T, White HD, Xavier D, Zeiher AM, Schwartz GG.
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
Roe MT, Li QH, Bhatt DL, Bittner VA, Diaz R, Goodman SG, Harrington RA, Jukema JW, Lopez-Jaramillo P, Lopes RD, Louie MJ, Moriarty PM, Szarek M, Vogel R, White HD, Zeiher AM, Baccara-Dinet MT, Steg PG, Schwartz GG.
Clinical Practice Patterns in Temporary Mechanical Circulatory Support for Shock in the Critical Care Cardiology Trials Network (CCCTN) Registry.
Berg DD, Barnett CF, Kenigsberg BB, Papolos A, Alviar CL, Baird-Zars VM, Barsness GW, Bohula EA, Brennan J, Burke JA, Carnicelli AP, Chaudhry SP, Cremer PC, Daniels LB, DeFilippis AP, Gerber DA, Granger CB, Hollenberg S, Horowitz JM, Gladden JD, Katz JN, Keeley EC, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Miller PE, Nativi-Nicolau J, Newby LK, Park JG, Phreaner N, Roswell RO, Schulman SP, Sinha SS, Snell RJ, Solomon MA, Teuteberg JJ, Tymchak W, van Diepen S, Morrow DA.
Admission Society for Cardiovascular Angiography and Intervention shock stage stratifies post-discharge mortality risk in cardiac intensive care unit patients.
Jentzer JC, Baran DA, van Diepen S, Barsness GW, Henry TD, Naidu SS, Bell MR, Holmes DR Jr.
Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease.
Welsh RC, Peterson ED, De Caterina R, Bode C, Gersh B, Eikelboom JW.
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
Dangas GD, Tijssen JGP, Wöhrle J, Søndergaard L, Gilard M, Möllmann H, Makkar RR, Herrmann HC, Giustino G, Baldus S, De Backer O, Guimarães AHC, Gullestad L, Kini A, von Lewinski D, Mack M, Moreno R, Schäfer U, Seeger J, Tchétché D, Thomitzek K, Valgimigli M, Vranckx P, Welsh RC, Wildgoose P, Volkl AA, Zazula A, van Amsterdam RGM, Mehran R, Windecker S; GALILEO Investigators.
Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease.
Shavadia JS, Zheng Y, Green JB, Armstrong PW, Westerhout CM, McGuire DK, Cornel JH, Holman RR, Peterson ED.
The “1-year-death number needed to treat” for comparing the impact of distinct interventions on patient outcomes.
Hryciw BN, McAlister FA, Tuna M, van Walraven C.
Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial.
Rachwan RJ, Butler J, Collins SP, Cotter G, Davison BA, Senger S, Ezekowitz JA, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, de Boer RA, Soergel DG, Felker GM, Pang PS.
All for one, but not one for all.
Ezekowitz JA.
Sodium Glucose Cotransporter-2 Inhibition and Cardiorenal Protection: JACC Review Topic of the Week.
Cherney DZ, Odutayo A, Aronson R, Ezekowitz J, Parker JD.
Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS.
Pagidipati NJ, Zheng Y, Green JB, McGuire DK, Mentz RJ, Shah S, Aschner P, Delibasi T, Rodbard HW, Westerhout CM, Holman RR, Peterson ED; TECOS Study Group.
Elevated fasting vs post-load glucose levels and pregnancy outcomes in gestational diabetes: a population-based study.
Ryan EA, Savu A, Yeung RO, Moore LE, Bowker SL, Kaul P.
The impact of cirrhosis in patients undergoing cardiac surgery: a retrospective observational cohort study.
Xavier S, Norris CM, Ewasiuk A, Kutsogiannis DJ, Bagshaw SM, van Diepen S, Townsend DR, Negendran J, Karvellas CJ.
2019 Canadian Cardiovascular Society Position Statement for Transcatheter Aortic Valve Implantation.
Asgar AW, Ouzounian M, Adams C, Afilalo J, Fremes S, Lauck S, Leipsic J, Piazza N, Rodes-Cabau J, Welsh R, Wijeysundera HC, Webb JG.
The hospital frailty risk score in patients with heart failure is strongly associated with outcomes but less so with pharmacotherapy.
McAlister FA, Savu A, Ezekowitz JA, Armstrong PW, Kaul P.
National trends in coronary intensive care unit admissions, resource utilization, and outcomes.
Woolridge S, Alemayehu W, Kaul P, Fordyce CB, Lawler PR, Lemay M, Jentzer JC, Goldfarb M, Wong GC, Armstrong PW, van Diepen S.
Will Cardiac Intensive Care Unit Admissions Warrant Appropriate Use Criteria in the Future?
van Diepen S, Katz JN, Morrow DA.
Capsule Commentary on Woodfine et. al., Criteria for Hyponatremic Overcorrection: Systematic Review and Cohort Study of Emergently Ill Patients.
McAlister E, McAlister FA.
Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial.
Rachwan RJ, Butler J, Collins SP, Cotter G, Davison BA, Senger S, Ezekowitz JA, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, de Boer RA, Soergel DG, Felker GM, Pang PS.
Role of Sodium-Glucose Cotransporter-2 Inhibition in the Treatment of Adults With Heart Failure.
Sharma A, Ezekowitz JA.
Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit.
Jentzer JC, van Diepen S, Barsness GW, Henry TD, Menon V, Rihal CS, Naidu SS, Baran DA.
Comparative Prognostic Accuracy of Risk Prediction Models for Cardiogenic Shock.
Miller RJH, Southern D, Wilton SB, James MT, Har B, Schnell G, van Diepen S, Grant ADM.
Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma: Combined Analysis of BRUISE CONTROL 1 and 2.
Essebag V, Healey JS, Joza J, Nery PB, Kalfon E, Leiria TLL, Verma A, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Philippon F, Eikelboom J, Sandhu RK, Sapp J, Leather R, Yung D, Thibault B, Simpson CS, Ahmad K, Toal S, Sturmer M, Kavanagh K, Crystal E, Wells GA, Krahn AD, Birnie DH.
Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice: Insights From the Vital Heart Response Registry.
Bainey KR, Armstrong PW, Zheng Y, Brass N, Tyrrell BD, Leung R, Westerhout CM, Welsh RC.
Outcomes of nurse practitioner-led care in patients with cardiovascular disease: A systematic review and meta-analysis.
Smigorowsky MJ, Sebastianski M, Mcmurtry MS, Tsuyuki RT, Norris CM.
Design and rationale of the North Indian ST-Segment Elevation Myocardial Infarction Registry: A prospective cohort study.
Arora S, Qamar A, Gupta P, Vaduganathan M, Chauhan I, Tripathi AK, Sharma VY, Bansal A, Fatima A, Jain G, Batra V, Tyagi S, Khandelwal L, Kaul P, Rao SV, Girish MP, Bhatt DL, Gupta MD.
The impact of cirrhosis in patients undergoing cardiac surgery: a retrospective observational cohort study.
Xavier S, Norris CM, Ewasiuk A, Kutsogiannis DJ, Bagshaw SM, van Diepen S, Townsend DR, Negendran J, Karvellas CJ.
National Trends in Incidence and Outcomes of Patients With Heart Failure Requiring Respiratory Support.
Miller PE, Patel S, Saha A, Guha A, Pawar S, Poojary P, Ratnani P, Chan L, Kamholz SL, Alviar CL, van Diepen S, Nasir K, Ahmad T, Nadkarni GN, Desai NR.
The association between hyperuricemia and coronary artery calcification development: A systematic review and meta-analysis.
Liang L, Hou X, Bainey KR, Zhang Y, Tymchak W, Qi Z, Li W, Banh HL.
Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial.
Windecker S, Lopes RD, Massaro T, Jones-Burton C, Granger CB, Aronson R, Heizer G, Goodman SG, Darius H, Jones WS, Aschermann M, Brieger D, Cura F, Engstrøm T, Fridrich V, Halvorsen S, Huber K, Kang HJ, Leiva-Pons JL, Lewis BS, Malaga G, Meneveau N, Merkely B, Milicic D, Morais J, Potpara TS, Raev D, Sabaté M, de Waha-Thiele S, Welsh RC, Xavier D, Mehran R, Alexander JH; AUGUSTUS Investigators.
Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit.
Jentzer JC, van Diepen S, Barsness GW, Henry TD, Menon V, Rihal CS, Naidu SS, Baran DA.
Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals.
Lowres N, Olivier J, Chao TF, Chen SA, Chen Y, Diederichsen A, Fitzmaurice DA, Gomez-Doblas JJ, Harbison J, Healey JS, Hobbs FDR, Kaasenbrood F, Keen W, Lee VW, Lindholt JS, Lip GYH, Mairesse GH, Mant J, Martin JW, Martín-Rioboó E, McManus DD, Muñiz J, Münzel T, Nakamya J, Neubeck L, Orchard JJ, Pérula de Torres LÁ, Proietti M, Quinn FR, Roalfe AK, Sandhu RK, Schnabel RB, Smyth B, Soni A, Tieleman R, Wang J, Wild PS, Yan BP, Freedman B.
The Canadian Cardiovascular Society 2018 guideline update for atrial fibrillation – A different perspective.
Stiell IG, McMurtry MS, McRae A, Parkash R, Scheuermeyer F, Atzema CL, Skanes A.
Associations of Osteopontin and NT-proBNP with Circulating miRNA Levels in Acute Coronary Syndrome.
Kwee LC, Neely ML, Grass E, Gregory SG, Roe MT, Ohman EM, Fox KAA, White HD, Armstrong PW, Bowsman LM, Haas JV, Duffin KL, Chan MY, Shah SH.
Substantial Differences Between Cohorts of Patients Hospitalized With Heart Failure in Canada and the United States-Reply.
McAlister FA, Youngson E.
Guidelines for the management of heart failure by pharmacists.
Beique LC, Ezekowitz JA, O'Meara E, McDonald M, Koshman SL. 2017
Effectiveness of Interventions Aimed at Increasing Statin-Prescribing Rates in Primary Cardiovascular Disease Prevention: A Systematic Review of Randomized Clinical Trials.
Sparrow RT, Khan AM, Ferreira-Legere LE, Ko DT, Jackevicius CA, Goodman SG, Anderson TJ, Stacey D, Tiszovszky I, Farkouh ME, Tu JV, Udell JA.
Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial.
Everett CC, Fox KA, Reynolds C, Fernandez C, Sharples L, Stocken DD, Carruthers K, Hemingway H, Yan AT, Goodman SG, Brieger D, Chew DP, Gale CP.
Quantification of lung water in heart failure using cardiovascular magnetic resonance imaging.
Thompson RB, Chow K, Pagano JJ, Sekowski V, Michelakis ED, Tymchak W, Haykowsky MJ, Ezekowitz JA, Oudit GY, Dyck JRB, Kaul P, Savu A, Paterson DI.
Safe Cardioversion for Patients With Acute-Onset Atrial Fibrillation and Flutter: Practical Concerns and Considerations.
Stiell IG, McMurtry MS, McRae A, Parkash R, Scheuermeyer F, Atzema CL, Skanes A.
Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial.
Welsh RC, Sidhu RS, Cairns JA, Lavi S, Kedev S, Moreno R, Cantor WJ, Stankovic G, Meeks B, Yuan F, Džavík V, Jolly SS.
Complete Revascularization with Multivessel PCI for Myocardial Infarction.
Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, Meeks B, Di Pasquale G, López-Sendón J, Faxon DP, Mauri L, Rao SV, Feldman L, Steg PG, Avezum Á, Sheth T, Pinilla-Echeverri N, Moreno R, Campo G, Wrigley B, Kedev S, Sutton A, Oliver R, Rodés-Cabau J, Stanković G, Welsh R, Lavi S, Cantor WJ, Wang J, Nakamya J, Bangdiwala SI, Cairns JA; COMPLETE Trial Steering Committee and Investigators.
Atrial fibrillation with percutaneous coronary intervention: Navigating the minefield of antithrombotic therapies.
Bainey KR, Morais J, Zeymer U, Welsh RC.
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery.
Goodman SG, Aylward PE, Szarek M, Chumburidze V, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Hanotin C, Harrington RA, Jukema JW, Kedev S, Letierce A, Moryusef A, Pordy R, Ramos López GA, Roe MT, Viigimaa M, White HD, Zeiher AM, Steg PG, Schwartz GG; ODYSSEY OUTCOMES Committees and Investigators.
Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction.
Januzzi JL Jr, Ahmad T, Mulder H, Coles A, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N, Mark DB, Piña IL, Passmore G, Whellan DJ, Cooper LS, Leifer ES, Desvigne-Nickens P, Felker GM, O'Connor CM.
Trends in the Explanatory or Pragmatic Nature of Cardiovascular Clinical Trials Over 2 Decades.
Sepehrvand N, Alemayehu W, Das D, Gupta AK, Gouda P, Ghimire A, Du AX, Hatami S, Babadagli HE, Verma S, Kashour Z, Ezekowitz JA.
Empirical Insights When Defining the Population Burden of Atrial Fibrillation and Oral Anticoagulation Utilization Using Administrative Data.
Hawkins NM, Daniele PR, Humphries KH, Ezekowitz JA, McAlister FA, Sandhu RK, Kaul P.
The Care Transitions Measure-3 Is Only Weakly Associated with Post-discharge Outcomes: a Retrospective Cohort Study in 48,384 Albertans.
McAlister FA, Lin M, Bakal J, Kemp KA, Quan H.
Prospective validation and refinement of the APPROACH cardiovascular surgical intensive care unit readmission score.
Verma S, Southern DA, Raslan IR, Norris CM, Graham MM, Bagshaw SM, Nagendran J, Maclure T, Sun LY, Chin WD, van Diepen S.
Intra-pulmonary arteriovenous anastomoses and pulmonary gas exchange: evaluation by microspheres, contrast echocardiography and inert gas elimination.
Stickland MK, Tedjasaputra V, Seaman C, Fuhr DP, Collins SÉ, Wagner H, van Diepen S, Byers BW, Wagner PD, Hopkins SR.
Tapered vs. Uniform tube-load modeling of blood pressure wave propagation in human aorta.
Mousavi A, Tivay A, Finegan B, McMurtry MS, Mukkamala R, Hahn J-O.
Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness.
Bohula EA, Katz JN, van Diepen S, Alviar CL, Baird-Zars VM, Park JG, Barnett CF, Bhattal G, Barsness GW, Burke JA, Cremer PC, Cruz J, Daniels LB, DeFilippis A, Granger CB, Hollenberg S, Horowitz JM, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Ng J, Orgel R, Overgaard CB, Phreaner N, Roswell RO, Schulman SP, Snell RJ, Solomon MA, Ternus B, Tymchak W, Vikram F, Morrow DA; Critical Care Cardiology Trials Network.
Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy?
Levy JH, Ghadimi K, Faraoni D, van Diepen S, Levy B, Hotchkiss R, Connors JM, Iba T, Warkentin TE.
Invasive and antiplatelet treatment of patients with non‐ST‐segment elevation myocardial infarction: Understanding and addressing the global risk‐treatment paradox.
Ahrens I, Averkov O, Zúñiga EC, Fong AYY, Alhabib KF, Halvorsen S, Abdul Kader MABSK, Sanz‐Ruiz R, Welsh R, Yan H, Aylward P.
An Update on the Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation and Atrial Flutter.
Sandhu RK, Wilton SB, Cruz J, Aztema CL, MacFarlane K, McKelvie R, Lambert L, Rush K, Zimmerman R, Oakes G, Deyell M, Wyse DG, Cox JL, Skanes A.
A Population-Based Study of Device Eligibility, Use, and Reasons for Nonimplantation in Patients at Heart Function Clinics.
Bernier R, Ng J, Tran DT, Lockwood E, Reyes L, Cowan K, Fine NM, Ezekowitz J, Exner DV, Raj SR, Sandhu RK.
Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery.
van Diepen S, Mehta RH, Leimberger JD, Goodman SG, Fremes S, Jankowich R, Heringlake M, Anstrom KJ, Levy JH, Luber J, Nagpal AD, Duncan AE, Argenziano M, Toller W, Teoh K, Knight JD, Lopes RD, Cowper PA, Mark DB, Alexander JH.
An overview of international cardiogenic shock guidelines and application in clinical practice.
van Diepen S, Thiele H.
Parental Atrial Fibrillation and Stroke or Atrial Fibrillation in Young Adults.
McAlister FA, Yan L, Roos LL, Lix LM.
Will Cardiac Intensive Care Unit Admissions Warrant Appropriate Use Criteria in the Future?
van Diepen S, Katz JN, Morrow DA.
Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy?
Levy JH, Ghadimi K, Faraoni D, van Diepen S, Levy B, Hotchkiss R, Connors JM, Iba T, Warkentin TE.
Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness.
Bohula EA, Katz JN, van Diepen S, Alviar CL, Baird-Zars VM, Park JG, Barnett CF, Bhattal G, Barsness GW, Burke JA, Cremer PC, Cruz J, Daniels LB, DeFilippis A, Granger CB, Hollenberg S, Horowitz JM, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Ng J, Orgel R, Overgaard CB, Phreaner N, Roswell RO, Schulman SP, Snell RJ, Solomon MA, Ternus B, Tymchak W, Vikram F, Morrow DA; Critical Care Cardiology Trials Network.
Prevalence and Postdischarge Outcomes Associated with Frailty in Medical Inpatients: Impact of Different Frailty Definitions.
McAlister FA, Lin M, Bakal JA.
2017 Guidelines for the management of heart failure by pharmacists.
Beique LC, Ezekowitz JA, O’Meara E, McDonald M, Koshman SL.
Total and Cause-Specific Mortality After Percutaneous Coronary Intervention: Observations From the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease Registry.
Tran DT, Barake W, Galbraith D, Norris C, Knudtson ML, Kaul P, McAlister FA, Sandhu RK.
Changes in the prevalence of overweight, obesity, and severe obesity between 2010 and 2017 in preschoolers: A population-based study.
Ball GDC, Savu A, Kaul P.
Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.
Mehta SR, Wood DA, Meeks B, Storey RF, Mehran R, Bainey KR, Nguyen H, Bangdiwala SI, Cairns JA; COMPLETE Trial Steering Committee and Investigators.
Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial.
Sharma A, Hagström E, Wojdyla DM, Neely ML, Harrington RA, Wallentin L, Alexander JH, Goodman SG, Lopes RD; Apixaban for Prevention of Acute Ischemic Safety Events APPRAISE-2 Steering Committee and Investigators.
A comparison of four risk models for the prediction of cardiovascular complications in patients with a history of atrial fibrillation undergoing non-cardiac surgery.
McAlister FA, Youngson E, Jacka M, Graham M, Conen D, Chan M, Szczeklik W, Alonso-Coello P, Devereaux PJ; vascular events in non-cardiac surgery patIents cohort evaluation (VISION) investigators.
When Is Syncope Arrhythmic?
Martow E, Sandhu R.
Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study.
Ghimire A, Fine N, Ezekowitz JA, Howlett J, Youngson E, McAlister FA.
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.
Outcomes Following Transcatheter Aortic Valve Replacement for Degenerative Stentless Versus Stented Bioprostheses.
Duncan A, Moat N, Simonato M, de Weger A, Kempfert J, Eggebrecht H, Walton A, Hellig F, Kornowski R, Spargias K, Mendiz O, Makkar R, Guerrero M, Rihal C, George I, Don C, Iadanza A, Bapat V, Welsh R, Wijeysundera HC, Wood D, Sathananthan J, Danenberg H, Maisano F, Garcia S, Gafoor S, Nombela-Franco L, Cobiella J, Dvir D.
Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit population.
Jentzer JC, van Diepen S, Barsness GW, Katz JN, Wiley BM, Bennett CE, Mankad SV, Sinak LJ, Best PJ, Herrmann J, Jaffe AS, Murphy JG, Morrow DA, Wright RS, Bell MR, Anavekar NS.
The Association of the Average Epinephrine Dosing Interval and Survival With Favorable Neurologic Status at Hospital Discharge in Out-of-Hospital Cardiac Arrest.
Grunau B, Kawano T, Scheuermeyer FX, Drennan I, Fordyce CB, van Diepen S, Reynolds J, Lin S, Christenson J.
Noncardiovascular Disease and Critical Care Delivery in a Contemporary Cardiac and Medical Intensive Care Unit.
Goldfarb M, van Diepen S, Liszkowski M, Jentzer JC, Pedraza I, Cercek B.
The Effects of Acute Atmospheric Pressure Changes on the Occurrence of ST-Elevation Myocardial Infarction: A Case-Crossover Study.
Hong Y, Graham MM, Rosychuk RJ, Southern D, McMurtry MS.
Success Begins With Failure: An Alternative Approach in Transfemoral Transcatheter Aortic Valve Replacement Using an Antegrade Wire Crossing Technique.
Narasimhan S, Shanks M, Meyer S, Tyrrell B, Taylor D, Welsh RC.
Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort.
Liu S, Singer A, McAlister FA, Peeler W, Heran BS, Drummond N, Manca DP, Allan GM, Korownyk C, Kolber MR, Greiver M, Garrison SR.
Twelve-Year Temporal Trends in Ambulance Use for Patients Hospitalized With a Primary Diagnosis of Syncope in Canada.
Gupta AK, Savu A, Sheldon RS, Raj S, Kaul P, Sandhu RK.
External Validation and Refinement of Emergency Heart Failure Mortality Risk Grade Risk Model in Patients With Heart Failure in the Emergency Department.
Sepehrvand N, Youngson E, Bakal JA, McAlister FA, Rowe BH, Ezekowitz JA.
Low altitude simulation without hypoxia improves left ventricular function after myocardial infarction by reducing ventricular afterload.
Shahid A, Patel VB, Morton JS, Stenson TH, Davidge ST, Oudit GY, McMurtry MS.
Ticagrelor versus Clopidogrel in Patients with STEMI Treated with Fibrinolytic Therapy: TREAT Trial.
Berwanger O, Lopes RD, Moia DDF, Fonseca FA, Jiang L, Goodman SG, Nicholls SJ, Parkhomenko A, Averkov O, Tajer C, Malaga G, Saraiva JFK, Guimaraes HP, de Barros E Silva PGM, Damiani LP, Santos RHN, Paisani DM, Miranda TA, Valeis N, Piegas LS, Granger CB, White HD, Nicolau JC.
P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes.
Povsic TJ, Ohman EM, Roe MT, White J, Rockhold FW, Montalescot G, Cornel JH, Nicolau JC, Steg PG, James S, Bode C, Welsh RC, Plotnikov AN, Mundl H, Gibson CM.
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.
White HD, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Erglis A, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lopes RD, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Sritara P, Tricoci P, Zeiher AM, Schwartz GG.
Are Cardiac Biomarkers the Key to Solving the Syncope Mystery?
Sandhu RK, Sheldon RS.
An overview of international cardiogenic shock guidelines and application in clinical practice.
van Diepen S, Thiele H.
Rationale and Design of the VITALITY-HFpEF Trial.
Butler J, Lam CSP, Anstrom KJ, Ezekowitz J, Hernandez AF, O'Connor CM, Pieske B, Ponikowski P, Shah SJ, Solomon SD, Voors AA, Wu Y, Carvalho F, Bamber L, Blaustein RO, Roessig L, Armstrong PW.
Incidence of Syncope During Pregnancy: Temporal Trends and Outcomes.
Chatur S, Islam S, Moore LE, Sandhu RK, Sheldon RS, Kaul P.
SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019.
Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, Hollenberg SM, Kapur NK, O'Neill W, Ornato JP, Stelling K, Thiele H, van Diepen S, Naidu SS.
External Validation of the H2F-PEF Model in Diagnosing Patients With Heart Failure and Preserved Ejection Fraction.
Sepehrvand N, Alemayehu W, Dyck GJB, Dyck JRB, Anderson T, Howlett J, Paterson I, McAlister FA, Ezekowitz JA.
High vs. low oxygen therapy in patients with acute heart failure: HiLo-HF pilot trial.
Sepehrvand N, Alemayehu W, Rowe BH, McAlister FA, van Diepen S, Stickland M, Ezekowitz JA.
Utilization and Costs of Noninvasive Cardiac Tests After Acute Coronary Syndromes: Insights From the Alberta COAPT Study.
Bainey KR, Durham D, Zheng Y, Westerhout CM, Kaul P, Welsh RC.
International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing.
Pereira NL, So D, Bae JH, Chavez I, Jeong MH, Kim SW, Madan M, Graham J, O'Cochlain F, Pauley N, Lennon RJ, Bailey K, Hasan A, Baudhuin LM, Bell MR, Lerman A, Goodman S, Mathew V, Farkouh M, Rihal CS.
Effects of early physician follow-up.
McAlister FA.
Commentary: More evidence for 24-7 intensivist cardiac surgical intensive care unit coverage.
van Diepen S.
Clopidogrel Pharmacogenetics.
Pereira NL, Rihal CS, So DYF, Rosenberg Y, Lennon RJ, Mathew V, Goodman SG, Weinshilboum RM, Wang L, Baudhuin LM, Lerman A, Hasan A, Iturriaga E, Fu YP, Geller N, Bailey K, Farkouh ME.
A Population Level Analysis of the Differing Impacts of Rheumatoid Arthritis and Spondyloarthritis on Peripartum Outcomes.
Keeling S, Bowker S, Savu A, Kaul P.
Acute Decompensated Heart Failure Complicated by Respiratory Failure.
Miller PE, van Diepen S, Ahmad T.
The History of Hypertension Guidelines in Canada.
Daskalopoulou SS, Feldman RD, McAlister FA, Rabi DM; Hypertension Canada.
Temporal Trends of Women Enrollment in Major Cardiovascular Randomized Clinical Trials.
Gong IY, Tan NS, Ali SH, Lebovic G, Mamdani M, Goodman SG, Ko DT, Laupacis A, Yan AT.
Creating order out of chaos: quality of care in heart failure.
Ezekowitz JA.
Counteracting Health Misinformation: A Role for Medical Journals?
Armstrong PW, Naylor CD.
Systematic Incorporation of Sex-Specific Information Into Clinical Practice Guidelines for the Management of ST -Segment-Elevation Myocardial Infarction: Feasibility and Outcomes.
Norris CM, Tannenbaum C, Pilote L, Wong G, Cantor WJ, McMurtry MS.
The continuous heart failure spectrum: moving beyond an ejection fraction classification.
Triposkiadis F, Butler J, Abboud FM, Armstrong PW, Adamopoulos S, Atherton JJ, Backs J, Bauersachs J, Burkhoff D, Bonow RO, Chopra VK, de Boer RA, de Windt L, Hamdani N, Hasenfuss G, Heymans S, Hulot JS, Konstam M, Lee RT, Linke WA, Lunde IG, Lyon AR, Maack C, Mann DL, Mebazaa A, Mentz RJ, Nihoyannopoulos P, Papp Z, Parissis J, Pedrazzini T, Rosano G, Rouleau J, Seferovic PM, Shah AM, Starling RC, Tocchetti CG, Trochu JN, Thum T, Zannad F, Brutsaert DL, Segers VF, De Keulenaer GW.
Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States.
Samsky MD, Ambrosy AP, Youngson E, Liang L, Kaul P, Hernandez AF, Peterson ED, McAlister FA.
Incremental costs of high intensive care utilisation in patients hospitalised with heart failure.
van Diepen S, Tran DT, Ezekowitz JA, Schnell G, Wiley BM, Morrow DA, McAlister FA, Kaul P.
Statin use and the risk of acute kidney injury in older adults.
Tonelli M, Lloyd AM, Bello AK, James MT, Klarenbach SW, McAlister FA, Manns BJ, Tsuyuki RT, Hemmelgarn BR.
Systematic Incorporation of Sex-Specific Information Into Clinical Practice Guidelines for the Management of ST -Segment-Elevation Myocardial Infarction: Feasibility and Outcomes.
Norris CM, Tannenbaum C, Pilote L, Wong G, Cantor WJ, McMurtry MS.
Improving Outcomes for Heart Failure Patients after Discharge: Mind the Gap.
McAlister FA.
Prognostic Implications of Changes in Amino-Terminal Pro-B-Type Natriuretic Peptide in Acute Decompensated Heart Failure: Insights from ASCEND-HF.
Grodin JL, Liebo MJ, Butler J, Metra M, Felker GM, Hernandez AF, Voors AA, McMurray JJ, Armstrong PW, O'Connor C, Starling RC, Troughton RW, Wilson Tang WH.
Epidemiology of Shock in Contemporary Cardiac Intensive Care Units.
Berg DD, Bohula EA, van Diepen S, Katz JN, Alviar CL, Baird-Zars VM, Barnett CF, Barsness GW, Burke JA, Cremer PC, Cruz J, Daniels LB, DeFilippis AP, Haleem A, Hollenberg SM, Horowitz JM, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Ng J, Orgel R, Overgaard CB, Park J-G, Phreaner N, Roswell RO, Schulman SP, Snell, JR, Solomon MA, Ternus B, Tymchak W, Vikram F, Morrow DA.
Role of Critical Care Medicine Training in the Cardiovascular Intensive Care Unit: Survey Responses From Dual Certified Critical Care Cardiologists.
Brusca SB, Barnett C, Barnhart BJ, Weng W, Morrow DA, Soble JS, Katz JN, Wiley BM, van Diepen S, Gomez AD, Solomon MA.
Sex And Prognostic Significance of Self-Reported Frailty in Non–ST-Segment Elevation Acute Coronary Syndromes: Insights From the TRILOGY ACS Trial.
Kaul P, Alexander KP, Ohman EM, Savu A, Roe MT, Goodman SG, Fox KA, White HD, Prabhakaran D, Hochman JS, Clemmensen P, Armstrong PW.
Titration and Tolerability of Sacubitril/Valsartan for Patients With Heart Failure in Clinical Practice.
Du AX, Westerhout CM, McAlister FA, Shanks M, Oudit GY, Paterson DI, Hanninen M, Thomas J, Ezekowitz JA.
The Relationship Between Heart-Failure Hospitalization and Mortality in Patients Receiving Transcatheter Aortic Valve Replacement.
Nazzari H, Hawkins NM, Ezekowitz J, Lauck S, Ding L, Polderman J, Yu M, Boone RH, Cheung A, Ye J, Wood D, Webb J, Toma M.
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.
Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Alexander KP, Senior R, Boden WE, Stone GW, Goodman SG, Lopes RD, Lopez-Sendon J, White HD, Maggioni AP, Shaw LJ, Min JK, Picard MH, Berman DS, Chaitman BR, Mark DB, Spertus JA, Cyr DD, Bhargava B, Ruzyllo W, Wander GS, Chernyavskiy AM, Rosenberg YD, Maron DJ.
Statin use and the risk of acute kidney injury in older adults.
Tonelli M, Lloyd AM, Bello AK, James MT, Klarenbach SW, McAlister FA, Manns BJ, Tsuyuki RT, Hemmelgarn BR; Alberta Kidney Disease Network.
Clinical Factors Related to Morbidity and Mortality in High-Risk Heart Failure Patients: The GUIDE-IT Predictive Model And Risk Score.
O'Connor C, Fiuzat M, Mulder H, Coles A, Ahmad T, Ezekowitz JA, Adams KF, Piña IL, Anstrom KJ, Cooper LS, Mark DB, Whellan DJ, Januzzi JL Jr, Leifer ES, Felker GM.
Physiological Association between Limb Ballistocardiogram and Arterial Blood Pressure Waveforms: A Mathematical Model-Based Analysis.
Yousefian P, Shin S, Mousavi AS, Kim CS, Finegan B, McMurtry MS, Mukkamala R, Jang DG, Kwon U, Kim YH, Hahn JO.
The Association between Chronic Obstructive Pulmonary Disease and Coronary Artery Disease in Patients Undergoing Coronary Angiography.
Hong Y, Graham MM, Southern D, McMurtry MS.
Epidemiology of Shock in Contemporary Cardiac Intensive Care Units.
Berg DD, Bohula EA, van Diepen S, Katz JN, Alviar CL, Baird-Zars VM, Barnett CF, Barsness GW, Burke JA, Cremer PC, Cruz J, Daniels LB, DeFilippis AP, Haleem A, Hollenberg SM, Horowitz JM, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Ng J, Orgel R, Overgaard CB, Park JG, Phreaner N, Roswell RO, Schulman SP, Jeffrey Snell R, Solomon MA, Ternus B, Tymchak W, Vikram F, Morrow DA.
Role of Critical Care Medicine Training in the Cardiovascular Intensive Care Unit: Survey Responses From Dual Certified Critical Care Cardiologists.
Brusca SB, Barnett C, Barnhart BJ, Weng W, Morrow DA, Soble JS, Katz JN, Wiley BM, van Diepen S, Gomez AD, Solomon MA.
Prevalence and Postdischarge Outcomes Associated with Frailty in Medical Inpatients: Impact of Different Frailty Definitions.
McAlister FA, Lin M, Bakal JA.
Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease.
Stewart RAH, Held C, Krug-Gourley S, Waterworth D, Stebbins A, Chiswell K, Hagstrom E, Armstrong PW, Wallentin L, White H.
Cardiac rehabilitation in people with peripheral arterial disease: A higher risk population that benefits from completion.
Devrome AN, Aggarwal S, McMurtry MS, Southern D, Hauer T, Lamb B, Arena R, Moore RD, Wilton SB, Stone J, Martin BJ.
Living alone and cardiovascular disease outcomes.
Gandhi S, Goodman SG, Greenlaw N, Ford I, McSkimming P, Ferrari R, Jang Y, Alcocer-Gamba MA, Fox K, Tardif JC, Tendera M, Dorian P, Steg G, Udell JA.
Maternal cardioautonomic responses during and following exercise throughout pregnancy.
Purdy GM, James MA, Wakefield PK, Skow RJ, van Diepen S, May LE, Davenport MH, Steinback CD.
Elevated pre-transplant left ventricular end-diastolic pressure increases primary graft dysfunction risk in double lung transplant recipients.
Li D, Weinkauf J, Hirji A, Kapasi A, Lien D, Nagendran J, Kim D, Ezekowitz J, Halloran K.
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study.
Wood DA, Lauck SB, Cairns JA, Humphries KH, Cook R, Welsh R, Leipsic J, Genereux P, Moss R, Jue J, Blanke P, Cheung A, Ye J, Dvir D, Umedaly H, Klein R, Rondi K, Poulter R, Stub D, Barbanti M, Fahmy P, Htun N, Murdoch D, Prakash R, Barker M, Nickel K, Thakkar J, Sathananthan J, Tyrell B, Al-Qoofi F, Velianou JL, Natarajan MK, Wijeysundera HC, Radhakrishnan S, Horlick E, Osten M, Buller C, Peterson M, Asgar A, Palisaitis D, Masson J-B, Kodali S, Nazif T, Thourani V, Babaliaros VC, Cohen DJ, Park JE, Leon MB, Webb JG.
Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation.
Lee H, Tan M, Yan AT, Angaran P, Dorian P, Bucci C, Gregoire JC, Bell AD, Green MS, Gross PL, Skanes A, Kerr CR, Mitchell LB, Cox JL, Essebag V, Heilbron B, Ramanathan K, Fournier C, Wheeler BH, Lin PJ, Berall M, Langer A, Goldin L, Goodman SG.
Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies.
Cerrato E, Bianco M, Bagai A, De Luca L, Biscaglia S, Luciano A, Destefanis P, Quadri G, Meynet I, Gravinese C, Chinaglia A, Goodman SG, Pozzi R, Campo G, Varbella F.
Is incentivising stroke prevention therapy in atrial fibrillation the key?
Sandhu RK, Ezekowitz JA.
NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF
Daubert MA, Adams K, Yow E, Barnhart HX, Douglas PS, Rimmer S, Norris C, Cooper L, Leifer E, Desvigne-Nickens P, Anstrom K, Fiuzat M, Ezekowitz J, Mark DB, O'Connor CM, Januzzi J, Felker GM.
Update on the diagnosis and management of acute heart failure.
Gouda P, Ezekowitz JA.
Cost-effectiveness of Osteoporosis Interventions to Improve Quality of Care after Upper Extremity Fracture: Results from a Randomized Trial (C-STOP Trial).
Majumdar SR, Lier DA, McAlister FA, Johnson JA, Rowe BH, Beaupre LA.
Risk factors for hypertension in Canada.
Leung AA, Bushnik T, Hennessy D, McAlister FA, Manuel DG.
Efficacy and Safety of Apixaban versus Warfarin in Patients with Atrial Fibrillation and Extremes in Body Weight: Insights from the ARISTOTLE Trial.
Hohnloser SH, Fudim M, Alexander JH, Wojdyla DM, Ezekowitz JA, Hanna M, Atar D, Hijazi Z, Bahit MC, Al-Khatib SM, Lopez-Sendon JL, Wallentin L, Granger CB, Lopes RD.
The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review.
Dyck GJB, Raj P, Zieroth S, Dyck JRB, Ezekowitz JA.
2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and Reperfusion.
M, Norris CM, Overgaard CB, Perry Arnesen M, Quraishi A, Tanguay JF, Traboulsi M, van Diepen S, Welsh R, Wood DA, Cantor WJ; members of the Secondary Panel.
Creating order out of chaos: quality of care in heart failure.
Ezekowitz JA.
Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes.
Saw J, Starovoytov A, Humphries K, Sheth T, So D, Minhas K, Brass N, Lavoie A, Bishop H, Lavi S, Pearce C, Renner S, Madan M, Welsh RC, Lutchmedial S, Vijayaraghavan R, Aymong E, Har B, Ibrahim R, Gornik HL, Ganesh S, Buller C, Matteau A, Martucci G, Ko D, Mancini GBJ.
Kidney function modifies the selection of treatment strategies and long-term survival in stable ischaemic heart disease: insights from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) registry
Shavadia JS, Southern DA, James MT, Welsh RC, Bainey KR.
Prevention of Cardiogenic Shock After Acute Myocardial Infarction.
Vanhaverbeke M, Bogaerts K, Sinnaeve PR, Janssens L, Armstrong PW, Van de Werf F.
Variables Associated With Cardiac Surgical Waitlist Mortality From a Population-Based Cohort.
Senaratne JM, Norris CM, Youngson E, McClure RS, Nagendran J, Butler CR, Meyer SR, Anderson TJ, van Diepen S.
Cost-effectiveness of home blood pressure telemonitoring and case management in the secondary prevention of cerebrovascular disease in Canada.
Padwal RS, So H, Wood PW, McAlister FA, Siddiqui M, Norris CM, Jeerakathil T, Stone J, Valaire S, Mann B, Boulanger P, Klarenbach SW.
Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes.
Fanaroff AC, Cyr D, Neely ML, Bakal J, White HD, Fox KAA, Armstrong PW, Lopes RD, Ohman EM, Roe MT.
Sodium Fluoride Imaging of Coronary Atherosclerosis in Ambulatory Patients With Diabetes Mellitus.
Raggi P, Senior P, Shahbaz S, Kaul P, Hung R, Coulden R, Yeung R, Abele J.
Patterns of use of targeted temperature management for acute myocardial infarction patients following out-of-hospital cardiac arrest: Insights from the National Cardiovascular Data Registry.
Fordyce CB, Chen AY, Wang TY, Lucas J, Goyal A, Wong GC, van Diepen S, Kontos MC, Henry TD, Granger CB, Roe MT.
Canadian Cardiovascular Society and Canadian Institute of Health Information Public Reporting of Percutaneous Coronary Intervention Quality Indicators.
Welsh RC, MacFarlane K, Quraishi AUR; Canadian Cardiovascular Society Percutaneous Coronary Intervention Quality Working Group.
Challenges With Severe Coronary Artery Calcification in Percutaneous Coronary Intervention: A Narrative Review of Therapeutic Options.
Shavadia JS, Vo MN, Bainey KR.
Update on the diagnosis and management of acute heart failure.
Gouda P, Ezekowitz JA.
The Titration and Tolerability of Sacubitril/Valsartan for Patients with Heart Failure in Clinical Practice.
Du AX, Westerhout CM, McAlister FA, Shanks M, Oudit GY, Paterson DI, Hanninen M, Thomas J, Ezekowitz JA.
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial.
Ungar L, Clare RM, Rodriguez F, Kolls BJ, Armstrong PW, Aylward P, Held C, Moliterno DJ, Strony J, Van de Werf F, Wallentin L, White HD, Tricoci P, Harrington RA, Mahaffey KW, Melloni C.
A Population-Based Study of Adherence to Guideline Recommendations and Appropriate-Use Criteria for Implantable Cardioverter Defibrillators.
Bernier R, Al-Shehri M, Raj SR, Reyes L, Lockwood E, Gulamhusein S, Williams R, Valtuille L, Sivakumaran S, Hruczkowski T, Kimber S, Exner DV, Sandhu RK.
Pulmonary capillary blood volume response to exercise is diminished in mild chronic obstructive pulmonary disease.
Tedjasaputra V, van Diepen S, Phillips DB, Wong EYL, Bhutani M, Michaelchuk WW, Bryan TL, Stickland MK.
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial.
Sandhu RK, Ezekowitz JA, Hijazi Z, Westerbergh J, Aulin J, Alexander JH, Granger CB, Halvorsen S, Hanna MS, Lopes RD, Siegbahn A, Wallentin L.
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial.
J Am Coll Cardiol. 2018 Oct 27. pii: S0735-1097(18)38961-7. doi: 10.1016/j.jacc.2018.10.039.
Association between maternal diabetes, being large for gestational age and breast-feeding on being overweight or obese in childhood.
Kaul P, Bowker SL, Savu A, Yeung RO, Donovan LE, Ryan EA.
Outcomes of medically managed patients with myocardial infarction.
Kaul P, Savu A, Hamza S, Knudtson ML, Bainey K, Brass N, Armstrong PW, Welsh RC.
Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure.
Mark DB, Cowper PA, Anstrom KJ, Sheng S, Daniels MR, Knight JD, Baloch KN, Davidson-Ray L, Fiuzat M, Januzzi JL Jr, Whellan DJ, Piña IL, Ezekowitz JA, Adams KF, Cooper LS, O'Connor CM, Felker GM.
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).
Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Verma A, Philippon F, Kalfon E, Eikelboom J, Sandhu RK, Nery PB, Lellouche N, Connolly SJ, Sapp J, Essebag V.
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.
Andrade JG, Verma A, Mitchell LB, Parkash R, Leblanc K, Atzema C, Healey JS, Bell A, Cairns J, Connolly S, Cox J, Dorian P, Gladstone D, McMurtry MS, Nair GM, Pilote L, Sarrazin JF, Sharma M, Skanes A, Talajic M, Tsang T, Verma S, Wyse DG, Nattel S, Macle L; CCS Atrial Fibrillation Guidelines Committee.
Cardiac involvement in critically ill patients with leptospirosis: A prospective study using myocardial deformation imaging.
Mathew A, Shanks M, Punnoose E, Fischer L, Koshy G, Potluri R, Bainey KR.
The Impact of the Implementation of the Enhanced Recovery After Surgery (ERAS®) Program in an Entire Health System: A Natural Experiment in Alberta, Canada.
AlBalawi Z, Gramlich L, Nelson G, Senior P, Youngson E, McAlister FA.
Impact of contrast echocardiography on accurate discrimination of specific degree of left ventricular systolic dysfunction and comparison with cardiac magnetic resonance imaging.
Alherbish A, Becher H, Alemayehu W, Paterson DI, Butler CR, Anderson TJ, Ezekowitz JA, Shanks M; Alberta HEART investigators.
Comparison of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Management Strategies Before Cardiac Surgery: A Pilot Randomized Controlled Registry Trial.
van Diepen S, Norris CM, Zheng Y, Nagendran J, Graham MM, Gaete Ortega D, Townsend DR, Ezekowitz JA, Bagshaw SM.
Frailty and Outcomes After Myocardial Infarction: Insights From the CONCORDANCE Registry.
Patel A, Goodman SG, Yan AT, Alexander KP, Wong CL, Cheema AN, Udell JA, Kaul P, D'Souza M, Hyun K, Adams M, Weaver J, Chew DP, Brieger D, Bagai A.
Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update.
Tobe SW, Stone JA, Anderson T, Bacon S, Cheng AYY, Daskalopoulou SS, Ezekowitz JA, Gregoire JC, Gubitz G, Jain R, Keshavjee K, Lindsay P, L'Abbe M, Lau DCW, Leiter LA, O'Meara E, Pearson GJ, Rabi DM, Sherifali D, Selby P, Tu JV, Wharton S, Walker KM, Hua-Stewart D, Liu PP.
Screening for undiagnosed atrial fibrillation.
Sandhu RK, Healey JS.
Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points.
Greene SJ, Hernandez AF, Sun JL, Butler J, Armstrong PW, Ezekowitz JA, Zannad F, Ferreira JP, Coles A, Metra M, Voors AA, Califf RM, O'Connor CM, Mentz RJ.
Short- and long-term mortality after pulmonary embolism in patients with and without cancer.
Alotaibi G, Wu C, Senthilselvan A, McMurtry MS.
Acute Coronary Syndromes and Heart Failure Critical Care Units Utilization and Outcomes in Teaching and Community Hospitals: A National Population-Based Analysis.
Verma S, Kaul P, Lin M, Ezekowitz JA, Zygun DA, Fordyce CB, Wang TY, McAlister FA, van Diepen S.
Adherence to osteoporosis therapy after an upper extremity fracture: a pre-specified substudy of the C-STOP randomized controlled trial.
McAlister FA, Ye C, Beaupre LA, Rowe BH, Johnson JA, Bellerose D, Hassan I, Majumdar SR.
Marital status and outcomes after myocardial infarction: Observations from the Canadian Observational Antiplatelet Study (COAPT).
Ghosh-Swaby OR, Tan M, Bagai A, Yan AT, Goodman SG, Mehta SR, Fisher HN, Cohen EA, Huynh T, Cantor WJ, Le May MR, Déry JP, Welsh RC, Udell JA.
Positive Pressure Ventilation in the Cardiac Intensive Care Unit.
Alviar CL, Miller PE, McAreavey D, Katz JN, Lee B, Moriyama B, Soble J, van Diepen S, Solomon MA, Morrow DA; ACC Critical Care Cardiology Working Group.
Rationale and design of the Study of Dietary Intervention Under 100 MMOL in Heart Failure (SODIUM-HF).
Colin-Ramirez E, Ezekowitz JA; SODIUM-HF investigators.
Oxygen therapy in acute myocardial infarctions: do we need to re-evaluate its necessity?
Sepehrvand N, Ezekowitz JA.
Health Care Resource Utilization Among Children With Congenital Heart Disease: A Population-Based Study.
Islam S, Kaul P, Tran DT, Mackie AS.
Circulation Global Rounds.
Armstrong PW, Hill JA.
Is incentivising stroke prevention therapy in atrial fibrillation the key?
Sandhu RK, Ezekowitz JA.
Norepinephrine as a First-Line Inopressor in Cardiogenic Shock: Oversimplification or Best Practice?
van Diepen S.
Transcatheter Mitral Valve Intervention for Chronic Mitral Regurgitation: A Plethora of Different Technologies.
Sidhu RS, Tyrrell BD, Welsh RC, Meyer SR, Shanks M, Bainey KR.
Evolution of Procedural and Clinical Outcomes After Balloon-Expanding Transcatheter Aortic Valve Implantation In Canada (from the Early Canadian Experience and SOURCE XT Registries).
Welsh RC.
Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF).
Fudim M, Parikh KS, Dunning A, DeVore AD, Mentz RJ, Schulte PJ, Armstrong PW, Ezekowitz JA, Tang WHW, McMurray JJV, Voors AA, Drazner MH, O'Connor CM, Hernandez AF, Patel CB.
Maternal cardioautonomic responses during and following exercise throughout pregnancy.
Purdy GM, James MA, Wakefield PK, Skow RJ, Van Diepen S, May LE, Davenport MH, Steinback CD.
Initial Rhythm and Resuscitation Outcomes for Patients Developing Cardiac Arrest in Kenyan Hospitals.
Ngunga LM, Yonga G, Wachira B, Ezekowitz JA.
Ethnic and sex differences in ambulance activation among hospitalized patients with acute coronary syndromes: Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study.
Bainey KR, Alemayehu W, Gupta AK, Bowker SL, Welsh RC, Kaul P.
Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation.
McAlister FA, Wiebe N, Ronksley PE, Healey JS.
Implantable Cardioverter Defibrillator Use in Catecholaminergic Polymorphic Ventricular Tachycardia: A Systematic Review.
Roston TM, Jones K, Hawkins NM, Bos JM, Schwartz PJ, Perry F, Ackerman MJ, Laksman ZWM, Kaul P, Lieve KVV, Atallah J, Krahn AD, Sanatani S.
The interplay between cholesterol and breast cancer: is there a potential role for statin therapy?
Potluri R, Carter PR, Lavu D, Bainey KR.
Comparing Strategies Targeting Osteoporosis to Prevent Fractures after an Upper Extremity Fracture (C-STOP Trial): A Randomized Controlled Trial.
Majumdar SR, McAlister FA, Johnson JA, Rowe BH, Bellerose D, Hassan I, Lier DA, Li S, Maksymowych WP, Menon M, Russell AS, Wirzba B, Beaupre LA.
Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial.
Tricoci P, Neely M, Whitley MJ, Edelstein LC, Simon LM, Shaw C, Fortina P, Moliterno DJ, Armstrong PW, Aylward P, White H, Van de Werf F, Jennings LK, Wallentin L, Held C, Harrington RA, Mahaffey KW, Bray PF.
Population-Level Outcomes With a 2-Step Approach for Gestational Diabetes Screening and Diagnosis: Response to the Letter to the Editor From Dr. Kong.
Donovan L, Edwards A, Savu A, Butalia S, Ryan E, Johnson J, Kaul P.
Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights from the ASCEND-HF Trial.
Grodin JL, Butler J, Metra M, Felker GM, Voors AA, McMurray JJ, Armstrong PW, Hernandez AF, O'Connor C, Starling RC, Wilson Tang WH.
Influence of hospital volume on outcomes for patients with heart failure: Evidence from a Canadian national cohort study.
McAlister FA, Youngson E, van Diepen S, Ezekowitz JA, Kaul P.
Geographical Differences in Comorbidity Burden and Outcomes in Adults With Syncope Hospitalizations in Canada.
Abulhamayel A, Savu A, Sheldon RS, Kaul P, Sandhu RK.
Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarction.
Rymer JA, Tempelhof MW, Clare RM, Pieper KS, Granger CB, Van de Werf F, Moliterno DJ, Harrington RA, White HD, Armstrong PW, Lopes RD, Mahaffey KW, Newby LK.
Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.
Alfredsson J, Green JB, Stevens SR, Reed SD, Armstrong PW, Angelyn Bethel M, Engel SS, McGuire DK, Van de Werf F, Hramiak I, White HD, Peterson ED, Holman RR; TECOS Study Group.
Factors associated with hypertension control among older Canadians.
Bushnik T, Hennessy DA, McAlister FA, Manuel DG.
Defining an Intraoperative Hypotension Threshold in Association with Stroke in Cardiac Surgery.
Sun LY, Chung AM, Farkouh ME, van Diepen S, Weinberger J, Bourke M, Ruel M.
The high cost of critical care unit over-utilization for patients with NSTE ACS.
van Diepen S, Tran DT, Ezekowitz JA, Zygun DA, Katz JN, Lopes RD, Newby LK, McAlister FA, Kaul P.
The Use of Biomarkers to Predict Specific Causes of Death in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial.
Sharma A, Hijazi Z, Andersson U, Al-Khatib SM, Lopes RD, Alexander JH, Held C, Hylek EM, Leonardi S, Hanna M, Ezekowitz JA, Siegbahn A, Granger CB, Wallentin L.
Leveraging electronic health records for clinical research.
Raman SR, Curtis LH, Temple R, Andersson T, Ezekowitz J, Ford I, James S, Marsolo K, Mirhaji P, Rocca M, Rothman RL, Sethuraman B, Stockbridge N, Terry S, Wasserman SM, Peterson ED, Hernandez AF.
Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis.
Scirica BM, Bansilal S, Davoudi F, Armstrong PW, Clare RM, Schulte PJ, Pieper KS, Becker RC, James SK, Storey RF, Steg PG, Held C, Himmelmann A, Mahaffey KW, Wallentin L, Cannon CP; PLATO Steering Committee and Investigators.
Examining the Influence of Component Outcomes on the Composite at the Design Stage.
Brown PM, Ezekowitz JA.
Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes.
Sharma A, Al-Khatib SM, Ezekowitz JA, Cooper LB, Fordyce CB, Michael Felker G, Bardy GH, Poole JE, Thomas Bigger J, Buxton AE, Moss AJ, Friedman DJ, Lee KL, Steinman R, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Peterson ED, Inoue LYT, Sanders GD.
Management of cardiogenic shock complicating myocardial infarction.
Mebazaa A, Combes A, van Diepen S, Hollinger A, Katz JN, Landoni G, Hajjar LA, Lassus J, Lebreton G, Montalescot G, Park JJ, Price S, Sionis A, Yannopolos D, Harjola VP, Levy B, Thiele H.
Prevalence of Pulmonary Embolism in Patients With Syncope.
Costantino G, Ruwald MH, Quinn J, Camargo CA Jr, Dalgaard F, Gislason G, Goto T, Hasegawa K, Kaul P, Montano N, Numé AK, Russo A, Sheldon R, Solbiati M, Sun B, Casazza G.
Chemoreflex mediated arrhythmia during apnea at 5,050 m in low- but not high-altitude natives.
Busch SA, Davies H, van Diepen S, Simpson LL, Sobierajski F, Riske L, Stembridge M, Ainslie PN, Willie CK, Hoiland R, Moore JP, Steinback CD.
Systematic review and directors survey of quality indicators for the cardiovascular intensive care unit.
Goldfarb M, Bibas L, Newby LK, Henry TD, Katz J, van Diepen S, Cercek B.
Insights on the Use of Twitter at the Canadian Cardiovascular Congress.
Gouda P, Ezekowitz J.
Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes.
Sharma A, Al-Khatib SM, Ezekowitz JA, Cooper LB, Fordyce CB, Michael Felker G, Bardy GH, Poole JE, Thomas Bigger J, Buxton AE, Moss AJ, Friedman DJ, Lee KL, Steinman R, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Peterson ED, Inoue LYT, Sanders GD.
Exploring New Cardiovascular Pathways: Are Soluble Guanylate Cyclase Stimulators the Right Direction?
Michalak M, Armstrong PW.
Applicability of the Systolic Blood Pressure Intervention Trial (SPRINT) to the Canadian Population.
Leung AA, Chang HJ, McAlister FA, Khan NA, Rabi DM, Quan H, Padwal RS.
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.
Tricoci P, Newby LK, Clare RM, Leonardi S, Gibson CM, Giugliano RP, Armstrong PW, Van de Werf F, Montalescot G, Moliterno DJ, Held C, Aylward PE, Wallentin L, Harrington RA, Braunwald E, Mahaffey KW, White HD.
Traveling the Interstices of Data Sharing.
Armstrong PW, Mentz RJ, Westerhout CM.
Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study.
Bainey KR, Welsh RC, Alemayehu W, Westerhout CM, Traboulsi D, Anderson T, Brass N, Armstrong PW, Kaul P.
Ambulance use, distance and outcomes in patients with suspected cardiovascular disease: a registry-based geographic information system study.
Sepehrvand N, Alemayehu W, Kaul P, Pelletier R, Bello AK, Welsh RC, Armstrong PW, Ezekowitz JA.
Early discontinuation of prasugrel or clopidogrel in acute coronary syndromes: insights from the TRILOGY ACS trial.
Yan AT, Roe MT, Neely M, Cyr DD, White H, Fox KAA, Prabhakaran D, Armstrong PW, Ohman EM, Goodman SG.
Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial).
Khan NA, Rabkin SW, Zhao Y, McAlister FA, Park JE, Guan M, Chan S, Humphries KH.
Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trials.
Sepehrvand N, James SK, Stub D, Khoshnood A, Ezekowitz JA, Hofmann R.
Marital status and outcomes after myocardial infarction: Observations from the Canadian Observational Antiplatelet Study (COAPT).
Ghosh-Swaby OR, Tan M, Bagai A, Yan AT, Goodman SG, Mehta SR, Fisher HN, Cohen EA, Huynh T, Cantor WJ, Le May MR, Déry JP, Welsh RC, Udell JA.
Beyond Stroke Prevention in Atrial Fibrillation: Exploring Further Unmet Needs with Rivaroxaban.
Gibson CM, Hankey GJ, Nafee T, Welsh RC.
The effect of provider affiliation with a primary care network on emergency department visits and hospital admissions.
McAlister FA, Bakal JA, Green L, Bahler B, Lewanczuk R.
The Impact of the Implementation of the Enhanced Recovery After Surgery (ERAS®) Program in an Entire Health System: A Natural Experiment in Alberta, Canada.
AlBalawi Z, Gramlich L, Nelson G, Senior P, Youngson E, McAlister FA.
Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.
Cerbin LP, Ambrosy AP, Greene SJ, Armstrong PW, Butler J, Coles A, DeVore AD, Ezekowitz JA, Hernandez AF, Metra M, Starling RC, Tang W, Teerlink JR, Voors AA, Wu A, O'Connor CM, Mentz RJ.
Systematic review and directors survey of quality indicators for the cardiovascular intensive care unit.
Goldfarb M, Bibas L, Newby LK, Henry TD, Katz J, van Diepen S, Cercek B.
Comparing Canadian health care to that in other countries: looking beyond the headlines.
McAlister FA, Cram P, Bell CM.
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy.
Mehta SR, Bainey KR, Cantor WJ, Lordkipanidzé M, Marquis-Gravel G, Robinson SD, Sibbald M, So DY, Wong GC, Abunassar JG, Ackman ML, Bell AD, Cartier R, Douketis JD, Lawler PR, McMurtry MS, Udell JA, van Diepen S, Verma S, Mancini GBJ, Cairns JA, Tanguay JF; members of the Secondary Panel.
Coronary Artery Bypass Surgery Improves Outcomes in Patients With Diabetes and Left Ventricular Dysfunction.
Nagendran J, Bozso SJ, Norris CM, McAlister FA, Appoo JJ, Moon MC, Freed DH, Nagendran J.
Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.
Guimarães PO, Leonardi S, Huang Z, Wallentin L, de Werf FV, Aylward PE, Held C, Harrington RA, Moliterno DJ, Armstrong PW, White HD, Alexander KP, Lopes RD, Mahaffey KW, Tricoci P.
Heparin use for diagnostic cardiac catheterization with a radial artery approach: An international survey of practice patterns.
Bossard M, Lavi S, Rao SV, Cohen DJ, Cantor WJ, Bainey KR, Valettas N, Jolly SS, Mehta SR.
A Population-Based Study of Syncope in the Young.
Roston TM, Tran DT, Sanatani S, Sandhu R, Sheldon R, Kaul P.
Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Bhatt AS, Cooper LB, Ambrosy AP, Clare RM, Coles A, Joyce E, Krishnamoorthy A, Butler J, Felker GM, Ezekowitz JA, Armstrong PW, Hernandez AF, O'Connor CM, Mentz RJ.
Control of glycemia and blood pressure in British adults with diabetes mellitus and subsequent therapy choices: a comparison across health states.
McAlister FA, Lethebe BC, Lambe C, Williamson T, Lowerison M.
Use of Direct Oral Anticoagulants in Canadian Primary Care Practice 2010-2015: A Cohort Study From the Canadian Primary Care Sentinel Surveillance Network.
McAlister FA, Garrison S, Kosowan L, Ezekowitz JA, Singer A.
Chemoreflex mediated arrhythmia during apnea at 5,050 m in low- but not high-altitude natives
Busch SA, Davies HE, Van Diepen S, Simpson LL, Sobierajski F, Riske L, Stembridge M, Ainslie PN, Willie CK, Hoiland RL, Moore JP, Steinback CD.
Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada.
McAlister FA, Wiebe N, Hemmelgarn BR.
Prevalence of Pulmonary Embolism in Patients With Syncope.
Costantino G, Ruwald MH, Quinn J, Camargo CA Jr, Dalgaard F, Gislason G, Goto T, Hasegawa K, Kaul P, Montano N, Numé AK, Russo A, Sheldon R, Solbiati M, Sun B, Casazza G.
Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial.
Sherwood MW, Lopes RD, Sun JL, Liaw D, Harrington RA. Wallentin L, Laskowitz DT, James SK, Goodman SG, Darius H, Lewis BS, Gibson CM, Pieper KS, Alexander JH.
Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype.
Standl E, Stevens SR, Armstrong PW, Buse JB, Chan JCN, Green JB, Lachin JM, Scheen A, Travert F, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group.
Impact of climate and air pollution on acute coronary syndromes: an update from the European Society of Cardiology Congress 2017.
Kaluzna-Oleksy M, Aunan K, Rao-Skirbekk S, Kjellstrom T, Ezekowitz JA, Agewall S, Atar D.
Electrocardiographic Findings in Patients With Acute Coronary Syndrome Presenting With Out-of-Hospital Cardiac Arrest.
Sarak B, Goodman SG, Brieger D, Gale CP, Tan NS, Budaj A, Wong GC, Huynh T, Tan MK, Udell JA, Bagai A, Fox KAA, Yan AT; Global Registry of Acute Coronary Events (GRACE) Investigators and the Canadian Acute Coronary Syndromes I Investigators.
Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC study.
Bagai A, Goodman SG, Cantor WJ, Vicaut E, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Lapostolle F, Lassen JF, Merkely B, Storey RF, ten Berg JM, Zeymer U, Diallo A, Hamm CW, Tsatsaris A, El Khoury J van't Hof AW.
Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI.
Yang A, Pon Q, Lavoie A, Crawford JJ, Harenberg S, Zimmermann RH, Booker J, Kelly S, Lavi S, Cantor WJ, Mehta SR, Bagai A, Goodman SG, Cheema AN, Dehghani P.
Prediction of Early Adverse Events in Emergency Department Patients With Acute Heart Failure: A Systematic Review.
Michaud AM, Parker SIA, Ganshorn H, Ezekowitz JA, McRae AD.
The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: Insights from the, United Kingdom ACALM registry.
Ziff OJ, Carter PR, McGowan J, Uppal H, Chandran S, Russell S, Bainey KR, Potluri R.
Inpatient bedspacing: could a common response to hospital crowding cause increased patient mortality?
McAlister FA, Shojania KG.
History of mood or anxiety disorders and risk of gestational diabetes mellitus in a population-based cohort.
Beka Q, Bowker S, Savu A, Kingston D, Johnson JA, Kaul P.
Cost-Effectiveness of Different Durations of Dual-Antiplatelet Use After Percutaneous Coronary Intervention.
Arbel Y, Bennell MC, Goodman SG, Wijeysundera HC.
Evaluating the potential for pharmacists to prescribe oral anticoagulants for atrial fibrillation.
Sandhu RK, Guirguis LM, Bungard TJ, Youngson E, Dolovich L, Brehaut JC, Healey JS, McAlister FA.
Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.
Pokorney SD, Al-Khatib SM, Sun JL, Schulte P, O'Connor CM, Teerlink JR, Armstrong PW, Ezekowitz JA, Starling RC, Voors AA, Velazquez EJ, Hernandez AF, Mentz RJ.
Relationships Between Baseline Q Waves, Time From Symptom Onset, and Clinical Outcomes in ST-Segment-Elevation Myocardial Infarction Patients: Insights From the Vital Heart Response Registry.
Zheng Y, Bainey KR, Tyrrell BD, Brass N, Armstrong PW, Welsh RC.
Noncardiovascular Disease and Critical Care Delivery in a Contemporary Cardiac and Medical Intensive Care Unit.
Goldfarb M, van Diepen S, Liszkowski M, Jentzer JC, Pedraza I, Cercek B.
Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI.
Dehghani P, Lavoie A, Lavi S, Crawford JJ, Harenberg S, Zimmermann RH, Booker J, Kelly S, Cantor WJ, Mehta SR, Bagai A, Goodman SG, Cheema AN.
Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis.
Russo JJ, Goodman SG, Cantor WJ, Ko DT, Bagai A, Tan MK, Di Mario C, Halvorsen S, Le May M, Fernandez-Avilés F, Scheller B, Armstrong PW, Borgia F, Piscione F, Sanchez PL, Yan AT.
Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis.
Venetsanos D, Sederholm Lawesson S, Alfredsson J, Janzon M, Cequier A, Chettibi M, Goodman SG, Van't Hof AW, Montalescot G, Swahn E.
Volume and Patterns of Physical Activity Across the Health and Heart Failure Continuum.
Yavari M, Haykowsky MJF, Savu A, Kaul P, Dyck JRB, Haennel RG; Alberta HEART Investigators.
Heart Failure in Young Adults Is Associated With High Mortality: A Contemporary Population-Level Analysis.
Wong CM, Hawkins NM, Ezekowitz JA, Jhund PS, Savu A, MacDonald MR, Kristensen SL, Petrie MC, McMurray JJV, McAlister FA, Kaul P.
2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure.
Ezekowitz JA, O'Meara E, McDonald MA, Abrams H, Chan M, Ducharme A, Giannetti N, Grzeslo A, Hamilton PG, Heckman GA, Howlett JG, Koshman SL, Lepage S, McKelvie RS, Moe GW, Rajda M, Swiggum E, Virani SA, Zieroth S, Al-Hesayen A, Cohen-Solal A, D'Astous M, De S, Estrella-Holder E, Fremes S, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Masoudi FA, Ross HJ, Roussin A, Sussex B.
Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.
Fudim M, O'Connor CM, Dunning A, Ambrosy AP, Armstrong PW, Coles A, Ezekowitz JA, Greene SJ, Metra M, Starling RC, Voors AA, Hernandez AF, Michael Felker G, Mentz RJ.
Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial.
Sharma A, Green JB, Dunning A, Lokhnygina Y, Al-Khatib SM, Lopes RD, Buse JB, Lachin JM, Van de Werf F, Armstrong PW, Kaufman KD, Standl E, Chan JCN, Distiller LA, Scott R, Peterson ED, Holman RR; TECOS Study Group.
Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF.
Cotter G, Davison BA, Butler J, Collins SP, Ezekowitz JA, Felker GM, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, Senger S, Bharucha D, Goin K, Soergel DG, Pang PS.
Association of Public Health Initiatives With Outcomes for Out-of-Hospital Cardiac Arrest at Home and in Public Locations.
Fordyce CB, Hansen CM, Kragholm K, Dupre ME, Jollis JG, Roettig ML, Becker LB, Hansen SM, Hinohara TT, Corbett CC, Monk L, Nelson RD, Pearson DA, Tyson C, van Diepen S, Anderson ML, McNally B, Granger CB.
Population-Based Study on Patterns of Cardiac Stress Testing After Percutaneous Coronary Intervention.
Bagai A, Eberg M, Koh M, Cheema AN, Yan AT, Dhoot A, Bhavnani SP, Wijeysundera HC, Bhatia RS, Kaul P, Goodman SG, Ko DT.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial.
Armstrong PW, Roessig L, Patel MJ, Anstrom KJ, Butler J, Voors AA, Lam CSP, Ponikowski P, Temple T, Pieske B, Ezekowitz J, Hernandez AF, Koglin J, O'Connor CM.
Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study.
Russo JJ, Goodman SG, Bagai A, Déry JP, Tan MK, Fisher HN, Zhang X, Zhu YE, Welsh RC, Siega AD, Kokis A, Wong BYL, Henderson M, Lutchmedial S, Lavi S, Mehta SR, Yan AT; COAPT investigators.
Subclinical Pulmonary Edema Is Associated With Reduced Exercise Capacity in HFpEF and HFrEF.
Thompson RB, Pagano JJ, Chow K, Sekowski V, Paterson I, Ezekowitz J, Anderson T, Dyck JRB, Haykowsky MJ; Alberta HEART investigators.
Physical Activity and Mortality in Patients With Stable Coronary Heart Disease.
Stewart RAH, Held C, Hadziosmanovic N, Armstrong PW, Cannon CP, Granger CB, Hagström E, Hochman JS, Koenig W, Lonn E, Nicolau JC, Steg PG, Vedin O, Wallentin L, White HD; STABILITY Investigators.
Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease.
Hagström E, Norlund F, Stebbins A, Armstrong PW, Chiswell K, Granger CB, López-Sendón J, Pella D, Soffer J, Sy R, Wallentin L, White HD, Stewart RAH, Held C; STABILITY Investigators.
Development of Perinatal Mental Illness in Women With Gestational Diabetes Mellitus: A Population-Based Cohort Study.
Beka Q, Bowker S, Savu A, Kingston D, Johnson JA, Kaul P.
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association.
van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline.
A Natural Biomarker Deserving Attention: Gasping Following Primary Cardiac Arrest.
Ewy GA, Armstrong PW.
Ivabradine in Heart Failure: The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure.
Das D, Savarese G, Dahlström U, Fu M, Howlett J, Ezekowitz JA, Lund LH.
Secondary prevention treatment after acute stroke in older South Asian, Chinese and other Canadians: a retrospective data analysis.
Khan NA, McAlister FA, Pilote L, Palepu A, Quan H, Hill MD, Fang J, Kapral MK.
Frequency of low-value care in Alberta, Canada: a retrospective cohort study.
McAlister FA, Lin M, Bakal J, Dean S.
Clinical and Angiographic Outcomes in Coronary Artery Bypass Surgery with Multiple versus Single Distal Target Grafts.
Alherbish A, Norris CM, Shavadia J, Almutawa M, Abualnaja S, Nagendran J, Graham MM, Van Diepen S.
Structural Heart Disease Intervention: The Canadian Landscape.
Asgar AW, Horlick E, McKenzie K, Brass N, Cantor WJ, Chan A, Della Siega A, Gobeil JF, Kassam S, Love MP, Mansour S, Martucci G, Nadeem N, Natarajan MK, Paddock V, Rodés-Cabau J, Traboulsi M, Velianou JL, Welsh RC, Wood D, Webb JG.
Bare metal versus drug eluting stents for ST-segment elevation myocardial infarction in the TOTAL trial.
Lavi S, Iqbal J, Cairns JA, Cantor WJ, Cheema AN, Moreno R, Meeks B, Welsh RC, Kedev S, Chowdhary S, Stankovic G, Schwalm JD, Liu Y, Jolly SS, Džavík V.
Utility of Unfractionated Heparin in Transradial Cardiac Catheterization: A Systematic Review and Meta-analysis.
Bossard M, Mehta SR, Welsh RC, Bainey KR.
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
Felker GM, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N, Januzzi JL Jr, Mark DB, Piña IL, Passmore G, Whellan DJ, Yang H, Cooper LS, Leifer ES, Desvigne-Nickens P, O'Connor CM.
Recalibrating Reperfusion Waypoints.
Armstrong PW, Welsh RC.
Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin.
Navar AM, Gallup DS, Lokhnygina Y, Green JB, McGuire DK, Armstrong PW, Buse JB, Engel SS, Lachin JM, Standl E, Van de Werf F, Holman RR, Peterson ED.
Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease.
Stewart RAH, Hagström E, Held C, Wang TKM, Armstrong PW, Aylward PE, Cannon CP, Koenig W, López-Sendón JL, Mohler ER 3rd, Hadziosmanovic N, Krug-Gourley S, Ramos Corrales MA, Siddique S, Steg PG, White HD, Wallentin L; STABILITY Investigators.
Quality of life following coronary artery bypass graft surgery vs. percutaneous coronary intervention in diabetics with multivessel disease: a five-year registry study.
McGrath BM, Norris CM, Hardwicke-Brown E, Welsh RC, Bainey KR.
Adult Congenital Heart Disease Intervention: The Canadian Landscape.
Frankfurter C, Asgar AW, Webb JG, Cantor WJ, Velianou JL, Gobeil F, Chan AW, Welsh RC, Love MP, Wood DA, McKenzie K, Horlick EM.
Finding the right balance between precision medicine and personalized care.
McAlister FA, Laupacis A, Armstrong PW.
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease.
Lindholm D, Lindbäck J, Armstrong PW, Budaj A, Cannon CP, Granger CB, Hagström E, Held C, Koenig W, Östlund O, Stewart RAH, Soffer J, White HD, de Winter RJ, Steg PG, Siegbahn A, Kleber ME, Dressel A, Grammer TB, März W, Wallentin L.
Organizational Structure, Staffing, Resources, and Educational Initiatives in Cardiac Intensive Care Units in the United States: An American Heart Association Acute Cardiac Care Committee and American College of Cardiology Critical Care Cardiology Working Group Cross-Sectional Survey.
van Diepen S, Fordyce CB, Wegermann ZK, Granger CB, Stebbins A, Morrow DA, Solomon MA, Soble J, Henry TD, Gilchrist IC, Katz JN, Cohen MG, Newby LK.
The effect of low-dose furosemide in critically ill patients with early acute kidney injury: A pilot randomized blinded controlled trial (the SPARK study).
Bagshaw SM, Gibney RTN, Kruger P, Hassan I, McAlister FA, Bellomo R.
Health Resource Implications of Heart Failure Hospitalizations in Younger Patients Compared With Older Patients.
McAlister FA, Youngson E, Kaul P.
A prospective evaluation of the established criteria for heart failure with preserved ejection fraction using the Alberta HEART cohort.
Ezekowitz JA, McAlister FA, Howlett J, Alemayehu W, Paterson I, Belenkie I, Oudit GY, Kaul P, Dyck JR, Anderson T; Alberta HEART Investigators.
Outcomes and Prognostic Impact of Prophylactic Oral Anticoagulation in Anterior ST-Segment Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction.
Shavadia JS, Youngson E, Bainey KR, Bakal J, Welsh RC.
Multitype Events and the Analysis of Heart Failure Readmissions: Illustration of a New Modeling Approach and Comparison With Familiar Composite End Points.
Brown PM, Ezekowitz JA.
A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure.
Sharma A, Demissei BG, Tromp J, Hillege HL, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Davison BA, Givertz MM, Bloomfield DM, Dittrich H, van Veldhuisen DJ, Cotter G, Ezekowitz JA, Khan MAF, Voors AA.
Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).
Pagidipati NJ, Navar AM, Pieper KS, Green JB, Bethel MA, Armstrong PW, Josse RG, McGuire DK, Lokhnygina Y, Cornel JH, Halvorsen S, Strandberg TE, Delibasi T, Holman RR, Peterson ED; TECOS Study Group.
Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.
Greene SJ, Hernandez AF, Dunning A, Ambrosy AP, Armstrong PW, Butler J, Cerbin LP, Coles A, Ezekowitz JA, Metra M, Starling RC, Teerlink JR, Voors AA, O'Connor CM, Mentz RJ.
Relationship between community hospital versus pre-hospital location of randomisation and clinical outcomes in ST-elevation myocardial infarction patients: insights from the Stream study.
Welsh RC, Goldstein P, Sinnaeve P, Ostojic MC, Zheng Y, Danays T, Westerhout CM, Van de Werf F, Armstrong PW.
GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome.
Gong IY, Goodman SG, Brieger D, Gale CP, Chew DP, Welsh RC, Huynh T, DeYoung JP, Baer C, Gyenes GT, Udell JA, Fox KAA, Yan AT; Canadian GRACE/GRACE-2 and CANRACE Investigators.
Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization.
Dalby AJ, Gottlieb S, Cyr DD, Magnus Ohman E, McGuire DK, Ruzyllo W, Bhatt DL, Wiviott SD, Winters KJ, Fox KAA, Armstrong PW, White HD, Prabhakaran D, Roe MT; TRILOGY ACS Investigators.
Association Between Diabetes During Pregnancy and Peripartum Cardiomyopathy: A Population-Level Analysis of 309,825 Women.
Dhesi S, Savu A, Ezekowitz JA, Kaul P.
Patterns of glucose-lowering therapies and neonatal outcomes in the treatment of gestational diabetes in Canada, 2009-2014.
Bowker SL, Savu A, Yeung RO, Johnson JA, Ryan EA, Kaul P.
Characterization of hemodynamically stable acute heart failure patients requiring a critical care unit admission: Derivation, validation, and refinement of a risk score.
Raslan IR, Brown P, Westerhout CM, Ezekowitz JA, Hernandez AF, Starling RC, O'Connor C, McAlister FA, Rowe BH, Armstrong PW, van Diepen S.
Composite End Points in Clinical Research: A Time for Reappraisal.
Armstrong PW, Westerhout CM.
Temporal trends in stroke incidence in South Asian, Chinese and white patients: A population based analysis.
Khan NA, McAlister FA, Pilote L, Palepu A, Quan H, Hill MD, Fang J, Kapral MK.
Geographic clustering of emergency department presentations for acute coronary syndromes and heart failure in Alberta: a population-based study.
Rosychuk RJ, Rowe BH, McAlister FA.
Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
Rodés-Cabau J, Masson JB, Welsh RC, Garcia Del Blanco B, Pelletier M, Webb JG, Al-Qoofi F, Généreux P, Maluenda G, Thoenes M, Paradis JM, Chamandi C, Serra V, Dumont E, Côté M.
Postpartum Diabetes Testing Rates after Gestational Diabetes Mellitus in Canadian Women: A Population-Based Study.
Butalia S, Donovan L, Savu A, Johnson J, Edwards A, Kaul P.
Length of Stay, Mortality, Cost, and Perceptions of Care Associated With Transition From an Open to Closed Staffing Model in the Cardiac Intensive Care Unit.
Katz JN, Lishmanov A, van Diepen S, Yu D, Shen H, Pauley E, Bhatia J, Buntaine A, Das A, Dangerfield C, McLaughlin B, Stouffer GA, Kaul P.
Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome.
Chan M, Neely ML, Roe MT, Goodman SG, Erlinge D, Cornel JH, Winters KJ, Jakubowski JA, Zhou C, Fox KAA, Armstrong PW, White HD, Prabhakaran D, Ohman EM, Huber K; TRILOGY ACS Investigators.
Navigating Choices Among a Sea of Comorbidities.
Armstrong PW, Ezekowitz JA.
Patients With Heart Failure Readmitted to the Original Hospital Have Better Outcomes Than Those Readmitted Elsewhere.
McAlister FA, Youngson E, Kaul P.
Hospital variation in treatment and outcomes in acute coronary syndromes: Insights from the Alberta Contemporary Acute Coronary Syndrome Patients Invasive Treatment Strategies (COAPT) study.
KR, Kaul P, Armstrong PW, Savu A, Westerhout CM, Norris CM, Brass N, Traboulsi D, O'Neill B, Nagendran J, Ali I, Knudtson M, Welsh RC.
Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF).
Pang PS, Butler J, Collins SP, Cotter G, Davison BA, Ezekowitz JA, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, Bharucha D, Goin K, Soergel DG, Felker GM.
Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery.
Mehta RH, Leimberger JD, van Diepen S, Meza J, Wang A, Jankowich R, Harrison RW, Hay D, Fremes S, Duncan A, Soltesz EG, Luber J, Park S, Argenziano M, Murphy E, Marcel R, Kalavrouziotis D, Nagpal D, Bozinovski J, Toller W, Heringlake M, Goodman SG, Levy JH, Harrington RA, Anstrom KJ, Alexander JH; LEVO-CTS Investigators.
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.
Valgimigli M, Costa F, Lokhnygina Y, Clare RM, Wallentin L, Moliterno DJ, Armstrong PW, White HD, Held C, Aylward PE, Van de Werf F, Harrington RA, Mahaffey KW, Tricoci P.
Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.
Alfredsson J, Neely B, Neely ML, Bhatt DL, Goodman SG, Tricoci P, Mahaffey KW, Cornel JH, White HD, Fox KA, Prabhakaran D, Winters KJ, Armstrong PW, Ohman EM, Roe MT; TRILOGY ACS Investigators.
Postoperative complications and outcomes associated with a transition to 24/7 intensivist management of cardiac surgery patients.
Benoit MA, Bagshaw SM, Norris CM, Zibdawi M, Chin WD, Ross DB, van Diepen S.
Treatment deintensification is uncommon in adults with type 2 diabetes mellitus: a retrospective cohort study.
McAlister FA, Youngson E, Eurich DT.
Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome.
Wang A, Kwee LC, Grass E, Neely ML, Gregory SG, Fox KAA, Armstrong PW, White HD, Ohman EM, Roe MT, Shah SH, Chan MY.
Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome.
Hess CN, Clare RM, Neely ML, Tricoci P, Mahaffey KW, James SK, Alexander JH, Held C, Lopes RD, Fox KAA, White HD, Wallentin L, Armstrong PW, Harrington RA, Ohman EM, Roe MT.
Impact of current versus previous cardiac resynchronization therapy guidelines on the proportion of patients with heart failure eligible for therapy.
Lyons KJ, Ezekowitz JA, Liang L, Heidenreich PA, Yancy CW, DeVore AD, Hernandez AF, Fonarow GC.
Population-level outcomes with a 2-step approach for gestational diabetes screening and diagnosis.
Donovan LE, Edwards AL, Savu A, Butalia S, Ryan EA, Johnson JA, Kaul P.
Prevalence of gestational diabetes among Chinese and South Asians: A Canadian population-based analysis.
Yeung RO, Savu A, Kinniburgh B, Lee L, Dzakpasu S, Nelson C, Johnson JA, Donovan LE, Ryan EA, Kaul P.
Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology position statement on the optimal care of the postarrest patient.
Wong GC, van Diepen S, Ainsworth C, Arora RC, Diodati JG, Liszkowski M, Love M, Overgaard C, Schnell G, Tanguay JF, Wells G, Le May M; CCS Post Cardiac Arrest Guidelines Committee.
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
Windecker S, Tijssen J, Giustino G, Guimarães AH, Mehran R, Valgimigli M, Vranckx P, Welsh RC, Baber U, van Es GA, Wildgoose P, Volkl AA, Zazula A, Thomitzek K, Hemmrich M, Dangas GD.
Challenges of assessing common problems presenting in uncommon high-risk patient populations.
Welsh RC.
Association between CK-MB area under the curve and tranexamic acid utilization in patients undergoing coronary artery bypass surgery.
van Diepen S, Merrill PD, Carrier M, Tardif JC, Podgoreanu M, Alexander JH, Lopes RD.
Dual antiplatelet therapy versus aspirin monotherapy in diabetics with multivessel disease undergoing CABG: FREEDOM insights.
van Diepen S, Fuster V, Verma S, Hamza TH, Siami FS, Goodman SG, Farkouh ME.
Interprovincial differences in Canadian coronary care unit resource use and outcomes.
van Diepen S, Lin M, Ezekowitz JA, McAlister FA, Lee DS, Goodman SG, Armstrong PW, Kaul.
Temporal trends of reperfusion strategies and hospital mortality for patients with STEMI in percutaneous coronary intervention-capable hospitals.
Tran DT, Welsh RC, Ohinmaa A, Thanh NX, Kaul P.
Identifying low-risk patients for early discharge from emergency department without using subjective descriptions of chest pain: Insights from Providing Rapid Out of hospital Acute Cardiovascular Treatment (PROACT) 3 and 4 trials.
Sepehrvand N, Zheng Y, Armstrong PW, Welsh RC, Ezekowitz JA.
Impact of electrical cardioversion on quality of life for the treatment of atrial fibrillation.
Sandhu RK, Smigorowsky M, Lockwood E, Savu A, Kaul P, McAlister FA.
Nationwide trends in syncope hospitalizations and outcomes from 2004 to 2014.
Sandhu RK, Sheldon RS, Savu A, Kaul P.
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park DW, Bode C, Welsh RC, Gibson CM.
Higher medication doses in heart failure?
McCormack J, McAlister FA, Kolber MR.
Are existing risk scores for nonvalvular atrial fibrillation useful for prediction or risk adjustment in patients with chronic kidney disease?
McAlister FA, Wiebe N, Jun M, Sandhu R, James MT, McMurtry MS, Hemmelgarn BR, Tonelli M.
Late presentation of an anomalous left coronary artery from the pulmonary artery treated with conservative surgical management with long-term cardiac magnetic resonance imaging follow-up.
Gouda P, Gouda J, Butler C, Welsh RC.
The impact and implications of Twitter for cardiovascular medicine.
Gouda P, Das D, Clark A, Ezekowitz JA.
Diabetes and heart failure in the crosshairs: where is the target?
Ezekowitz JA, Armstrong PW.
Dietary self-management in heart failure: high tech or high touch?
Colin-Ramirez E, Arcand J, Ezekowitz JA.
Composite end points in clinical trials of heart failure therapy: how do we measure the effect size?
Brown PM, Ezekowitz JA.
Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy.
Bagai A, Wang TY, Goodman SG, Fisher HN, Welsh RC, Dery JP, Zhang X, Zhu YE, Cheema AN, Dehghani P, Kassam SA, Ducas J, Brass N, Kim HH, Fung A, Schampaert E, Quraishi AU, Mehta SR; Canadian Observational AntiPlatelet sTudy (COAPT) Investigators.
2016 AHA/ACC Clinical performance and quality measures for prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
Al-Khatib SM, Yancy CW, Solis P, Becker L, Benjamin EJ, Carrillo RG, Ezekowitz JA, Fonarow GC, Kantharia BK, Kleinman M, Nichol G, Varosy PD.
Multistate 5-Year Initiative to Improve Care for Out-of-Hospital Cardiac Arrest: Primary Results From the HeartRescue Project.
van Diepen S, Girotra S, Abella BS, Becker LB, Bobrow BJ, Chan PS, Fahrenbruch C, Granger CB, Jollis JG, McNally B, White L, Yannopoulos D, Rea TD.
Quality of Acute Myocardial Infarction Care in Canada: A 10-Year Review of 30-Day In-Hospital Mortality and 30-Day Hospital Readmission.
Tran DT, Welsh RC, Ohinmaa A, Thanh NX, Bagai A, Kaul P.
Patients With Heart Failure Readmitted to the Original Hospital Have Better Outcomes Than Those Readmitted Elsewhere.
McAlister FA, Youngson E, Kaul P.
Outcomes of women and men with acute coronary syndrome treated with and without percutaneous coronary revascularization.
Udell JA, Koh M, Qiu F, Austin PC, Wijeysundera HC, Bagai A, Yan AT, Goodman SG, Tu JV, Ko DT
Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.
Josse RG, Majumdar SR, Zheng Y, Adler A, Bethel MA, Buse JB, Green JB, Kaufman KD, Rodbard HW, Tankova T, Westerhout CM, Peterson ED, Holman RR, Armstrong PW; TECOS Study Group
Interprovincial differences in Canadian coronary care unit resource use and outcomes.
van Diepen S, Lin M, Ezekowitz JA, McAlister FA, Lee DS, Goodman SG, Armstrong PW, Kaul P
Prevention of critical care complications in the coronary intensive care unit: protocols, bundles, and insights from intensive care studies.
van Diepen S, Sligl WI, Washam JB, Gilchrist IC, Arora RC, Katz JN
Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial.
Kitai T, Grodin JL, Mentz RJ, Hernandez AF, Butler J, Metra M, Mcmurray JJ, Armstrong PW, Starling RC, O'Connor CM, Swedberg K, Tang WW
Comparison of two commonly used clinical cognitive screening tests to diagnose mild cognitive impairment in heart failure with the golden standard European Consortium Criteria.
Alagiakrishnan K, Mah D, Dyck JR, Senthilselvan A, Ezekowitz JA
Body weight change during and after hospitalization for acute heart failure: patient characteristics, markers of congestion, and outcomes: findings from the ASCEND-HF trial.
Ambrosy AP, Cerbin LP, Armstrong PW, Butler J, Coles A, DeVore AD, Dunlap ME, Ezekowitz JA, Felker GM, Fudim M, Greene SJ, Hernandez AF, O'Connor C, Schulte P, Starling RC, Teerlink JR, Voors AA, Mentz RJ
Challenges of assessing common problems presenting in uncommon high-risk patient populations.
Welsh RC
Are existing risk scores for nonvalvular atrial fibrillation useful for prediction or risk adjustment in patients with chronic kidney disease?
McAlister FA, Wiebe N, Jun M, Sandhu R, James MT, McMurtry MS, Hemmelgarn BR, Tonelli M
Hyperkalemia, sacubitril/valsartan, and mineralocorticoid antagonists in patients with heart failure.
Ezekowitz JA
Impact of presentation and transfer delays on complete ST segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial.
Fabris E, Van't Hof A, Hamm CW, Lapostolle F, Lassen JF, Goodman SG, Ten Berg JM, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Cantor WJ, Rousseau H, Vicaut E, Montalescot G
Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension.
Rymkiewicz P, Ravani P, Hemmelgarn BR, McAlister FA, Southern DA, Walker R, Chen G, Quan H.
Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.
Mehta RH, Van Diepen S, Meza J, Bokesch P, Leimberger JD, Tourt-Uhlig S, Swartz M, Parrotta J, Jankowich R, Hay D, Harrison RW, Fremes S, Goodman SG, Luber J, Toller W, Heringlake M, Anstrom KJ, Levy JH, Harrington RA, Alexander JH; LEVO-CTS Investigators.
Erratum to “Direct oral anticoagulant use and stent thrombosis following an acute coronary syndrome: A potential new pharmacological option?”
Welsh RC, Zeymer U, Tarantini G.
The intersection of health and wealth: association between personal bankruptcy and myocardial infarction rates in Canada.
Savu A, Schopflocher D, Scholnick B, Kaul P.
Clinical and angiographic outcomes associated with surgical revascularization of angiographically borderline 50-69% coronary artery stenoses.
Senaratne JM, Norris CM, Graham MM, Galbraith D, Nagendran J, Freed DH,Afilalo J, van Diepen S; APPROACH Investigators.
Factors Associated With Natriuretic Peptide Testing in Patients Presenting to Emergency Departments With Suspected Heart Failure.
Sepehrvand N, Bakal JA, Lin M, McAlister FA, Wesenberg JC, Ezekowitz JA.
Oxygen Therapy in Patients With Acute Heart Failure: Friend or Foe?
Sepehrvand N, Ezekowitz JA.
Alignment of site versus adjudication committee-based diagnosis with patient outcomes: Insights from the Providing Rapid out of Hospital Acute Cardiovascular Treatment 3 trial.
Sepehrvand N, Zheng Y, Armstrong PW, Welsh RC, Goodman SG, Tymchak W, Khadour F, Chan M, Weiss D, Ezekowitz JA.
Coenzyme Q10 and Heart Failure: A State-of-the-Art Review.
Sharma A, Fonarow GC, Butler J, Ezekowitz JA, Felker GM.
Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy.
Giannitsis E, Wallentin L, James SK, Bertilsson M, Siegbahn A, Storey RF, Husted S, Cannon CP, Armstrong PW, Steg PG, Katus HA; PLATO investigators.
Regional variation in out-of-hospital cardiac arrest survival in the United States.
Girotra S, van Diepen S, Nallamothu BK, Carrel M, Vellano K, Anderson ML, McNally B, Abella B, Sasson C, Chan PS; in collaboration with CARES Surveillance Group and the HeartRescue Project.
Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction with a Pharmacoinvasive versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study.
Shavadia J, Welsh RC, Gershlick A, Zheng Y, Huber K, Halvorsen S, Steg PG,Van de Werf F, Armstrong PW for the STREAM investigators.
Medication discrepancies associated with a medication reconciliation program and clinical outcomes after hospital discharge.
Shiu JR, Fradette M, Padwal RS, Majumdar SR, Youngson E, Bakal JA, McAlister FA.
Prior bleeding, future bleeding and stroke risk with oral anticoagulation in atrial fibrillation: What new lessons can ARISTOTLE teach us?
Goodman SG.
Insights into the importance of the electrocardiogram in patients with acute heart failure.
Gouda P, Brown P, Rowe BH, McAlister FA, Ezekowitz JA.
Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials.
Graham JJ, Yan AT, Tan MK, Cantor WJ, DiMario C, Jolly SS, Halvorsen S, Fernandez-Aviles F, Le May MR, Scheller B, Borgia F, Piscione F, Madan M, Goodman SG.
Influence of clinical trial site enrollment on patient characteristics, protocol completion, and end points: Insights from the ASCEND-HF trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Greene SJ, Hernandez AF, Sun J-L, Metra M, Butler J, Ambrosy AP, Ezekowitz JA, Starling RC, Teerlink JR, Schulte PJ, Voors AA, Armstrong PW, O'Connor CM, Mentz RJ.
Drug Treatment of STEMI in the Elderly: Focus on Fibrinolytic Therapy and Insights from the STREAM Trial.
Sinnaeve PR, Danays T, Bogaerts K, Van de Werf F, Armstrong PW.
Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy.
Sra S, Tan MK, Mehta SR, Fisher HN, Déry J-P, Welsh RC, Eisenberg MJ, Overgaard CB, Rose BF, Siega AJD, Cheema AN, Wong BYL, Henderson MA, Lutchmedial S, Lavi S, Goodman SG, Yan AT.
Efficacy of Early Invasive Management After Fibrinolysis for ST-Segment Elevation Myocardial Infarction in Relation to Initial Troponin Status.
Tan NS, Goodman SG, Cantor WJ, Russo JJ, Borgundvaag B, Fitchett D, Džavík V, Tan MK, Elbarouni B, Lavi S, Bagai A, Heffernan M, Ko DT, Yan AT.
Association between very low levels of high-density lipoprotein cholesterol and long-term outcomes of patients with acute coronary syndrome treated without revascularization: Insights from the TRILOGY ACS trial.
Hagström E, Roe MT, Hafley G, Neely ML, Sidhu MS, Brown EB, Prabhakaran D, White HD, Armstrong PW, Fox KAA, Ohman EM, Boden WE ; TRIOLOGY ACS Investigators
Association of clinical factors and therapeutic strategies with improvements in survival following non-ST-elevation myocardial infarction, 2003-2013.
Hall M, Dondo TB, Yan AT, Goodman SG, Bueno H, Chew DP, Brieger D, Timmis A, Batin PD, Deanfield JE, Hemingway H, Fox KAA, Gale CP.
Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
Tang WHW, Wu Y, Grodin JL, Hsu AP, Hernandez AF, Butler J, Metra M, Voors AA, Felker GM, Troughton RW, Mills RM, McMurray JJ, Armstrong PW, O'Connor CM, Starling RC.
Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial.
Harskamp RE, Clare RM, Ambrosio G, Held C, Lokhnygina Y, Moliterno DJ, White HD,Aylward PE, Armstrong PW, Mahaffey KW, Harrington RA, Van de Werf F, WallentinL, Strony J, Tricoci P.
The choice is reperfusion therapy: but which one?
Henry TD, Armstrong PW.
Chronic kidney disease and prognosis in elderly patients with cardiovascular disease: Comparison between CKD-EPI and Berlin Initiative Study-1 formulas.
Tarantini L, McAlister FA, Barbati G, Ezekowitz JA, Cioffi G, Faggiano P, Pulignano G, Cherubini A, Grisolia Franceschini E, Di Lenarda A.
Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.
Teerlink JR, Felker GM, McMurray JJ, Ponikowski P, Metra M, Filippatos GS, Ezekowitz JA, Dickstein K, Cleland JG, Kim JB, Lei L, Knusel B, Wolff AA, Malik FI, Wasserman SM; ATOMIC-AHF Investigators.
Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial.
Teerlink JR, Felker GM, McMurray JJV, Solomon SD, Adams KF, Jr, Cleland JGF, Ezekowitz JA, Goudev A, Macdonald P, Metra M, Mitrovic V, Ponikowski P, Serpytis P, Spinar J, Tomcsányi J, Vandekerckhove HJ, Voors AA, Monsalvo ML, Johnston J, Malik FI, Honarpour N
Sudden cardiac death after non-ST-segment elevation acute coronary syndrome.
Hess PL, Wojdyla DM, Al-Khatib SM, Lokhnygina Y, Wallentin L, Armstrong PW, Roe MT, Ohman EM, Harrington RA, Alexander JH, White HD, Van de Werf F, Piccini JP, Held C, Aylward PE, Moliterno DJ, Mahaffey KW, Tricoci P.
Cost Effectiveness of Eplerenone for the Treatment of Systolic Heart Failure with Mild Symptoms in Alberta, Canada.
Thanh NX, Ezekowitz JA, Tran DT, Kaul P.
Pay-for-performance remuneration for pharmacist prescribers’ management of hypertension: A substudy of the RxACTION trial.
Houle SKD, Charrois TL, McAlister FA, Kolber MR, Rosenthal MM, Lewanczuk R, Campbell NRC, Tsuyuki RT.
The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice.
Howlett JG, Chan M, Ezekowitz JA, Harkness K, Heckman GA, Kouz S, Leblanc M-H, Moe GW, O'Meara E, Abrams H, Ducharme A, Grzeslo A, Hamilton PG, Koshman SL, Lepage S, McDonald M, McKelvie R, Rajda M, Swiggum E, Virani S, Zieroth S.
Hospital Readmission of Patients With Congenital Heart Disease in Canada.
Islam S, Yasui Y, Kaul P, Mackie AS.
Congenital Heart Disease Hospitalizations in Canada: A 10-Year Experience.
Islam S, Yasui Y, Kaul P, Marelli AJ, Mackie AS.
Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.
Jackson LR 2nd, Piccini JP, Cyr DD, Roe MT, Neely ML, Martinez F, LüscherTF, Lopes RD, Winters KJ, White HD, Armstrong PW, Fox KA, PrabhakaranD, Bhatt DL, Magnus Ohman E, Corbalán R.
Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial.
Jolly SS, Cairns JA, Yusuf S, Rokoss MJ, Gao P, Meeks B, Kedev S, Stankovic G, Moreno R, Gershlick A, Chowdhary S, Lavi S, Niemela K, Bernat I, Cantor WJ, Cheema AN, Steg PG, Welsh RC, Sheth T, Bertrand OF, Avezum A, Bhindi R, Natarajan MK, Horak D, Leung RCM, Kassam S, Rao SV, El-Omar M, Mehta SR, Velianou JL, Pancholy S, Džavík V
Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction.
van Diepen S, Alemayehu WG, Zheng Y, Theroux P, Newby LK, MahaffeyKW, Granger CB, Armstrong PW.
Warfarin initiation, atrial fibrillation, and kidney function: Comparative effectiveness and safety of warfarin in older adults with newly diagnosed atrial fibrillation.
Jun M, James MT, Ma Z, Zhang J, Tonelli M, McAlister FA, Manns BJ, Ravani P, Quinn RR, Wiebe N, Perkovic V, Wilton SB, Winkelmayer WC, Hemmelgarn BR.
The genesis, maturation, and future of critical care cardiology.
Katz JN, Minder M, Olenchock B, Price S, Goldfarb M, Washam JB, BarnettCF, Newby LK, van Diepen S
Do stable non-ST-segment elevation acute coronary syndromes require admission to coronary care units?
van Diepen S, Lin M, Bakal JA, McAlister FA, Kaul P, Katz JN, Fordyce CB, Southern DA, Graham MM, Wilton SB, Newby LK, Granger CB, Ezekowitz JA
Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial.
Kaul P, Ohman EM, Knight JD, Anstrom KJ, Roe MT, Boden WE, Hochman JS, Gašparović V, Armstrong PW, McCollam P, Fakhouri W, Cowper P, Davidson-Ray L, Clapp-Channing N, White HD, Fox KA, Prabhakaran D, Mark DB; TRILOGY ACS Investigators.
Sulfonylurea use is associated with larger infarct size in patients with diabetes and ST-elevation myocardial infarction.
Abdelmoneim AS, Welsh RC, Eurich DT, Simpson SH.
Temporal and Provincial variation in ambulance use among patients who present to acute care hospitals with ST-elevation myocardial infarction.
Kaul P, Welsh RC, Liu W, Savu A, Weiss DR, Armstrong PW.
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial.
Åkerblom A, Clare RM, Lokhnygina Y, Wallentin L, Held C, Van de Werf F,Moliterno DJ, Patel UD, Leonardi S, Armstrong PW, Harrington RA, WhiteHD, Aylward PE, Mahaffey KW, Tricoci P.
Competing risk bias was common in Kaplan-Meier risk estimates published in prominent medical journals.
Van Walraven C, McAlister FA.
Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primarypercutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes.
Vavalle JP, van Diepen S, Clare RM, Hochman JS, Weaver WD, Mehta RH, Pieper KS,Patel MR, Patel UD, Armstrong PW, Granger CB, Lopes RD.
Cognitive decline in heart failure.
Alagiakrishnan K, Mah D, Ahmed A, Ezekowitz JA.
Trends in enrollment, clinical characteristics, treatment and outcomes according to age in non-ST-segment evaluation acute coronary syndromes clinical trials.
Kragholm K, Goldstein SA, Yang Q, Lopes RD, Schulte PJ, Bernacki GM, White HD, Mahaffey KW, Giugliano RP, Armstrong PW, Harrington RA, Tricoci P, Van de Werf F, Alexander JH, Alexander KP, Newby LK.
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.
Vranckx P, White HD, Huang Z, Mahaffey KW, Armstrong PW, Van de Werf F, Moliterno DJ, Wallentin L, Held C, Aylward PE, Cornel JH, Bode C, Huber K, Nicolau JC, Ruzyllo W, Harrington RA, Tricoci P.
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial.
Alexander JH, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz JA, Halvorsen S, Hanna M, Commerford P, Ruzyllo W, Huber K, Al-Khatib SM, Granger CB, Wallentin L; Apixaban for Reduction of Stroke and Other Thromboembolic Complications in Atrial Fibrillation (ARISTOTLE) Investigators.
Outcomes of singleton and twin pregnancies complicated by pre-existing diabetes and gestational diabetes: A population-based study in Alberta, Canada, 2005-11.
Lai FY, Johnson JA, Dover D, Kaul P.
Patient and System-Related Delays of Emergency Medical Services Use in Acute ST-Elevation Myocardial Infarction: Results from the Third Gulf Registry of Acute Coronary Events (Gulf RACE-3Ps).
AlHabib KF, Sulaiman K, Al Suwaidi J, Almahmeed W, Alsheikh-Ali AA, Amin H, AlJarallah M, Alfaleh HF, Panduranga P, Hersi A, Kashour T, Al Aseri Z, Ullah A,Altaradi HB, Nur Asfina K, Welsh RC, Yusuf S.
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.
Wallentin L, Held C, Armstrong PW, Cannon CP, Davies RY, Granger CB, Hagström E, Harrington RA, Hochman JS, Koenig W, Krug-Gourley S, Mohler ER 3rd, Siegbahn A, Tarka E, Steg PG, Stewart RA, Weiss R, Östlund O, White HD; STABILITY Investigators.
Patient isolation precautions and 30-day risk of readmission or death after hospital discharge: A prospective cohort study.
Lau D, Majumdar SR, McAlister FA
Patient-Reported Discharge Readiness and 30-Day Risk of Readmission or Death: A Prospective Cohort Study.
Lau D, Padwal RS, Majumdar SR, Pederson JL, Belga S, Kahlon S, Fradette M, Boyko D, McAlister FA
From coronary care units to cardiac intensive care units: Recommendations for organizational, staffing, and educational transformation.
Le May M, van Diepen S, Liszkowski M, Schnell G, Tanguay J-F, Granger CB, Ainsworth C, Diodati JG, Fam N, Haichin R, Jassal D, Overgaard C, Tymchak W, Tyrrell B, Osborne C, Wong G.
Short Duration vs Standard Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents – A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials.
Wassef AWA, Khafaji H, Syed I, Yan AT, Udell JA, Goodman SG, Cheema AN, Bagai A.
The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF.
Ambrosy AP, Hernandez AF, Armstrong PW, Butler J, Dunning A, Ezekowitz JA, Felker GM, Greene SJ, Kaul P, McMurray JJ, Metra M, O'Connor CM, Reed SD, Schulte PJ, Starling RC, Tang WH, Voors AA, Mentz RJ.
The Risk Stratification and Stroke Prevention Therapy Care Gap in Canadian Atrial Fibrillation Patients.
Angaran P, Dorian P, Tan MK, Kerr CR, Green MS, Gladstone DJ, Mitchell LB, Fournier C, Cox JL, Talajic M, Lin PJ, Langer A, Goldin L, Goodman SG.
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.
Angiolillo DJ, Goodman SG, Bhatt DL, Eikelboom JW, Price MJ, Moliterno DJ, Cannon CP, Tanguay J-F, Granger CB, Mauri L, Holmes DR, Gibson CM, Faxon DP.
The Interplay Between Continuity of Care, Multimorbidity, and Adverse Events in Patients With Diabetes.
Weir DL, McAlister FA, Majumdar SR, Eurich DT.
Temporal trends in all-cause mortality according to smoking status: Insights from the Global Registry of Acute Coronary Events.
Arbel Y, Fitzgerald G, Yan AT, Tan MK, Fox KAA, Gore JM, Steg PG, Eagle KA, Brieger D, Montalescot G, Budaj A, Lopez-Sendon J, Avezum A, Granger CB, Goodman SG.
Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.
Armaganijan LV, Alexander KP, Huang Z, Tricoci P, Held C, Van de Werf F,Armstrong PW, Aylward PE, White HD, Moliterno DJ, Wallentin L, Chen E,Harrington RA, Strony J, Mahaffey KW, Lopes RD.
Evaluating clinical reason and rationale for not delivering reperfusion therapy in ST elevation myocardial infarction patients: Insights from a comprehensive cohort.
Welsh RC, Deckert-Sookram J, Sookram S, Valaire S, Brass N.
Selecting the Duration of Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Complex Decision or Not?
Welsh RC, Peterson ED.
A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease.
Welsh RC, Roe MT, Steg PG, James S, Povsic TJ, Bode C, Gibson CM, Ohman EM.
Searching for Adherence: Can We Fulfil the Promise of Evidence Based Medicines?
Armstrong PW, McAlister FA.
Direct oral anticoagulant use and stent thrombosis following an acute coronary syndrome: A potential new pharmacological option?
Welsh RC, Zeymer U, Tarantini G.
Spontaneous MI after non-ST-segment elevation acute coronary syndrome managed without revascularization: The TRILOGY ACS trial.
Lopes RD, Leonardi S, Neely B, Neely ML, Ohman EM, Ardissino D, HammCW, Goodman SG, Bhatt DL, White HD, Prabhakaran D, Martinez F, NicolauJC, Winters KJ, Fox KA, Armstrong PW, Roe MT.
Dichotomous Relationship between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted with Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial.
Whellan DJ, Stebbins A, Hernandez AF, Ezekowitz JA, McMurray JJ, Mather PJ,Hasselblad V, O’Connor CM.
Transcatheter Valve-in-Valve: A Cautionary Tale.
Luc JG, Shanks M, Tyrrell BD, Welsh RC, Butler CR, Meyer SR.
Infective Endocarditis Hospitalizations Before and After the 2007 American Heart Association Prophylaxis Guidelines.
Mackie AS, Liu W, Savu A, Marelli AJ, Kaul P.
Nesiritide in Patients Hospitalized for Acute Heart Failure – Does Timing Matter? Implication for Future Acute Heart Failure Trials Eur J.
Wong YW, Mentz RJ, Felker GM, Zekowitz J, Pieper K, Heizer G, Hasselblad V, MetraM, O’Connor CM, Armstrong PW, Starling RC, Hernandez AF.
Prevalence of gestational diabetes among Chinese and South Asians: A Canadian population-based analysis.
Yeung RO, Savu A, Kinniburgh B, Lee L, Dzakpasu S, Nelson C, Johnson JA, Donovan LE, Ryan EA, Kaul P.
Defining and validating comorbidities and procedures in ICD-10 health data in ST-elevation myocardial infarction patients.
Youngson E, Welsh RC, Kaul P, McAlister FA, Quan H, Bakal J.
Diabetes for Cardiologists: Practical Issues in Diagnosis and Management.
Mancini GBJ, Cheng AY, Connelly K, Fitchett D, Goldenberg R, Goodman SG, Leiter LA, Lonn E, Paty B, Poirier P, Stone J, Thompson D, Yale J-F
Transatlantic Comparison of ST-Segment Elevation Myocardial Infarction Guidelines: Insights From the United States and Europe.
Bainey KR, Armstrong PW.
Implications of ischaemic area at risk and mode of reperfusion in ST-elevation myocardial infarction.
Bainey KR, Fresco C, Zheng Y, Halvorsen S, Carvalho A, Ostojic M, Goldstein P,Gershlick AH, Westerhout CM, Van de Werf F, Armstrong PW; STREAMInvestigators.
Response to: Letter to the Editor regarding the manuscript “Symptomatic graft failure and impact on clinical outcome after coronary artery bypass grafting surgery: Results from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease registry”.
Bainey KR, Norris C, Shavadia J.
Does reducing inpatient length of stay have upstream effects on the emergency room: exploring the impact of the general Internal Medicine care Transformation initiative.
McAlister FA, Bakal JA, Rosychuk RJ, Rowe BH.
Letter by McAlister and Ezekowitz Regarding Article, “Temporal Trends and Variation in Early Scheduled Follow-Up After a Hospitalization for Heart Failure: Findings From Get With the Guidelines-Heart Failure”.
McAlister FA, Ezekowitz JA.
Complete vs Culprit-Only Percutaneous Coronary Intervention in STEMI With Multivessel Disease: A Meta-analysis and Trial Sequential Analysis of Randomized Trials.
Bainey KR, Welsh RC, Toklu B, Bangalore S.
Bleeding in STEMI with staged multivessel PCI: Is it truly benign?
Bainey KR, Welsh RC.
Variations in the emergency department management of atrial fibrillation: Lessons to be learned.
McAlister FA, Rowe BH.
Comparing three different measures of frailty in medical inpatients: Multicenter prospective cohort study examining 30-day risk of readmission or death.
Belga S, Majumdar SR, Kahlon S, Pederson J, Lau D, Padwal RS, Forhan M, Bakal JA, McAlister FA.
Treated glycosylated hemoglobin levels in individuals with diabetes mellitus vary little by health status: A retrospective cohort study.
McAlister FA, Youngson E, Eurich DT.
Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis.
Berry C, Poppe KK, Gamble GD, Earle NJ, Ezekowitz JA, Squire IB, McMurray JJ, McAlister FA, Komajda M, Swedberg K, Maggioni AP, Ahmed A, Whalley GA, Doughty RN, Tarantini L; MAGGIC Collaborative Group.
Early Follow-Up After a Heart Failure Exacerbation: The Importance of Continuity.
Mcalister FA, Youngson E, Kaul P, Ezekowitz JA.
Validation of administrative and clinical case definitions for gestational diabetes mellitus against laboratory results.
Bowker SL, Savu A, Donovan LE, Johnson JA, Kaul P.
Overtreatment of Low-Risk Patients With Atrial Fibrillation- The Quality Coin Has 2 Sides.
McAlister FA.
The relationship between the proportion of admitted high risk ACS patients and hospital delivery of evidence based care.
Brieger D, Hyun K, Chew D, Amerena J, Farouque O, MacIsaac A, Goodman SG, Yan A, Aliprandi Costa B, Dabin B, D'Sousa M.
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial.
McGuire DK, Van de Werf F, Armstrong PW, Standl E, Koglin J, Green JB, Bethel MA, Cornel JH, Lopes RD, Halvorsen S, Ambrosio G, Buse JB, Josse RG, Lachin JM, Pencina MJ, Garg J, Lokhnygina Y, Holman RR, Peterson ED; Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS) Study Group.
Composite End Points in Acute Heart Failure Research: Data Simulations Illustrate the Limitations.
Brown PM, Anstrom KJ, Felker GM, Ezekowitz JA.
Canadian Cardiovascular Society Quality Indicators for Heart Failure.
McKelvie RS, Heckman GA, Blais C, Cox JL, Ezekowitz JA, Gong Y, Harkness K, Moe G, Dai S, Dorian P, Johnstone DE, McGeachie EC, Tu JV, Lambert LJ.
Exploring unmet needs in venous and arterial thromboembolism with rivaroxaban.
Cappato R, Welsh RC.
Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requ
Mehta RH, van Diepen S, Meza J, Bokesch P, Leimberger JD, Tourt-Uhlig S, Swartz M, Parrotta J, Jankowich R, Hay D, Harrison RW, Fremes S, Goodman SG, Luber J, Toller W, Heringlake M, Anstrom KJ, Levy JH, Harrington RA, Alexander JH.
Clinical Characteristics, Management, and Outcomes of Acute Coronary Syndrome in Patients With Right Bundle Branch Block on Presentation.
Chan WK, Goodman SG, Brieger D, Fox KAA, Gale CP, Chew DP, Udell JA, Lopez-Sendon J, Huynh T, Yan RT, Singh SM, Yan AT; ACS I and GRACE Investigators.
Influence of Using Different Databases and ‘Look Back’ Intervals to Define Comorbidity Profiles for Patients with Newly Diagnosed Hypertension: Implications for Health Services Researchers.
Chen G, Lix L, Tu K, Hemmelgarn BR, Campbell NR, McAlister FA, Quan H, Hypertension Outcome and Surveillance Team.
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial).
Metra M, Mentz RJ, Hernandez AF, Heizer GM, Armstrong PW, Clausell N, Corbalan R, Costanzo MR, Dickstein K, Dunlap ME, Ezekowitz JA, Howlett JG, Komajda M, Krum H, Lombardi C, Fonarow GC, McMurray JJ, Nieminen MS, Swedberg K, Voors AA, Starling RC, Teerlink JR, O’Connor CM.
Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients.
Chin CT, Boden WE, Roe MT, Neely B, Neely ML, Leiva-Pons JL, Corbalán R,Gottlieb S, Dalby AJ, Armstrong PW, Prabhakaran D, Fox KA, White HD,Ohman EM, Winters KJ, Schiele F.
Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke after Acute Coronary Syndromes: Results from the TRILOGY ACS Trial.
Chin CT, Neely B, Magnus Ohman E, Armstrong PW, Corbalán R, White HD,Prabhakaran D, Winters KJ, Fox KA, Roe MT.
Effect of Pre-Hospital Ticagrelor During the First 24 Hours After Primary PCI in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis.
Montalescot G, van ‘t Hof AW, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Collet JP, Goodman SG, Hammett CJ, Huber K, Janzon M, Lapostolle F, Lassen JF, Licour M, Merkely B, Salhi N, Silvain J, Storey RF, Ten Berg JM, Tsatsaris A, Zeymer U, Vicaut E, Hamm CW; ATLANTIC Investigators.
Salt in the diet in patients with heart failure: what to recommend.
Colin-Ramirez E, Ezekowitz JA.
Changes in dietary intake and nutritional status associated with a significant reduction in sodium intake in patients with heart failure. A sub-analysis of the SODIUM-HF pilot study.
Colin-Ramirez E, McAlister FA, Zheng Y, Sharma S, Ezekowitz JA.
Does Ivabradine SIGNIFY Improvements in Quality of Life?
Norris CM, Bainey KR.
Trends and Regional Variation in Hospital Mortality, Length of Stay and Cost in Hospital of Ischemic Stroke Patients in Alberta Accompanying the Provincial Reorganization of Stroke Care.
Ohinmaa A, Zheng Y, Jeerakathil T, Klarenbach S, Häkkinen U, Nguyen T, Friesen D, Ruseski J, Kaul P, Ariste R, Jacobs P.
Epidemiology of Hypertension in Canada: An Update.
Padwal RS, Bienek A, McAlister FA, Campbell NRC.
Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.
Déry J-P, Mahaffey KW, Tricoci P, White HD, Podder M, Westerhout CM, Moliterno DJ, Harrington RA, Chen E, Strony J, Van de Werf F, Ziada KM, Held C, Aylward PE, Armstrong PW, Rao SV.
Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT).
Déry J-P, Mehta SR, Fisher HN, Zhang X, Zhu YE, Welsh RC, Lavi S, Cieza T, Henderson MA, Lutchmedial S, Siega AJD, Cheema AN, Wong BYL, Kokis A, Dehghani P, Goodman SG.
Sharing Data from Cardiovascular Clinical Trials – A Proposal.
Patel M, Peterson ED, Armstrong PW, Stone G, Mehran R, Kirtane A, Solomon S, Sabatine M, Bhatt D, Mauri L, Harrington R, Mahaffey K, Perkovic V, Lincoff M, Fox K, Nicols S, Steg PG, Wallentin L, Gibson CM.
Sleep Quality and Factors Influencing Self-Reported Sleep Duration and Quality in the General InternalMedicine Inpatient Population.
Dobing S, Frolova N, McAlister FA, Ringrose J
Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel.
Doll JA, Neely ML, Roe MT, Armstrong PW, White HD, Prabhakaran D, Winters KJ,Duvvuru S, Sundseth SS, Jakubowski JA, Gurbel PA, Bhatt DL, Ohman EM, Fox KA;TRILOGY ACS Investigators.
Depressive symptoms are associated with higher rates of readmission or mortality after medical hospitalization: A systematic review and meta-analysis.
Pederson JL, Warkentin LM, Majumdar SR, McAlister FA.
Prevalence and Timing of Screening and Diagnostic Testing for Gestational Diabetes Mellitus: A Population-Based Study in Alberta, Canada.
Donovan LE, Savu A, Edwards AL, Johnson JA, Kaul P.
What happens when healthcare innovations collide?
Pendharkar SR, Woiceshyn J, Da Silveira GJC, Bischak D, Flemons W, McAlister FA, Ghali WA.
Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy.
Perez AL, Grodin JL, Wu Y, Hernandez AF, Butler J, Metra M, Felker GM, Voors AA, McMurray JJ, Armstrong PW, Starling RC, O'Connor CM, Tang WHW.
High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction.
Pokorney SD, Radder C, Schulte PJ, Al-Khatib SM, Tricocci P, Van de Werf F, James SK, Cannon CP, Armstrong PW, White HD, Califf RM, Gibson CM, Giugliano RP, Wallentin L, Mahaffey KW, Harrington RA, Newby LK, Piccini JP.
Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy.
Popma CJ, Sheng S, Korjian S, Daaboul Y, Chi G, Tricoci P, Huang Z, Moliterno DJ,White HD, Van de Werf F, Harrington RA, Wallentin L, Held C, Armstrong PW,Aylward PE, Strony J, Mahaffey KW, Gibson CM.
Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to egnivacogin, a PEGylated aptamer.
Povsic TJ, Lawrence MG, Lincoff AM, Mehran R, Rusconi CP, Zelenkofske SL, Huang Z, Sailstad J, Armstrong PW, Steg PG, Bode C, Becker RC, Alexander JH, Adkinson NF, Levinson AI; REGULATE-PCI Investigators.
A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study.
Povsic TJ, Roe MT, Ohman EM, Steg PG, James S, Plotnikov A, Mundl H, Welsh RC, Bode C, Gibson CM.
Quality of Care for Percutaneous Coronary Intervention: Development of Canadian Cardiovascular Society Quality Indicators.
Quraishi AUR, Lambert LJ, Madan M, Gong Y, Forsey A, Galbraith D, Gill N, Oakes GH, Lavoie A, Carere RG, Welsh RC.
Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.
Roe MT, Cyr DD, Eckart D, Schulte PJ, Morse MA, Blackwell KL, Ready NE, Zafar SY, Beaven AW, Strickler JH, Onken JE, Winters KJ, Houterloot L, Zamoryakhin D, Wiviott SD, White HD, Prabhakaran D, Fox KAA, Armstrong PW, Ohman EM.
Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF).
Ezekowitz JA, Podder M, Hernandez AF, Armstrong PW, Starling RC,O’Connor CM, Califf RM.
Heterogeneity across one disease, two drugs, three trials, and four guidelines: are we further ahead?
Ezekowitz JA, Sepehrvand N.
Successful inter-hospital transfer for extracorporeal membrane oxygenation after an amniotic fluid embolism induced cardiac arrest.
Fang ZA, van Diepen S; Royal Alexandra Hospital and University of AlbertaHospital Cardiac Arrest Teams.
Liver function tests in patients with acute heart failure and associated outcomes: Insights from ASCEND-HF.
Samsky MD, Dunning A, DeVore AD, Schulte PJ, Starling RC, Wilson Tang WH, Armstrong PW, Ezekowitz JA, Butler J, McMurray JJ, Teerlink JR, Voors AA, Metra M, Mentz RJ, O'Connor CM, Patel CB, Hernandez AF.
The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial.
Sandhu RK, Ezekowitz JA, Andersson U, Alexander JH, Granger CB, HalvorsenS, Hanna M, Hijazi Z, Jansky P, Lopes RD, Wallentin L.
Secondary prevention beyond hospital discharge for acute coronary syndrome: Evidence-based recommendations.
Fitchett DH, Goodman SG, Leiter LA, Lin P, Welsh RC, Stone J, Grégoire J,Mcfarlane P, Langer A.
Prognostic value of dynamic electrocardiographic T wave changes in non-ST elevation acute coronary syndrome.
Sarak B, Goodman SG, Yan RT, Tan MK, Steg PG, Tan NS, Fox KA, Udell JA, Brieger D, Welsh RC, Gale CP, Yan AT; Canadian Acute Coronary Syndromes I, and Global Registry of Acute Coronary Events (GRACE) Investigators.
Cardiovascular Drug Development: Is it Dead or Just Hibernating?
Fordyce CB, Roe MT, Ahmad T, Libby P, Borer JS, Hiatt WR, Bristow MR, Packer M, Wasserman SM, Braunstein N, Pitt B, DeMets DL, Cooper-Arnold K, Armstrong PW, Berkowitz SD, Scott R, Prats J, Galis ZS, Stockbridge N, Peterson ED, Califf RM
Assessing the use of international classification of diseases-10th revision codes from the emergency department for the identification of acute heart failure.
Frolova N, Bakal JA, McAlister FA, Rowe BH, Quan H, Kaul P, Ezekowitz JA
Limited Impact of Drug Exposure Misclassification from Non-Benefit Thiazolidinedione Drug Use on Mortality and Hospitalizations from Saskatchewan, Canada: A Cohort Study.
Gamble J-M, Johnson JA, McAlister FA, Majumdar SR, Simpson SH, Eurich DT
Thrombocytopenia in Acute Coronary Syndromes: Etiologies and Proposed Management.
Sharma A, Ferguson C, Bainey KR
Preoperative Stress Tests-Superfluous Investigations Resulting in Excessive Treatment Delay: A Teachable Moment.
Sharma A, Khan JS, Bainey KR
Impact of a pharmacoinvasive strategy when delays to primary PCI are prolonged.
Gershlick AH, Westerhout CM, Armstrong PW, Huber K, Halvorsen S, Steg PG, Ostojic M, Goldstein P, Carvalho AC, Van de Werf F, Wilcox RG
The role of the novel oral anticoagulants in the secondary prevention of acute coronary syndromes.
Sharma R, Bainey KR
Symptomatic graft failure and impact on clinical outcome after coronary artery bypass grafting surgery: Results from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease registry.
Shavadia J, Norris CM, Graham MM, Verma S, Ali I, Bainey KR
Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis.
Simpson J, Castagno D, Doughty RN, Poppe KK, Earle N, Squire I, Richards M, Andersson B, Ezekowitz JA, Komajda M, Petrie MC, McAlister FA, Gamble GD, Whalley GA, McMurray JJ; Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC)
High-grade atrioventricular block in acute coronary syndromes: Insights from the Global Registry of Acute Coronary Events.
Singh SM, FitzGerald G, Yan AT, Brieger D, Fox KAA, López-Sendón J, Yan RT, Eagle KA, Steg PG, Budaj A, Goodman SG
Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van De Werf F, Peterson ED, Holman RR
Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Grodin JL, Perez AL, Wu Y, Hernandez AF, Butler J, Metra M, Felker GM, Voors AA, McMurray JJ, Armstrong PW, Califf RM, Starling RC, O'Connor CM, Tang WH
Incorporating patient preferences into clinical trial design: Results of the Opinions of Patients on Treatment Implications of New Studies (OPTIONS) project.
Stafinski T, Menon D, Nardelli A, Bakal J, Ezekowitz JA, Tymchak W, Welsh RC, Gyenes G, Armstrong PW
Prognostic significance of low QRS voltage on the admission electrocardiogram in acute coronary syndromes.
Tan NS, Goodman SG, Yan AT
Comparative assessment of short-term adverse events in acute heart failure with cystatin c and other estimates of renal function: results from the ASCEND-HF trial.
Tang WH, Dupont M, Hernandez AF, Voors AA, Hsu AP, Felker GM, Butler J, Metra M, Anker SD, Troughton RW, Gottlieb SS, McMurray JJ, Armstrong PW, Massie BM, Califf RM, O'Connor CM, Starling RC
Clinical implications of the CKD epidemiology collaboration (CKD-EPI) equation compared with the modification of diet in renal disease (MDRD) study equation for the estimation of renal dysfunction in patients with cardiovascular disease.
Tarantini L, Barbati G, Cioffi G, McAlister FA, Ezekowitz JA, Mazzone C, Faganello G, Russo G, Grisolia EF, Di Lenarda A
Apixaban plus mono versus dual antiplatelet therapy in acute coronary syndromes: Insights from the APPRAISE-2 trial.
Hess CN, James S, Lopes RD, Wojdyla DM, Neely ML, Liaw D, Hagstrom E, Bhatt DL, Husted S, Goodman SG, Lewis BS, Verheugt FWA, De Caterina R, Ogawa H, Wallentin L, Alexander JH
Dopamine receptor blockade improves pulmonary gas exchange but decreases exercise performance in healthy humans.
Tedjasaputra V, Bryan TL, van Diepen S, Moore LE, Bouwsema MM, Welsh RC, Petersen SR, Stickland MK
Cardiovascular Critical Care: A Perceived Deficiency among U.S. Trainees.
Hill T, Means G, van Diepen S, Paul T, Katz JN
Diuretic response in acute heart failure-an analysis from ASCEND-HF.
Ter Maaten JM, Dunning AM, Valente MA, Damman K, Ezekowitz JA, Califf RM, Starling RC, van der Meer P, O'Connor CM, Schulte PJ, Testani JM, Hernandez AF, Tang WH, Voors AA
Health Service Use and Costs Associated with Low Birth Weight-A Population Level Analysis.
Thanh NX, Toye J, Savu A, Kumar M, Kaul P
Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION).
Tsuyuki RT, Houle SKD, Charrois TL, Kolber MR, Rosenthal MM, Lewanczuk R, Campbell NRC, Cooney D, McAlister FA
Is Coronary Intensive Care Unit Volume a Quality Metric?
van Diepen S
Randomized trial of primary PCI with or without routine manual thrombectomy.
Jolly SS, Cairns JA, Yusuf S, Meeks B, Pogue J, Rokoss MJ, Kedev S, Thabane L, Stankovic G, Moreno R, Gershlick A, Chowdhary S, Lavi S, Niemelä K, Steg PG, Bernat I, Xu Y, Cantor WJ, Overgaard CB, Naber CK, Cheema AN, Welsh RC, Bertrand OF, Avezum A, Bhindi R, Pancholy S, Rao SV, Natarajan MK, Ten Berg JM, Shestakovska O, Gao P, Widimsky P, Džavík V; TOTAL Investigators
Variation in critical care unit admission rates and outcomes for patients with acute coronary syndromes or heart failure among high- and low-volume cardiac hospitals.
van Diepen S, Bakal JA, Lin M, Kaul P, McAlister FA, Ezekowitz JA
Association between frailty and 30-day outcomes after discharge from hospital.
Kahlon S, Pederson J, Majumdar SR, Belga S, Lau D, Fradette M, Boyko D, Bakal JA, Johnston C, Padwal RS, McAlister FA
The unmet need for addressing cardiac issues in intensive care research.
van Diepen S, Granger CB, Jacka M, Gilchrist IC, Morrow DA, Katz JN
Impact of Gestational Diabetes Mellitus and high Maternal Weight on the Development of Diabetes, Hypertension and Cardiovascular Disease: A Population-Level Analysis.
Kaul P, Savu A, Nerenberg K, Donovan L, Chik C, Ryan E, Johnson J
Consistency of benefit from an early invasive strategy after fibrinolysis: a patient-level meta-analysis.
Abdel-Qadir H, Yan AT, Tan M, Borgia F, Piscione F, Di Mario C, Halvorsen S, Cantor WJ, Westerhout CM, Scheller B, Le May MR, Fernandez-Aviles F, Sánchez PL, Lee DS, Goodman SG
Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery.
van Diepen S, Tricoci P, Podder M, Westerhout CM, Aylward PE, Held C, Van de Werf F, Strony J, Wallentin L, Moliterno DJ, White HD, Mahaffey KW, Harrington RA, Armstrong PW
Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial.
Abualnaja S, Podder M, Hernandez AF, McMurray JJ, Starling RC, O'Connor CM, Califf RM, Armstrong PW, Ezekowitz JA
Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF).
Kelly JP, Mentz RJ, Hasselblad V, Ezekowitz JA, Armstrong PW, Zannad F, Felker GM, Califf RM, O'Connor CM, Hernandez AF
Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome.
Khan R, Lopes RD, Neely ML, Stevens SR, Harrington RA, Diaz R, Cools F, Jansky P, Montalescot G, Atar D, Lopez-Sendon J, Flather M, Liaw D, Wallentin L, Alexander JH, Goodman SG; Apixaban for Prevention of Acute Ischemic Safety Events (APPRAISE)-2 Steering Committee and Investigators
Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models.
Khazanie P, Heizer GM, Hasselblad V, Armstrong PW, Califf RM, Ezekowitz JA, Dickstein K, Levy WC, McMurray JJV, Metra M, Wilson Tang WH, Teerlink JR, Voors AA, O'Connor CM, Hernandez AF, Starling R
External validation of the Hospital-patient One-year Mortality Risk (HOMR) model for predicting death within 1 year after hospital admission.
Van Walraven C, McAlister FA, Bakal JA, Hawken S, Donzé J
Correlation between peak expiratory flow rate and NT-proBNP in patients with acute heart failure. An analysis from ASCEND-HF trial.
Al-Majed NS, Armstrong PW, Bakal JA, Hernandez AF, Ezekowitz JA
Baseline Q waves and time from symptom onset to ST-segment elevation myocardial infarction: insights from PLATO on the influence of sex.
Kholaif N, Zheng Y, Jagasia P, Himmelmann A, James SK, Steg PG, Storey RF, Westerhout CM, Armstrong PW
Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials.
Verma S, Goodman SG, Mehta SR, Latter DA, Ruel M, Gupta M, Yanagawa B, Al-Omran M, Gupta N, Teoh H, Friedrich JO
Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights from Clinical Trials over 17 Years.
Kragholm K, Halim SA, Yang Q, Schulte PJ, Hochman JS, Melloni C, Mahaffey KW, Moliterno DJ, Harrington RA, White HD, Armstrong PW, Ohman EM, Van De Werf F, Tricoci P, Alexander JH, Giugliano RP, Newby LK
Cost Implication of an Early Invasive Strategy on Weekdays and Weekends in Patients With Acute Coronary Syndromes.
Lamy A, Tong WR, Bainey KR, Gafni A, Rao-Melacini P, Mehta SR
Cardiovascular Risk Factors and In-hospital Mortality in Acute Coronary Syndromes: Insights From the Canadian Global Registry of Acute Coronary Events.
Wang JY, Goodman SG, Saltzman I, Wong GC, Huynh T, Dery J-P, Leiter LA, Bhatt DL, Welsh RC, Spencer FA, Fox KAA, Yan AT
Late consequences of acute coronary syndromes: Global registry of acute coronary events (GRACE) follow-up.
Alnasser SMA, Huang W, Gore JM, Steg PG, Eagle KA, Anderson FA, Fox KAA, Gurfinkel E, Brieger D, Klein W, Van De Werf F, Avezum Á, Montalescot G, Gulba DC, Budaj A, Lopez-Sendon J, Granger CB, Kennelly BM, Goldberg RJ, Fleming E, Goodman SG
Comparison of transient associations of air pollution and AMI hospitalisation in two cities of Alberta, Canada, using a case-crossover design.
Wang X, Kindzierski W, Kaul P
Air Pollution and Acute Myocardial Infarction Hospital Admission in Alberta, Canada: A Three-Step Procedure Case-Crossover Study.
Wang X, Kindzierski W, Kaul P
The impact of multimorbidity on short-term events in patients with community-acquired pneumonia: Prospective cohort study.
Weir DL, Majumdar SR, McAlister FA, Marrie TJ, Eurich DT
The making of an author.
Armstrong PW
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial.
Lincoff AM, Mehran R, Povsic TJ, Zelenkofske SL, Huang Z, Armstrong PW, Steg PG, Bode C, Cohen MG, Buller C, Laanmets P, Valgimigli M, Marandi T, Fridrich V, Cantor WJ, Merkely B, Lopez-Sendon J, Cornel JH, Kasprzak JD, Aschermann M, Guetta V, Morais J, Sinnaeve PR, Huber K, Stables R, Sellers MA, Borgman M, Glenn L, Levinson AI, Lopes RD, Hasselblad V, Becker RC, Alexander JH; REGULATE-PCI Investigators
Novel approaches to composite endpoints in clinical trials.
Westerhout CM, Bakal JA
Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early after Myocardial infarction trial.
Armstrong PW, Zheng Y, Westerhout CM, Rosell-Ortiz F, Sinnaeve P, Lambert Y, Lopes RD, Bluhmki E, Danays T, Van De Werf F
Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: A patient-level analysis of the randomized early routine invasive c
Madan M, Halvorsen S, Di Mario C, Tan M, Westerhout CM, Cantor WJ, Le May MR, Borgia F, Piscione F, Scheller B, Armstrong PW, Fernandez-Aviles F, Sanchez PL, Graham JJ, Yan AT, Goodman SG
Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization.
Bagai A, Huang Z, Lokhnygina Y, Harrington RA, Armstrong PW, Strony J, White HD, Leonardi S, Held C, Van De Werf F, Wallentin L, Tricoci P, Mahaffey KW
Impact of Rural Residence on Warfarin Use and Clinical Events in Patients with Non-Valvular Atrial Fibrillation: A Canadian Population Based Study.
Wu C, McMurtry MS, Sandhu RK, Youngson E, Ezekowitz JA, Kaul P, McAlister FA
In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study.
Bagai A, Peterson ED, Honeycutt E, Effron MB, Cohen DJ, Goodman SG, Anstrom KJ, Gupta A, Messenger JC, Wang TY
Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis.
Yousef A, Simard T, Webb J, Rodés-Cabau J, Costopoulos C, Kochman J, Hernández-Garcia JM, Chiam PT, Welsh RC, Wijeysundera HC, García E, Ribeiro HB, Latib A, Huczek Z, Shanks M, Testa L, Farkouh ME, Dvir D, Velianou JL, Lam BK, Pourdjabbar A, Glover C, Hibbert B, Labinaz M
Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction.
Zordoky BN, Sung MM, Ezekowitz JA, Mandal R, Han B, Bjorndahl TC, Bouatra S, Anderson T, Oudit GY, Wishart DS, Dyck JR; Alberta HEART
Evaluation of Cardiac Magnetic Resonance as a Surrogate in ST-Segment Elevation Myocardial Infarction.
Bainey KR, Patel MR, Armstrong PW
Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Bloc
Bainey KR, Rahim S, Etherington K, Rokoss ML, Natarajan MK, Velianou JL, Brons S, Mehta SR
The prediction of postoperative stroke or death in patients with preoperative atrial fibrillation undergoing non-cardiac surgery: a VISION sub-study.
McAlister FA, Jacka M, Graham M, Youngson E, Cembrowski G, Bagshaw SM, Pannu N, Townsend DR, Srinathan S, Alonso-Coello P, Devereaux PJ J Thromb Haemost
Applying novel methods to assess clinical outcomes: Insights from the TRILOGY ACS trial.
Bakal JA, Roe MT, Ohman EM, Goodman SG, Fox KAA, Zheng Y, Westerhout CM, Hochman JS, Lokhnygina Y, Brown EB, Armstrong PW
Influence of Patient Goals of Care on Performance Measures in Patients Hospitalized for Heart Failure: An Analysis of the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) Registry.
McAlister FA, Wang J, Donovan L, Lee DS, Armstrong PW, Tu JV
Impact of weighted composite compared to traditional composite endpoints for the design of randomized controlled trials.
Bakal JA, Westerhout CM, Armstrong PW
Physician experience and outcomes among patients admitted to general internal medicine teaching wards.
McAlister FA, Youngson E, Bakal JA, Holroyd-Leduc J, Kassam N
Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
Bethel MA, Green JB, Milton J, Tajar A, Engel SS, Califf RM, Holman RR, Armstrong PW, Buse JB, Josse RG, Kaufman K, Koglin J, Korn S, Lachin JM, McGuire DK, Standl E, Stein P, Suryawanshi S, Van de Werf F
Similar outcomes among general medicine patients discharged on weekends.
McAlister FA, Youngson E, Padwal RS, Majumdar SR
Correlation of cardiovascular magnetic resonance imaging findings and endomyocardial biopsy results in patients undergoing screening for heart transplant rejection.
Butler CR, Savu A, Bakal JA, Toma M, Thompson R, Chow K, Wang H, Kim DH, Mengel M, Haykowsky M, Pearson GJ,Kaul P, Paternson I
Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
Mentz RJ, Hasselblad V, DeVore AD, Metra M, Voors AA, Armstrong PW, Ezekowitz JA, Tang WH, Schulte PJ, Anstrom KJ, Hernandez AF, Velazquez EJ, O'Connor CM
A cluster randomized trial of objective risk assessment versus standard care for acute coronary syndromes: Rationale and design of the Australian GRACE Risk score Intervention Study (AGRIS).
Chew DP, Astley CM, Luker H, Alprandi-Costa B, Hillis G, Chow CK, Quinn S, Yan AT, Gale CP, Goodman SG, Fox KAA, Brieger D
The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications.
Moe GW, Ezekowitz JA, O'Meara E, Lepage S, Howlett JG, Fremes S, Al-Hesayen A, Heckman GA, Abrams H, Ducharme A, Estrella-Holder E, Grzeslo A, Harkness K, Koshman SL, McDonald M, McKelvie R, Rajda M, Rao V, Swiggum E, Virani S, Zieroth S; Secondary Panel:, Arnold JM, Ashton T, D'Astous M, Chan M, De S, Dorian P, Giannetti N, Haddad H, Isaac DL, Kouz S, Leblanc M, Liu P, Ross HJ, Sussex B, White M
Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acu
Clemmensen P, Roe MT, Hochman JS, Cyr DD, Neely ML, McGuire DK, Cornel JH, Huber K, Zamoryakhin D, White HD, Armstrong PW, Fox KA, Prabhakaran D, Ohman EM; TRILOGY ACS Investigators
Estimates of Dietary Sodium Consumption in Patients With Chronic Heart Failure.
Colin-Ramirez E, Arcand J, Ezekowitz JA
Re. “Dietary fatty acids intake and mortality in patients with heart failure”: Authors’ response.
Colin-Ramirez E, Ezekowitz JA
Cardiovascular Medication Utilization and Adherence Among Heart Failure Patients in Rural and Urban Areas: A Retrospective Cohort Study.
Murphy GK, McAlister FA, Eurich DT
Association Between Self-reported Adherence to a Low-Sodium Diet and Dietary Habits Related to Sodium Intake in Heart Failure Patients.
Colin-Ramirez E, McAlister FA, Woo E, Wong N, Ezekowitz JA
The long-term effects of dietary sodium restriction on clinical outcomes in patients with heart failure. The SODIUM-HF (Study of Dietary Intervention Under 100 mmol in Heart Failure): A pilot study.
Colin-Ramirez E, McAlister FA, Zheng Y, Sharma S, Armstrong PW, Ezekowitz JA
Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial.
Nicolau JC, Bhatt DL, Roe MT, Lokhnygina Y, Neely B, Corbalán R, Leiva-Pons JL, Martinez F, Goodman SG, Winters KJ, Verheugt FW, Armstrong PW, White HD, Fox KA, Prabhakaran D, Ohman EM; TRILOGY ACS investigators
Early Management of Patients with Acute Heart Failure: State of the Art and Future Directions: A Consensus Document from the SAEM / HFSA Acute Heart Failure Working Group.
Collins S, Storrow AB, Storrow AB, Albert N, Butler J, Ezekowitz JA, Felker GM, Fermann GJ, Fonarow GC, Givertz MM, Hiestand B, Hollander J, Lanfear D, Levy PD, Pang PS, Peacock WF, Sawyer DB, Teerlink J, Lenihan DJ
Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society of America acute heart failure working group.
Collins SP, Storrow AB, Levy PD, Albert N, Butler J, Ezekowitz JA, Felker GM, Fermann GJ, Fonarow GC, Givertz MM, Hiestand B, Hollander JE, Lanfear DE, Pang PS, Peacock WF, Sawyer DB, Teerlink JR, Lenihan DJ
Glycoprotein iib/iiia receptor inhibitors in combination with vorapaxar, a platelet thrombin receptor antagonist, among patients with non-ST-segment elevation acute coronary syndromes (from the TRACER Trial).
Cornel JH, Tricoci P, Lokhnygina Y, Moliterno DJ, Wallentin L, Armstrong PW, Aylward PE, Clare RM, Chen E, Leonardi S, Van de Werf F, White HD, Held C, Strony J, Mahaffey KW, Harrington RA
Economic analysis of ticagrelor therapy from a U.S. perspective: Results from the PLATO study.
Cowper PA, Pan W, Anstrom KJ, Kaul P, Wallentin L, Davidson-Ray L, Nikolic E, Janzon M, Levin LÅ, Cannon CP, Harrington RA, Mark DB
The Effects of Climate Change on Cardiac Health.
De Blois J, Kjellstrom T, Agewall S, Ezekowitz JA, Armstrong PW, Atar D
Validity and utility of ICD-10 administrative health data for identifying ST- and non-ST-elevation myocardial infarction based on physician chart review.
Patel AB, Quan H, Welsh RC, Deckert-Sookram J, Tymchak W, Sookram S, Surdhar I, Kaul P
Risk stratification and stroke prevention therapy care gaps in canadian atrial fibrillation patients (from the co-ordinated national network to engage physicians in the care and treatment of patients with atrial fibrillation chart audit).
Patel AD, Tan MK, Angaran P, Bell AD, Berall M, Bucci C, Demchuk AM, Essebag V, Goldin L, Green MS, Gregoire JC, Gross PL, Heilbron B, Lin PJ, Ramanathan K, Skanes A, Wheeler BH, Goodman SG
Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
DeVore AD, Hasselblad V, Mentz RJ, O'Connor CM, Armstrong PW, McMurray JJ, Ezekowitz JA, Tang WH, Starling RC, Voors AA, Califf RM, Hernandez AF
Delirium is a robust predictor of morbidity and mortality among critically ill patients treated in the cardiac intensive care unit.
Pauley E, Lishmanov A, Schumann S, Gala GJ, van Diepen S, Katz JN
Refining hypertension surveillance to account for potentially misclassified cases.
Peng M, Chen G, Lix LM, McAlister FA, Tu K, Campbell NR, Hemmelgarn BR, Svenson LW, Quan H
Ethnic-specific normative reference values for echocardiographic LA and LV Size, LV Mass, and systolic function: The EchoNoRMAL study.
Poppe KK, Doughty RN, Gardin JM, Nagueh SF, Whalley GA, Cameron V, Chadha DS, Chien KL, Detrano R, Akif Duzenli M, Ezekowitz JA, Di Pasquale P, Mogelvang R, Altman DG, Perera R, Triggs CM, Au Yeung H, Beans Picón GA, Anderson T, Dyck J, Ezekowitz JA, Chirinos JA, De Buyzere ML, Gillebert TC, Rietzschel E, Segers P, Van daele CM, Walsh HA, Whalley GA, Izzo R, De Luca N, Trimarco B, De Simone G, Chadha DS, Goel K, Misra A, Chen P-C, Chien K-L, Lin H-J, Su T-C, Detrano R, Cameron V, Richards AM, Troughton R, Mogelvang R, Skov Jensen J, Di Pasquale P, Paterna S, Akif Duzenli M, Hobbs FDR, Davies MK, Davis RC, Roalfe A, Calvert M, Freemantle N, Gill PS, Lip GYH, Kuznetsova T, Staessen JA, Dargie HJ, Ford I, McDonagh TA, McMurray JJV, Grossman E, Galasko G, Lahiri A, Senior R, Brown A, Carrington M, Krum H, McGrady M, Stewart S, Zeitz C, Blauwet L, Sliwa K, Dalen H, Moelmen Hansen HE, Støylen A, Thorstensen A, Daimon M, Watanabe H, Yoshikawa J, Fukuda S, Kim H-K, Leung NKW, Linhart A, Chahal N, Chambers JC, Kooner J, Davies J, Loke I, Ng L, Squire IB, Aune E, Otterstad JE, Leung DY, Ng ACT, Ojji D, Arnold L, Coffey S, D'Arcy J, Hammond C, Mabbett C, Lima C, Loudon M, Pinheiro N, Prendergast B, Reynolds R, Badano LP, Muraru D, Peluso D, Dal Bianco L, Petrovic DJ, Petrovic J, Schvartzman P, Fuchs FD, Katova T, Simova I, Kaku K, Takeuchi M, Boyd A, Chia EM, Thomas L, Schirmer H, Angelo LC, Pereira AC, Krieger JE, Mill JG, Rodrigues SL, Muiesan ML, Paini A, Agabiti Rosei E, Salvetti M
Reply: Coenzyme Q10: Will this natural substance become a guideline-directed adjunctive therapy in heart failure?
Ezekowitz JA
The Prognostic Importance of Changes in Renal Function during Treatment for Acute Heart Failure Depends on Admission Renal Function.
Reid R, Ezekowitz JA, Brown PM, McAlister FA, Rowe BH, Braam B
Heart failure guidelines fail.
Ezekowitz JA, OMeara E, Howlett JG
The future of cardiovascular clinical research in North America and beyond – addressing challenges and leveraging opportunities through unique academic and grassroots collaborations.
Roe MT, Mahaffey KW, Ezekowitz JA, Alexander JH, Goodman SG, Hernandez A, Temple T, Berdan L Califf RM, Harrington RA, Peterson ED, Armstrong PW
Providing Rapid Out of Hospital Acute Cardiovascular Treatment 4 (PROACT-4).
Ezekowitz JA, Welsh RC, Weiss D, Chan M, Keeble W, Khadour F, Sharma S, Tymchak W, Sookram S, Brass N, Knapp D, Koshy TL, Zheng Y, Armstrong PW
Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome.
Roy A, Roe MT, Neely ML, Cyr DD, Zamoryakhin D, Fox KA, White HD, Armstrong PW, Ohman EM, Prabhakaran D
Efficacy and safety of a routine early invasive strategy in relation to time from symptom onset to fibrinolysis (a subgroup analysis of TRANSFER-AMI).
Russo JJ, Goodman SG, Cantor WJ, Tan MK, Borgundvaag B, Fitchett D, Džavík V, Yan RT, Graham JJ, Mehta SR, Yan AT
Intraclass differences among antihypertensive drugs.
Feldman RD, Hussain Y, Kuyper LM, McAlister FA, Padwal RS, Tobe SW
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 Type 1 receptor: Rationale and design of the BLAST-AHF Study (Biased Ligand of the Angiotensin receptor Study in Acute Heart Failure).
Felker GM, Butler J, Collins SP, Cotter G, Davison BA, Ezekowitz JA, Filippatos G, Levy PD, Metra M, Ponikowski P, Soergel DG, Teerlink JR, Violin JD, Voors AA, Pang PS
Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure.
Sandhu RK, Hohnloser SH, Pfeffer MA, Yuan F, Hart RG, Yusuf S, Connolly SJ, McAlister FA, Healey JS
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial.
Schwartz GG, Bessac L, Berdan LG, Bhatt DL, Bittner V, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Rorick T, Sasiela WJ, Shirodaria C, Szarek M, Tamby J-F, Tricoci P, White H, Zeiher A, Steg PG
Diabetes, impaired fasting glucose, and heart failure: Its not all about the sugar.
Sharma A, Ezekowitz JA
Characteristics and Evidence-Based Management of Stable Coronary Artery Disease Patients in Canada Compared With the Rest of the World: Insights From the CLARIFY Registry.
Gandhi S, Dorian P, Greenlaw N, Tardif JC, Steg PG, Huynh T, Wong GC, Love MP, Poirier P, Goodman SG; Prospective Observational Longitudinal Registry of Patients With Stable Coronary Artery Disease CLARIFY Registry Investigators
Increased uptake of guideline-recommended oral antiplatelet therapy: insights from the Canadian acute coronary syndrome reflective.
Gandhi S, Zile B, Tan MK, Saranu J, Bucci C, Yan AT, Robertson P, Quantz MA, Letovsky E, Tanguay JF, Dery JP, Fitchett D, Madan M, Cantor WJ, Heffernan M, Natarajan MK, Wong GC, Welsh RC, Goodman SG; Canadian ACS Reflective Group
Factors associated with major bleeding events: insights from the rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF).
Goodman SG, Wojdyla DM, Piccini JP, White HD, Paolini JF, Nessel CC, Berkowitz SD, Mahaffey KW, Patel MR, Sherwood MW, Becker RC, Halperin JL, Hacke W, Singer DE, Hankey GJ, Breithardt G, Fox KAA, Califf RM, for the ROCKET AF Investigators
Physician continuity improves outcomes for heart failure patients treated and released from the emergency department.
Sidhu RS, Youngson E, McAlister FA
ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention strategic reperfusion early after myocardial infarction (STREAM) 1-year mortality follow-up.
Sinnaeve PR, Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Lambert Y, Danays T, Soulat L, Halvorsen S, Ortiz FR, Vandenberghe K, Regelin A, Bluhmki E, Bogaerts K, Van De Werf F
Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada.
Grima DT, Brown ST, Kamboj L, Bainey KR, Goeree R, Oh P, Ramanathan K, Goodman SG
Inching Closer to a Solution: Sorting Out the Optimal Strategy for STEMI Patients With Multi-Vessel Coronary Artery Disease.
Gyenes GT, Welsh RC
Comparison of the efficacy of pharmacoinvasive management for ST-segment elevation myocardial infarction in smokers versus non-smokers (from the trial of routine angioplasty and stenting after fibrinolysis to enhance reperfusion in acute myocardial infarc
Tan NS, Goodman SG, Cantor WJ, Tan MK, Yan RT, Bagnall AJ, Mehta SR, Fitchett D, Strauss BH, Yan AT
Smoking status and survival: impact on mortality of continuing to smoke one year after the angiographic diagnosis of coronary artery disease, a prospective cohort study.
Hammal F, Ezekowitz JA, Norris CM, Wild TC, Finegan B
Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial.
Held C, Tricoci P, Huang Z, Van de Werf F, White HD, Armstrong PW, Ambrosio G, Aylward PE, Moliterno DJ, Wallentin L, Chen E, Erkan A, Jiang L, Strony J, Harrington RA, Mahaffey KW
Independent data monitoring committees: preparing a path for the future.
Hess N, Row M, Gibson M, Temple R, Pencina M, Zarin D, Anstrom K, Alexander J, Sherman R, Fiedorek F, Mahaffey K, Lee K, Chow S, Armstrong PW, Califf R
Practice patterns and clinical outcomes among non-ST-Segment elevation acute coronary syndrome (NSTE-ACS) patients presenting to primary and tertiary hospitals: Insights from the EARLY glycoprotein IIb/IIIa inhibition in NSTE-ACS (EARLY-ACS) trial.
Toleva O, Westerhout CM, Senaratne MPJ, Bode C, Lindroos M, Sulimov VA, Montalescot G, Newby LK, Giugliano RP, Van De Werf F, Armstrong PW
The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF trial.
Toma M, Ezekowitz JA, Bakal JA, O’Connor CM, Hernandez AF, Sardar MR, Zolty R, Massie BM, Swedberg K, Armstrong PW, Starling RC
The organization, function, and outcomes of ST-elevation myocardial infarction networks worldwide: Current state, unmet needs and future directions.
Huber K, Gersh BJ, Goldstein P, Granger CB, Armstrong PW
Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: Results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial.
Tricoci P, Lokhnygina Y, Huang Z, Van De Werf F, Cornel JH, Chen E, Wallentin L, Held C, Aylward PE, Moliterno DJ, Jennings LK, White HD, Armstrong PW, Harrington RA, Strony J, Mahaffey KW
Antihypertensive drug prescribing and persistence among new elderly users: Implications for persistence improvement interventions.
Tu K, Anderson LN, Butt DA, Quan H, Hemmelgarn BR, Campbell NR, McAlister FA, Baclic O, Bartlett G, Butt D, Campbell N, Chen G, Dai S, Hemmelgarn B, Hill M, Johansen H, Khan N, Lix L, McAlister FA, Onysko J, Smith M, Svenson L, Teare G, Walker R, Wielgosz A
Basis for sex-dependent outcomes in acute coronary syndrome.
Izadnegahdar M, Norris C, Kaul P, Pilote L, Humphries KH
Usefulness and safety of vorapaxar in patients with non-ST segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER trial).
Valgimigli M, Tricoci P, Huang Z, Aylward P, Armstrong PW, Van de Werd F, Leonardi S, White HD, Widimsky P, Harrington RA, Cequier A, Chen E, Lokhnygina Y, Wallentin L, Strony J, Mahaffey KW, Moliterno DJ
Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from ASCEND-HF.
van Deursen VM, Hernandez AF, Stebbins A, Hasselblad V, Ezekowitz JA, Califf RM, Gottlieb SS, O’Connor CM, Starling RC, Tang WH, McMurray JJ, Dickstein K, Voors AA
Design and rationale of the TOTAL trial: A randomized trial of routine aspiration ThrOmbecTomy with percutaneous coronary intervention (PCI) versus PCI ALone in patients with ST-elevation myocardial infarction undergoing primary PCI.
Jolly SS, Cairns J, Yusuf S, Meeks B, Shestakovska O, Thabane L, Niemelä K, Steg PG, Bertrand OF, Rao SV, Avezum A, Cantor WJ, Pancholy SB, Moreno R, Gershlick A, Bhindi R, Welsh RC, Cheema AN, Lavi S, Rokoss M, Džavík V
Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER).
Jones WS, Tricoci P, Huang Z, Moliterno DJ, Harrington RA, Sinnaeve PR, Strony J, Van de Werf F, White HD, Held C, Armstrong PW, Aylward PE, Chen E, Patel MR, Mahaffey KW
Endoscopic harvesting device type and outcomes in patients undergoing coronary artery bypass surgery.
van Diepen S, Brennan JM, Hafley GE, Reyes EM, Allen KB, Ferguson TB, Peterson ED, Williams JB, Gibson CM, Mack MJ, Kouchoukos NT, Alexander JH, Lopes RD
Influence of heart failure symptoms and ejection fraction on short- and long-term outcomes for older patients with non-ST-segment elevation myocardial infarction.
van Diepen S, Chen AY, Wang T, Alexander K, Ezekowitz JA, Peterson ED, Roe MT
Long-term survival with revascu-larization in South Asians admitted with an acute coronary syndrome (from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease Registry).
Kaila KS, Norris CM, Graham MM, Ali I, Bainey KR
High-sensitivity C-reactive protein in acute heart failure: Insights from the ASCEND-HF trial.
Kalogeropoulos AP, Tang WH, Hsu A, Felker GM, Hernandez AF, Troughton RW, Voors AA, Anker SD, Metra M, McMurray JJ, Massie BM, Ezekowitz JA, Califf RM, O'Connor CM, Starling RC, Butler J
Predicting cardiovascular intensive care unit readmission after cardiac surgery: Derivation and validation of the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) cardiovascular intensive care unit clinical predictio
van Diepen S, Graham MM, Nagendran J, Norris CM
Acute decompensated heart failure patients admitted to critical care units: Insights from ASCEND-HF.
van Diepen S, Podder M, Hernandez AF, Westerhout CM, Armstong PW, McMurray JJ, Eapen ZJ, Califf RM, Starling RC, O'Connor CM, Ezekowitz JA
Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock.
van Diepen S, Reynolds HR, Stebbins A, Lopes RD, Džavík V, Ruzyllo W, Geppert A, Widimsky P, Ohman EM, Parrillo JE, Dauerman HL, Baran DA, Hochman JS, Alexander JH
Which risk score best predicts perioperative outcomes in nonvalvular atrial fibrillation patients undergoing noncardiac surgery?
van Diepen S, Youngson E, Ezekowitz JA, McAlister FA
Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome.
Vora AN, Chenier M, Schulte PJ, Goodman SG, Peterson ED, Pieper K, Jolicoeur ME, Mahaffey KW, White H, Wang TY
Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS trial).
Kunadian V, Giugliano RP, Newby LK, Zorkun C, Guo J, Bagai A, Montalescot G, Braunwald E, Califf RM, Van de Werf F, Armstrong PW, Harrington R, Gibson CM
Relationship between primary care physician visits and hospital/emergency use for uncomplicated hypertension, an ambulatory care-sensitive condition.
Walker RL, Chen G, McAlister FA, Campbell NR, Hemmelgarn BR, Dixon E, Ghali W, Rabi D, Tu K, Jette N, Quan H; Hypertension Outcome and Surveillance Team
Trends in death attributed to myocardial infarction, heart failure and pulmonary embolism in Europe and Canada over the last decade.
Laribi S, Aouba A, Resche-Rigon M, Johansen H, Eb M, Peacock FW, Masip J, Ezekowitz JA, Cohen-Solal A, Jougla E, Plaisance P, Mebazaa A
Representativeness of RELAX-AHF clinical trial population in acute heart failure.
Wang TS, Hellkamp AS, Patel CB, Ezekowitz JA, Fonarow GC, Hernandez AF
Prognostic implications of prominent r wave in electrocardiographic leads V1 or V2 in patients with acute coronary syndrome.
Alqarawi WA, Goodman SG, Yan RT, Constance C, Fung AY, Cha JY, Gosselin G, Brieger D, Fox KA, Van de Werf F, Yan AT; Global Registry of Acute Coronary Events (GRACE) and Canadian Acute Coronary Syndromes I Investigators
Risk stratification in acute heart failure.
Lee DS, Ezekowitz JA
Sitagliptin Use in Patients With Diabetes and Heart Failure. A Population-Based Retrospective Cohort Study.
Weir DL, McAlister FA, Senthilselvan A, Minhas-Sandhu JK, Eurich DT
Acute coronary syndromes: Right direction – Moving proximally in timing of STEMI care.
Armstrong PW
Targeted temperature management processes and outcomes after out-of-hospital cardiac arrest: An observational cohort study.
Lin S, Scales DC, Dorian P, Kiss A, Common MR, Brooks SC, Goodman SG, Salciccioli JD, Morrison LJ
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: Results of the PROTECTION AMI randomized controlled trial.
Lincoff AM, Roe M, Aylward P, Galla J, Rynkiewicz A, Guetta V, Zelizko M, Kleiman N, White H, McErlean E, Erlinge D, Laine M, Dos Santos Ferreira JM, Goodman SG, Mehta S, Atar D, Suryapranata H, Jensen SE, Forster T, Fernandez-Ortiz A, Schoors D, Radke P, Belli G, Brennan D, Bell G, Krucoff M
Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] Study).
Welsh RC, Van de Werf F, Westerhout CM, Goldstein P, Gershlick AH, Wilcox RG, Danays T, Bluhmki E, Lopes RD, Steg PG, Armstrong PW
No STEMI left behind (invited editorial re 2013 STEMI consensus statement in India).
Armstrong PW, Van de Werf FV
Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery: Subgroup Analysis From the TRACER Trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).
Whellan D, Tricoci P, Chen E, Huang Z, Leibowitz D, Pascal Vranckx P, Marhefka G, Held C, Nicolau J, Storey RF, Ruzyllo W, Huber K, Sinnaeve P, Weiss AT, Déry J-P, Moliterno D, Van de Werf F, Aylward P, White, H, Armstrong PW, Wallentin L, Strony J, Harrington RA, Mahaffey KW
Darapladib for preventing ischemic events in stable coronary heart disease.
White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen M-F, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim H-S, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler III ER, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse H-F, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L
Reduction in overall occurrences of ischemic events with vorapaxar: Results from TRACER.
White HD, Huang Z, Tricoci P, Van de Werf F, Wallentin L, Lokhnygina Y, Moliterno DJ, Aylward PE, Mahaffey KW, Armstrong PW
Patient outcomes in teaching versus nonteaching general internal medicine services: A systematic review and meta-analysis.
Au AG, Padwal RS, Majumdar SR, McAlister FA
Mortality outcomes among status aboriginals and caucasians with heart failure.
Lyons KJ, Ezekowitz JA, Liu W, McAlister FA, Kaul P
Rates and reasons for device-based quideline eligibility in patients with heart failure.
Lyons KJ, Podder M, Ezekowitz JA
Pharmacodynamic and clinical implications of switching between P2Y12 receptor antagonists: Considerations for practice.
Bagai A, Chua D, Cohen EA, Saw J, Verma S, Vijayaraghavan R, Welsh RC, Fitchett D
Association of Aspirin dose and Vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER trial).
Mahaffey KW, Huang Z, Wallentin L, Storey RF, Jennings LK, Tricoci P, White HD, Armstrong PW, Aylward PE, Moliterno DJ, Van de Werf F, Chen E, Leonardi S, Rorick T, Held C, Strony J, Harrington RA
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial.
Mahaffey KW, Stevens SR, White HD, Nessel CC, Goodman SG, Piccini JP, Patel MR, Becker RC, Halperin JL, Hacke W, Singer DE, Hankey GJ, Califf RM, Fox KA, Breithardt G; for the ROCKET AF Investigators
Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
Bagai A, Schulte PJ, Granger CB, Mahaffey KW, Christenson RH, Bell G, Lopes RD, Green CL, Lincoff AM, Armstrong PW, Roe MT
Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials.
Bagai A, Tan M, Di Mario C, Halvorsen S, Cantor WJ, Le May MR, Fernandez-Aviles F, Scheller B, Armstrong PW, Borgia F, Piscione F, Sánchez PL, Westerhout CM, Goodman SG, Yan AT
Clinical characteristics and outcomes of acute coronary syndrome patients with left anterior hemiblock.
Zhang H, Goodman SG, Steg GP, Budaj A, Lopez-Sendon J, Dorian P, Huynh T, Mangat I, Wong GC, Spencer FA, Yan AT
Ameliorating reperfusion injury in STEMI: Dead or alive?
Bainey KR, Armstrong PW
Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: Secondary analyses from two controlled trials.
Majumdar SR, McAlister FA, Johnson JA, Weir DL, Bellerose D, Hanley DA, Russell AS, Rowe BH
Clinical perspectives on reperfusion injury in acute myocardial infarction.
Bainey KR, Armstrong PW
Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program.
Bainey KR, Armstrong PW, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Zhao X, Schwamm LH, Bhatt DL
Impact of reperfusion strategy on aborted myocardial infarction: insights from a large Canadian ST-Elevation Myocardial Infarction Clinical Registry.
Bainey KR, Ferguson C, Ibrahim QI, Tyrrell B, Welsh RC; Vital Heart Response Registry Investigators
The cost implications of an early versus delayed invasive strategy in Acute Coronary Syndromes: the TIMACS study.
Bainey KR, Gafni A, Rao-Melacini P, Tong W, Steg PG, Faxon DP, Lamy A, Granger CB, Yusuf S, Mehta SR; TIMACS Investigators
Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
Bainey KR, Mehta SR, Lai T, Welsh RC
Safely and effectively reducing inpatient length of stay: A controlled study of the General Internal Medicine Care Transformation Initiative.
McAlister FA, Bakal JA, Majumdar SR, Dean S, Padwal RS, Kassam N, Bacchus M, Colbourne A
Revascularization strategies for coronary disease: Art or science?
Bainey KR, O'Neill BJ
Case management reduces global vascular risk after stroke: secondary results from the The preventing recurrent vascular events and neurological worsening through intensive organized case-management randomized controlled trial.
McAlister FA, Grover S, Padwal RS, Youngson E, Fradette M, Thompson A, Buck B, Dean N, Tsuyuki RT, Shuaib A, Majumdar SR
Cholesterol End Points Predict Outcome in Patients With Coronary Disease: Quality Improvement Metrics from The Enhancing Secondary Prevention in Coronary Artery Disease (ESP-CAD) Trial.
McAlister FA, Majumdar SR, Lin M, Bakal J, Fradette M, Anderson T
Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial.
McAlister FA, Majumdar SR, Padwal RS, Fradette M, Thompson A, Buck B, Dean N, Bakal JA, Tsuyuki R, Grover S, Shuaib A
Heart failure re-admission: measuring the ever shortening gap between repeat heart failure hospitalizations.
Bakal JA, McAlister FA, Liu W, Ezekowitz JA
Prognostic implications of quantitative evaluation of baseline Q-wave width in ST-segment elevation myocardial infarction.
Bao MH, Zheng Y, Westerhout CM, Fu Y, Wagner GS, Chaitman B, Granger CB, Armstrong PW
Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes.
Botto F, Alonso-Coello P, Chan MT, Villar JC, Xavier D, Srinathan S, Guyatt G, Cruz P, Graham M, Wang CY, Berwanger O, Pearse RM, Biccard BM, Abraham V, Malaga G, Hillis GS, Rodseth RN, Cook D, Polanczyk CA, Szczeklik W, Sessler DI, Sheth T, Ackland GL, Leuwer M, Garg AX, Lemanach Y, Pettit S, Heels-Ansdell D, Luratibuse G, Walsh M, Sapsford R, Schünemann HJ, Kurz A, Thomas S, Mrkobrada M, Thabane L, Gerstein H, Paniagua P, Nagele P, Raina P, Yusuf S, Devereaux PJ, Devereaux PJ, Sessler DI, Walsh M, Guyatt G, McQueen MJ, Bhandari M, Cook D, Bosch J, Buckley N, Yusuf S, Chow CK, Hillis GS, Halliwell R, Li S, Lee VW, Mooney J, Polanczyk CA, Furtado MV, Berwanger O, Suzumura E, Santucci E, Leite K, Santo JA, Jardim CA, Cavalcanti AB, Guimaraes HP, Jacka MJ, Graham M, McAlister FA, McMurtry S, Townsend D, Pannu N, Bagshaw S, Bessissow A, Bhandari M, Duceppe E, Eikelboom J, Ganame J, Hankinson J, Hill S, Jolly S, Lamy A, Ling E, Magloire P, Pare G, Reddy D, Szalay D, Tittley J, Weitz J, Whitlock R, Darvish-Kazim S, Debeer J, Kavsak P, Kearon C, Mizera R, O'Donnell M, McQueen M, Pinthus J, Ribas S, Simunovic M, Tandon V, Vanhelder T, Winemaker M, Gerstein H, McDonald S, O'Bryne P, Patel A, Paul J, Punthakee Z, Raymer K, Salehian O, Spencer F, Walter S, Worster A, Adili A, Clase C, Cook D, Crowther M, Douketis J, Gangji A, Jackson P, Lim W, Lovrics P, Mazzadi S, Orovan W, Rudkowski J, Soth M, Tiboni M, Acedillo R, Garg A, Hildebrand A, Lam N, Macneil D, Mrkobrada M, Roshanov PS, Srinathan SK, Ramsey C, John PS, Thorlacius L, Siddiqui FS, Grocott HP, McKay A, Lee TW, Amadeo R, Funk D, McDonald H, Zacharias J, Villar JC, Cortés OL, Chaparro MS, Vásquez S, Castañeda A, Ferreira S, Coriat P, Monneret D, Goarin JP, Esteve CI, Royer C, Daas G, Chan MT, Choi GY, Gin T, Lit LC, Xavier D, Sigamani A, Faruqui A, Dhanpal R, Almeida S, Cherian J, Furruqh S, Abraham V, Afzal L, George P, Mala S, Schünemann H, Muti P, Vizza E, Wang CY, Ong GS, Mansor M, Tan AS, Shariffuddin II, Vasanthan V, Hashim NH, Undok AW, Ki U, Lai HY, Ahmad WA, Razack AH, Malaga G, Valderrama-Victoria V, Loza-Herrera JD, De Los Angeles Lazo M, Rotta-Rotta A, Szczeklik W, Sokolowska B, Musial J, Gorka J, Iwaszczuk P, Kozka M, Chwala M, Raczek M, Mrowiecki T, Kaczmarek B, Biccard B, Cassimjee H, Gopalan D, Kisten T, Mugabi A, Naidoo P, Naidoo R, Rodseth R, Skinner D, Torborg A, Paniagua P, Urrutia G, Maestre ML, Santaló M, Gonzalez R, Font A, Martínez C, Pelaez X, De Antonio M, Villamor JM, García JA, Ferré MJ, Popova E, Alonso-Coello P, Garutti I, Cruz P, Fernández C, Palencia M, Díaz S, Del Castillo T, Varela A, de Miguel A, Muñoz M, Piñeiro P, Cusati G, Del Barrio M, Membrillo MJ, Orozco D, Reyes F, Sapsford RJ, Barth J, Scott J, Hall A, Howell S, Lobley M, Woods J, Howard S, Fletcher J, Dewhirst N, Williams C, Rushton A, Welters I, Leuwer M, Pearse R, Ackland G, Khan A, Niebrzegowska E, Benton S, Wragg A, Archbold A, Smith A, McAlees E, Ramballi C, Macdonald N, Januszewska M, Stephens R, Reyes A, Paredes LG, Sultan P, Cain D, Whittle J, Del Arroyo AG, Sessler DI, Kurz A, Sun Z, Finnegan PS, Egan C, Honar H, Shahinyan A, Panjasawatwong K, Fu AY, Wang S, Reineks E, Nagele P, Blood J, Kalin M, Gibson D, Wildes T; Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION) Writing Group, on behalf of The Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION) Investigators; Appendix 1 The Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION) Study Investigators Writing Group; Appendix 2 The Vascular events In noncardiac Surgery patIents cOhort evaluatioN Operations Committee; Vascular events In noncardiac Surgery patIents cOhort evaluatioN VISION Study Investigators
Association between blood lead and blood pressure: Results from the Canadian Health Measures Survey (2007 to 2011).
Bushnik T, Levallois P, D'Amour M, Anderson TJ, McAlister FA
Large streamlined trials in cardiovascular disease.
Calvo G, McMurray JJV, Granger CB, Alonso-Gracia A, Armstrong PW, Flather M, Gómez-Outes A, Pocock S, Stockbridge N, Svensson A, Van de Werf F
Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary Syndromes.
Mehta RH, Westerhout CM, Zheng Y, Giugliano RP, Huber K, Prabhakaran D, Harrington RA, Newby KL, Armstrong PW; EARLY ACS Investigators
The 2013 Canadian cardiovascular society heart failure management guidelines update: Focus on rehabilitation and exercise and surgical coronary revascularization.
Moe GW, Ezekowitz JA, O'Meara E, Howlett JG, Fremes SE, Al-Hesayen A, Heckman GA, Ducharme A, Estrella-Holder E, Grzeslo A, Harkness K, Lepage S, McDonald M, McKelvie RS, Nigam A, Rajda M, Rao V, Swiggum E, Virani S, Van Le V, Zieroth S, Arnold JMO, Ashton T, D'Astous M, Dorian P, Giannetti N, Haddad H, Isaac DL, Kouz S, Leblanc M-H, Liu P, Ross HJ, Sussex B, White M
Primary care physician visits by patients with incident hypertension.
Clement FM, Chen G, Khan N, Tu K, Campbell NR, Smith M, Quan H, Hemmelgarn BR, McAlister FA; Hypertension Outcome and Surveillance Team
Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: The Randomized Double-Blind Reminder Study.
Montalescot G, Pitt B, Lopez De Sa E, Hamm CW, Flather M, Verheugt F, Shi H, Turgonyi E, Orri M, Vincent J, Zannad F, Noll G, Weir R, O'Neill B, Böhm M, Hillis WS, Grieve A, Rouleau J-L, Gerasimos F, Fitchett D, Lepage S, Madan M, Sussex B, Tremblay G, Welsh RC, Wong G, Hutyra M, Kettner J, Ostadal P, Spinar J, Vojacek J, Barboteu M, Collet J-P, Coste P, Cottin Y, Ducos D, Galinier M, Teiger E, Zemour G, Bauersachs J, Hambrecht R, Hauf G, Heuer H, Mudra H, Münzel T, Steiner S, Strasser R, Sydow K, Tschöpe C, Wachter R, Werner N, Alexopoulos D, Babalis D, Pyrgakis V, Dezsi C, Lupkovics G, Polgar P, Tomcsanyi J, Herrman J, Ten Berg JM, Gorny J, Kubica J, Lewczuk J, Zmuda W, Hranai M, Kovar F, Margoczy R, Micko K, Sumbal J, Genover XB, Ortiz AF, Sala MF, Garcia CG, Muñoz CP, Blas JRR, Soriano FR, Adamson D, Alamgir F, Chauhan A, Lip G, Martin T, McCann G, Newby D, Smith D
Dietary fatty acids intake and mortality in patients with heart failure.
Colin-Ramirez E, Castillo-Martinez L, Orea-Tejeda A, Zheng Y, Westerhout CM, Ezekowitz JA
Prehospital ticagrelor in ST-segment elevation myocardial infarction.
Montalescot G, Van't Hof AW, Lapostolle F, Silvain J, Lassen JF, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Stibbe O, Ecollan P, Heutz WMJM, Swahn E, Collet J-P, Willems FF, Baradat C, Licour M, Tsatsaris A, Vicaut E, Hamm CW
Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial.
Cornel JH, Ohman EM, Neely B, Clemmensen P, Sritara P, Zamoryakhin D, Armstrong PW, Prabhakaran D, White HD, Fox KA, Gurbel PA, Roe MT; TRILOGY ACS Investigators
The association between meteorological events and acute heart failure: New insights from ASCEND-HF.
Das D, Bakal JA, Westerhout CM, Hernandez AF, O'Connor CM, Atar D, McMurray JJ, Armstrong PW, Ezekowitz JA
Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction.
Park DW, Clare RM, Schulte PJ, Pieper KS, Shaw LK, Califf RM, Ohman EM, Van de Werf F, Hirji S, Harrington RA, Armstrong PW, Granger CB, Jeong MH, Patel MR
Use of electrocardiogram indices of myocardial ischemia for risk stratification and decision making of reperfusion strategies.
Dianati Maleki N, Ehteshami Afshar A, Armstrong PW.
An assessment of ST-segment measurement variability between two core electrocardiogram laboratories.
Dianati Maleki N, Stocke K, Zheng Y, Westerhout CM, Fu Y, Chaitman BR, Awad A, Jagasia P, Armstrong PW
Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF.
Patel PA, Heizer G, O'Connor CM, Schulte PJ, Dickstein K, Ezekowitz JA, Armstrong PW, Hasselblad V, Mills RM, McMurray JJ, Starling RC, Tang WH, Califf RM, Hernandez AF
Aborted myocardial infarction in ST-elevation myocardial infarction: insights from the STrategic Reperfusion Early After Myocardial infarction trial.
Dianati Maleki N, Van de Werf F, Goldstein P, Adgey JA, Lambert Y, Sulimov V, Rosell-Ortiz F, Gershlick AH, Zheng Y, Westerhout CM, Armstrong PW
Determinants of early readmission after hospitalization for heart failure.
Eastwood CA, Howlett JG, King-Shier KM, McAlister FA, Ezekowitz JA, Quan H
Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: Results from the ROCKET AF trial.
Piccini JP, Garg J, Patel MR, Lokhnygina Y, Goodman SG, Becker RC, Berkowitz SD, Breithardt G, Hacke W, Halperin JL, Hankey GJ, Nessel CC, Mahaffey KW, Singer DE, Califf RM, Fox KAA
Efficacy of an Early Invasive Strategy After Fibrinolysis in ST-Elevation Myocardial Infarction Relative to the Extent of Coronary Artery Disease.
Elbarouni B, Cantor WJ, Ducas J, Borgundvaag B, Džavík V, Heffernan M, Buller CE, Langer A, Goodman SG, Yan AT; TRANSFER-AMI Trial Investigators
Time to energize coenzyme Q10 for patients with heart failure?
Ezekowitz JA
The many faces of hypertension in Canada.
Quan H, McAlister FA, Khan N
The Alberta Heart Failure Etiology and Analysis Research Team (HEART) study.
Ezekowitz JA, Becher H, Belenkie I, Clark AM, Duff HJ, Friedrich MG, Haykowsky MJ, Howlett JG, Kassiri Z, Kaul P, Kim DH, Knudtson ML, Light PE, Lopaschuk GD, McAlister FA, Noga ML, Oudit GY, Paterson DI, Quan H, Schulz R, Thompson RB, Weeks SG, Anderson TJ, Dyck JR
Exercise training improves aerobic capacity, muscle strength, and quality of life in renal transplant recipients.
Riess KJ, Haykowsky M, Lawrance R, Tomczak CR, Welsh RC, Lewanczuk R, Tymchak W, Haennel RG, Gourishankar S
Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 (PROACT-3).
Ezekowitz JA, Welsh RC, Gubbels C, Brass N, Chan M, Keeble W, Khadour F, Koshy TL, Knapp D, Sharma S, Sookram S, Tymchak W, Weiss D, Westerhout CM, Armstrong PW
Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: A pre-specified subgroup analysis of the transfer-ami randomised controlled trial.
Russo JJ, Goodman SG, Cantor WJ, Fitchett D, Heffernan M, Borgundvaag B, Ducas J, Cohen EA, Džavík V, Mehta SR, Buller CE, Yan AT
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure.
Felker GM, Ahmad T, Anstrom KJ, Adams KF, Cooper LS, Ezekowitz JA, Fiuzat M, Houston-Miller N, Januzzi JL, Leifer ES, Mark DB, Desvigne-Nickens P, Paynter G, Piña IL, Whellan DJ, O'Connor CM
Similarities and differences in patient characteristics between heart failure registries versus clinical trials.
Sharma A, Ezekowitz JA
Bridging the gap for nonmetropolitan STEMI patients through implementation of a pharmacoinvasive reperfusion strategy.
Shavadia J, Ibrahim Q, Sookram S, Brass N, Knapp D, Welsh RC
Acute management of ST-elevation myocardial infarction patients taking dabigatran.
Shavadia J, Welsh RC
Effects of nesiritide and predictors of urine output in acute decompensated heart failure: Results from ASCEND-HF (Acute Study of Clinical effectiveness of nesiritide and decompensated heart failure).
Gottlieb SS, Stebbins A, Voors AA, Hasselblad V, Ezekowitz JA, Califf RM, O'Connor CM, Starling RC, Hernandez AF
Do anticoagulants or antiplatelet drugs have a role in treating heart failure in the absence of atrial fibrillation?
Gouda P, Ezekowitz JA
Stroke After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: Timing, Characteristics, and Clinical Outcomes (APEX-AMI).
Guptill JT, Mehta RH, Armstrong PW Horton J, Laskowitz D, James S, Granger CB, Lopes RD
Physical activity in patients with stable coronary heart disease: an international perspective.
Stewart R, Held C, Brown R, Vedin O, Hagstrom E, Lonn E, Armstrong PW, Granger CB, Hochman J, Davies R, Soffer J, Wallentin L, White H
Use and timing of coronary angiography and associated in-hospital outcomes in Canadian non-ST-segment elevation myocardial infarction patients: Insights from the Canadian Global Registry of Acute Coronary Events.
Gyenes GT, Yan AT, Tan M, Welsh RC, Fox KAA, Grondin FR, DeYoung JP, Rose BF, Gallo R, Kornder JM, Wong GC, Goodman SG
Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non-ST-segment elevation acute coronary syndromes.
Tan NS, Goodman SG, Yan RT, Elbarouni B, Budaj A, Fox KA, Gore JM, Brieger D, López-Sendón J, Langer A, van de Werf F, Steg PG, Yan AT
Neither Diabetes nor Glucose-Lowering Drugs Are Associated With Mortality After Noncardiac Surgery in Patients With Coronary Artery Disease or Heart Failure
Hanninen M, McAlister FA, Bakal JA, van Diepen S, Ezekowitz JA
Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS.
Hess CN, Schulte PJ, Newby LK, Steg PG, Dalby AJ, Schweiger MJ, Lewis BS, Armstrong PW, Califf RM, van de Werf F, Harrington RA
Identification and management of patients at elevated cardiometabolic risk in Canadian primary care: How well are we doing?
Teoh H, Després JP, Dufour R, Fitchett DH, Goldin L, Goodman SG, Harris SB, Langer A, Lau DC, Lonn EM, John Mancini GB, McFarlane PA, Poirier P, Rabasa-Lhoret R, Tan MK, Leiter LA
N-terminal Pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: Insights from the ARISTOTLE trial (Apixaban for the prevention of stroke in subjects with atrial fibrillation).
Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Christersson C, Ezekowitz JA, Gersh BJ, Hanna M, Hohnloser S, Horowitz J, Huber K, Hylek EM, Lopes RD, McMurray JJ, Granger CB
A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care.
Teoh H, Després JP, Dufour R, Fitchett DH, Goldin L, Goodman SG, Harris SB, Langer A, Lau DC, Lonn EM, Mancini GB, McFarlane PA, Poirier P, Rabasa-Lhoret R, Tan MK, Leiter LA
Global Variation in Quality of Care Among Patients Hospitalized With Acute Heart Failure in an International Trial Findings From the Acute Study Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
Howlett JG, Ezekowitz JA, Podder M, Hernandez AF, Diaz R, Dickstein K, Dunlap ME, Corbalán R Armstrong PW, Starling RC, O’Connor CM, Califf RM, Fonarow GC; on behalf of the ASCEND-HF Investigators
Enhancing the efficacy of delivering reperfusion therapy: A European and North American experience with ST-segment elevation myocardial infarction networks
Huber K, Goldstein P, Danchin N, Fox KA, Welsh RC, Granger CB, Henry T, Gersh BJ
Myocardial deformation analysis in contrast echocardiography: First results using two-dimensional cardiac performance analysis
Huqi A, He A, Klas B, Paterson I, Thompson R, Irwin M, Ezekowitz JA, Choy JB, Becher H
Cardian Troponin after Percutaneous Coronary Intervention and 1-Year Mortality in NSTE ACS Using Systematic Evaluation of Biomarker Trends.
Tricoci P, Leonardi S, White J, White HD, Armstrong PW, Montalescot G, Giugliano RP, Gibson CM, Van de Werf F, Califf RM, Harrington RA, Braunwald E, Mahaffey KW, Newby LK
Canada acute coronary syndrome risk score: A new risk score for early prognostication in acute coronary syndromes
Huynh T, Kouz S, Yan AT, Danchin N, O'Loughlin J, Schampaert E, Yan RT, Rinfret S, Tardif JC, Eisenberg MJ, Afilalo M, Chong A, Dery JP, Nguyen M, Lauzon C, Mansour S, Ko DT, Tu JV, Goodman SG
Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study.
Joffres M, Falaschetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N, McAlister FA, Johansen H, Baclic O, Campbell N
Do clinical factors explain persistent sex disparities in the use of acute reperfusion therapy in STEMI in Sweden and Canada?
Johnston N, Bornefalk-Hermansson A, Schenck-Gustafsson K, Held C, Goodman SG, Yan AT, Bierman AS
Multistate implementation of guideline-based cardiac resuscitation systems of care: Description of the HeartRescue Project.
van Diepen S, Abella BS, Bobrow BJ, Nichol G, Jollis JG, Mellor J, Racht EM, Yannopoulos D, Granger CB, Sayre MR
Critical care cardiology research: A call to action.
van Diepen S, Cook DJ, Jacka M, Granger CB
Management and outcomes of non-ST elevation acute coronary syndromes in relation to previous use of antianginal therapies (from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE])
Kang JS, Goodman SG, Yan RT, Lopez-Sendon J, Pesant Y, Graham JJ, Fitchett D, Wong GC, Rose BF, Spencer FA, Yan AT; Canadian GRACE and CANRACE Investigators
Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation insights from ROCKET AF.
van Diepen S, Hellkamp AS, Patel MR, Becker RC, Breithardt G, Hacke W, Halperin JL, Hankey GJ, Nessel CC, Singer DE, Berkowitz SD, Califf RM, Fox KA, Mahaffey KW
Incidence of heart failure and mortality after acute coronary syndromes.
Kaul P, Ezekowitz JA, Armstrong PW, Leung BK, Savu A, Welsh RC, Quan H, Knudtson ML, McAlister FA
Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: An APEX AMI substudy.
van Diepen S, Newby LK, Lopes RD, Stebbins A, Hasselblad V, James S, Roe MT, Ezekowitz JA, Moliterno DJ, Neumann FJ, Reist C, Mahaffey KW, Hochman JS, Hamm CW, Armstrong PW, Granger CB, Theroux P; on behalf of the APEX AMI Investigators
Response to letter “associations of inflammatory biomarkers to body mass index among patients with acute coronary syndrome”.
van Diepen S, Newby LK, Stebbins A, Armstrong PW, Granger CB
Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States.
Kaul P, Reed SD, Hernandez AF, Howlett JG, Ezekowitz JA, Li Y, Zheng Y, Rouleau JL, Starling RC, O'Connor CM, Califf RM, Armstrong PW
Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: Insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial.
Kaul P, Tanguay JF, Newby K, Hochman JS, Westerhout CM, Califf RM, Tricoci P, Gibson M, Giugliano RP, Harrington RA, Van de Werf F, Armstrong PW
The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction.
van Diepen S, Vavalle JP, Newby LK, Clare R, Pieper KS, Ezekowitz JA, Hochman JS, Mahaffey KW, Armstrong PW, Granger CB
Risk factors, quality of care and prognosis in South Asian, East Asian and White patients with stroke
Khan NA, Quan H, Hill MD, Pilote L, McAlister FA, Palepu A, Shah BR, Zhou L, Zhen H, Kapral MK
Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: Results from the ARISTOTLE trial.
Al-Khatib SM, Thomas L, Wallentin L, Lopes RD, Gersh B, Garcia D, Ezekowitz JA, Alings M, Yang H, Alexander JH, Flaker G, Hanna M, Granger CB
Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategy.
Klutstein MW, Westerhout CM, Armstrong PW, Giugliano RP, Lewis BS, Gibson CM, Lutchmedial S, Widimsky P, Steg PG, Dalby A, Zeymer U, Van de Werf F, Harrington RA, Newby LK, Rao SV
Random error in cardiovascular meta-analyses: how common are false positive and false negative results?
AlBalawi Z, McAlister FA, Thorlund K, Wong M, Wetterslev J
Hospitalization for uncomplicated hypertension: An ambulatory care sensitive condition.
Walker RL, Chen G, McAlister FA, Campbell NR, Hemmelgarn BR, Dixon E, Ghali W, Rabi D, Tu K, Jette N, Quan H; Hypertension Outcome and Surveillance Team
The Forgotten Lead: Does aVR ST-deviation Add Insight into the Outcomes of STEMI Patients?
Alherbish A, Westerhout CM, Fu Y, White HD, Granger CB, Wagner G, Armstrong PW
Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertension
Lee D, Goodman SG, Fox KA, DeYoung JP, Lai CC, Bhatt DL, Huynh T, Yan RT, Gallo R, Steg PG, Yan AT
Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review.
Leonardi S, Armstrong PW, Schulte PJ, Ohman EM, Newby LK
Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: Insights from the CHAMPION percutaneous coronary intervention trial
Leonardi S, Stebbins A, Lopes RD, Lokhnygina Y, Todd M, Bhatt DL, Stone GW, Lincoff AM, Dauerman HL, Gibson CM, White HD, Parikh KH, Gruberg L, Herrmann HC, McLaurin BT, Goodman SG, Mahaffey KW
Effect of Vorapaxar on Myocardial Infarction in the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA•CER) Trial.
Leonardi S, Tricoci P, White HD, Armstrong PW, Huang Z, Wallentin L, Aylward PE, Moliterno DJ, Van de Werf F, Chen E, Providencia L, Nordrehaug JE, Held C, Strony J, Rorick TL, Harrington RA, Mahaffey KW
Preoperative hypernatremia predicts increased perioperative morbidity and mortality.
Leung AA, McAlister FA, Finlayson SR, Bates DW
Health-Related Quality of Life of Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes-Results from the PLATO Trial.
Levin LÅ, Wallentin L, Bernfort L, Andersson D, Storey RF, Bergström G, Lamm CJ, Janzon M, Kaul P
Pre-hospital cardiac arrest in acute coronary syndromes: Insights from the global registry of acute coronary events and the Canadian registry of acute coronary eventson behalf of the global registry of acute coronary events and the Canadian registry of ac
Li Q, Goodman SG, Yan RT, Gore JM, Polasek P, Lai K, Baer C, Goldberg RJ, Pinter A, Ahmad K, Kornder JM, Yan AT; Global Registry of Acute Coronary Events and the Canadian Registry of Acute Coronary Events Investigators
Data and Safety Monitoring Boards: Academic Credit Where Credit Is Due?
Armstrong PW, Califf RM
Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction.
Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, Sulimov V, Ortiz FR, Ostojic M, Welsh RC, Carvalho AC, Nanas J, Arntz H-R, Halvorsen S, Huber K, Grajek S, Fresco C, Bluhmki E, Regelin A, Vandenberghe K, Bogaerts K, Van de Werf F, on behalf of the STREAM Investigators
The Power of more than one (Editorial).
Armstrong PW, Westerhout CM
Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy.
Lopes RD, Lokhnygina Y, Hasselblad V, Newby KL, Yow E, Granger CB, Armstrong PW, Hochman JS, Mills JS, Ruzyll W, Mahaffey KW
Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Westerhout CM, Pieper KS, James SK, Mahaffey KW, Van de Werf F, Califf RM, Granger CB, Armstrong PW on behalf of the APEX AMI Investigators
Quantitative ST-depression in acute coronary syndromes: the PLATO Electrocardiographic Substudy.
Armstrong PW, Westerhout CM, Fu Y, Harrington RA, Storey RF, Katus H, James S, Wallentin L
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes.
Lopes RD, White JA, Atar D, Keltai M, Kleiman NS, White HD, Widimsky P, Zeymer U, Giugliano RP, Tricoci P, Braunwald E, Bode C, Ohman EM, Armstrong PW, Newby LK
Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: Insights from the EARLY ACS trial.
Lopes RD, White JA, Tricoci P, White HD, Armstrong PW, Braunwald E, Giugliano RP, Harrington RA, Lewis BS, Brogan GX Jr, Gibson CM, Califf RM, Newby LK
Prognostic implications of left ventricular end diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the APEX-AMI study.
Bagai A, Armstrong PW, Stebbins A, Mahaffey KW, Hochman JS, Weaver WD, Patel MR, Granger CB, Lopes RD
Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial.
Wiviott SD, White HD, Ohman EM, Fox KAA, Armstrong PW, Prabhakaran D, Hafley G, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzyllo W, Widimsky P, Oto A, Leiva-Pons J, Pavlides G, Winters KJ, Roe MT, Bhatt DL
Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study.
Bagai A, Cantor WJ, Tan M, Tong W, Lamy A, Fitchett D, Cohen EA, Mehta SR, Borgundvaag B, Ducas J, Heffernan M, Džavík V, Morrison L, Schwartz B, Lazzam C, Langer A, Goodman SG
Temporal differences in out-of-hospital cardiac arrest incidence and survival.
Bagai A, McNally BF, Al-Khatib SM, Myers JB, Kim S, Karlsson L, Torp-Pedersen C, Wissenberg M, van Diepen S, Fosbol EL, Monk L, Abella BS, Granger CB, Jollis JG
Cost-effectiveness of osteoporosis interventions for ‘incidental’ vertebral fractures
Majumdar SR, Lier DA, McAlister FA, Rowe BH, Siminoski K, Hanley DA, Russell AS, Johnson JA
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.
Zannad F, Garcia AA, Anker SD, Armstrong PW, Calvo G, Cleland JGF, Cohn JN, Dickstein K, Domanski MJ, Ekman I, Filippatos GS,Gheorghiade M, Hernandez AF, Jaarsma T, Koglin J, Konstam M, Kupfer S, Maggioni AP, Mebazaa A, Metra M, Nowack C, Pieske B, Piña IL Pocock SJ, Ponikowski P, Rosano G, Ruilope LM, Ruschitzka F, Severin T, Solomon S, Stein K, Stockbridge NL, Stough WG, Swedberg K, Tavazzi L, Voors AA, Wasserman SM, Woehrle H, Zalewski A, McMurray JJV
Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in non-ST-Segment Elevation Acute Coronary Syndrome trial.
Bagai A, White JA, Lokhnygina Y, Giugliano RP, Van de Werf F, Montalescot G, Armstrong PW, Tricoci P, Gibson CM, Califf RM, Harrington RA, Newby LK
Heart Failure Complicating Non–ST-Segment Elevation Acute Coronary Syndrome: Timing, Predictors, and Clinical Outcomes.
Bahit MC, Lopes RD, Clare RM, Newby LK, Pieper KS, Van de Werf F, Armstrong PW, Mahaffey KW, Harrington RA, Diaz R, Ohman M, White HD, James S, Granger CB
Decreasing readmissions: it can be done but one size does not fit all.
McAlister FA
Postdischarge outcomes in heart failure are better for teaching hospitals and weekday discharges
McAlister FA, Au AG, Majumdar SR, Youngson E, Padwal RS
Changes in heart failure outcomes after a province-wide change in health service provision a natural experiment in Alberta, Canada.
McAlister FA, Bakal JA, Kaul P, Quan H, Blackadar R, Johnstone D, Ezekowitz J
Treatment assignment of high-risk symptomatic severe aortic stenosis patients referred for transcatheter AorticValve implantation.
Bainey KR, Natarajan MK, Mercuri M, Lai T, Teoh K, Chu V, Whitlock RP, Velianou JL
Treatment and outcomes of patients with suspected acute coronary syndromes in relation to initial diagnostic impressions (insights from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE])
Bajaj RR, Goodman SG, Yan RT, Bagnall AJ, Gyenes G, Welsh RC, Eagle KA, Brieger D, Ramanathan K, Grondin FR, Yan AT; Canadian GRACE and CANRACE Investigators
Association of Global Weather Changes with Acute Coronary Syndromes: Gaining Insights from Clinical Trials Data.
Bakal JA, Ezekowitz JA, Westerhout CM, Boersma E, Armstrong PW
The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States
McAlister FA, Robitaille C, Gillespie C, Yuan K, Rao DP, Grover S, Dai S, Johansen H, Joffres M, Loustalot F, Campbell N
Evaluation of early percutaneous coronary intervention vs. standard therapy after fibrinolysis for ST-segment elevation myocardial infarction: contribution of weighting the composite endpoint.
Bakal JA, Westerhout CM, Cantor WJ, Fernandez-Avilés F, Welsh RC, Fitchett D, Goodman SG, Armstrong PW
Impact of physician continuity on death or urgent readmission after discharge among patients with heart failure.
McAlister FA, Youngson E, Bakal JA, Kaul P, Ezekowitz JA, van Walraven C
The 2012 Canadian Cardiovascular Society Heart Failure Management guidelines update: Focus on acute and chronic heart failure.
McKelvie RS, Moe GW, Ezekowitz JA, Heckman GA, Costigan J, Ducharme A, Estrella-Holder E, Giannetti N, Grzeslo A, Harkness K, Howlett JG, Kouz S, Leblanc K, Mann E, Nigam A, O'Meara E, Rajda M, Steinhart B, Swiggum E, Le VV, Zieroth S, Arnold JM, Ashton T, D'Astous M, Dorian P, Haddad H, Isaac DL, Leblanc MH, Liu P, Rao V, Ross HJ, Sussex B
Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: Insights from the ARISTOTLE trial.
McMurray JJ, Ezekowitz JA, Lewis BS, Gersh BJ, van Diepen S, Amerena J, Bartunek J, Commerford P, Oh BH, Harjola VP, Al-Khatib SM, Hanna M, Alexander JH, Lopes RD, Wojdyla DM, Wallentin L, Granger CB; ARISTOTLE Committees and Investigators
Recent Temporal Trends and Geographic Distribution of Cardiac Procedures in Alberta
McMurtry MS, Southern DA, Lewin AM, Galbraith PD, Kaul P, Ghali WA, Knudtson ML, Graham MM
Monitoring and evaluating efforts to control hypertension in Canada: why, how, and what it tells us needs to be done about current care gaps.
Campbell NR, McAlister FA, Quan H; Hypertension Outcomes Research Task Force
Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years
Chan MY, Sun JL, Newby LK, Lokhnygina Y, White HD, Moliterno DJ, Théroux P, Ohman EM, Simoons ML, Mahaffey KW, Pieper KS, Giugliano RP, Armstrong PW, Califf RM, Van de Werf F, Harrington RA
Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF.
Mentz RJ, Hernandez AF, Stebbins A, Ezekowitz JA, Felker GM, Heizer GM, Atar D, Teerlink JR, Califf RM, Massie BM, Hasselblad V, Starling RC, O'Connor CM, Ponikowski P
Treatment and outcomes of non-ST elevation acute coronary syndromes in relation to burden of pre-existing vascular disease.
Mohareb M, Goodman SG, Yan RT, Bhatt DL, Elbarouni B, DeYoung JP, Gallo R, Kornder JM, Welsh RC, Saposnik G, Rose B, Wong GC, Grondin FR, Yan AT
Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the
Montalescot G, Lassen JF, Hamm CW, Lapostolle F, Silvain J, ten Berg JM, Cantor WJ, Goodman SG, Licour M, Tsatsaris A, van't Hof AW
Risks of Gestational Diabetes and Preeclampsia Over the Last Decade in a Cohort of Alberta Women.
Nerenberg KA, Johnson JA, Leung B, Savu A, Ryan EA, Chik CL, Kaul P
Temporal trends and referral factors for cardiac rehabilitation post-acute coronary syndrome in ontario: Insights from the canadian global registry of acute coronary events.
Nguyen TN, Abramson BL, Galluzzi A, Tan M, Yan AT, Goodman SG; Canadian GRACE Investigators
Cardiovascular clinical research in South America.
Nicolau JC, Corbalan R, Rafael Diaz R, Bahit C, Armstrong PW, Granger CB, Lopes RD
Canadian cardiovascular society guidelines on the use of cardiac resynchronization therapy: Implementation.
Parkash R, Philippon F, Shanks M, Thibault B, Cox J, Low A, Essebag V, Bashir J, Moe G, Birnie DH, Larose E, Yee R, Swiggum E, Kaul P, Redfearn D, Tang AS, Exner DV; Canadian Cardiovascular Society
Aborted myocardial infarction after primary percutaneous coronary intervention: Magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Patel MR, Westerhout CM, Granger CB, Brener SJ, Fu Y, Siha H, Kim RJ, Armstrong PW
Routine versus selective cardiac magnetic resonance in non-ischemic heart failure – OUTSMART-HF: Study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B).
Paterson I, Wells GA, Ezekowitz JA, White JA, Friedrich MG, Mielniczuk LM, O'Meara E, Chow B, DeKemp RA, Klein R, Dennie C, Dick A, Coyle D, Dwivedi G, Rajda M, Wright GA, Laine M, Hanninen H, Larose E, Connelly KA, Leong-Poi H, Howarth AG, Davies RA, Duchesne L, Yla-Herttuala S, Saraste A, Farand P, Garrard L, Tardif JC, Arnold M, Knuuti J, Beanlands R, Chan KL
Do Countries or Hospitals With Longer Hospital Stays for Acute Heart Failure Have Lower Readmission Rates? Findings From ASCEND-HF.
Eapen ZJ, Reed SD, Li Y, Kociol RD, Armstrong PW, Starling RC, McMurray JJ, Massie BM, Swedberg K, Ezekowitz JA, Fonarow GC, Teerlink JR, Metra M, Whellan DJ, O’Connor CM, Califf RM, Hernandez AF
Practice-level variation in use of recommended medications among outpatients with heart failure insights from the NCDR PINNACLE Program.
Peterson PN, Chan PS, Spertus JA, Tang F, Jones PG, Ezekowitz JA, Allen LA, Masoudi FA, Maddox TM
Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
Eggers KM, Armstrong PW, Califf RM, Johnston N, Simoons ML, Venge P, James SK
Management of risk factors among ambulatory patients at high cardiovascular risk in canada: A follow-up study.
Elbarasi EA, Goodman SG, Yan RT, Tan MK, Hackam DG, Leiter LA, Langer A, Yan AT; Guidelines Oriented Approach in Lipid Lowering (GOALL) Registry and Vascular Protection (VP) Registry Investigators
Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study.
Eurich DT, Simpson S, Senthilselvan A, Asche CV, Sandhu-Minhas JK, McAlister FA
Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure systematic review of observational studies involving 34 000 patients
Eurich DT, Weir DL, Majumdar SR, Tsuyuki RT, Johnson JA, Tjosvold L, Vanderloo SE, McAlister FA
Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report.
Poppe KK, Squire IB, Whalley GA, Køber L, McAlister FA, McMurray JJ, Pocock S, Earle NJ, Berry C, Doughty RN; Meta-Analysis Global Group in Chronic Heart Failure
Novel pharmacologic therapies in development for acute decompensated heart failure.
Ezekowitz JA
Outcomes among 3.5 million newly diagnosed hypertensive Canadians.
Quan H, Chen G, Tu K, Bartlett G, Butt DA, Campbell NR, Hemmelgarn BR, Hill MD, Johansen H, Khan N, Lix LM, Smith M, Svenson L, Walker RL, Wielgosz A, McAlister FA; Hypertension Outcome and Surveillance Team
Incidence, cardiovascular complications and mortality of hypertension by sex and ethnicity.
Quan H, Chen G, Walker RL, Wielgosz A, Dai S, Tu K, Campbell NR, Hemmelgarn BR, Hill MD, Johansen H, McAlister FA, Khan N; Hypertension Outcome and Surveillance Team
The relationship between meteorological conditions and index acute coronary events in a global clinical trial.
Ezekowitz JA, Bakal JA, Westerhout CM, Giugliano RP, White H, Keltai M, Prabhakaran D, Tricoci P, Van de Werf F, Califf RM, Newby LK, Armstrong PW
Medical Resource Use, Costs, and Quality of Life in Patients With Acute Decompensated Heart Failure: Findings From ASCEND-HF.
Reed SD, Kaul P, Li Y, Eapen ZJ, Davidson-Ray L, Schulman KA, Massie BM, Armstrong PW, Starling RC, O’Connor CM, Hernandez AF, Califf RM
Elderly Patients with Acute Coronary Syndromes Managed Without Revascularization: Insights into the Safety of Long-Term Dual Antiplatelet Therapy with Reduced-Dose Prasugrel versus Standard-Dose Clopidogrel.
Roe MT, Goodman SG, Ohman EM, Stevens SR, Hochman JS, Gottlieb S, Martinez F, Dalby AJ, Boden WE, White HD, Prabhakaran D, Winters KJ, Aylward PE, Bassand JP, McGuire DK, Ardissino D, Fox KA, Armstrong PW
Left bundle branch block in non-ST segment elevation acute coronary syndromes: incidence, angiographic characteristics and clinical outcomes.
Rose JJ, Newby LK, Broderick S, Chiswell K, Van de Werf F, Armstrong PW, Mahaffey KW, Harrington RA, Ohman EM, Giugliano RP, Goodman SG, White HD, Califf RM, Granger CB, Lopes RD
An international survey of clinical practice during primary percutaneous coronary intervention for ST-elevation myocardial infarction with a focus on aspiration thrombectomy.
Russo JJ, Dzavík V, Cairns JA, Rao SV, Niemelä KO, Natarajan MK, Bertrand OF, Eskola M, Welsh RC, Maciejewski P, Cheema AN, Fung A, Cantor WJ, Lavi S, Widimsky P, Jolly SS
Stroke prevention for patients with atrial fibrillation: Improving but not perfect yet.
Sandhu RK, McAlister FA
Quantifying the impact of drug exposure misclassification due to restrictive drug coverage in administrative databases: A simulation cohort study.
Gamble JM, McAlister FA, Johnson JA, Eurich DT
Restrictive drug coverage policies can induce substantial drug exposure misclassification in pharmacoepidemiologic studies.
Gamble JM, McAlister FA, Johnson JA, Eurich DT
Factors associated with lack of awareness and uncontrolled high blood pressure among Canadian adults with hypertension.
Gee ME, Bienek A, McAlister FA, Robitaille C, Joffres M, Tremblay MS, Johansen H, Campbell NR
Prevalence, Awareness, Treatment, and Control of Hypertension Among Canadian Adults With Diabetes, 2007 to 2009.
Gee ME, Janssen I, Pickett W, McAlister FA, Bancej CM, Joffres M, Johansen H, Campbell NR
Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial.
Goodman SG, Clare R, Pieper KS, Nicolau JC, Storey RF, Cantor WJ, Mahaffey KW, Angiolillo DJ, Husted S, Cannon CP, James SK, Kilhamn J, Steg PG, Harrington RA, Wallentin L; Platelet Inhibition and Patient Outcomes Trial Investigators
Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial.
Siha H, Das D, Fu Y, Zheng Y, Westerhout CM, Storey RF, James S, Wallentin L, Armstrong PW
ICDs, guidelines, and national registries: opportunities to enhance quality of patient care.
Singh JP, Ellenbogen KA, Desai NR, McAlister FA
Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromes.
Singh SM, Goodman SG, Yan RT, Dery JP, Wong GC, Gallo R, Grondin FR, Lai K, Lopez-Sendon J, Fox KA, Yan AT; Canadian GRACE, GRACE(2) and CANRACE Investigators
Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee.
Stevenson WG, Hernandez AF, Carson PE, Fang JC, Katz SD, Spertus JA, Sweitzer NK, Tang WH, Albert NM, Butler J, Westlake Canary CA, Collins SP, Colvin-Adams M, Ezekowitz JA, Givertz MM, Hershberger RE, Rogers JG, Teerlink JR, Walsh MN, Stough WG, Starling RC; Heart Failure Society of America Guideline Committee
Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy.
Gurbel PA, Erlinge D, Ohman EM, Neely B, Neely M, Goodman SG, Huber K, Chan MY, Cornel JH, Brown E, Zhou C, Jakubowski JA, White HD, Fox KA, Prabhakaran D, Armstrong PW, Tantry US, Roe MT; TRILOGY ACS Platelet Function Substudy Investigators
Translational platelet research in patients with coronary artery disease: what are the major knowledge gaps?
Gurbel PA, Roe MT, Jakubowski JA, Shah S, Erlinge D, Goodman SG, Huber K, Chan MY, Cornel JH, Tantry US, Ohman EM
Effect of a pharmacist-managed hypertension program on health system costs: An evaluation of the study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
Houle SK, Chuck AW, McAlister FA, Tsuyuki RT
Does performance-based remuneration for individual health care practitioners affect patient care?: a systematic review.
Houle SK, McAlister FA, Jackevicius CA, Chuck AW, Tsuyuki RT
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin.
Thomas MP, Mahaffey KW, Chiswell K, Cohen M, Kontos MC, Antman EM, Ferguson JJ, Califf RM, Goodman SG, Becker RC
Testosterone supplementation in heart failure: a meta-analysis.
Toma M, McAlister FA, Coglianese EE, Vidi V, Vasaiwala S, Bakal JA, Armstrong PW, Ezekowitz JA
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.
Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, et al
Pre-dismissal surveillance echocardiography second day after TAVR.
Iida R, Welsh RC, Meyer SR, Tyrrell BD, Taylor DA, Shanks M
Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes.
Truffa AA, Granger CB, White KR, Newby LK, Mehta RH, Hochman JS, Patel MR, Pieper KS, Al-Khalidi HR, Armstrong PW, Lopes RD
Relative prognostic value of baseline Q wave and time from symptom onset among men and women with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
Kaul P, Fu Y, Westerhout CM, Granger CB, Armstrong PW
Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.
van Diepen S, Roe MT, Lopes RD, Stebbins A, James S, Newby LK, Moliterno DJ, Neumann FJ, Ezekowitz JA, Mahaffey KW, Hochman JS, Hamm CW, Armstrong PW, Theroux P, Granger CB
Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights.
van Diepen S, Widimsky P, Lopes RD, White KR, Weaver WD, Van de Werf F, Ardissino D, van't Hof AW, Armstrong PW, Granger CB
Management and Outcome of Acute Coronary Syndrome Patients in Relation to Prior History of Atrial Fibrillation
Al Khdair D, Alshengeiti L, Elbarouni B, Yan RT, Grondin FR, Spencer FA, Pallie S, Brieger D, Eagle KA, Mangat I, Singh S, Goodman SG, Yan AT; Global Registry of Acute Coronary Events (GRACE/GRACE2) and the Canadian Registry of Coronary Events (CANRACE) Investigators
The timing of implantable cardioverter-defibrillator implantation in patients with heart failure.
Al-Majed NS, Ezekowitz JA
International variation in and factors associated with hospital readmission after myocardial infarction.
Kociol RD, Lopes RD, Clare R, Thomas L, Mehta RH, Kaul P, Pieper KS, Hochman JS, Weaver WD, Armstrong PW, Granger CB, Patel MR
Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction: Insights from the TRANSFER-AMI trial.
Lavi S, Cantor WJ, Casanova A, Tan MK, Yan AT, Džavík V, Fitchett D, Cohen EA, Borgundvaag B, Heffernan M, Ducas J, Goodman SG
The Association Between Prior Use of Aspirin and/or Warfarin and the In-hospital Management and Outcomes in Patients Presenting With Acute Coronary Syndromes: Insights From the Global Registry of Acute Coronary Events (GRACE)
Amad H, Yan AT, Yan RT, Huynh T, Gore JM, Montalescot G, DeYoung JP, Gallo R, Rose B, Steg PG, Goodman SG; Canadian Global Registry of Acute Coronary Events (GRACE) Investigators
Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement.
Webb J, Rodés-Cabau J, Fremes S, Pibarot P, Ruel M, Ibrahim R, Welsh RC, Feindel C, Lichtenstein S
Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (I
Angiolillo DJ, Welsh RC, Trenk D, Neumann FJ, Conley PB, McClure MW, Stephens G, Kochman J, Jennings LK, Gurbel PA, Wójcik J, Dabrowski M, Saucedo JF, Stumpf J, Buerke M, Broderick S, Harrington RA, Rao SV
Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
Leonardi S, Thomas L, Neely ML, Tricoci P, Lopes RD, White HD, Armstrong PW, Giugliano RP, Antman EM, Califf RM, Newby LK, Mahaffey KW
Computer-assisted paramedic electrocardiogram interpretation with remote physician over-read: the future of prehospital STEMI care?
Welsh RC
Preoperative hyponatremia and perioperative complications.
Leung AA, McAlister FA, Rogers SO Jr, Pazo V, Wright A, Bates DW
Contemporary pharmacological reperfusion in ST elevation myocardial infarction.
Welsh RC, Armstrong PW
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PC
Welsh RC, Rao SV, Zeymer U, Thompson VP, Huber K, Kochman J, McClure MW, Gretler DD, Bhatt DL, Gibson CM, Angiolillo DJ, Gurbel PA, Berdan LG, Paynter G, Leonardi S, Madan M, French WJ, Harrington RA; INNOVATE-PCI Investigators
Road mapping ATLAS ACS 2: are we there yet?
Armstrong PW, Harrington RA
Cardiac resynchronization therapy (CRT): clinical trials, guidelines, and target populations.
Linde C, Ellenbogen K, McAlister FA
Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction.
Lofthus DM, Stevens SR, Armstrong PW, Granger CB, Mahaffey KW
Anticoagulation after subcutaneous enoxaparin is time sensitive in STEMI patients treated with tenecteplase.
Welsh RC, Westerhout CM, Buller CE, O'Neill B, Gordon P, Armstrong PW
ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy.
Armstrong PW, Siha H, Fu Y, Westerhout CM, Steg PG, James SK, Storey RF, Horrow J, Katus H, Clemmensen P, Harrington RA, Wallentin L
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.
Lopes RD, Al-Khatib SM, Wallentin L, Yang H, Ansell J, Bahit MC, De Caterina R, Dorian P, Easton JD, Erol C, Ezekowitz JA, Gersh BJ, Granger CB, Hohnloser SH, Horowitz J, Hylek EM, McMurray JJ, Mohan P, Vinereanu D, Alexander JH
Preoperative thienopyridine use and outcomes after Surgery: A systematic review.
Au AG, Majumdar SR, McAlister FA
Predicting the risk of unplanned readmission or death within 30 days of discharge after a heart failure hospitalization.
Au AG, McAlister FA, Bakal JA, Ezekowitz JA, Kaul P, van Walraven C
Cardiogenic shock complicating acute coronary syndromes: Insights from the Global Registry of Acute Coronary Events.
Awad HH, Anderson FA Jr, Gore JM, Goodman SG, Goldberg RJ
Heart failure is a clinically and densitometrically independent risk factor for osteoporotic fractures: population-based cohort study of 45,509 subjects.
Majumdar SR, Ezekowitz JA, Lix LM, Leslie WD
Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study.
Zeymer U, Huber K, Fu Y, Ross A, Granger C, Goldstein P, van de Werf F, Armstrong PW; for the ASSENT-4 PCI Investigators
Interventions to increase osteoporosis treatment in patients with ‘incidentally’ detected vertebral fractures.
Majumdar SR, McAlister FA, Johnson JA, Bellerose D, Siminoski K, Hanley DA, Qazi I, Lier DA, Lambert RG, Russell AS, Rowe BH
A cluster randomized trial of an enhanced eGFR prompt in chronic kidney disease.
Manns B, Tonelli M, Culleton B, Faris P, McLaughlin K, Chin R, Gooch K, McAlister FA, Taub K, Thorlacius L, Krause R, Kearns M, Hemmelgarn B; Alberta Kidney Disease Network
Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Martel C, Granger CB, Ghitescu M, Stebbins A, Fortier A, Armstrong PW, Bonnefoy A, Theroux P
Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.
McAlister FA, Ezekowitz JA, Tarantini L, Squire I, Komajda M, Bayes-Genis A, Gotsman I, Whalley G, Earle N, Poppe KK, Doughty RN; Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) Investigators
Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: A subgroup analysis from Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
Bhan V, Cantor WJ, Yan RT, Mehta SR, Morrison LJ, Heffernan M, Fitchett D, Džavík V, Ducas J, Borgundvaag B, Cohen EA, Goodman SG, Yan AT
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials.
McAlister FA; Renin Angiotension System Modulator Meta-Analysis Investigators
Poor achievement of guidelines-recommended targets in type 2 diabetes: Findings from a contemporary prospective cohort study.
Braga MF, Casanova A, Teoh H, Gerstein HC, Fitchett DH, Honos G, McFarlane PA, Ur E, Yale JF, Langer A, Goodman SG, Leiter LA; Diabetes Registry to Improve Vascular Events [DRIVE] Investigators
The effects of dobutamine and dopamine on intrapulmonary shunt and gas exchange in healthy humans.
Bryan TL, van Diepen S, Bhutani M, Shanks M, Welsh RC, Stickland MK
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.
Butler J, Ezekowitz JA, Collins SP, Givertz MM, Teerlink JR, Walsh MN, Albert NM, Westlake Canary CA, Carson PE, Colvin-Adams M, Fang JC, Hernandez AF, Hershberger RE, Katz SD, Rogers JG, Spertus JA, Stevenson WG, Sweitzer NK, Tang WH, Stough WG, Starling RC
Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial.
Mehta RH, Kaul P, Lopes RD, Patel MR, Zheng Y, Pieper KS, Welsh RC, Armstrong PW, Granger CB
Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis.
Mehta RH, Stebbins AS, Lopes RD, Califf RM, Pieper KS, Armstrong PW, Van de Werf F, Hochman JS, White HD, Topol EJ, Alexander JH, Granger CB
Atrioventricular nodal ablation in atrial fibrillation a meta-analysis and systematic review.
Chatterjee NA, Upadhyay GA, Ellenbogen KA, McAlister FA, Choudhry NK, Singh JP
Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction.
Mills JS, Mahaffey KW, Lokhnygina Y, Nicolau JC, Ruzyllo W, Adams PX, Todaro TG, Armstrong PW, Granger CB; CARDINAL investigators
Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program.
O'Donoghue ML, Bhatt DL, Flather MD, Goto S, Angiolillo DJ, Goodman SG, Zeymer U, Aylward PE, Montalescot G, Ziecina R, Kobayashi H, Ren F, Wiviott SD
Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Cornel JH, Becker RC, Goodman SG, Husted S, Katus H, Santoso A, Steg G, Storey RF, Vintila M, Sun JL, Horrow J, Wallentin L, Harrington R, James S
Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE).
Czarnecki A, Welsh RC, Yan RT, DeYoung JP, Gallo R, Rose B, Grondin FR, Kornder JM, Wong GC, Fox KA, Gore JM, Goodman SG, Yan AT; Global Registry of Acute Coronary Events (GRACE/GRACE2); Canadian Registry of Coronary Events (CANRACE) Investigators
Prevalence and non-invasive predictors of left main or three-vessel coronary disease: Evidence from a collaborative international meta-analysis including 22 740 patients.
D'Ascenzo F, Presutti DG, Picardi E, Moretti C, Omedè P, Sciuto F, Novara M, Yan AT, Goodman SG, Mahajan N, Kosuge M, Palazzuoli A, Jong GP, Isma'eel H, Budoff MJ, Rubinshtein R, Gewirtz H, Reed MJ, Theroux P, Biondi-Zoccai G, Modena MG, Sheiban I, Gaita F
Temporal patterns of lipid testing and statin therapy in acute coronary syndrome patients (from the Canadian GRACE Experience).
Elbarouni B, Banihashemi SB, Yan RT, Welsh RC, Kornder JM, Wong GC, Anderson FA, Spencer FA, Grondin FR, Goodman SG, Yan AT; Canadian Global Registry of Acute Coronary Events (GRACE/GRACE(2)) and Canadian Registry of Acute Coronary Events (CANRACE) Investigators
Bridging the gender gap: Insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes.
Poon S, Goodman SG, Yan RT, Bugiardini R, Bierman AS, Eagle KA, Johnston N, Huynh T, Grondin FR, Schenck-Gustafsson K, Yan AT
Heart failure: Can we define, assess, and treat diastolic heart failure?
Ezekowitz JA
Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.
Ezekowitz JA, Hernandez AF, O'Connor CM, Starling RC, Proulx G, Weiss MH, Bakal JA, Califf RM, McMurray JJ, Armstrong PW
Acute heart failure: perspectives from a randomized trial and a simultaneous registry.
Ezekowitz JA, Hu J, Delgado D, Hernandez AF, Kaul P, Leader R, Proulx G, Virani S, White M, Zieroth S, O'Connor C, Westerhout CM, Armstrong PW
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.
Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng CD, Merkely B, Gasparovic V, Corbalan R, Cinteză M, McLendon RC, Winters KJ, Brown EB, Lokhnygina Y, Aylward PE, Huber K, Hochman JS, Ohman EM; TRILOGY ACS Investigators
Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial.
Roe MT, White JA, Kaul P, Tricoci P, Lokhnygina Y, Miller CD, van't Hof AW, Montalescot G, James SK, Saucedo J, Ohman EM, Pollack CV Jr, Hochman JS, Armstrong PW, Giugliano RP, Harrington RA, Van de Werf F, Califf RM, Newby LK
Caring for the radial artery post-angiogram: A pilot study on a comparison of three methods of compression.
Fech JC, Welsh RC, Hegadoren K, Norris CM
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study.
Felker GM, Hasselblad V, Tang WH, Hernandez AF, Armstrong PW, Fonarow GC, Voors AA, Metra M, McMurray JJ, Butler J, Heizer GM, Dickstein K, Massie BM, Atar D, Troughton RW, Anker SD, Califf RM, Starling RC, O'Connor CM
Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from “Assessment of Pexelizumab in Acute Myocardial Infarction.
French JK, Armstrong PW, Cohen E, Kleiman NS, O’Connor CM, Hellkamp AS, Stebbins A, Holmes DR, Hochman JS, Granger CB, Mahaffey KW for APEX-AMI Investigators
Patterns of care and outcomes differ for urban versus rural patients with newly diagnosed heart failure, even in a universal healthcare system.
Gamble JM, Eurich DT, Ezekowitz JA, Kaul P, Quan H, McAlister FA
Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trial.
Gharacholou SM, Lopes RD, Alexander KP, Mehta RH, Stebbins AL, Pieper KS, James SK, Armstrong PW, Granger CB
Apixaban versus warfarin in patients with atrial fibrillation.
Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators
Carotid chemoreceptor modulation of blood flow during exercise in healthy humans.
Stickland MK, Fuhr DP, Haykowsky MJ, Jones KE, Paterson DI, Ezekowitz JA, McMurtry MS
Comparison of impact of mortality risk on the survival benefit of primary percutaneous coronary intervention versus facilitated percutaneous coronary intervention.
Tarantini G, Facchin M, Frigo AC, Welsh RC
Efficacy of statins for primary prevention in people at low cardiovascular risk: A meta-analysis.
Tonelli M, Lloyd A, Clement F, Conly J, Husereau D, Hemmelgarn B, Klarenbach S, McAlister FA, Wiebe N, Manns B; Alberta Kidney Disease Network
Mortality implications of primary percutaneous coronary intervention treatment delays: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial (APEX-AMI trial).
Hudson MP, Armstrong PW, O’Neill WW, Stebbins AL, Weaver WD, Widimsky P, Aylward PE, Ruzyllo W, Holmes D, Mahaffey KW, Granger CB
The pre-hospital fibrinolysis experience in Europe and North America and implications for wider dissemination.
Huynh T, Birkhead J, Huber K, O'Loughlin J, Stenestrand U, Weston C, Jernberg T, Schull M, Welsh RC, Denktas AE, Travers A, Sookram S, Theroux P, Tu JV, Timmis A, Smalling R, Danchin N
Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials.
Tricoci P, Newby LK, Hasselblad V, Kong DF, Giugliano RP, White HD, Théroux P, Stone GW, Moliterno DJ, Van de Werf F, Armstrong PW, Prabhakaran D, Rasoul S, Bolognese L, Durand E, Braunwald E, Califf RM, Harrington RA
Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review.
Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JG
Mode of hospital presentation in patients with non-ST-elevation myocardial infarction: implications for strategic management.
Tymchak W, Armstrong PW, Westerhout CM, Sookram S, Brass N, Fu Y, Welsh RC
Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007.
Unroe KT, Greiner MA, Hernandez AF, Whellan DJ, Kaul P, Schulman KA, Peterson ED, Curtis LH
Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: An analysis of 38 047 patients.
van Diepen S, Bakal JA, McAlister FA, Ezekowitz JA
Temporal trends in patient and treatment delay among men and women presenting with ST-elevation myocardial infarction.
Kaul P, Armstrong PW, Sookram S, Leung BK, Brass N, Welsh RC
Resource use in the last 6 months of life among patients with heart failure in Canada.
Kaul P, McAlister FA, Ezekowitz JA, Bakal JA, Curtis LH, Quan H, Knudtson ML, Armstrong PW
Ethnic differences in 1-year mortality among patients hospitalised with heart failure.
Kaul P, McAlister FA, Ezekowitz JA, Grover VK, Quan H
Cardiac resynchronisation therapy is efficacious in patients with mild heart failure symptoms.
Al-Majed NS, Ezekowitz JA
Meta-analysis: Cardiac resynchronization therapy for patients with less symptomatic heart failure.
Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA
Canadian Provincial Trends in Antihypertensive Drug Prescriptions Between 1996 and 2006.
Walker RL, Chen G, Campbell NR, McAlister FA, Quan H, Tu K, Khan NA, Hemmelgarn BR; Canadian Hypertension Education Program Outcomes Research Task Force
The prevalence of natural health product use in patients with acute cardiovascular disease.
Alherbish A, Charrois TL, Ackman ML, Tsuyuki RT, Ezekowitz JA
Upstream clopidogrel use and the efficacy and safety of early eptifbatide treatment in patients with acute coronary syndrome: An analysis from the early glycoprotein IIb/IIIa inhibition in patients with non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial.
Wang TY, White JA, Tricoci P, Giugliano RP, Zeymer U, Harrington RA, Montalescot G, James SK, Van de Werf F, Armstrong PW, Braunwald E, Califf RM, Newby LK
Cardiovascular assessment of diabetic end-stage renal disease patients before renal transplantation.
Welsh RC, Cockfield SM, Campbell P, Hervas-Malo M, Gyenes G, Dzavik V
Aldosterone antagonists – Last man standing?
Armstrong PW
Reperfusion paradox in ST-segment elevation myocardial infarction.
Armstrong PW, Boden WE
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil.
Lopes RD, Becker RC, Alexander JH, Armstrong PW, Califf RM, Chan MY, Crowther M, Granger CB, Harrington RA, Hylek EM, James SK, Jolicoeur EM, Mahaffey KW, Newby LK, Peterson ED, Pieper KS, Van de Werf F, Wallentin L, White HD, Carvalho AC, Giraldez RR, Guimaraes HP, Nader HB, Kalil RAK, Mizzachi JMA, Lopes AC, Garcia DA
Rear-view mirror observations on bleeding in acute coronary syndromes.
Armstrong PW, Welsh RC
The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST.
Westerhout CM, Bonnefoy E, Welsh RC, Steg PG, Boutitie F, Armstrong PW
Diagnosing acute myocardial infarction in patients with left bundle branch block.
Lopes RD, Siha H, Fu Y, Mehta RH, Patel MR, Armstrong PW, Granger CB
“No one dies of old age”: implications for research, practice, and policy.
Wilson DM, Cohen J, Birch S, Macleod R, Mohankumar D, Armstrong PW, Froggatt K, Francke AL, Low G, McCormack B, Hollis V, Williams A
The unrecognized burden of osteoporosis-related vertebral fractures in patients with heart failure.
Lyons KJ, Majumdar SR, Ezekowitz JA
Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Mahaffey KW, Wampole JL, Stebbins A, Berdan LG, McAfee D, Rorick TL, French JK, Kleiman NS, O’Connor CM, Cohen EA, Granger CB, Armstrong PW for the APEX-AMI investigators
Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: Randomized controlled pilot study.
Majumdar SR, Johnson JA, Bellerose D, McAlister FA, Russell AS, Hanley DA, Garg S, Lier DA, Maksymowych WP, Morrish DW, Rowe BH
Intraluminal thrombus in facilitated versus primary percutaneous coronary intervention: an angiographic substudy of the ASSENT-4 PCI (Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention) trial.
Zalewski J, Bogaerts K, Desmet W, Sinnaeve P, Berger P, Grines C, Danays T, Armstrong PW, Van de Werf F
Cost-effectiveness of a multifaceted intervention to improve quality of osteoporosis care after wrist fracture.
Majumdar SR, Lier DA, Rowe BH, Russell AS, McAlister FA, Maksymowych WP, Hanley DA, Morrish DW, Johnson JA
The end of the risk-treatment paradox?: A rising tide lifts all boats.
McAlister FA
Evaluating research in cardiovascular medicine: citation counts are not sufficient.
McAlister FA, Lawson FME, Good AH, Armstrong PW Circulation
Determining the cost economic “tipping point” for the addition of a regional percutaneous coronary intervention facility.
Bakal JA, Kaul P, Welsh RC, Johnstone D, Armstrong PW
Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades.
McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, Tremblay MS, Walker R, Johansen H, Campbell N
The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines.
Bell AD, Roussin A, Cartier R, Chan WS, Douketis JD, Gupta A, Kraw ME, Lindsay TF, Love MP, Pannu N, Rabasa-Lhoret R, Shuaib A, Teal P, Théroux P, Turpie AG, Welsh RC, Tanguay JF
The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: A population-based longitudinal analysis.
McAlister FA, Zhang J, Tonelli M, Klarenbach S, Manns BJ, Hemmelgarn BR; Alberta Kidney Disease Network
The 2011 Canadian cardiovascular society heart failure management guidelines update: Focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care.
McKelvie RS, Moe GW, Cheung A, Costigan J, Ducharme A, Estrella-Holder E, Ezekowitz JA, Floras J, Giannetti N, Grzeslo A, Harkness K, Heckman GA, Howlett JG, Kouz S, Leblanc K, Mann E, O'Meara E, Rajda M, Rao V, Simon J, Swiggum E, Zieroth S, Arnold JM, Ashton T, D'Astous M, Dorian P, Haddad H, Isaac DL, Leblanc MH, Liu P, Sussex B, Ross HJ
The future of clinical trials in secondary prevention after acute coronary syndromes.
Bueno H, Armstrong PW, Buxton MJ, Danchin N, Lubsen J, Roland E, Verheugt FW, Zalewski A, Jackson N, Komajda M, Steg PG; Cardiovascular Round Table Clinical Trials ThinkTank participants
Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary PCI with varying underlying baseline risk.
Mehta RH Starr AZ, Lopes RD, Piccini JP, Patel MR, Pieper KS, Armstrong PW, Granger CB
Association of mortality with years of education in patients with ST elevation myocardial infarction treated with fibrinolysis.
Mehta RH, O’Shea JC, Stebbins AL, Granger CB, Armstrong PW, White HD, Topol EJ, Califf RM, Ohman EM
Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy.
Mehta RH, Stebbins A, Lopes RD, Rao SV, Bates ER, Pieper KS, Armstrong PW, Van de Werf F, White HD, Califf RM, Alexander JH, Granger CB
Improving hypertension management through pharmacist prescribing; the rural Alberta clinical trial in optimizing hypertension (Rural RxACTION): trial design and methods.
Charrois TL, McAlister FA, Cooney D, Lewanczuk R, Kolber MR, Campbell NR, Rosenthal M, Houle SK, Tsuyuki RT
Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function.
Melloni C, James SK, White JA, Giugliano RP, Harrington RA, Huber K, Tricoci P, Armstrong PW, Van de Werf F, Montalescot G, Califf RM, Newby LK
Cardiovascular outcomes in framingham participants with diabetes: The importance of blood pressure.
Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NR
Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk.
Conly J, Clement F, Tonelli M, Hemmelgarn B, Klarenbach S, Lloyd A, McAlister FA, Husereau D, Wiebe N, Au F, Manns B; Alberta Kidney Disease Network
Effect of nesiritide in patients with acute decompensated heart failure.
O’Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJV, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF Jr, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Wilson WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors A, Whellan DJ, Zannad F, Califf RM
Do Anthropometric Indices Accurately Reflect Directly Measured Body Composition in Men and Women With Chronic Heart Failure?
Oreopoulos A, Fonarow GC, Ezekowitz JA, McAlister FA, Sharma AM, Kalantar-Zadeh K, Norris CM, Johnson JA, Padwal RS
Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory setting.
Oudit GY, Bakal JA, McAlister FA, Ezekowitz JA
2010 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiologists Guidelines for Training and Maintenance of Competency in Adult Interventional Cardiology.
Palisaitis D, Love M, Zimmerman R, Radhakrishnan S, Welsh RC, Saw J, Renner S, Kells C, Schampaert E
Has the ClOpidogrel and Metoprolol in Myocardial Infarction Trial (COMMIT) of early β-blocker use in acute coronary syndromes impacted on clinical practice in Canada? Insights from the Global Registry of Acute Coronary Events (GRACE).
Edwards J, Goodman SG, Yan RT, Welsh RC, Kornder JM, Deyoung JP, Chauret D, Picard JP, Eagle KA, Yan AT
Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101 – Breast): A randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI.
Pituskin E, Haykowsky M, Mackey JR, Thompson RB, Ezekowitz JA, Koshman S, Oudit G, Chow K, Pagano JJ, Paterson I
Levels of evidence needed for changing indications, contraindications, and food and drug administration labeling: the case of metformin.
Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA
Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes.
Quinlan DJ, Eikelboom JW, Goodman SG, Welsh RC, Fitchett DH, Théroux P, Mehta SR
Trends in heart failure care: Has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics?
Ezekowitz JA, Kaul P, Bakal JA, Quan H, McAlister FA
The correlation of standard heart failure assessment and palliative care questionnaires in a multidisciplinary heart failure clinic.
Ezekowitz JA, Thai V, Hodnefield TS, Sanderson L, Cujec B
Risk stratification schemes, anticoagulation use and outcomes: The risk – Treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation.
Sandhu RK, Bakal JA, Ezekowitz JA, McAlister FA
The epidemiology of atrial fibrillation in adults depends on locale of diagnosis.
Sandhu RK, Bakal JA, Ezekowitz JA, McAlister FA
Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 1: Non-ST-Segment Elevation ACS.
Fitchett DH, Theroux P, Brophy JM, Cantor WJ, Cox JL, Gupta M, Kertland H, Mehta SR, Welsh RC, Goodman SG
Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment–part 2: ST-segment elevation myocardial infarction.
Fitchett DH, Theroux P, Brophy JM, Cantor WJ, Cox JL, Gupta M, Kertland H, Mehta SR, Welsh RC, Goodman SG